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ABSTRACT
A large number of transgenic mouse lines have been screened for 
post-natal m utant phenotypes by breeding to homozygosity, along with 
partial screening for pre- and peri-natal phenotypes during Caesarean re­
derivation of the lines in Bath. Various developmental abnormalities were 
observed, some of which have been caused by disruption of somatic gene 
function by transgene insertion. Two lines were selected for further 
characterisation.
In the Harry transgenic line, the transgene has integrated close to the 
SoxlO locus on chromosome 15. SoxlO encodes a transcription factor which 
is expressed in a subset of neural crest cells during development and 
continues to be expressed in peripheral glia and oligodendrocytes during 
adult life. Harry homozygous mutants display a recessive phenotype 
which features limited skin pigmentation and toxic megacolon caused by a 
lack of enteric neurons. This is caused by transgene-induced disruption of 
correct function of the SoxlO gene product in neural crest cells. SoxlODom 
(dominant megacolon) is a spontaneous mouse m utant which encodes a 
truncated form of the SoxlO protein. SoxlODom/SoxlODom homozygotes are 
embryonic lethal by E13, but heterozygotes display essentially the same 
phenotype observed in Harry mice which are homozygous for the 
transgene. Harry mutants express wild-type levels of full-length SoxlO 
mRNA in the CNS, however, and there is no disruption either w ithin the 
SoxlO gene itself or within 2kb of the start or end of the transcribed region.
3In the Holly transgenic line, homozygosity for the transgene causes 
acute angle-closure glaucoma to develop shortly after the eyes open 
around day 12 post-partum. Insertion of the transgene into proximal 
chromosome 1 appears to have disrupted the expression of Col9al in a 
tissue-specific manner. Col9al encodes the a l  chain of type IX collagen, a 
heterotrimeric protein thought to be im portant in mediating the interaction 
between structural collagen fibrils and the extracellular matrix in which 
they are embedded.
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The mouse as a model system
The mouse is widely used as a model for the study of mammalian genetics, 
growth and development. It is attractive as an experimental system, both for its 
rapid and prolific breeding cycle, and for the wealth of genetic data available, 
including high density genome maps which greatly simplify the task of positional 
cloning (Mouse Genome Database, 1999). Aside from these technical advantages, 
the divergence of mice and humans occurred relatively recently in evolutionary 
terms (around 60 million years ago), hence the mouse provides a reasonably good 
model for determing gene function in humans.
Alternative model systems
In the following discussion, it is important to draw  a clear distinction 
between model organisms for the study of hum an genetic diseases and for the 
study of developmental genetics, although the line can be blurred.
When trying to dissect the genetics of clinical syndromes, a mammalian 
model is clearly essential, preferably as close to hum an as is practicable. Defined 
inbred strains (in which all animals are genetically homogenous and homozygous 
at all loci) are also essential to obviate the effects of modifer genes segregating in 
the genetic background. For experimental purposes, inbred strains are defined as 
deriving from at least 20 generations of strict brother-sister inbreeding at each 
generation. Many inbred strains of mice have been established since the 
pioneering work of Abbie Lathrop and William Ernest Castle early in the 
twentieth century (Morse, 1981), and this, coupled with the advantages of rapid 
generation time, detailed genetics and, crucially, the ability to manipulate the 
germline in vitro using recombinant DNA techniques (discussed below), have
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ensured that mice have become the preeminent system for modelling 
hum an genetic defects and elucidating the function of mammalian genes.
Outwith the strict context of modelling clinical genetic syndromes, the 
major systems currently used in developmental molecular genetic studies and their 
key features can be summarised as follows:
1) Drosophila: easily and quickly bred; cheap; small genome; sequence-tagged 
mutagenesis by transposable elements possible; transgenesis possible; in 
vitro germline manipulation by homologous recombination not possible; not 
very closely related to humans; very good genetics data available.
2) C. elegans: easily and quickly bred; cheap; small genome; precisely defined 
cellular ontogeny which can be followed under the microscope; sequence- 
tagged mutagenesis by transposable elements not possible; transgenesis 
possible;in vitro germline manipulation by homologous recombination not 
possible; not closely related to humans; very good genetics data available.
3) Laboratory mouse: easily bred, fairly cheap provided facilities are available 
(animal house); fairly rapid breeding cycle; large genome, sequence-tagged 
mutagenesis by transposable elements not possible; transgenesis possible; in 
vitro germline manipulation by homologous recombination possible; closely 
related to humans; very good genetics data available.
4) Zebrafish: easily bred; fairly cheap once facilities are available (aquarium); 
fairly rapid breeding cycle; large genome; sequence-tagged mutagenesis by 
transposable elements not possible; transgenesis possible; in vitro germline 
manipulation by homologus recombination not possible; reasonably closely 
related to humans; poor but rapidly increasing genetics data available; 
transparent nature facilitates observation and manipulation during rapid 
development of the embryo.
5) Xenopus: very slow breeding cycle; tetraploid genome; practically no 
genetics data available. However, embryos are easily observed and 
manipulated and transgenesis is now possible. Recent investigations using a 
diploid species, X. Tropicalis, may herald the birth of Xenopus genetics 
(Amaya et al.r 1998).
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6) Laboratory rat: easily bred; more expensive than mouse; fairly rapid
breeding cycle; large genome; sequence-tagged mutagenesis by transposable 
elements not possible; transgenesis possible; in vitro germline manipulation 
by homologus recombination not possible (yet?); closely related to humans; 
poor but rapidly increasing genetics data available.
Rat genetics is in its infancy at the moment, but seems likely to explode 
over the next decade with the recent advent of detailed genetic maps of the rat 
genome along with accompanying polymorphic sequence-tagged site markers. 
The signal advantage of the rat over the mouse is the availability of various inbred 
or partially inbred strains which provide pharmacological and physiological 
models for various hum an conditions, such as epilepsy. This is of particular 
importance in the genetic dissection of multifactorial diseases such as spontaneous 
hypertension or obesity.
The other major system widely used for molecular genetics is Arabidopsis, 
but this is, of course, not strictly relevant for a discussion of animal genetics. It is, 
however, worth pointing out that Arabidopsis is cheap, easily bred, has fairly 
good genetics, sequence-tagged mutagenesis is possible, and is the system of 
choice for plant genomics. This can become relevant when studying highly 
conserved themes between plant and animal kingdoms e.g. homeotic genes.
Vertebrate genome evolution by duplication
Vertebrates are generally considered to have undergone two rounds of 
whole genome duplication early during their evolution, and this has led to 
considerable diversification of functions (Nadeau & Sankoff, 1997). Gene 
duplication is believed to buffer the effect of null mutations and allows greater 
opportunities for new functions to evolve (Spring, 1997). Indeed, genome 
duplication may be the mechanism underlying saltatory evolutionary jumps in 
organism complexity (Aparicio, 1998). To further complicate matters, tandem 
duplications of single genes or gene clusters have occurred. The overall effect of 
this, combined with >500 million years of normal evolutionary drift has created a 
situation where it can be extremely difficult to identify a direct functional
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orthologue of any given hum an gene in Drosophila or C. Elegans, although an 
homologous "ancestral" gene can often be found.
From the list above, zebrafish would seem to satisfy many of the criteria for 
the perfect model organism with which to investigate vertebrate (although not 
mammalian) developmental genetics, and this may well be true. Although the 
overall breeding cycle is relatively slow, fertile fish can produce very large 
numbers of Fi progeny every two weeks or so, the embryo is accessible and 
amenable to manipulation during development, it is transparent and 
embryogenesis can be observed and followed throughout, the fish are easily 
mutagenised and the genetic m apping data, as with the rat, is currently 
expanding at an exponential rate. Whilst not as closely related to humans as the 
mouse, zebrafish have been found to possess functional orthologues of most of the 
major genes looked for so far. However, w hat is of particular interest is that 
rather more homologous genes are being found in zebrafish than were expected 
from a priori considerations.
As an illustrative example: in Drosophila, there is one ancestral hedgehog 
gene. The mouse might reasonably be expected to have from one to four 
hedgehog genes (from 2 rounds of genome duplication) and three have been 
found so far. Of these, Shh (sonic hedgehog), has been extensively studied and 
found to be of critical importance during development. In due course, zebrafish 
geneticists looked for an shh orthologue and found two, rather than one 
(Schauerte et al., 1998). This lends weight to the accumulation of recent evidence 
which strongly suggests that teleost fishes underw ent a further genome 
duplication early in their evolution, perhaps quite soon after their divergence 
from the mammalian evolutionary line (Aparicio, 1998). Paradoxically, this 
abundance of homologues can both complicate and simplify the dissection of gene 
function during development. That is to say, while one might have to isolate and 
identify multiple genes to cover the functionality of one ancestral gene (from 
Drosophila, say), individual genes may be performing less functions. In the 
particular case of mouse knockouts, it may be necessary to knock out two or even 
three members of a related group to achieve the expected phenotype from fly 
m utant studies. However, individual knockouts can reveal the subtleties of
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particular functions which the global mutant masks by virtue of its more 
severe effects.
The close relationship between mouse and human genomes
Thus, while Drosophila and C. elegans provide certain advantages to the 
geneticist, it can be crudely stated that humans and mice are ten times more 
closely related to each other than either species is to flies or nematodes. Indeed, 
so closely related are the two genomes that it has been estimated that only around 
150 major rearrangements have occurred since the divergence of mouse and 
hum an from a common ancestor some 65 million years ago. To put it another 
way, one can construct an approximate replica of the hum an genome by breaking 
the mouse genome into -150 pieces and reassembling them in the correct order 
(Copeland et ah, 1993).
With the twin advantages of conservation at the sequence level and large 
syntenic regions at the genomic, cloning of a new hum an gene almost invariably 
leads to the discovery of its murine counterpart, and the reciprocal generally 
holds true. Corresponding genes in mouse and hum an are often, although not 
always, direct functional orthologues, and this can be directly exploited in the 
mouse through the use of targeted mutagenesis and transgenesis experiments. 
The logical corollary of this is that exploring gene function in the mouse through 
the identification and characterisation of novel mutant alleles can shed light on 
what role the gene plays in humans.
Mouse m utants
Genome sequencing projects
The hum an genome project is on schedule to produce a complete sequence 
of the hum an genome by 2003, somewhat ahead of the original projections 
(Collins et a l, 1998)(h ttp ://www .ncbi.nlm .nih.gov/genem ap/, 1999). The mouse 
genome project is proceeding along a similar course, although lagging a few years 
behind, but advances in sequencing technology, although inherently 
unpredictable, are projected to take place such that the mouse genome will have
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been completely sequenced by 2005, with a "draft copy" ready by 2003, consisting 
of most or all cDNA sequences on a framework map.
The required technical advances in sequencing capacity are being 
aggressively pursued by academic and private concerns. For example, the 
Genome Science Laboratory at the Institute of Physical and Chemical Research 
(RIKEN) in Japan, recently announced details of an automated system for high- 
throughput preparation and sequencing of high-quality cDNA libraries using a 
number of cutting-edge innovative technologies. They claimed to be able to 
rapidly prepare cDNA libraries containing >90% full-length message using 
trehalose-stabilised high temperature reverse transcription (Carninci et ah, 1998), 
to mini-prep 4X104 sequence-ready templates per 24 hours using an advanced 
robot, and to generate megabases of sequence per day using RNA polymerase- 
based fluorescent sequencing. If borne out, this technology represents a quantum  
leap in genome sequencing capacity compared to current high-throughput 
methodologies (Hayashizaki et al.f 1998). Similar advances can confidently be 
predicted to emerge over the next decade.
If the sequence of every gene and cDNA in mouse and hum an will be 
known in seven years or less, why expend any great effort now to identify novel 
genes via mutagenesis screens? The answer lies in the deficit in our current ability 
to predict gene function from gene sequence. This was recently highlighted in a 
fascinating report published on the Web by the steering group at the NIH 
coordinating the American mouse genome project. The report summarises the 
committee's reasoning and decisions on how much resources should be allocated 
over the next few years to which aspects of mouse genomics 
(h ttp ://w w w .nih .gov/w elcom e/director/reports/m genom e.htm , 1998). (A letter 
describing the outline of the report was recently also published (Battey et a\., 
1999).) To quote from the report: "As the Hum an Genome Project progresses and 
the sequence of more hum an and mouse genes is determined, the function of a 
large number of these genes will not be predictable by sequence and expression 
alone. Phenotype-driven mutagenesis screens provide an im portant approach to 
understanding the function of genes."
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Classical spontaneous mutants
In the 18th and 19th centuries, Asian breeders selected and bred lines of 
"fancy" mice with various coat and eye colouring. During the 19th century, British 
and American breeders joined in and a wide variety of lines of fancy mice were 
traded around the world. This was an attractive resource for early genetics 
researchers, since it offered visible genetic variation - rare in wild animals - and 
defined inbred strains carrying visible phenotypic markers could be more quickly 
derived from the fancy mice than from wild animals (Silver, 1995). Various 
naturally occurring alleles were mapped using these mice, including the recessive 
s locus, discussed extensively in this thesis, now known to contain the Ednrb gene 
which encodes the endothelin receptor B.
"Piebald" fancy mice are small with spotted white coats, and carry a 
recessive allele at the s locus which causes a dramatic reduction in the level of 
Ednrb mRNA (Hosoda et at., 1994; Lyon et ah, 1996). The original Japanese fancy 
mice were described in "Chingan-sodategusa", an 18th century guide to mouse 
breeding (Tokuda, 1935), and the first known images of piebald mice are 
reproduced from this manuscript on the Dedications page of this thesis. This 
particular strain was believed to have become extinct sometime in the mid-19th 
century, but a pair of so-called "Japanese" fancy mice resembling classical piebalds 
were purchased in a market in Denmark in 1987 and introduced to a breeding 
centre for establishment of an inbred line. In a remarkable recent paper, the 
authors describe the resultant inbred JF1 strain, which carries the identical s allele 
at the Ednrb locus to that seen in classical piebald mice, but is otherwise 
genetically closely related to M.m. molossinus, the asiatic sub-species (Koide et ah, 
1998). This strain is therefore considered to be a "resurrected" version of the 
original piebald Japanese fancy mouse, before this allele became bred onto the 
varied genetic backgrounds seen in modern laboratory strains. (The JF1 strain is 
of more than historical interest, however, as it shows a very high level of genetic 
polymorphism compared to most common laboratory inbred strains of mice, due 
to its M.m.molossinus heritage, and can be interbred with these, but is tame and 
tractable compared to other inbred strains derived from this sub-species.
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Furthermore it carries a visible marker which does not compromise viability. This 
strain may therefore prove very useful in mapping studies.)
Early mutagenesis programmes
In addition to the array of classically-derived m utants from breeding 
studies, there exists a range of m utant strains derived from mutagenesis 
programmes using agents such as ethylnitrosourea or ionising radiation (Lyon et 
al., 1996). ENU generally induces point mutations and X-rays generally give rise 
to large deletions. Prior to recombinant DNA technology, many such mutations 
were studied at the phenotypic level, and some were m apped using large-scale 
breeding programs, but this was very time-consuming and expensive. However, 
the recent advent of detailed genetic maps and genotyping based on microsatellite 
and other PCR-typable polymorphic loci has meant that any m utation - even a 
point m utation in a single base pair - can be rapidly m apped with high resolution. 
The Jackson Labs and other institutions such as Harwell in Britain and 
Neuherberg in Germany have maintained live or frozen stocks of many poorly- 
defined m utant alleles, and some of these are now beginning to be "resurrected" 
and investigated using the new technology.
Transgenic mutants
Transgenic mice - defined herein as mice carrying additional exogenous 
DNA sequences stably integrated into the host DNA - were originally derived by 
injection of DNA into the pronuclei of fertilised eggs (Gordon et al., 1980) or by 
microinjection of retroviral DNA into the blastocoel cavity of blastocyst stage 
embryos (Jaenisch & Mintz, 1974). Early on, it was found that the random  
insertion of transgene DNA can cause the disruption of normal somatic gene 
function and a m utant phenotype (Gridley et al., 1987), albeit at fairly low 
frequency. This is discussed in more detail below. The explosion in transgenic 
technology has led to the generation of thousands of transgenic mouse lines and a 
number of such transgenic insertional mouse mutants.
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ES cell mutagenesis
An added level of sophistication was brought to this approach to mutant 
generation w ith the establishment of murine embryonic stem (ES) cell lines 
(Evans & Kaufman, 1981; Martin, 1981), and the subsequent discovery that when 
ES cells are injected into the blastocoel cavity of pre-implantation blastocysts, they 
can integrate w ith the inner cell mass, and go on to form a part of the normal 
somatic tissues of the resultant chimeric mouse (Bradley et al, 1984). A great deal 
of cell mixing occurs during early post-implantation development (Rossant, 1985; 
Beddington et al., 1989), and consequently, the ES cell-derived tissues in the 
chimeric mouse will quite often include the germline. As a consequence of this, 
mice can be bred which are clonally derived from the injected ES cells. Prior to 
the establishment of ES cells, embryonal carcinoma (EC) cells derived from 
murine teratocarcinomas were employed in this fashion, but it was found that 
although they could contribute to normal somatic tissues to form chimeric mice 
quite successfully, they rarely contributed to the germline, presumably due to 
karyotypic abnormality. The early experiments with EC cells acted as "proof of 
concept", however, and paved the way for the success of ES cell-derived 
germlines in mice (Brinster, 1974).
The genomes of cells in culture are readily amenable to manipulation and, 
unlike injected eggs, can be selected for successful integration events, clonally 
amplified for storage and for multiple rounds of injection. It also appears that 
homologous recombination occurs at very low frequencies w hen targeting 
constructs are injected directly into the pronuclei of fertilised eggs compared to 
transfecting the same construct into ES cells. Manipulations most commonly 
performed in ES cells can be broadly divided into two categories: Gene targeting 
and gene trapping.
Gene targeting
Gene targeting by homologous recombination in ES cells has been used to 
generate specific mutations in genes of interest (Capecchi, 1989). The injection of 
modified ES cells into pre-implantation blastocysts can then introduce the m utant 
alleles into the mouse germ-line at a reasonable frequency. Alternatively, the
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more sophisticated technique of ES cell aggregation with tetraploid embryos can 
be employed, which results in entirely ES-cell derived animals w ithout the need 
for subsequent breeding to screen for germline transmission (Nagy et al, 1993). 
These strategies are now widely used with particular emphasis placed on gene 
"knockouts" in which the target gene is rendered completely non-functional, and 
mice transmitting the null allele in the germline are bred to homozygosity to 
generate animals in which the gene function is entirely absent.
Gene trapping
While homologous recombination can be used to perform targeted 
mutagenesis to alter known genes, this does not address the question of 
developmentally important genes or gene families which have not yet been 
characterised. The need for efficient random  screening led to the development of 
gene trapping experiments in ES cells to generate transgenic m utant mice 
(Gossler et al, 1989). This usually involves insertion of a reporter gene, commonly 
the p-galactosidase lacZ gene, into the ES cell genome in such a way that 
expression of the reporter is dependent upon integration into a functional 
genomic region. This can be used to randomly screen for active coding sequences 
(Gossler et al, 1989), promoters (Friedrich & Soriano, 1991), enhancers (Skarnes et 
al, 1992) and secreted and membrane-spanning proteins (Skarnes et al, 1995). 
The reporter gene can be used to map the expression patterns of the trapped 
genes and to clone and sequence the flanking regions of interest (Skarnes et al, 
1995; W urst et al, 1995).
Insertional mutagenesis
The insertion of linear DNA into the genome following micro-injection into 
single-cell embryos is thought to occur randomly, although it has been suggested 
from the statistical analysis of a number of transgene integration sites that there 
are structural requirements, or "hot spots" for the integration of transgene DNA. 
The integration events may involve the presence of nearby inverted repeats 
(Wilkie & Palmiter, 1987), and possibly the conserved family of T1 dispersed 
repeats (Makarova et al, 1988). If true, this pseudo-random  insertion would
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probably affect the frequency with which transgenes disrupt somatic gene 
function. This has been estimated to be around 5-10% in the past although the 
accumulation of more data from transgenic screens - such as the one discussed 
herein - may alter this figure (Palmiter & Brinster, 1986; Jaenisch, 1988). In 
particular, the figure of 5-10% given refers mainly to visible, post-natal 
phenotypes. Screening for pre-natal phenotypes is likely to increase this figure 
significantly.
Transgene integration
It was found early on that DNA micro-injected into the pronucleus of 
fertilised eggs tended to integrate more frequently if it was linear. It was also 
thought possible that sticky ends rather than blunt ends enhanced integration 
frequency, as did injection into the male, rather than the female, pronucleus 
(Brinster et al., 1985).
A number of studies have confirmed that injected linear transgene DNA 
tends to integrate into the genome as a multiple head-to-tail array at a single 
chromosomal site. Multiple, independently segregating integration sites have also 
been observed, and can be readily detected through breeding, but these occur at 
low frequency. Single copy integrations are possible, but somewhat less frequent 
than multi-copy. In addition, it is not uncommon for some copies of the transgene 
to be inserted in the reverse orientation within a multi-copy array, but this seems 
to be a less stable configuration (Wilkie & Palmiter, 1987). If long inverted repeats 
are unstable in the mammalian genome (as they are in bacteria and yeast), this 
offers a ready explanation for the instability of head-to-head and tail-to-tail 
transgenes within an array. In support of this, Collick and co-workers have 
shown that long inverted repeats within a transgene are inherently unstable 
following integration into the mouse genome (Collick et al, 1996).
In addition to the tendency towards multi-copy integration of the injected 
transgene construct, the chromosomal sequence flanking the integration site 
frequently undergoes rearrangements, deletions, translocations or duplications 
(Mark et al, 1985; Covarrubias et al, 1986). It has been suggested, based on the 
detailed analysis of several integration sites, that the initial product of transgene
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integration is highly unstable, and that the DNA subsequently undergoes a 
number of rearrangements, possibly involving the insert as well as the host DNA, 
until it achieves a stable configuration. This can result in duplicated host 
sequence being inserted between copies of the transgene inside a multi-copy array 
(Covarrubias et al., 1986). The sequence of the injected DNA seems to influence 
the process of transgene integration and aberration in the flanking genomic 
sequence (Chen et a l, 1995).
It has been postulated, with the support of experiments performed in 
transfected cells by Bishop and others, that prior to integration with the host 
genome, the injected DNA circularises and is then randomly cleaved by cellular 
nucleases. This generates a set of overlapping linear fragments which have been 
"circularly permuted". These could then form extrachromosomal concatemers by 
rounds of homologous recombination events between overlapping fragments. 
This model would account for the intact nature of many of the internal copies of 
the transgene construct in a multi-copy array (despite the disruptive nature of the 
integration event) and their propensity to be aligned head-to-tail (since end-to- 
end concatemerisation would result in random  orientations) (Bishop, 1996).
The actual integration probably takes place by illegitimate recombination 
with genomic DNA, possibly during DNA replication during mitosis, since 
founder transgenic mice are generally mosaic in composition. The precise 
mechanism of integration remains unknown, but it has been suggested that the 
free ends of the injected DNA molecules may induce repair enzymes, which can 
cause random  chromosome breaks, these acting as integration sites for the 
transgenic DNA (Brinster et al., 1985). It has also been observed that the 
chromosomal rearrangements associated with transgene integration are similar to 
those induced by ionizing radiation, which is known to cause double-stranded 
breaks in DNA. It has been postulated that the microinjection and handling of the 
zygotes during the procedure might induce double-stranded breaks in the host 
DNA (Woychik & Alagramam, 1998). It is certainly true that deliberate induction 
of double-stranded breaks at a target site in chromosomal DNA using transient 
expression of I-Scel endonuclease greatly enhances the frequency of homologous 
recombination events at this locus in ES cells (Smih et al., 1995), the implication
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being that the presence of naked double-stranded ends enhances recruitment of 
the cellular recombinogenic machinery. It is also known that the formation of 
double-stranded chromosome breaks is an essential early step during meiotic 
recombination of sister chromatids (Shinohara & Ogawa, 1995), although whether 
any of this this can be extrapolated to transgene integration is a moot point.
Identification o f disrupted genes
Although mutations in mice can be readily induced with chemical agents 
or ionising radiation, traditionally it has required a huge breeding programme to 
map the mutant alleles. This has now changed with the advent of polymorphic 
DNA loci which can be typed by PCR, and the mouse genome now has complete 
coverage (>98%) with 3000 such markers in lcM  "bins" (Dietrich et al., 1996). The 
upshot of this is that any mutation can be rapidly mapped to w ithin ~lcM 
provided that the laboratory concerned has the facilities to handle large numbers 
of PCRs and subsequent detection on high resolution agarose or polyacrylamide 
gels. The initial cost of buying large numbers of PCR primers to give genome- 
wide coverage is also high.
However, the presence of a known sequence nearby to act as a tag, such as 
a gene trap construct or an injected transgene, can greatly facilitate the mapping, 
cloning and characterisation of a disrupted gene. The transgene can be treated as a 
dominant allele and incorporated into PCR-based linkage mapping protocols as a 
marker which is very tightly linked to the mutant locus, eliminating the need for 
high resolution genetic crosses. More directly, the foreign nature of the DNA 
sequence of many transgenes can be usefully employed to directly map the 
transgene using fluorescent in situ hybridisation (FISH) on metaphase 
chromosome spreads. These twin approaches can be combined (see chapters 6 
and 11), with significant advantages for small laboratories which are not set up for 
genome-wide linkage scans.
The chromosomal rearrangements associated with transgene integration 
can make identification and cloning of the disrupted gene quite difficult. 
Typically, however, flanking deletions are no larger than 10-100Kb (Zhou et al., 
1995), and mapping a mutant allele to within 100Kb can be considered to be
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extremely high resolution mapping by conventional genetic standards. Modern 
chromosome walking techniques can readily be applied to sub-megabase regions 
of interest, making mapping, cloning and sequencing of genomic DNA flanking a 
transgene feasible, and considerably easier than conventional m apping of m utant 
loci and identification of the altered genes. This task is made even easier if large 
genomic clones (PACs, YACs or BACs) of the region of interest are available, and 
one of the stated priorities of the NIH working group report mentioned 
previously is to provide complete two-fold BAC coverage of the mouse genome 
(to "close the gaps" in molecular genetics parlance), to place all BACs on a 
framework map and and to make them available to the mouse genomics 
community (Dove & Cox, 1998). Gridded BACs which span most or all of the 
mouse genome are already available at low cost from Research Genetics, but most 
have not been placed on the map (Research Genetics Inc., 1999). Gridded YACs 
have been available for some time, but their utility has now been greatly enhanced 
by the publication of a YAC-based physical map covering 92% of the mouse 
genome (Nusbaum et ah, 1999).
Broadly speaking, compared to conventional positional cloning, armed 
with the map position of a transgene insertion site and having cloned some 
flanking sequence, gene identification can be confined to a genomic region 
containing perhaps only 1 or 2 genes compared to 10 or 20 (Meisler et ah, 1997).
Alternative approaches to mutagenesis in the mouse
Conventional mutagenesis
The contrast between the transgenic approach and the conventional genetic 
approach is exemplified by the Id (limb deformity) locus, comprising several 
alleles causing severe lower limb deformity and renal aplasia (Lyon et ah, 1996). 
This had previously been studied extensively and m apped to Chr 2 by classical 
means. Once disrupted serendipitously by a transgenic insertion, it was quickly 
cloned and turned out to be a large gene encoding a num ber of protein isoforms, 
termed formins, which are involved in the morphogenesis and patterning of the 
limb and kidney (Woychik et ah, 1985; Vogt et ah, 1992; Vogt et ah, 1993).
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Another previously known locus now characterised at the molecular level 
through insertional transgene mutagenesis is the pigmy locus, which had been 
defined classically as a dwarf phenotype which was, uniquely, not associated with 
the growth hormone deficiency pathways characteristic of dwarf mice. 
Transgenic insertional mutagenesis has now revealed this phenotype to be 
associated with the loss of function of the hmgi-c gene, a member of a family of 
nuclear proteins which function as architectural factors during the assembly of 
stereospecific transcriptional complexes (Zhou et al, 1995).
A final, and more recent example, underscores the power of transgene 
insertions to uncover previously unknown types of developmentally important 
gene. The inv mouse (inversion of embryo turning) is the only known mouse 
m utant in which visceral left-right asymmetry is consistently inverted. The 
phenotype resulted from a complex transgene insertional event which deleted a 
small region of chromosome 4 and duplicated another small region. Recent work 
convincingly showed that the transgene integration had partly deleted the inv 
gene, and transgenic rescue experiments showed that this was indeed responsible 
for the phenotype (Morgan et al., 1998). The inv gene codes for a completely 
novel protein containing no recognisable motifs other than 16 ankyrin-like 
tandem  repeats and nuclear localisation signals. However, it is clear that the inv 
gene product plays a critical role in the determination of left-right asymmetry and 
lies upstream  of all other known genes in this pathway with the possible 
exception of iv (inversus viscerum).
ES cells
In comparing strategies for disrupting and characterising genes involved in 
mouse development, it is a perhaps obvious, but important, point that 
homologous recombination techniques can only be used on previously 
characterised genes and related genes within homology groups, and cannot be 
used to identify unknown genes. It has been estimated that targeted mutations 
currently sample less than 1% of the genes in the mouse genome (Evans et al,
1997).
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On the other hand, random  strategies such as gene trapping and transgenic 
insertional mutagenesis have the potential to reveal novel gene functions, but it is 
important to recognise that gene trapping experiments are optimised for the 
detection of genes expressed in undifferentiated ES cell lines. Thus, for example, 
En-2 and Hoxl.3(Hox-A5) are expressed, whereas others such as wnt-1 and En-1 , 
whilst of equal developmental interest, are not, and a gene trap vector integration 
event in these latter genes in ES cells would not be selected during screening 
(Joyner et al.r 1985; Joyner & Martin, 1987; McMahon & Bradley, 1990; Jeannotte et 
al., 1991). (All four genes have, however, been knocked out by homologus 
recombination and the phenotypic effects studied.) However, it m ust be pointed 
out that it is possible to assess the pattern of expression of gene trap constructs in 
ES cells differentiated in vitro, although the extent to which this reflects the pattern 
of gene expression in the developing mouse embryo, particularly at later stages, is 
perhaps questionable. Furthermore, the range of somatic cell types which can be 
derived from ES cells in culture is not particularly comprehensive at present.
Perhaps more usefully, recent work offers the exciting possibility of being 
able to pre-select ES cell clones which express the gene trap construct only in 
specific lineages after differentiation. After sequencing to gain some knowledge 
of the trapped gene, these ES cells can then be injected into blastocysts with some 
assurance of tissue-specific loss-of-function (Baker et al., 1997).
A further caveat is that while gene trapping experiments and, to a lesser 
extent, transgenic insertional mutagenesis, have proved to be highly efficient at 
generating mutants, they provide no control over phenotype, concomitant with 
their random  nature. That is to say, they do not allow you to select for mutations 
in any particular loci of interest, and furthermore, they simply act as insertional 
loss-of-function mutations, as opposed to the more subtle targeted mutagenesis 
experiments which can be performed by homologous recombination in ES cells.
One final consideration is that, thus far, it has only proved possible to 
derive ES cells which can contribute to the germline with high efficiency from one 
particular strain of mouse, namely 129. Unfortunately, the canonical "129 strain" 
has a highly chequered genetic history with a great deal of accidental outcrossing. 
As a consequence, there is considerable genetic variability between 129 substrains
33
and ES cells derived from them, and this can further confuse the results of 
experiments perform ed in ES-cell derived mice. The Jackson Labs have recently 
published an excellent investigation of this problem (Simpson et al., 1997).
Summary
Overall, while some of the alternative strategies mentioned above are 
undoubtedly more efficient for the identification and cloning of genes of 
developmental interest, somatic gene disruption by transgene insertion can be 
viewed as an interesting by-product of mouse transgenic experiments, it also has 
the potential to reveal genes of developmental importance which might otherwise 
be missed. Once a m utant phenotype has been identified in a transgenic line, the 
presence of the transgene as a molecular tag can enormously facilitate the 
mapping and cloning of the disrupted gene.
The future?
Retrovirus
One aspect of transgenic technology conspicuous by its absence in the 
preceding discussion is the use of retroviral vectors to make transgenic mice 
an d /o r to generate insertional mutants. Early retroviral vectors were found to 
integrate randomly, or perhaps pseudo-randomly, into the genome and acted as 
efficent mutagenic agents. Retroviral integration tends to be much "cleaner" than 
integration of micro-injected DNA, reflecting the virus' nature, and there is much 
less disruption to the surrounding chromosomal DNA. Retroviral transfer into 
cells tends also to be much more efficient than the transfer of gene-trap constructs 
by electroporation (Evans et al., 1997). Technical difficulties with the earlier 
retroviral vectors resulted in their being overshadowed by homologous 
recombination and gene-trapping experiments, but the new generation of 
retroviral vectors have overcome the procedural drawbacks and this may become 
the methodology of choice in the future for large-scale mutagenesis (Bradley et al,
1998). Retroviral mutagenesis shares the key advantage of transgenic insertional 
mutation - the presence of a molecular tag - and the new generation of retroviral
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vectors can be readily identified, can be selected for integration into an actively 
transcribed gene and integrate at high efficiency into the host genome. In theory, 
any locus of interest could be mutagenised in a tagged fashion w ith minimal 
effort. This approach has been validated in zebrafish (Gaiano et al., 1996), and 
has recently been applied to the mouse with retroviral mutagenesis performed on 
a large scale by Lexicon Genetics with the stated intention of knocking out every 
gene in the mouse genome (Omnibank, Lexicon Genetics Inc. 1999).
One "feature" of retroviral integration, at least in mice, is that many 
retroviruses have preferred, or at least consensus, integration sites and the 
mutagenesis is not entirely random. For example, several studies have shown 
that the provirus will often integrate within several hundred base pairs of a 
DNAse I-hypersensitive site, diagnostic of a region of active transcription. Hence 
pro viral integrations are often found at the 5' end of a gene (Rijkers et a l, 1994). 
This may not be disadvantageous, but it does perhaps limit the types of mutation 
induced by retrovirus. Furthermore, a recent pilot study sequenced some 400 
retroviral gene-trap events in ES cells, and found that two particular genes were 
each disrupted three times in the sample of 400 (Hicks et a l, 1997), a much higher 
frequency than predicted. This suggests that retroviral mutagenesis can be 
skewed in favour of certain genes, but that the bias may be quite small. 
Futhermore, if there are "hot-spots" for integration, there may well be "cold- 
spots", hence some genes might never be mutated by these methods.
Large-scale ENU mutagenesis screens
The power of ENU lies in its mutagenic efficiency - with careful dosage, 
one can generate one mutation in any locus of interest within a cohort of 700 Fi 
progeny (Hitotsumachi et al., 1985). Given an efficient screen for mutant 
phenotypes, PCR-based linkage mapping can rapidly map m utant alleles and 
provide a systematic mutant screen for genes involved in particular pathways. 
While this approach is only really practicable for a large laboratory or institution, 
a recent pilot study in Kathryn Anderson's laboratory proved its validity in 
screening for genes affecting early embryogenesis (Kasarskis et al., 1998), and 
again, the NIH working group report earmarks this as a priority area of research
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(Dove & Cox, 1998). Large-scale ENU mutagenesis screens are currently 
underway in both Britain and Germany (h ttp ://w w w .gsf.de /isg /g roups/enu- 
mouse.html; http://w w w .m gu.har.m rc.ac.uk/m utabase/, 1999)
Other ES cells and EG cells
One exciting area of research to emerge recently is the establishment of 
pluripotent stem cell lines from the gonadal primordial germ cells of post­
implantation embryos. These embryonic germ (EG) cells have been derived from 
several species, including hum an (Shamblott et al., 1998).
Traditionally, ES cell lines have been derived from the inner cell mass of 
pre-implantation embryos. ES cell lines have been generated from several species, 
and have been shown in many cases to be pluripotent and to contribute to somatic 
tissues in chimeric animals, but one reason for the mouse's dominance in 
mammalian genetic research has been the impossibility of deriving ES cell lines 
from any other species which are capable of contributing to the germline. Indeed, 
as discussed previously, even mouse ES cells from strains other than 129 have 
been found to colonise the germline at very low frequency (Gardner & Brook, 
1997).
Culture conditions have now been established for the successful 
propagation of pluripotent embryonic stem cells derived from primordial germ 
cells from multiple species, including humans. These have not as yet been shown 
to colonise the germline, however, except in the case of mouse EG cells. 
Nevertheless, the tantalising possibility of in vitro manipulation of the germline in 
species other than the mouse may soon become a reality.
Amongst more obvious direct clinical applications, such as in vitro organ 
cultures for tissue transplants, hum an pluripotent stem cells offer the intriguing 
possibility of being able to first test genetic models of disease in an in vitro culture 
system which more faithfully mimics the hum an condition, before trying to 
extend this to a whole animal model such as the mouse (Lewis, 1997; Trounson & 
Pera, 1998). This may help overcome some of the problems attendant in trying to 
extrapolate from the rodent to the hum an condition.
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ES cell deletion banks
To reiterate: targeted homologous recombination is limited to genes of 
known sequence, current alternatives for mutagenesis are entirely random, with 
little or no control over phenotype or location. An attractive alternative has 
recently become feasible with the publication of two independent methods for 
generating and selecting ES cell clones with specific deletions on one chromosome 
(Ramirez-Solis et al, 1995; You et al, 1997). Armed with a mouse which possesses 
only one copy of a gene in a region of interest, it then becomes possible to use 
conventional random  mutagenesis e.g. ENU, to saturate a target area, rapidly 
screen for recessive mutations (since they will manifest as "dominant" due to the 
opposing deletion on the sister chromosome) and to generate an allelic series of 
mutations in a specific region.
Radiation hybrid mapping panels
Radiation hybrid mapping panels can almost be viewed as the complement 
to the small chromosomal deletions discussed in the preceding section, as they 
comprise segments of mouse chromosomal DNA generated by X-irradiation of ES 
cells and transferred into hamster cells by fusion. Due to the high level of genetic 
polymorphism between mouse and hamster, m apping is relatively 
straightforward in these panels, but they have the signal disadvantage that large- 
scale linkage studies are made difficult by the nature of panel generation, with X- 
irradiation leading to frequent breaks in chromosomes and non-contiguous 
linkage groups. Backcross or recombinant inbred (RI) m apping remain the 
protocols of choice for initial establishment of linkage (discussed more fully in 
chapter 6). However, the numerous random  breaks in each chromosome mean 
that radiation hybrid panels can be used for very fine genetic mapping. To attain 
the same degree of resolution from the alternatives mentioned above would 
require a very large backcross or set of RI strains, particularly in cases where the 
locus of interest lies within a recombination-poor region, such as close to the 
centromere (Flaherty & Herron, 1998).
A new radiation hybrid panel, T31, has recently been produced and made 
available to the mouse community and promises to allow fine genetic m apping of
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loci of interest (McCarthy et al., 1997). The first detailed characterisation of the 
panel has recently been completed and published, encompassing 2483 loci 
distributed across the 93 cell lines in the panel (Van Etten et al, 1999).
Excisable targeting constructs
Referring back to the list of developmental model organisms given earlier, 
one of the most desirable features is the ability to perform sequence-tagged 
mutagenesis via transposable elements, such as the P element widely used in 
Drosophila. After a phenotype has been observed, and a disrupted gene 
identified, if one can then rescue the phenotype by excising the foreign element, 
this categorically proves that the mutation was due to the disruption of that gene. 
Up until now, this has not been possible in mice, but recent work suggests the 
exciting possibility of an "exchangeable gene trap" vector being used in an even 
more sophisticated way (Yamamura et al, 1998). Briefly, this involves a fairly 
standard gene-trapping protocol in ES cells using a vector which includes two 
compromised flanking Cre-LoxP lox sites. After an interesting gene has been 
trapped and identified by the usual methods, Cre recombinase can be used to 
excise the integrated gene-trap vector and optionally replace it with new 
sequence. Due to the nature of the m utant lox sites used, the lox sites which re­
form after successful excision/exchange are insensitive to Cre recombinase, 
resulting in stable exchange and integration of the new exogenous DNA.
Since gene-trapping of this kind usually generates loss-of-function 
mutations in the first instance, this exchangeable gene trap vector can be used to 
identify developmentally important genes via loss-of-function, to map their 
patterns of expression via a lacZ reporter and then to reconstitute gene function to 
rescue the phenotype, with the option of introducing deliberate mutations (e.g. 
novel enhancer elements) to further probe the gene's role.
Mouse balancer chromosomes
One of the most powerful genetic aids to m utation analysis has only been 
available to Drosophila geneticists until now. Balancer chromosomes, as with non- 
lethal defined chromosomal deletions, allow one to rapidly screen for recessive
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mutations in a region of interest (as part of an ENU mutagenesis screen, for 
example). This is achieved by having some readily assayed phenotypic 
characteristic present as a dominant allele, since the absence of this trait is 
diagnostic for progeny lacking the balancer i.e. homozygous for the wild-type 
chromosome.
They also perform the useful function of maintaining stocks of a recessive 
lethal mutation without the need for selection. Balancer chromosomes contain a 
chromosomal inversion, with the inverted region containing a single recessive 
lethal allele. In a heterozygote, the inversion suppresses recombination between 
balancer chromosome and a wild-type sister chromosome, since meiotic 
recombination generates di- or acentric chromatids, leading to inviable progeny. 
Crossing a balancer onto another recessive m utation in the same region generates 
a double heterozygote, which, when in-crossed, will only generate viable progeny 
with the same genotype as the parents i.e. the doubly heterozygous 
balancer/m utant stock is maintained. This is because homozygosity for either the 
new mutation or the balancer is lethal, and the suppression of recombination by 
the balancer region means that the lethal alleles cannot be removed during 
meosis.
In order to generate a balancer for a genomic region of interest, therefore, 
one has to have a recessive lethal allele present in the region, and one has to be 
able to engineer a sizeable (viable) chromosomal inversion w ith the said allele 
contained within it. It is also desirable to have a visible trait to mark the presence 
of the balancer, such as coat or eye colour.
Recent advances in engineering mouse chromosomes using Cre-LoxP 
recombination have led to the generation of a bona fide balancer chromosome, 
consisting of an inversion spanning some 24cM between Trp53 and Wnt3 on Chr 
11 (Ramirez-Solis et «/., 1995; Zheng et al., 1999). During the process of generating 
the targeted loxP sites, both the delimiting genes were inactivated, so that balancer 
homozygotes were embryonic lethal due to the absence of Wnt3. In addition, a 
dominant allele of Agouti was introduced (as a transgene targeted into the 
inactivated Wnt3 gene) to provide a visible coat colour marker diagnostic for the 
presence of the balancer.
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As a proof of concept experiment, the balancer line was crossed onto a 
m utant strain carrying a recessive lethal m utation in Hoxb4, which lies w ithin the 
inversion region. This resulted in viable double heterozygotes, carrying the 
inversion on one chromosome and the Hoxb4 m utation on the other. Inbreeding 
of these stocks generates 25% Hoxb4-/~ homozygotes, which are lethal, 50% 
heterozygotes (bearing parental genotypes), and 25% balancer homozygotes, also 
lethal due to their Wnt3-/~ genotype.
Although the process of generating balancer stocks is laborious, once 
achieved for any region of interest they are self-perpetuating, and w ould greatly 
assist in the generation and maintenance of mouse m utant stocks. Drosophila 
geneticists have been trading useful balancers for most regions of the fly genome 
for many years now, and it is to be hoped that the mouse genetics community 
might also reach this happy state of affairs
Improved transgene integration
Research into the exact nature of the integration mechanism pertaining to 
micro-injected transgene DNA remains somewhat sparse. However, one 
interesting paper described a detailed investigation of a highly unusual transgene 
integration event (McFarlane & Wilson, 1996). The transgene had integrated very 
cleanly, as two head-to-tail copies with virtually no disruption of the flanking 
sequence or the transgene itself. The investigators postulate that the nearby 
presence of several motifs implicated in recombination events in the host DNA, 
coupled with short regions of homology at the ends of the transgene construct 
combined to favour a very clean integration. As well as shedding some light on 
the mechanism of transgene integration, the nature of the transgene sequence 
itself allowed the investigators to go on to speculate and make some suggestions 
towards designing transgene constructs which might integrate more cleanly into 
the host genome e.g. incorporating a recombination-associated sequence, such as 
the "Chi-like motif", (the mammalian homologue of the yeast Chi sequence, 
believed to be an initiation site for meiotic crossover) into the transgene construct 
near its ends. This might promote precise integration by recruiting the natural 
cellular recombination machinery.
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Clearly, the above is speculative at present, but as more transgene 
integration events are characterised at the sequence level and our understanding 
of the precise mechanisms involved increases, it may become possible to design 
transgene constructs to favour clean integrations.
At a more practical level, a new and highly efficient method of generating 
transgenic mice has recently been described which differs significantly from the 
traditional pronuclear micro-injection route. The new technique involves 
incubating the transgene DNA briefly with sperm before injecting a single sperm 
head into the cytoplasm of an unfertilised egg (Perry et al, 1999). The authors 
claim that between 64% and 94% of embryos developing from injected eggs 
expressed the transgene construct, figures considerably higher than those 
associated with pronuclear microinjection, generally <20% (Hogan et al, 1994). 
Intracytoplasmic sperm injection (ICSI) has been tried in the past as a vehicle for 
the introduction of transgene constructs, but the results were disappointing, with 
very low rates of transgene integration (Lavitrano et al, 1989a; Lavitrano et al, 
1989b). The critical differences between the original experiments and the more 
recent successes achieved by Perry and co-workers hinge upon pre-treatment of 
the sperm heads to partially disrupt the membrane and upon the use of a piezo­
electric injector to introduce the sperm head to the oocyte. Given access to the 
interior of the sperm, transgene DNA has been shown to rapidly and reversibly 
associate with internal membrane structures and to "decorate" the sperm  head. 
This appears to greatly enhance the likelihood of the transgene integrating with 
the host genome.
Although these experiments are unrepeated as yet, should the initial 
promise of this technique be borne out, it could well supplant pronuclear 
microinjection as the method of choice for generation of transgenic mice.
Aims of the project
Rationale
Some 92 independent transgenic lines had been derived in our laboratory 
during the course of research into the nature of the imprinted Igf2/H19 loci (Ward
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et al., 1997). 78 of these lines were shown to transmit the transgene construct 
through the germline, with most of these lines expressing the luciferase reporter at 
detectable levels in a tail biopsy, facilitating ready detection of the transgene. With 
some research conclusions already draw n from the expression levels and patterns 
of the various constructs, a number of the transgenic lines were now considered 
surplus to requirements and could be extinguished. However, given the 
availability of 78 transgenic lines which already existed as part of a separate 
study, it seemed wasteful to extinguish lines at the end of the experiments 
without first ascertaining whether a transgenic insertion had generated a 
serendipitous mutation. Two putative insertional mutations had already been 
observed during routine breeding. Given this, combined with the ease with 
which the transgene could be tracked during breeding, it was felt that the 78 lines 
represented a valuable opportunity to do a more comprehensive, relatively large- 
scale screen for insertional mutations.
Objective
It was hoped that at least one transgenic insertion had generated a classical, 
recessive loss-of-function mutation with a readily discernible phenotype, and that 
this could be mapped and characterised at a molecular and phenotypic level by 
the end of the project. Further mutants could be characterised to a lesser degree, 
given enough time.
The major drawback in a screen of this nature, discussed in more detail in 
Chapter 3, is that roughly half of all transgene insertional m utations to date have 
been found to be allelic with classical m utant loci. The danger in a project of this 
kind is therefore that a great deal of effort could be expended characterising an 
already well-studied locus.
With published frequencies of 5-10% of transgene insertions causing a 
visible phenotype, it seemed reasonable to expect several m utants to emerge from 
the primary screen (Meisler, 1992). It was therefore felt that, following 
preliminary investigations, judicious choice of which phenotype(s) to investigate 





Generation of transgenic mice
All transgenic mice were originally generated by the micro-injection of 
linear construct DNA into one pronucleus of an Fi zygote resulting from a cross 
between a C57BL/6Jc? and a CBACa? cross (hereafter abreviated as C57/CBA) 
(Ward et al., 1997). As well as having the advantages of hybrid vigour, including 
large litter sizes, this combination has been found empirically to respond well to 
superovulation and has been widely used in the production of transgenic mice 
(McLaren & Michie, 1954; Hogan et al., 1994).
Animal husbandry
Transgenic lines were maintained by both incrossing of randomly selected 
wild-type transgenic mice and outcrossing to C57/CBA Fi non-transgenics as 
required. This resulted in maintenance of hybrid vigour (McLaren & Michie, 
1954), but as a consequence the transgene was transmitted through various 
combinations of the C57 and CBA genomes.
Caesarean re-derivation
The protocol for Caesarean re-derivation during transfer of transgenic lines 
from Oxford to Bath, was designed to minimise the possibility of contact between 
sectioned neonates and maternal blood, which was assumed to be contaminated 
with virus (it was further assumed that any viruses present did not cross the 
placental barrier during gestation). Caesarean re-derivation was performed by 
setting up matings in Oxford between homozygous animals, where such were 
known to exist, or hemizygotes with either transgenic or non-transgenic 
C57/CBA Fi partners. The mothers were transported to Bath and sacrificed by 
cervical dislocation on day 18.5 of gestation. The bodies were then dipped in 70% 
ethanol at 37°C, and the uterus dissected out and rinsed in sterile phosphate
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buffered saline (PBS) (Oxoid) at 37°C to remove traces of maternal blood. A 
second person was then required to dissect out the foetuses, which were then 
passed to a third person for revival and fostering to a host mother. Host mothers 
were usually MF1 mice which had given birth the same day (or in non-ideal 
circumstances, the day before) and whose own litter had been removed up to four 
hours previously.
Luciferase assay
This was performed essentially according to W ard et al. (1997). Animals 
were tested for the presence of the transgene by taking a tail biopsy on or around 
day 4 post-partum  and freezing this at -20°C. The thawed tail was then vortexed 
in lOOpl luciferase assay cell lysis buffer (25mM Tris.HsPCh, 2mM DTT, 2mM 
CDTA, 10% glycerol, 1% Triton X-100, pH 7.8), and re-frozen at -20°C to assist cell 
lysis. lOjil aliquots of the re-thawed lysate were then assayed in duplicate for 
luciferase activity, using 50pl luciferase assay substrate (Promega) in an E.G. & G. 
Berthold AutoLumat LB953 luminometer, or 50pl Genglow-1000 luciferase assay 
substrate (LabTech) in an Anthos Lucy 1 luminometer (LabTech). Light emission 
was counted for 10s in each case. Lines which expressed low levels of luciferase 
required homogenisation of tail samples in lysis buffer to release additional 
enzyme, and this was performed using the 0.1-5ml dispersing tool of an IKA- 
Labortechnik Ultra-Turrax T8 homogeniser (about 10 s at m edium  speed).
Genomic DNA preparation
This was performed according to Hogan et al. (1994) w ith modifications. 
Mice were euthanased by intra-peritoneal injection of 50-100}il 200mg/ ml sodium 
pentobarbital (Rhone Merieux), or anaesthetised by inhalation of Halothane BP 
(Rhone Merieux). Following euthanasia or recovery anaesthesia, a 5-15mm tail 
biopsy was obtained and placed in 525jd tail buffer (50mM Tris.HCl pH 8.0, 
lOOmM EDTA, lOOmM NaCl, 1% SDS) containing 285fig/m l proteinase K 
(Boeringher Mannheim). This was digested overnight at 55°C, and then treated 
with 0.7pg/m l RNase A for 1 hr at 37°C. NaCl was added to 1.25M, and then an 
equal volume of chloroform/isoamylalcohol 24:1 (vol/vol) was added and gentle 
mixing allowed to occur for 2 hr at room  temperature. The solution was spun in a
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micro-centrifuge at 15000rpm for 10 min, and the upper, aqueous layer removed 
to a fresh tube. To this was added an equal volume of propan-2-ol, and mixed 
gently to precipitate the DNA. This was then spun down at 15000rpm for 10 min, 
and the supernatant aspirated off. The pellet was washed for 1 hr at 4°C with 
300pl ice-cold 70% ethanol, spun down, and the ethanol aspirated off. The 
genomic DNA pellet was then dissolved in lOOpl TE (lOmM Tris.HCl pH 8.0, 
ImM  EDTA) by mixing on a roller overnight at room  tem perature or leaving at 
4°C for several days.
Transgene genotyping by PCR
Some lines failed to express luciferase in sufficient quantities to be reliably 
detected using the assay above, and these litters were tested for the presence of 
the transgene using PCR. Following a luciferase assay in which it was impossible 
to distinguish samples positive for the transgene from background, the remaining 
80(0,1 of lysate containing the tail fragment was diluted into 525pl tail buffer and 
genomic DNA prepared as in the section above.
O.lpl genomic DNA solution (about 0.05pg) was added to 24.9jil PCR 
reaction master mix to give final PCR reaction conditions (optimised for Mg2+ 
concentration) of: 75mM Tris.HCl pH 9.0, 20mM (NHi)2S04, 0.01% Tween-20 
(Advanced Biosciences reaction buffer IV), 3mM MgCl2(Advanced Biosciences), 
250pM dATP (Promega), 250pM dCTP, 250pM dGTP, 250joM dTTP , 0.5 units 
"Red Hot" Taq DNA polymerase (Advanced Biosciences Inc.) and 0.2pM each of 
four primers:
IGF2-03 (5'-CAGTTTGTCTGTTCGGACCGCGGC)
(bpl60-183 of Igf-2 exon 4)
IGF2IN-89 (5'-TCACTGCCTTCTGTGAGCAGTGAG)
(from Igf-2 intron between exons 4 and 5)
LUCIF-41 (5' -GTGTTGGGCGCGTTATTT AT CGG A )
(bp 668-691 ofP 3 -luc)
LUCIF-42 (5'-GGGTTGGTACTAGCAACGCACTTT)
(bp 1341-1364 of P3-luc)
PCR reactions were denatured for 5 min at 94°C, then cycled at 94°C for 1 
min, 62°C for 1 min, 74°C for 1 min for 36 cycles, followed by 10 min final
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extension at 74°C. 10pl of each reaction was run  on 2% agarose gels, stained with 
ethidium bromide and examined.
Primers IGF2-03+IGF2IN-89 give a 420bp product from the endogenous Igf- 
2 gene, which should be present in samples from all mice.
Primers LUCIF-42 and LUCIF-42 give a 696bp product from the luciferase 
coding region, which should only be present in samples from transgenic mice.
Probes used in Southern and Northern blots
Probes derived from the transgene construct are illustrated 
digrammatically in Figure 1 on page 69 (the constructs have been described 
previously in W ard et. al. (1997)). A Luc probe based on the 5' end of the 
luciferase coding region was cut out from construct vector P3MM (used to make 
M construct transgenic mouse lines) with Hindlll/BstEII and the appropriate 
743bp band purified from the gel using the Qiagen gel extraction kit (Qiagen) 
according to the manufacturer's instructions. A P3 probe specific to the Igf2 P3 
promoter region (and the endogenous Igfl gene) was prepared by digestion with 
BamHI and H indlll and purifying the appropriate 265bp band. A CCD probe, 
specific to the 3' end of the transgene construct (and the endogenous Igf2/H19 
intergenic region) was cut out from plasmid pl80.49A containing the H  construct 
by digestion with EcoRI and BstEII and the appropriate 1144bp band was gel 
purified as above. A DMR probe based on the 5' differentially methylated region 
of the Igfl gene was prepared from construct vector p l76a.l4  (used to make G 
construct transgenic mouse lines). The plasmid was digested with Bam HI and 
Pvul to give a 2.8kb fragment which spans the DMR, and this was gel purified for 
use as a probe.
Probes representing the 5' and 3' end of the SoxlO cDNA which excluded 
the highly conserved HMG box were obtained cloned into the Bluescript Sk(-) 
vector (Stratagene) (Southard-Smith et al., 1998). Both probes were cut out by 
digesting their respective vectors w ith EcoRI and Kpnl and gel purifying the 
appropriate bands. The 5' probe contained 606bp of the SoxlO sequence upstream 
of the XmnI site at position 676 relative to the transcription start site. The 3' probe 
contained 1294bp of SoxlO sequence commencing at the PvuII site just 
downstream of the HMG box.
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Col9al probes COL9A1-1 (corresponding to the 3' end of the mRNA and 
recognising both isoforms) and COL9A1-2 (corresponding to the 5' end of the long 
isoform) were as described by Savontaus et al (1998). The COL9A1-1 probe was 
prepared by digesting the plasmid pMCOL9Al-l w ith Kpnl and EcoRI and 
purifying the 444bp band from a gel as described above. The COL9A1-2 probe 
was prepared in a similar manner using an EcoRV digest to liberate the 792bp 
probe fragment from plasmid pMCOL9Al-2.
Southern blotting and hybridisation
24pl (representing 5-15pg) of genomic DNA samples were digested with 
restriction enzymes overnight and run  on 1% agarose gels. Following staining 
with ethidium bromide and photography of the markers, the gels were capillary 
transferred onto Hybond-N (Amersham) membranes under high salt 
denaturating conditions according to standard procedures (Sambrook et al., 1989). 
DNA was cross-linked to the membrane either by UV cross-linking or by baking 
at 80°C for 2hr.
10-50ng of purified probe was labelled to high specific activity with 
Redivue a 32P-dCTP (Amersham) using the High-Prime labelling kit (Boeringher 
Mannheim), according to the manufacturers instructions, w ith nucleotide 
incorporation allowed to proceed for lh r  at 37°C. Unincorporated nucleotide was 
removed using G-50 spin columns, as follows: The reaction was stopped by the 
addition of 5pl of stop solution (5% SDS, 50mM EDTA, 0.25% bromophenol blue) 
and made up to lOOpl by the addition of 75pl TNE buffer (lOOmM NaCl, lOmM 
Tris.HCl, pH 7.5, ImM  EDTA). This was then applied to a 0.9ml column of 
Sephadex G-50 Superfine beads (Pharmacia) prepared in a 1ml syringe barrel with 
a glass wool frit and packed and pre-equilibrated in TNE. The column was then 
spun for 5min at 250g and the eluate collected. A further lOOpl of TNE was 
applied to the column, the column spun and the eluate collected and pooled with 
the first aliquot. The resultant 200pl of labelled probe solution was denatured 
before use by boiling at 100°C for lOmin, chilled on ice and added to the 
hybridisation mixture.
47
The cross-linked filter was pre-hybridized at 65°C for 2hr in 30ml "Church 
& Gilbert" hybridisation buffer (500mM Na2HPC>4 pH  7.2, Im M  EDTA, 7% SDS, 
1% BSA, 100pg/ml sonicated salmon sperm DNA) (Church & Gilbert, 1984) or in 
30ml "FBI buffer" (10% PEG 8000; 7% SDS; 1.5x SSPE) (K. Foley, Zymogenetics 
Inc., pers. comm.). The use of FBI hybridisation buffer (used in FBI crime labs) 
was found to give enhanced sensitivity at the expense of increased background. 
The filters were then hybridized for 12hr at 65°C in 15-30ml fresh hybridisation 
buffer containg >106cpm / ml denatured probe , then washed twice for 15 min at 
65°C in 40mM Na2H P 0 4pH 7.2, ImM  EDTA, 5% SDS, 0.5% BSA, followed by two 
washes for lh r  at 65°C in 40mM Na2HP04 pH  7.2, Im M  EDTA, 1 % SDS. The 
filters were then briefly rinsed at room tem perature in 40mM Na2H P 04 pH 7.2, 
ImM EDTA, w rapped in SaranWrap and pu t down for autoradiography with 
blue sensitive X-ray film (Genetic Research Instrumentation) or with Kodak X- 
Omat AR film (Sigma) or with Kodak BIO-Max film (Sigma) at -80°C with 
intensifying screens.
Image scanning and densitometry
X-ray films of Southern blots were scanned on a UMAX S6E flat-bed 
scanner using Vista-Scan software to generate 256 greyscale TIFF images. 
Contrast and gamma were adjusted using Adobe Photoshop V4.0 and the scans 
were analyzed quantitatively using NIH Image Win95 Beta V3 (Scion 
Corporation) and its "Gelplot 2" macro, to give numerical values representing the 
integrated density of each band by measuring the area under the peak.
Alizarin red/alcian blue skeletal preparations
This was performed according to Hogan et al. (1994) with modifications. 
Mice were euthanased by intra-peritoneal injection of 50-100pl 200mg/ml sodium 
pentobarbital (Euthatal, Rhone Merieux), skinned, eviscerated and muscle tissue 
trimmed off. The carcasses were then fixed in ethanol for 5 days, rinsed in water 
for a few minutes, and transferred to staining solution for 4 days: 1 volume 0.3% 
alcian blue (Gurr) dissolved in 70% ethanol, 1 volume 0.1% alizarin red (Raymond 
Lamb) dissolved in 95% ethanol, 1 volume glacial acetic acid, 17 volumes 70% 
ethanol. The stained preparations were washed in distilled water for a few
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minutes, then cleared in 20% glycerol, 1% KOH until the bones were visible 
(several weeks), then dehydrated through a 70%, 80%, 90%, 100% ethanol series 
and stored and photographed in methyl salicylate (BDH).
FISH
Metaphase chromosome spreads from splenocytes
This protocol was based upon that used in the MRC Hum an Genetics Unit, 
Edinburgh (M. Lee, pers. comm.) with modifications. Splenocytes were found to 
proliferate more readily and yield more metaphase chromosome spreads when 
spleens from two or more animals were pooled together.
Following sacrifice by cervical dislocation or intra-peritoneal injection of 
Euthatal, spleens were dissected out into PBS and then transferred into roome 
temperature RPMI1640 medium (Glutamax II variant, Gibco-BRL) in a 5cm petri 
dish. Spleens were then pricked all over with a 26G syringe needle, and using one 
needle to hold the spleen steady, a second needle was used to inject 5-10ml of 
medium into the body of the spleen to flush out cells into the surrounding 
medium. The spleen was then discarded and the cells pelleted by spinning the 
medium down for 6min at 400g. The supernatant was removed, and the cells 
resuspended in 5ml of pre-warmed splenocyte culture m edium  (RPMI1640 
containing 15% fetal calf serum(Gibco-BRL) and O .lm g/m l gentamicin sulfate 
(Sigma). Various volumes of cell suspension ranging from 0.2 to 2ml were added 
to 5ml total volume of splenocyte culture m edium  in a 15ml snap-cap round- 
bottomed polystyrene tissue culture tube and lipopolysaccharide (from Salmonella 
enteriditis, Sigma #L-6011) was added to each tube to a final concentration of 
50pg/m l (stored at -20°C as a 5m g/m l stock in H 2O). Cells were cultured with 
lids left on loosely in 5% CO2 at 37°C for 44 and 46hrs (independent cultures). 
They were then optionally treated with demecolcine (Sigma) added to 0.1pg/ml 
for 30min. This can give more spreads, but the chromosomes are more condensed 
and G-banding is impaired. Cells were spun down for 6min at 400g, supernatant 
removed, and cells were resuspended in 1ml freshly made room temperature 
0.56% w /v  KC1 (75mM). Cells were resuspended by adding this hypotonic 
solution dropwise and flicking the tube vigorously between additions. After the
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first 1ml had been added, the suspension was carefully overlaid with 9ml 
hypotonic solution and left for lOmin at room  temperature. The swollen cells 
were then spun down for 6min at 400g, the supernatant carefully aspirated off, 
and the cells were fixed by the addition of 1ml freshly made methanol:glacial 
acetic acid (3:1). As before, this was added dropwise, w ith vigorous flicking of the 
tube between additions to resuspend the cells and prevent clumping during 
fixation. After the first ml had been added, the suspension was carefully overlaid 
with 9ml of fixative and left overnight at 4°C. The next day, the cells were spun 
down for 6min at 400g, fixative removed, and the cells were resuspended in 10ml 
fixative, spun down and supernatant removed. This was repeated, followed by 
final resuspension of cells in 0.1-0.5ml fixative.
Glass slides which had been previously cleaned overnight in absolute 
alcohol/concentrated HC1 1:1 (vol/vol), washed extensively in deionized H2O, 
and stored in absolute alcohol were placed in deionized water for 5min before 
use. They were removed from the water and given a single wipe with a piece of 
tissue moistened in deionized H 2O. If this did not result in a uniform thin film of 
water on the slide (i.e. if any beading was observed), the slide was discarded. lOpl 
of cell suspension was applied directly to the wet slide using the tip of a Gilson 
pipette. The resulting spreads were allowed to air-dry at room  temperature for 
several hours, then placed under vacuum with no desiccant for 72hr at room 
temperature. They were then ready for use in FISH experiments, but optimal G- 
banding was obtained if the slides were subsequently left at room  temperature 
(without vacuum) for around 14 days. This accords w ith the recommendations 
given by E.P. Evans (Hogan et at, 1994).
M etaphase chromosome spreads from embryonic fibroblasts
This was performed essentially according to Hogan e t al. (1994). E12-E15 
embryos were dissected from the uterus and placed in a small petri dish in 
Medium 199 (Sigma) containing 25mM HEPES (Sigma) w ith Earles salts (Sigma), 
2mM L-glutamine (Sigma) and 10% foetal calf serum (Gibco-BRL). The yolk sacs 
were assayed for luciferase to determine which embryos were transgenic. The 
livers were rem oved from the embryos. The embryos were then teased apart 
using forceps to release cells. The cell suspension was transferred to a second dish
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and incubated in 5% CO2 at 37°C to generate embryonic fibroblasts. Once the 
cells were judged to be growing in log phase (24-36 hr), they were treated with 
0.05|ig/m l demecolcine (Sigma) for 2 hr to induce mitotic arrest. The cells were 
trypsinised and pipetted up and down to generate a single-cell suspension. The 
suspension was removed, serum-containing m edium  added to neutralise the 
trypsin, and the cells were pelleted by centrifugation at 500g for 5min. The 
supernatant was discarded and the cells resuspended in hypotonic KC1 solution 
and thereafter treated exactly as in the preceding method.
Metaphase chromosome spreads from peripheral lymphocytes
Lymphocyte culture was performed essentially according to McFee et al. 
1997) and was found to be successful for hum an blood, but not for mouse. Adult 
mice were sacrificed by intraperitoneal injection of Euthatal and exsanguinated 
into heparinised syringes. For hum an experiments, 10ml was removed from the 
median cubital vein of the arm into a heparinised syringe. Whole blood (l-2ml 
from each mouse) was carefully layered onto 0.5 volumes density gradient 
centrifugation medium Histopaque 1077 (Sigma) and centrifuged at 1000# for 
15min. Most of the upper yellow (plasma) layer was then discarded and the 
middle white monocyte layer (enriched for small lymphocytes) was carefully 
removed, leaving behind the bottom red layer containing the erythrocytes. The 
cell suspension was then mixed with 10ml PBS and centrifuged at 1000# for lOmin 
to pellet the cells. The cell pellet was washed with 10ml PBS and resuspended in 
2ml mitogenic culture medium: Medium 199 (HEPES modification, Sigma), 15% 
foetal calf serum (Gibco-BRL), 2mM L-glutamine (Sigma), O .lm g/m l gentamicin 
sulfate (Sigma), 6pg/m l phytohemagglutinin (PHA-P lectin, Sigma), 3.3pg/ml 
lipopolysaccharide (E. Coli serotype 0111.B4, Sigma). Cells were cultured at 37°C 
with 5% CO2 for 48hr then democolcine added to 0.05pg/ml and left for 2hr to 
induce mitotic arrest and chromosome spreads prepared exactly as in the 
preceding methods.
Probe template purification
Transgene probes were prepared from vector Bluescript 2 SK(+) 
(Stratagene) containing the H construct, consisting of the Igf-2 P3 promoter, Luc
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coding region and the conserved central domain (CCD) lying between the Igf-2 
and the H19 loci (Figure 1). The construct was purified away from the vector 
backbone by performing a triple restriction digest w ith Sail, Nhel and Pvul, then 
running the restriction fragments out on a 1% agarose gel and purifying the 3kb 
band corresponding to the transgene construct using a Geneclean II gel extraction 
kit (Anachem), according to the manufacturer's instructions. Purified construct 
was re-dissolved in H 2O to a concentration of ~100ng/pl and 0.5pg aliquots 
labelled with either biotin or digoxigen by nick translation.
The Dvl probe, corresponding to 17kb of genomic sequence from the Dvl 
locus on Chr 4 contained in a phage lambda cloning vector, was obtained (D. 
Sussman, University of Maryland School of Medicine, Baltimore, USA) as purified 
DNA and labelled directly by nick translation.
Probe labelling
This was performed according to Wilkinson e t al (1992) with 
modifications. For biotinylated probe, 5pl (corresponding to 500ng) of purified 
DNA was added to the nick translation mix, which was assembled on ice, and also 
contained: 2pl lOx nick translation salts (0.5M Tris.HCl pH  7.5; 0.1M MgSQi; ImM 
dithiothreitol; 500pg/ml BSA fraction V (all from Sigma)); 2.5pl 0.5mM dATP 
(Pharmacia), 2.5pl 0.5mM dCTP (Pharmacia), 2.5jil 0.5mM dGTP (Pharmacia), 
2.5pl 0.5mM bio-16-dUTP (Boeringher Mannheim) and lp l of RNAse-free DNAse 
I (Pharmacia) which had been freshly diluted 1:500 in ice-cold H 2O. This totalled 
a reaction volume of 19jo,l, which was mixed and spun down briefly to collect. To 
this was added lp l of E. Coli DNA polymerase I (Sigma) to give final reaction 
conditions of 50mM Tris.HCl pH 7.5, lOmM MgSC>4, O.lmM DTT, 50jig/m l BSA, 
62.5mM dATP, 62.5mM dCTP, 62.5mM dGTP and 62.5mM bio-16-dUTP. The 
reaction was incubated at 15°C for 90min and then stopped by the addition of 2pl 
0.2M EDTA and lp l 5% SDS followed by incubation at 65°C for lOmin. The 
reaction was then made up to lOOpl by the addition of TNE and unincorporated 
nucleotide was separated from the labelled probe using G-50 spin columns as 
described previously under 'Southern blotting'. 5fil of lO m g/m l sheared salmon 
sperm DNA (Sigma), 50pl of 3M NH 4 acetate pH4.6 and 500pl of ice-cold absolute
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ethanol were then added to the probe mixture and the DNA allowed to 
precipitate overnight at -20°C. The precipitated DNA was pelleted by spinning at 
12000g for lOmin, the supernatant removed, the pellet washed with 1ml 70% 
EtOH, dried and re-dissolved in 50pl of TE for use in the hybridisation cocktail.
For digoxigenin labelling of probe, an identical procedure was followed, 
except that the biotinylated nucleotide was replaced with 1.5pl 0.5M d l'l'P and lp l 
0.5M dig-ll-dU TP (Boeringher Mannheim).
G-banding
This was based upon standard protocols, with modifications (Franke & 
Oliver, 1978; Wilkinson, 1992; Hogan et al.f 1994). Giemsa stain stock was prepared 
by dissolving 7.63g Giemsa powder (BDH) in 500ml glycerol by leaving it for 
30min in a 50°C water-bath with periodic mixing. This was allowed to cool and 
500ml methanol added. This stock solution was filtered and stored at room 
temperature.
After aging as described above, slides bearing chromosome spreads were 
equilibrated in 2xSSC (lxSSC = 15mM Na citrate, 150mM NaCl pH 7.0) for 5min 
at room temperature, then incubated in 2xSSC at 60°C for lh r  in glass coplin jars. 
The jars were removed from the water bath and allowed to cool for 5min then 
cooled to room  temperature by placing them (with lids) under a running cold tap. 
The slides were then equilibrated in PBS. Trypsin solution was made fresh by 
diluting 0.25ml Difco Bacto-trypsin stock (dissolved in H 2O and stored at -20°C) 
(Difco Labs #0153-60-2) in 50ml PBS. Slides were then dipped in trypsin solution 
for varying times ranging from 5-30s (this required optimisation for each batch of 
slides) and then briefly rinsed in lOmM sodium phosphate buffer pH 6.8 followed 
by staining for 15-20min in 50ml freshly prepared Giemsa stain (1ml Giemsa stock 
in 50ml lOmM sodium phosphate buffer pH  6.8). Slides were then rinsed in 
deionized H 2O and air dried.
Following staining, the resultant G-banding was documented (without 
mounting) the same day and the immersion oil removed by 2 x lm in  incubation in 
xylene:ethanol (1:1) in a fume hood. Giemsa stain was then removed by 2x5min 
washes in methanol:acetic acid (3:1). the destained chromosome spreads were 
then re-fixed in 4% paraformaldehyde in PBS for lOmin, followed by 4x5min
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washes in PBS, then briefly rinsed in deionized H 2O and air-dried. Slides were 
taken through to FISH within 24hr.
Hybridisation
This was performed according to the protocol used in the MRC Human 
Genetics Unit, Edinburgh, with modifications. If slides had not been G-banded, 
pre-treatment with RNase was necessary. Slides were equilibrated in 2xSSC at 
room temperature for 5min, then incubated in O .lm g/m l RNase (Sigma) for lh r  at 
37°C. Slides were then washed briefly in 2xSSC then dehydrated by taking them 
sequentially through 70%, 90% and 100% EtOH (2min in each) and air-dried 
under vacuum for lOmin. Slides which had been G-banded the previous day were 
simply equilibrated in 2xSSC and dehydrated without the RNAse treatment.
During RNAse treatment, the probe cocktail was prepared. For each slide, 
a tube was prepared containing 5pl labelled probe DNA (~50ng), 2\i\ mouse 
genomic C0t-1 DNA (Gibco-BRL) and 2 volumes of absolute EtOH. The DNA was 
precipitated and the pellet dried by evaporating the 21pl of liquid in a speedivac. 
The dried pellet was resuspended in 15pl hybridisation mix (stored at -20°C) 
consisting of 50% formamide (Ultra grade, Sigma), 2xSSC, 1% Tween-20 (Sigma) 
and 10% dextran sulfate (Sigma) by incubation for at least 15min at 37°C during 
slide treatment. The DNA was denatured by incubating the hybridisation cocktail 
at 70°C for 5min, then left at 37°C for around 30min to pre-anneal the C0t-1 DNA 
to any repetitive sequence elements of the probe. It is considered desirable to 
synchronise probe preparation with slide preparation, but longer pre-annealing 
times did not seem to affect results.
Dried slides were placed in an oven at 70°C for 5min to pre-warm then 
placed in pre-warmed denaturing solution at 70°C for exactly 2min. This 
consisted of 50ml 70% formamide, 2xSSC in a coplin jar, and this step was 
performed in a fume hood. Following denaturation, slides were immediately 
plunged into ice-cold 70% EtOH and left for 2min, followed by dehydration 
through 70&, 80% and 100% EtOH at room tem perature as before, then dried 
under vacuum.
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Slides were pre-warmed on a 37°C hotplate for no more than 2min, then 
used to pick up the 15pl of pre-annealed hybridisation cocktail which had been 
placed on a 22x22mm coverslip on the hotplate. The edge of the coverslip was 
sealed with Tip-Top rubber cement ( Cat #5059128, Rema Tip-Top UK, Westland 
Square, Leeds LS11 5X5), and slides hybridised overnight at 37°C without the 
need for a humidity chamber.
Following overnight hybridisation, the rubber cement was carefully peeled 
off, and the coverslips allowed to fall off by leaving the slides in 2xSSC for lOmin. 
Slides were then washed by incubation in a 45°C water-bath in pre-warmed 
2xSSC, 50% formamide (4x3min), 2xSSC (4x3min), followed by high-stringency 
washes in O.lxSSC at 60°C (4x3min). Slides were then equilibrated in SSCT (4xSSC 
0.1% Tween-20) at room temperature for lOmin prior to detection.
Detection
All antibodies were diluted in SSCTM, prepared by dissolving 5% non-fat 
milk (Sainsburys) in SSCT, and spinning this solution for lOmin at 3000g to clarify 
it. The diluted antibodies were further clarified to remove particulate matter by 
spinning at 15000g for lOmin. All antibody incubations were carried out at 37°C 
in a hum idity chamber, applying 50pl per slide under a coverslip. Washes in 
between antibody incubations consisted of 3x2min washes in SSCT at 37°C.
For green detection of biotinylated probe, slides were blocked in SSCTM 
for 30min, then incubated in avidin-FITC (Vector) diluted 1:500 for 30min, 
biotinylated anti-avidin (Vector) diluted 1:100 for 30min, followed by another 
round of 1:500 avidin-FITC for 30min. For red detection, avidin-Texas Red 
(Vector) was substituted for avidin-FITC. For detection of digoxigen-labelled 
probe, slides were incubated in sheep anti-digoxigenin-FITC (Boeringher 
Mannheim) diluted 1:15, followed by anti-sheep FITC (Vector) diluted 1:200.
Following antibody incubation and final washes, slides were incubated in 
the dark for 5min in PBS containing 0.25fig/ml 4,6-diamidino-2-phenylindole 
(DAPI) (Sigma), followed by 2x5min washes in PBS. Slides were then mounted in 




Slides were examined on a Leica DMRB microscope equipped with 
epifluorescence illumination and appropriate filter blocks. Spreads were located 
at low power, then examined and photographed at xlOOO magnification using a 
lOOx oil immersion objective and a cooled CCD camera (Hamamatsu) linked to an 
IBM-compatible PC equipped with a frame grabber card. Images were captured 
and processed for contrast and brightness using Image Pro Plus V3.0 software 
(Media Cybernetics), and were then transferred into Adobe Photoshop V5.0 for 
false colouring and merging of fluorescent images from multiple channels.
For G-banding, it was found empirically that the best images (those 
showing the greatest fine banding detail) were obtained by first setting up Kohler 
brightfield illumination, then using phase ring 1 rather than the brightfield setting 
in the condenser turret (it should be noted that the xlOO objective was not rated 
for phase contrast). This was believed to be caused by a decrease in numerical 
aperture, leading to an increase in both contrast and depth of field, but a decrease 
in resolution (V. de las Casas, pers. comm.). Much the same effect could be 
achieved by stopping down the aperture diaphragm  under normal brightfield 
illumination, but this was found to be slightly inferior to the first method.
Multiple G-banded spreads were documented and their locations noted 
using the X-Y stage ruler on each slide prior to destaining and FISH hybridisation. 
The same spreads could then be located following FISH.
Histology
Fixation, embedding and sectioning
Tissue blocks were fixed in Zamboni's fixative overnight at 4°C, prepared 
by mixing 200ml 0.2M Na phospate buffer pH  7.3 with 200ml 2% 
paraformaldehyde and 70ml saturated picric acid (Culling, 1974). The fixed 
blocks were then dehydrated through 70%, 80%, 90%, 95%, 95%, 100% and 100% 
EtOH (lOminutes - 1 hour in each, depending on tissue block size), cleared in 
xylene or Histoclear (National Diagnostics), and then imbedded in paraffin wax.
Tissue sections were cut at between 5 and 10pm, floated on a water-bath 
and dried onto slides which had been previously subbed with TESPA (3-
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aminopropyltriethoxysilane) (Sigma), as per standard procedures (Wilkinson, 
1992).
Haematoxylin & Eosin (H & E) staining
This was performed according to standard procedures (Bancroft & 
Stevens, 1977). Ehrlich's haematoxylin was either purchased pre-prepared 
(Raymond Lamb) or made by dissolving 2g haematoxylin (BDH) in 100ml 
absolute EtOH, then adding 100ml glycerol, 100ml deionised H 2O, 10ml glacial 
acetic acid and 15g potassium alum (A1KS04.12H20)(BDH), mixing and allowing 
to ripen for 2 months before use.
Slides were dewaxed in Histoclear 2 x 3min, then rehydrated through 
100%, 100%, 95%, 90%,70% and 50% EtOH (2min in each), followed by lm in  in 
deionized H 2O and lOmin in Ehrlich's haematoxylin. Slides were washed in 
running cold tap water for lm in  to turn the stain blue, rinsed in deionised H 20 
then differentiated by dipping in acid alcohol (1% conc. HC1 in EtOH) for 15s 
followed by 30s in 1% NH 3 in 70% EtOH. Slides were then left in 70% EtOH for 1 
min and stained for lm in  in Eosin Yellow (BDH)(0.1% in 70% EtOH). Slides were 
then dehydrated through an ethanol series: lm in  each in 70%, 90%, 95%, 100%, 
100% EtOH, 2 x 2min in Histoclear and m ounted under coverslips in DPX 
m ountant (BDH).
Periodic acid-Schiff reaction (PAS) staining
This reagent reacts with tissue carbohydrates and stains 
mucopolysaccharides and other glycoproteins magenta, emphasizing certain 
basement membranes in particular. PAS staining was performed essentially 
according to standard procedures (Culling, 1974; Bancroft & Stevens, 1977), 
except that in some cases the Schiff's reagent (Feulgen stain) was purchased pre­
prepared (Raymond Lamb). Otherwise, Schiff's reagent was prepared by 
dissolving lg  basic fuchsin (BDH) in 200ml boiling deionised H 2O, removing the 
flask from the heat just before the addition of the dye. Once the solution had 
cooled to 50°C, 2g of potassium metabisulfite (BDH) was added and dissolved by 
mixing. Once the solution had cooled to room  temperature, 2ml conc. HC1 was 
added and the mixture allowed to stand overnight in the dark. The following
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day, 0.2g activated charcoal (BDH) was added and the mixture shaken for 2min. 
This was then filtered through No. 1 W hatman paper and stored in a dark bottle 
at 4°C for no more than two months.
For staining, slides were dewaxed in Histoclear 2 x 3min, then rehydrated 
through 100%, 100%, 95%, 90%,70% and 50% EtOH (2min in each), followed by 
lm in  in deionized H 2O. They were then incubated in freshly-prepared 1% w /v  
periodic acid (BDH) in distilled H 2O for 6min, followed by 3min wash in running 
tap water and lm in  in distilled H 2O. They were then incubated for 15min in 
Schiff's reagent which was stored at 4°C and had been allowed to warm to room 
temperature before use. Slides were then washed for 5min in running tap water, 
then counterstained in haematoxylin, dehydrated and m ounted as described for 
H&E staining, with the exception that the time in haematoxylin was reduced to 1- 
2min only, since PAS accentuates the nuclear staining seen w ith haematoxylin.
Immunofluorescence
Following dewaxing and rehydration, 7pm sections of m utant and wild- 
type colons from Harry mice were blocked by incubation in SSCTM for 30min at 
37°C. Following washes in SSCT (3x2min at 37°C in all cases), the slides were 
incubated with either SSCTM (control) or 50pl rabbit anti-neurofilament (Sigma) 
diluted 1:100 overnight at 4°C. The next day, the slides were washed and 
incubated with biotinylated anti-rabbit diluted 1:200 for 30min at 37°C, washed 
again and incubated with streptavidin-Texas red (Vector) diluted 1:200 for 30min 
at 37°C, Slides were then equilibrated in PBS, counter-stained with DAPI and 
mounted in Vectashield as described previously for FISH detection.
a-PCNA immunohistochemistry
Following dewaxing and rehydration, antigen retrieval was performed: 
Slides were pressure cooked for lm in  in lOmM citrate buffer pH 6.0 (the pressure 
cooker was filled w ith sufficient buffer to cover the slides, brought to the boil, the 
slides were placed in it and the lid sealed. Timing began once the pressure 
indicator rose to visibility), then washed for 3 x 5min in PBS + 0.1% Tween-20 + 
0.01% sodium azide (PBST) at room temperature. Endogenous peroxidase activity 
was then quenched by incubating slides for 5min in 3% hydrogen peroxide
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(Sigma) in tap water, followed by 30min in 0.5% hydrogen peroxide in methanol. 
Slides were then washed 3 x lOmin in PBST. Slides were immunostained using 
the MOM (Mouse on Mouse) kit (Vector), designed to allow the use of mouse 
monoclonals on mouse tissue sections without incurring undue background. This 
is achieved using proprietary blocking reagent, the nature of which was not 
disclosed, and kit-specific biotinylated anti-mouse IgG. Slides were blocked for 
lh r  at room temperature in the blocking reagent supplied w ith the kit diluted as 
per the manufacturer's instructions. They were then incubated at 37°C for 30min 
in monoclonal a-PCNA clone PC10 (Dako) diluted 1:200 in the diluent supplied 
with the MOM kit. Slides were then washed 3 x lOmin in PBST, followed by 
incubation in biotinylated anti-mouse-IgG (supplied with MOM kit) diluted 1:250 
in kit diluent. Slides were incubated in this secondary antibody layer for lOmin at 
room temperature, then washed 3 x lOmin in PBST. Slides were then incubated 
for 5min at room temperature in ABC kit streptavidin-horseradish peroxidase 
complex (Vector), prepared according to the manufacturer's instructions 30min 
previously. Following the final 3 x 5min washes in PBT, the slides were stained in 
diaminobenzidine (DAB) substrate prepared from the ABC kit according to the 
manufacturer's instructions, with the nickel compound added to give a blue-black 
coloured substrate. The substrate reaction was allowed to proceed for 5-10min, 
with staining monitored under the dissecting microscope, and stopped by placing 
the slides in distilled H 2O at the appropriate time and incubating for lOmin. 
Slides were then lightly counterstained in methyl green (0.1% in distilled H 2O) for 
30s, followed by rapid dehydration and mounting in DEPX. This was found to 
give optimal contrast to the antibody staining.
Documentation
H & E or PAS stained slides were photographed on a Leica DMRB or a 
Nikon Eclipse E800 microscope using brightfield illumination and Kodak 
Ektachrome 64 film. Images were digitised using a Nikon Coolscan 35mm slide 
scanner and colour balance and contrast adjusted using Adobe Photoshop V5.0.




Isolation of total RNA
This was performed according to the manufacturer's instructions using TRI 
reagent (acid guanidinium thiocyanate phenol chloroform extraction) 
(Chomczynski & Sacchi, 1987).
50-100mg of tissue (brain, kidney, hindlimb or eye) was removed from 
animals immediately after sacrifice and placed in 1ml TRI reagent (Sigma) on ice. 
This was homogenised using the 0.1-5ml dispersing tool of an Ultra-Turrax T8 
homogeniser (IKA-Labortechnik), and the homogenate clarified by spinning at 
12000g for lOmin at 4°C. The supernatant was removed (avoiding fatty scum at 
the surface) and allowed to stand for lOmin at room temperature, then 0.2ml 
chloroform was added and the tube shaken vigorously to mix the phases and left 
to stand for 15min at room temperature. The mixture was spun at 12000g for 
15min at 4°C and the upper, aqueous phase removed to a fresh tube. 1/10 volume 
propan-2-ol was added to this and following mixing, this was allowed to stand at 
room temperature for 5min, then spun down at 12000g for lOmin at 4°C. The 
supernatant was removed and RNA precipitated by the addition of an equal 
volume of propan-2-ol. This was mixed and allowed to stand for lOmin at room 
temperature, then the RNA pelleted by spinning at 12000g for lOmin at 4°C. The 
supernatant was removed and the pellet washed with 1ml 75% EtOH. The pellet 
was spun down again, the supernatant removed, and the pellet was allowed to 
air-dry for lOmin at room temperature, then re-dissolved in DEPC-treated H 2O 
(for RT-PCR and Northerns)or in formamide (for Northerns only) by incubating it 
at 55°C for 15min with occasional vigorous pipetting using a Gilson, lp l 
recombinant RNAse inhibitor (Promega) was added in some cases.
SoxlO RT-PCR
For diagnostic SoxlO RT-PCR, two pairs of nested primers were used 
whose positions and orientations are illustrated diagrammatically on Figure 18 in 
chapter 7. The sequences of these primers were as follows:
S o x l 0 - 9 8  5 ' - C T G T C C A G C C A G G G T G T T T G - 3 '
S o x l O - 9 9  5 1 - T C T C A G G T C C T G G G A T A G A G - 3 '
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S o x l O - 9 6  5 ' - A G G T C A A G A A G G A A C A G C A G G A C G - 3 '
S o x l O - 9 7  5 ' - G C A G G T A T T G G T C C A G C T C A G T C A - 3 '
The first PCR was performed using the Access RT-PCR kit (Promega) 
which allows first strand reverse transcription and amplification using a pair of 
PCR primers to occur in a single reaction. This kit has the added advantage that 
the reverse transcriptase used (Avian Myeloblastosis Virus (AMV) reverse 
transcriptase) can operate at 48°C. This higher working tem perature obviates 
some of the RNA secondary structure formation which can cause premature 
termination of reverse transcription w ith enzymes which operate at lower 
tem peratures (Promega Corporation, 1995).
0.5pg total RNA was placed on ice and the other reaction components 
added: lOpl 5x reaction buffer (proprietary reaction buffer supplied with Access 
RT-PCR kit, composition unknown), lp l dNTP mixture (lOmM each nucleotide), 
3.25pl 15pM SoxlO-98 primer, 3.25pl 15pM SoxlO-99 primer, 2jil 25mM MgSCh 
and nuclease-free H 2O to a total volume of 48pl. To this was added lp l (5U)AMV 
reverse transcriptase and lp l (5U) Tfl DNA polym erase.Ihe reaction was mixed, 
spun dow n and incubated at 48°C for 45min to produce reverse transcribed first 
strand product. It was then denatured at 94°C for 2min, then 40 cycles were 
performed, w ith each cycle comprising 40s at 94°C, 30s at 55°C and 2min at 68°C, 
followed by final extension for 7min at 68°C, and cooling to 4°C.
lp l of the primary RT-PCR reaction was used as a template in a nested PCR 
using primers 96 and 97. 25pl PCR reactions were set up containing 75mM 
Tris.HCl pH  9.0, 20mM (N H ^SQ i, 0.01% Tween-20 (Advanced Biosciences 
reaction buffer IV), 2mM MgCl2(Promega), 250pM dATP, 250jiM dCTP, 250pM 
dGTP, 250pM d'lTP , 1U "RedTaq" DNA polymerase (Sigma) and 150nM each 
primer. Reactions were denatured for 5min at 95°C, then 40 cycles performed, 
with each cycle consisting of 45s at 95°C, 30s at 60°C and 2min at 72°C, followed 
by final extension for lOmin at 72°C and cooling to 4°C.
lOpl of the nested PCR was run  out on a 2% agarose gel, stained with 
ethidium bromide and photographed on a UV transilluminator using a black and
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white video camera (UVP) equipped with an appropriate filter and documented 
using a video graphic thermal printer (Sony).
Eyal RT-PCR
An Eyal probe was generated for use in Northern blotting using RT-PCR. 
The published cDNA sequences of Eyal, Eyal and Eya3 were aligned against each 
other using the Pileup function of the GCG software package, and regions of the 
Eyal message which were not conserved or not present in the other two family 
members (the sequence of Eya4 was not available in the databases at the time of 
experimental design) were used to design RT-PCR primers which would 
specifically amplify the Eyal message (Xu et ah, 1997b).
E y a I F - 1 1 0  5 ' - C C T C C T A T G G T G C A T T G T G G - 3 '
E y a l R - 1 1 1  5 ' - G G C T G G T G T T A C T G C T C G T C - 3 '
0.5pg of brain total RNA from a non-transgenic animal was used as a 
template for RT-PCR using the Access system, with reaction conditions exactly as 
described above for SoxlO RT-PCR. This was followed by nested amplification 
using the same primer pair, using O.lpl of the primary RT-PCR as a template. 25pl 
PCR reactions were set up containing 75mM Tris.HCl pH  9.0, 20mM (NH^SCh, 
0.01% Tween-20 (Advanced Biosciences reaction buffer IV), 1.5mM 
MgCl2(Promega), 250pM dATP, 250pM dCTP, 250pM dGTP, 250pM dTTP , 1U 
"RedTaq" DNA polymerase (Sigma) and 150nM each primer. Reactions were 
denatured for 5min at 95°C, then 40 cycles performed, w ith each cycle consisting 
of 45s at 95°C, 30s at 58°C and lm in  at 72°C, followed by final extension for lOmin 
at 72°C and cooling to 4°C.
Upon analysis of the PCR products on a 2% agarose gel, a single strong 
band of the predicted size of 320bp was observed. This band was cut out of the 
gel, purified using a Quiagen gel extraction kit (Qiagen) according to the 
manufacturer's instructions, and aliquots of the purified fragment were restriction 
digested with enzymes calculated to give a diagnostic pattern unique to the Eyal 
cDNA (utilising the presence of Knpl and XmnI sites which are not present in 
either Eyal or Eya3). The restriction digests gave the predicted fragments (data
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not shown), and it was concluded that the amplified fragment represented a 
320bp central fragment of the Eyal cDNA.
Northern blotting and hybridisation
Northern blots were performed according to standard protocols 
(Sambrook et a\., 1989) with modifications. RNA samples were analysed using 
1.2% gels: 4.2g agarose was dissolved in 304ml nuclease-free H 2O and cooled to 
65°C in a water-bath. To this was added 35ml lOx MOPS running buffer (lOx 
MOPS buffer = 200mM MOPS (3-[N-Morpholino]propanesulfonic acid)(Sigma) 
pH 7.0, 50mM Na acetate, lOmM EDTA) and 10.5ml 37% formaldehyde (Sigma), 
and the gel was immediately poured. RNA samples were prepared for loading by 
mixing up to 11.25pl RNA solution w ith 5pl lOxMOPS buffer, 8.75pl 
formaldehyde, 25pl formamide and bringing the total volume to 50pl. This was 
denatured for 15min at 55°C, 5pl lOx Ficoll loading buffer (Sambrook et al.r 1989) 
added and the samples loaded onto the gel and run  in lx  MOPS buffer for 18hr at 
50V. The gel was then capillary blotted (without pre-treatment) onto Hybond-N 
membrane and subsequent hybridisations with labelled probes were carried out 
exactly as described earlier under Southern blotting.
Linkage mapping
Microsatellite PCR
All primers were purchased as pairs (MapPairs, Research Genetics). Each 
primer pair used required optimisation of the Mg2+ concentration and annealing 
temperature. Following the recommended protocol from the W hitehead Institute 
(http://w w w .genom e.w i.m it.edu, 1999), primer pairs were tested at annealing 
temperatures of 54°C and 57°C using concentrations of 1.5mM and 3mM Mg2+.
All PCR reactions were carried out using 5pl of genomic DNA (prepared 
from tail biopsies exactly as detailed above) which had been diluted 1:150 in H 2O, 
corresponding to ~25ng of template DNA per PCR reaction. Reactions were 
carried out in a final volume of 20pl containing 75mM Tris.HCl pH 9.0, 20mM 
(NH4)2SO4, 0.01% Tween-20 (Reaction Buffer IV, Advanced Biosciences), 1.5mM
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or 3mM MgCl2 (Promega), 200pM dATP, 2 0 0 j iM  dCTP, 200pM dGTP, 200pM 
dTTP (Pharmacia), 1U "RedTaq" DNA polymerase (Sigma) and 133nM each 
primer. The results from experiments to determine optimal reaction conditions 
for each primer pair are summarised in Table 1:
Table 1. PCR conditions and results for microsatellite PCR prim er pairs




















D15Mit2 SoxlO 93 84 YES OK GOOD u/t u/t
D15M it238 SoxlO 122 134 u/n NO NO NO NO
D 15M itl SoxlO 184 188 YES NO YES u/t u/t
D15Mit71 SoxlO 118 132 YES GOOD u/t u/t u/t
Ednrb 136 121 u/n C57
ONLY
NO u/t u/t
D 14M itl97 Ednrb 94 90 YES GOOD u/t u/t u/t
D 2M itl48 Edn3 117 121 YES FAINT GOOD u/t u/t
D2Mit265 Edn3 103 146 YES C57
ONLY
GOOD u/t u/t
D4Mit263 Tcm 110 104 YES NO OK u/t u/t
D 4M itl01 Tcm 102 96 YES NO GOOD u/t u/t
D lM it64 Proximal 
Chr 1
110 104 u/n NO NO NO NO
D lM it66 Proximal 
Chr 1
158 170 YES GOOD u/t u/t u/t
u /n  = unknown; u / t  = untested; GOOD = strong bands; OK = satisfactory
(distinguishable) bands; NO = no specific products observed
Subsequent to this, with the exception of DlMit64, D14Mitl65, D4Mit263 
and D15Mit238, which could not be successfully amplified, PCRs were performed 
using the best conditions obtained from the results above.
Non-denaturing polyacrylamide mini-gels
Those PCR products with sizeable differences (>10bp) between C57 and 
CBA alleles could be analyzed on 10cm polyacrylamide minigels for test 
purposes, although it was found more convenient to run  large numbers of 
samples simultaneously on the larger sequencing gels detailed below.
Mini-gels were cast and run using the Mini-Protean II rig (Bio-Rad), 
according to the manufacturer's instructions. 12.5ml of 8% non-denaturing gel
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mix was prepared by mixing together 7.75ml H 2O, 3.3ml 30% acrylamideibis- 
acrylamide (19:1) (Bio-Rad) and 1.25ml lOxTBE buffer (lxTBE = 90mM Tris base, 
90mM boric acid, 2mM EDTA). Polymerisation was initiated by the addition of 
125pl freshly made 10% ammonium persulfate (BDH) and 15pl TEMED 
(N,N,N',N'-Tetramethylethylenediamine) (Sigma), the gel was poured and left to 
set for 30-60min at room temperature. The gel rig was then assembled, and the 
PCR reaction samples prepared by addition of lOx Ficoll loading buffer. 5pl of 
each PCR reaction was electrophoresed on the gels at 100V for lh r. Gels were 
then fixed in clean glass troughs in 200ml 40% methanol for at least 30min prior 
to silver staining.
Denaturing polyacrylamide sequencing gels
These were cast in sequencing gel rigs (Flowgen) assembled essentially 
according to the manufacturers instructions. Both glass plates were scrupulously 
cleaned with hot soapy water, cold deionized water, acetone and 70% EtOH. The 
notched plate was treated before every fourth rim  with repel silane (Sigmacote SL- 
2, Sigma), while the un-notched plate was treated every run  with 3pl of bind 
silane (Silane A-174, Electran grade, BDH) dissolved in 1ml of 70% EtOH 
containing 0.05% glacial acetic acid. In either case, silane was wiped over the 
surface of the plate, left for 5min, then the plate was cleaned 4 times with 70% 
EtOH. Following this, the plates and spacers were assembled, sealed with 
pressure-sensitive tape (Gibco-BRL) and the gel mix prepared.
Denaturing 6% urea polyacrylamide gels were prepared by dissolving 21g 
urea in 20ml Milli-Q H 2 0 ,10m l 30% acrylamide:bis-acrylamide (19:1) and 5ml lOx 
TBE. When this solution had warmed to room  temperature, it was filtered 
through a 0.22pm syringe filter (Gelman) and polymerisation initiated by the 
addition of 400pl freshly prepared 10% ammonium persulfate and 37pl TEMED. 
The gel was allowed to set for 2hr to overnight, then pre-run until it had warmed 
to 50°C using a tem perature probe linked to the power-pack (PowerPac 3000, Bio- 
Rad) to automatically vary the voltage to maintain this tem perature throughout 
electrophoresis. Alternatively, electrophoresis was performed at 45W constant 
power.
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Samples were prepared by adding 3x STR loading buffer (lOmM NaOH, 
95% formamide, 0.05% bromophenol blue, 0.05% xylene cyanol) and incubating at 
95°C for 2min, then placed on ice before loading 5pl onto the gel. A 24-well 
sharks-tooth sequencing comb was used to load sets of 24 samples at lOmin 
intervals, with the reactions being loaded in order of size, smallest first. 4 sets of 
PCR reactions could be loaded, resulting in visualisation of up 96 reactions on one 
gel.
The bind silane retained the gel firmly on the un-notched plate throughout 
silver staining, and the gel could only be removed at the end of staining by 
incubating it in 10% NaOH for 2 hours. An eccentric rotary shaker was used to 
incubate the sequencing gel and plate with 500ml of solution contained in a large 
plastic tray (purchased from a gardening centre).
Silver staining
This was performed essentially according to the manufacturers instructions 
included w ith a commercial silver stain kit (Bio-Rad) based on the method of 
Merril e t al 1981). Further modifications to this protocol were derived from the 
manufacturers instructions included with a second commercial silver stain kit 
designed to detect microsatellite PCR products on sequencing gels 
(http://w w w .prom ega.eom /tbs/tm d005/tm d005.htm l, 1993). Staining was 
performed identically for both gel types, the only difference being that solution 
volumes were 100ml for mini-gels and 500ml for sequencing gels. Following 
fixation, the gels were washed 2xl5min in 10% EtOH, then oxidised for 5min in 
dichromate oxidiser solution, purchased commercially as a lOx stock (Bio-Rad). 
The gel was then rinsed for 15min in several changes of deionized H 2O until all 
hint of yellow colouring was gone. It was then incubated for 20min in freshly 
made 0.1% silver nitrate (Sigma), rinsed for lm in  in deionized H 2O and developed 
in several changes of freshly-made developer solution, consisting of 2% sodium 
carbonate (Sigma) containing 0.005% formaldehyde. Developer solution was 
discarded and replaced after it started to turn "smoky-brown" due to the presence 
of silver precipitate. 3-4 changes were usually required to develop good staining.
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Documentation
Silver-stained gels were scanned using the same set-up described 
previously under Densitometry. It was found that the use of a dampened sheet of 






Origin of transgenic lines used in this study
A series of some 78 lines of transgenic mice had been generated in our 
laboratory by micro-injection of linear construct DNA into the pronuclei of 
fertilised eggs. Eight different constructs were used, in which regulatory elements 
from the murine insulin-like growth factor II (Igf-2) locus and the associated H19 
locus (Figure 1) drove expression of the firefly luciferase reporter enzyme (Ward 
et al.f 1997). Each transgenic line represented an independent integration event of 
one or more copies of the transgene construct at a single position in the genome, 
as determined by Southern blotting and breeding analysis. Most lines could 
readily be tested for the presence or absence, but not the copy number, of the 
transgene by performing a simple luciferase assay on a tail biopsy from one to five 
day old mice (at which time expression from the P3 promoter driving the 
luciferase gene was maximal). Those few lines which did not express luciferase at 
detectable levels in this assay could be genotyped by PCR or Southern blotting.
Nature of the transgene constructs
All eight transgene constructs contained an Igf-2 P3 prom oter region of 
153bp attached to the luc construct. This consisted of the firefly (Photinus pyralis) 
luciferase-encoding sequence followed by the SV40 small t 
intron/polyadenylation signal to ensure stability of the mRNA and proper 
expression of the gene product in mammalian cells (Caricasole & Ward, 1993). 
While this basic construct displayed minimal levels of expression in transgenic 
mice, seven of the constructs contained additional sequences from the Igf-2/H19 
region (Figure 2) which included enhancers and other regulatory elements which 
might have a role in  the regulation of both genes through genomic imprinting.
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Figure 1. The Igf2 and H19 loci and surrounding genomic regions
A lOOkb region of distal Chr 7 containing the Igfl and H19 gene, w ith the 
relevant regions used to make transgene constructs illustrated diagrammatically, 
along with transcription start sites and CpG dinucleotides which are known to be 
differentially methylated.
Figure 2. Transgene constructs used in this study
All transgene constructs contain the P3 promoter of Ifg2 linked to a 
luciferase reporter gene and a polyadenylation signal derived from SV40 (not 
shown). With the exception of the minimal construct M, all constructs contain 
various combinations of regulatory regions derived from the Igf2/H19 gene 
complex shown in Figure 1.
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Transgenic line names
The naming convention for transgenic lines was as follows: the construct 
letter gave the first letter of the line name and the sex of the transgenic founder 
mouse determines the sex of the name. Thus, Alicia is derived from a female 
founder carrying the 'A ' construct and Harry is derived from a male founder 
carrying the 'H ' construct. Although this scheme did not adhere to the 
conventions laid down for naming transgenic mice (Lyon et al.r 1996), it proved to 
be highly useful as a mnemonic aid during the course of these studies.
Research aims involving the transgene constructs
The transgene expression analyses form part of ongoing studies in Oxford 
and Bath, which are not strictly relevant to this project (Ward et al., 1997). Briefly, 
however, the closely linked Igf-2/H19 loci are imprinted in mice, with differential 
allelic expression depending upon paternal or maternal inheritance. The 
constructs were designed to determine the function of four elements of the Igf- 
2/H19 region in isolation from their normal genomic environment. Some of the 
functions of these elements may depend on cis interactions, and it is important to 
dissect out these regions in order to elucidate their precise behaviour. This is 
easier to do w ith injection transgenesis and comparison of multiple transgenic 
lines carrying different constructs, than with directed mutagenic experiments on 
the regulatory elements in situ in their normal environment. A consequence of 
these studies has therefore been the generation of a large num ber of independent 
transgenic lines.
Screening strategy
During the first stage of the screen a breeding programme was instigated to 
breed all lines to homozygosity and this is still an ongoing process. This simple 
screen was designed to detect m utant phenotypes, either by obvious physical or 
behavioural abnormalities amongst the litters, or by small litter size and absence 
of homozygotes, as assayed by breeding and Southern blots, which would suggest 
impairment of development in homozygous embryos. A number of possible 
mutants were detected by this means.
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The screen involved two phases for each line tested: Crossing hemizygous 
males against hemizygous females to test for homozygous embryonic or peri­
natal lethality among their offspring, or for other developmental effects on 
homozygous pups; and crossing transgenic animals against non-transgenic FI 
animals to test for homozygosity in both sexes w ithout obvious phenotype, thus 
eliminating this line from enquiries and permitting extinction of the line if 
appropriate. Hemizygous intercrosses are self-explanatory, since 25% of pups 
should be homozygous for the transgene, allowing for a simple screen for readily 
detectable phenotypes. The rationale behind the homozygous testing perhaps 
requires some clarification, however.
In the absence of a simple direct test for hemi- or homozygosity for the 
transgene (see the introduction to chapter 4 for a more detailed discussion of this 
problem) a breeding approach was adopted. Clearly, when crossing a transgenic 
animal against a non-transgenic, a hemizygote should generate equal numers of 
transgenic and non-transgenic offspring, while a homozygote should generate 
only transgenics. The question therefore becomes, how many transgenic offspring 
need be scored without observing any non-transgenic siblings before the parent 
can be designated homozygous for the transgene? Taking the null hypothesis to 
be that the (transgenic) parent is hemizygous, for a y} test to have significance, the 
expected numbers in each class must be at least 5 (Appendix A). At least 10 
offspring need to be scored therefore. In fact, if 11 offspring are tested, and all 
carry the transgene, the likelihood of the transgenic parent being hemizygous is 
less than one in a thousand (i.e. P<0.001), and this was chosen as a cut-off.
Caesarean rederivation
All lines used in this study were originally derived in Oxford. At the time 
of commencement of this project, it was planned to transfer all or most of the 
transgenic lines from Oxford to Bath. Unfortunately, stocks in Oxford proved to 
have been exposed to a variety of common mouse viruses, and it was decided that 
each line would have to be re-derived by Caesarean section before transfer to the 
animal house in Bath. Since the viruses do not cross the placental barrier, careful 
handling procedures during the re-derivation should have resulted in non-
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infected litters, which were raised by foster mothers. During this process, a 
number of developmental abnormalities came to light that might not otherwise 
have been observed, since still-born or abnormal pups are frequently consumed 
by the mother, leaving only an apparently healthy litter.
Caveats
It m ust be pointed out that the screening strategy, whilst having the 
advantage of simplicity, could easily have missed more subtle phenotypes, or 
those with variable penetrance or expressivity, particularly with regard to strain- 
dependent variable expression of m utant genes. A further pitfall was the 
possibility of spontaneous mutations and their reinforcement in the gene pool by 
the in-breeding necessitated by this strategy. The possibility of transgene- 
associated phenotypes appearing in hemizygous animals cannot be ignored, but 
the wealth of data on knockout mice and transgene insertions support the 
premise, as a first approximation, that mutations in many genes of developmental 
importance will only produce a phenotype in a homozygous environment (Copp, 
1995). That is to say, a single wild-type allele of the gene can, in most cases, give 
rise to normal development.
Results
General breeding data
Of the 78 original transgenic lines derived, 16 were bred to homozygosity 
in both sexes and in sufficient numbers with no observable phenotype (one 
homozygote of each sex was considered sufficient, unless the ratio of observed 
homozygotes deviated significantly from the expected 25%). These lines were 
therefore eliminated (data not shown for 14 of these lines), and 9 lines failed to 
breed and became extinct (Andrew, Edmond, Elton, Gloria, Heidi, Irk, Tessa, 
Theresa and Tutu).
Caesarean re-derivation was performed for the remaining 55 lines, but 
failed in a number of cases due to the mothers rejecting the fostered litters. A 
number of abnormalities came to light during Caesarean sectioning, and these,
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together with the results of the breeding programme are tabulated below. All 
homozygous animals were so designated on the basis that they produced at least 
11 transgenic offspring (and no non-transgenics) when crossed against non- 
transgenic animals.
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Viable animals genotyped by 
breeding 










Alicia 2 c? 3? NO NO 8 6 3 1
Amanda 5 c? 29 NO NO 2 4 1 1
Annabella 5d  5? NO NO 1 2
Ann 1 d  69 NO YES 3
Antonio 7c? 49 NO NO 1 4
Archy I d NO NO 1 2 1 4
Axe 6c? 4 9 YES NO 10 1 1
Ayah 5c? 7 9 NO NO 2 6
Azure 2c? 3 9 NO NO 5 2
Eleanor NO NO
Elvis 4c? 2 9 NO NO 5 7 1
Ethel 13c? 119 NO NO 3 6 1
Eva 10c? 8 9 YES NO 7 5 1 2
George 2c? 4 9 NO NO 2 13 2 2
Gertrude 14c? 89 NO YES
Grace 6c? 2 9 NO NO 6 10 1
Graham 3c? 2 9 NO NO 2 8 2 1
Gentian 16c? 189 NO NO 3 11 1
Hamish 4c? 6 9 YES NO 5 3 2 2
Harold 3c? 79 YES NO 3 4 3 7
Harry 2c? 3 9 NO YES
Helen 5 c? 1 0 9 NO NO
Helga 3c? 3 9 NO NO 10 7 1 1
Holly 2c? 59 NO YES
Ian 2c? 119 YES NO 2
Ibadan 12c? 119 NO NO 2 4 1 1
Ice 8c? 6 9 YES NO
Id 8c? 6 9 YES NO
If 10c? 4 9 NO NO 3 5 1 4
III 8c? 2 9 NO NO 4 1
In 6c? 9 9 YES NO 2 3 1
Ingrid 8c? 20 9 YES NO 2 9
Isac 7c? 9 9 NO NO
May 8c? 129 NO NO
































Ob 9 c? 8 9 NO YES 5
Oc 5 c? 8 ? YES NO 4 3 1
Odd 2c? 5 ? YES NO 1 1
Of
Oh
Oil 17c? 2 7 ? YES NO 7 i 1
Ok 8c? 119 NO NO
On 4c? 4 9 YES NO
Open 2c? 5 9 NO NO
Ost 6c? 109 YES NO
Oui 5c? 109 NO NO
Ovid 11c? 4 9 NO NO 3 2
Owl 5c? 3 9 YES NO 3 1 1
Tarquin 13c? 8 9 NO NO 1
Tiberius 0 NO YES
Tilly 4c? 4 9 NO NO 3 1 2
Tim 8c? 169 NO NO
Titus 9c? 9 9 NO NO 8 2 2
Tracy 8c? 3 9 NO NO 3 2 2




Ian 1 exencephaly, 2 omphalocoel,
1 "puffer" - fluid-filled thoracic region and pale appearance
Ice 1 "thalidomide" - stunted limbs
Id 1 thalidomide
In 1 hindleg deformity
Ingrid 1 thalidomide
Oc I hindlimb deformity - "paddle limb"
Odd 1 hindlimb deformity - "flipper foot"




Table 4. Mutants observed during breeding
Line Defect
Ann Poss. neurological defect - progressive paralysis 
and death by 3-6 weeks
Axe 1 craniofacial defect - lower jaw severely affected
Eva 2 "big-skulls" - grossly expanded crania
Hamish poss. sex ratio distortion - low numbers of females
Harry "piebald" runts
Holly blind mice - opaque corneas
Ob male sterile
Owl poss. sex ratio distortion - low numbers of females
Tiberius very poor breeder - poss. hemizygous phenotype, 
all transgenics "less robust"
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Harry
During early hemizygous intercrosses in Oxford (to raise stock for 
Caesarean re-derivation), Harry produced a litter of nine still-borns, seven of 
which appeared normal and may have been abandoned. The remaining two 
showed extreme ventral curvature, small size and highly abnormal skin texture 
and colour (Figure 3). Luciferase assays on the dead litter (Table 5) showed that 
both the abnormal pups were transgenic, although they showed extremely low 
luciferase activity compared to their transgenic littermates. This could be because 
the mutants had been dead for considerably longer than their siblings and the 
enzyme activity had started to degrade.
Table 5. Luciferase assays on still-born Harry litter born 5/12/95











































During breeding in Oxford (again, to raise stocks for re-derivation), it was 
observed that Holly consistently gave small litters, which were frequently 
consumed shortly after birth, or occasionally found dead in the cage. Whether 
neonatal death occurred through phenotypic abnormality or through being 
abandoned by the mother was indeterminate. All the transgenic pups derived by
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Figure 3. Still-born Harry mutants
Two presumptive m utant animals (centre and right) from a litter of nine, all 
found dead on the day of birth. A wild-type littermate is shown for 
comparison (left). Both mutants were transgenic, and showed extreme 
ventral curvature and highly abnormal skin texture.
Figure 4. W ild-type and Eva m utant skulls
a) Alizarin red/alcian blue preparation of a 4-week old skull from a wild- 
type mouse. In this preparation, bone is red, cartilage is blue.
b) Skull from a 4-week old transgenic animal from a hemizygous Eva 
intercross, showing marked cranial expansion. This is a composite of 






Caesarean from a single hemizygous intercross of the Holly line appeared 
normal at the time of birth. By about two weeks of age, three of the transgenic 
animals displayed distinct opacity of the corneas, which worsened with age.
Other possible msertional mutants observed
All hemizygous animals appeared phenotypically normal, with the 
possible exception of Tiberius, which showed consistently small litter sizes even 
when bred against non-transgenic animals, (and which subsequently failed to 
breed and became extinct) and Archy, which produced a large number of runts 
during breeding against non-transgenic animals.
2 lines had previously been found to display an abnormal recessive 
phenotype: Gertrude and Ann.
Ann m utant mice were relatively inactive, and when resting, lie on their 
sides rather than their bellies. They showed weight loss from around twelve days 
post-partum, together with tremors and kyphosis (hunched spinal posture). 
Paralysis increased until the mice died at 3-6 weeks of age.
Gertrude m utant mice appeared normal at birth but typically died 7-10 
days after birth (although one or two survived for some weeks), at which time 
they weighed 30-40% less than their siblings. They appeared to feed normally, 
since their stomachs contain milk whenever this has been examined.
Both of these mutations have formed the focus of parallel investigation in 
our laboratory.
The Ham ish line gave rise to one "wobbler" mouse, which showed a 
markedly awkward gait. This could have resulted from careless handling during 
sectioning, but may also reflect a skeletal or neurological defect.
An Eva hemizygous intercross gave rise to two pups with markedly 
enlarged crania, which were both transgenic. These were killed at about four 
weeks of age, and alizarin/alcian red skeletal preparations made, w ith calcified 
bone stained red and cartilage blue. Figure 4 shows one of these skulls with a 
normal skull for comparison. The highly visible cranial sutures (white) perhaps 
suggest intracranial pressure as a causal factor, rather than overproliferation of
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the skull plates. No further such m utants were observed during subsequent 
breeding of this line, however.
Possible Neural tube defects
Many of the sporadic abnormalities observed during Caesarean sectioning 
appeared to fall into distinct classes which are observed across multiple lines. 
These are tabulated in more detail in Table 3, but can be summarised as follows:
Limb deformity (fused digits, stunted or absent fore-limbs): In, Ice, Ingrid, 
Id, Oc and Odd.
Fluid-filled thoracic cavity ("Puffer" mutants): Owl, Ian, On.
Exencephaly: Ian, Harold, Hamish
It is notable that all of these defects, and the omphalocoele and sacro­
lumbar defects observed in Ian, Oil and Ost could be considered to fall within the 
gamut of neural tube defects (NTD), caused by failure of the neural tube to close 
at various sites along its length. While there is clear precedent for failure of neural 
tube closure as a cause of exencephaly, limb defects, omphalocoele and lower 
spinal defects, the thoracic oedema observed in some animals is perhaps worth 
discussing in more detail: Neural crest cells which migrate along the sixth aortic 
arch colonise the cardiac outflow tract. If this were to be disrupted by failure of 
the neural tube to close in the region of origin of this group of neural crest cells, 
this might lead to defects in cardiac outflow septation (truncus arteriosus) and 
oedema into the thoracic cavity. This would also help to explain the pale 
appearance of these mice, which had presumably lost most of their blood supply 
into the thoracic cavity. A similar oedematous phenotype is known to occur with 
variable penetrance in a mouse model for neural tube defects, the sp (Splotch) 
m utant which is deficient for the transcription factor Pax3 (Conway et al, 1997a; 
Conway et al., 1997b). However, in the sixth branchial arch, the Pax3 deficiency 
affects the migration of neural crest cells (via modulation of the extracellular 
matrix) rather than neural tube closure (Henderson et al., 1997). It is highly 
questionable whether failure to close the neural tube would affect the migration of 
trunk neural crest cells in this fashion.
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Discussion
Further lines of investigation
The m utant phenotype observed in some Harry animals was highly visible 
and characteristic, and this line was selected for further investigation. Chapters 4- 
8 cover this work in more detail.
However, the very visibility of a m utant phenotype can be a drawback, as 
this might prove to be a m utant allele of an already well-characterised locus. In a 
1992 review of 23 visible, viable insertional mutations in transgenic mice, it was 
notable that 13 of them  proved to be at known loci (Meisler, 1992).
It was decided that, rather than focus entirely on one line, which might 
well prove to harbour an uninformative m utation in a known gene, a second 
m utant line would be at least partially characterised. The phenotype observed in 
Holly suggested itself as an interesting line to pursue, and Chapters 9-13 detail the 
results of this parallel investigation.
Gertrude and Ann
The recessive phenotype displayed in Ann, while not forming part of this 
work, have been shown during the course of parallel investigations in our 
laboratory to be associated with the transgene and fully penetrant (D. Paisley, 
personal communication) and therefore can be considered as bona fide transgene 
insertional mutations. The phenotype observed in Gertrude, on the other hand 
was found not to be reproducible during subsequent breeding.
Other possible mutants
A num ber of lines showed small litter sizes in hemizygous intercrosses, 
with some giving birth to runts or transgenic still-borns, and these are being 
actively pursued through breeding to homozygosity (Annabella, Archy, Eleanor, 
111, Oui, On). It is possible that some of these lines have insertional events which 
cause foetal death in early or mid-gestation, giving rise to small litters, and this 
could be investigated by sacrificing mothers from hemizygous intercrosses and 
examining embryos in utero at earlier stages,
83
In addition, two lines showed possible sex ratio distortion throughout 
multiple litters, with Owl lacking males, and Ham ish lacking females. This might 
represent conditional male or female lethality.
Ob, whilst not showing any sex ratio distortion, appears to harbour a 
transgene-associated recessive trait causing male sterility - homozygous males 
plug females but have consistently failed to impregnate them. This is now being 
investigated in our laboratory, and may be a defect in spermatogenesis.
Tiberius failed to produce any litters from hemizygous intercrosses, and 
even crosses between transgenic animals and Fi non-transgenics produced small 
litters. It had been previously observed that the Tiberius line had been a 
generally poor breeder, with physically less robust animals, since its inception 
some years ago (L.Richardson, personal communication). This may reflect an 
insertional event which produced a phenotype in hemizygous animals. T iberius 
was not established in Bath and subsequently became extinct in Oxford through 
poor breeding.
Neural tube defects
Since some of the defects appeared remarkably similar in different 
transgenic lines, with presumptive different integration sites for the same 
construct, it is tempting to speculate that the phenotypic effects were caused by 
the transgene construct itself, rather than by an insertional effect on the host 
genome. Within this context, it is of interest to note that the constructs used to 
make the lines (H, I and O) in which these NTDs were observed all contain the 
centrally conserved domain (CCD), which has been proposed as the putative 
mesoderm-specific enhancer for the Igf2 locus (Koide et al., 1994; W ard et al., 
1997). Given that the notochord and somites are of mesodermal origin, it is 
possible that the constructs containing the CCD are highly expressed during 
development in these regions, and that this might, in some cases, perturb neural 
tube formation. The mechanisms of neural tube closure are very poorly 
understood, but it is clear that it is a multifactorial process which is exquisitely 
sensitive to perturbation (Copp, 1994).
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A further intriguing possibility is that, although the original investigators 
found no evidence for any transcripts deriving from the CCD, work in our 
laboratory has recently located a putative open reading frame (M. Charalambous, 
personal communication) at the 3' end. The CCD, and by implication those 
transgene constructs containing it, might therefore encode a functional RNA or 
protein. Multiple exogenous copies of such a molecule might conceivably have a 
dose-dependent effect upon tissues in which the endogenous gene acts.
A final putative mechanism by which CCD-bearing transgene constructs 
might exert an effect upon tissues of mesodermal origin lies in the CCD's 
suggested enhancer function: The CCD was originally identified as a DNAsel- 
hypersensitive region, which implies exposed chromatin, and possibly bound 
transcription factors and other ancillary proteins. It is possible that multiple 
exogenous copies of the CCD might also bind such transcription factors and "mop 
them up", thus perturbing normal gene expression in certain tissues.
While these phenotypic effects are likely to be independent of the 
insertional mutagenic events which are the focus of this project, the mechanism by 
which a putative cis-acting regulatory element linked to a luciferase reporter gene 
construct could produce neural tube defects is of considerable interest, and may 
be worth pursuing at some point in the future. One starting point might be to 
study the expression patterns of the various constructs in the mouse embryo at the 
time of neural tube closure, paying particular attention to differences in 
expression between constructs with and w ithout the CCD. It m ight also prove 
interesting to look for correlations between the lines most affected and the copy- 
number of the transgene or its expression levels in these lines.
CHAPTER FOUR:
HARRY - INITIAL CHARACTERISATION OF THE PHENOTYPE
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Introduction
As discussed in the previous chapter, during primary screening an initial 
hemizygous intercross using Harry mice generated two abnormal pups in a single 
litter of nine - a frequency consistent with a recessive m utant phenotype. 
Following Caesarean re-derivation and establishment of the Harry line in Bath, 
further hemizygous intercrosses were therefore set up w ith three initial aims: 
Firstly, to see if the phenotype was reproducible, recessive and fully penetrant. 
Secondly, to characterise the phenotype itself at a gross level w ith a view towards 
assigning candidate loci, should such exist. Thirdly, and vitally, to ensure that the 
phenotype truly was associated with the transgene i.e. that the transgene insertion 
site was genetically linked to the phenotype.
The first two objectives are self-evident - was the initial observation merely 
a fluke event, or was there a consistent recessive m utant trait present in the Harry 
transgenic line? If so, what was the nature of this trait?
The last objective is a little more subtle - due to space considerations when 
keeping 78 lines of transgenic mice, many of the lines in Oxford were propagated 
and maintained by inbreeding a very small population of mice. Referring back to 
Table 2, it should be noted that all Harry mice established in Bath are descended 
from only 2 males and 3 females which survived Caesarean re-derivation. All of 
the transgenic lines in this study could be considered to have been through at least 
one population bottleneck (not to mention the bottleneck necessarily incurred 
when deriving a transgenic line from a single founder mouse). Clearly, 
spontaneous mutations do occur at normal frequencies, and subsequent 
inbreeding can easily reinforce a m utant trait in a transgenic line. If the five Harry 
animals re-derived in Bath came from a single cross, 50% (or more) of them  could 
conceivably have been heterozygous carriers of a m utant allele which had nothing 
to do with the transgene insertion.
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Determining linkage between transgene and phenotype
There can be said to be two basic approaches to determining whether a 
m utant trait is associated with the transgene, one direct and one statistical. Both 
are predicated on the assumption that the m utant trait is fully recessive. The 
direct approach relies on being able to unambiguously detect animals 
homozygous for the transgene - if this is possible, then it becomes simply a matter 
of asking whether all observed mutants are homozygotes (linkage) and whether 
all homozygotes display the phenotype (penetrance).
Direct identification of homozygotes
There were a number of possible approaches to this problem:
Reporter specific activity: The luciferase reporter gene activity in the 
transgene constructs could be quantitatively measured in a luminometric assay, 
and such measurements could be converted into specific enzyme activity by 
measuring protein levels in the sample and dividing luciferase counts by protein 
concentration. In theory, comparison of specific activity levels w ithin a litter from 
a hemizygous intercross would allow identification of homozygotes. This method 
has been successfully used in E13 embryos in transgenic mice expressing a 
different luciferase reporter construct (Depierreux et al., 1997). During pilot 
studies in our laboratory however, it was found, at least in our hands, that the 
specific activities obtained by this method varied too widely to perm it such 
identification (data not shown).
Breeding: If the m utant animals were viable and fertile, they could be 
crossed w ith non-transgenic animals. Clearly, if no non-transgenic offspring are 
observed among a statistically significant num ber of transgenics, the m utant 
parent is likely to be homozygous for the transgene. This approach was 
successfully used in many lines during primary screening to determine 
homozygosity in the absence of a phenotype (see Table 2). Unfortunately, all 
Harry m utants died before reaching breeding age (see Results).
Southern blotting: Using a transgene-specific fragment to probe a
Southern blot of genomic DNA from a full hemizygous intercross litter 
(containing mutants and wild-type transgenics), densitometric measurements 
could be made from the X-ray film. Such measurements need to be divided by
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parallel results obtained from a probe which hybridises to an endogenous gene, to 
control for variation in the amount of genomic DNA loaded in each lane. The 
ratio of these two measurements gives a "specific activity" for the am ount of 
transgene present - homozygotes should be double the level of hemizygotes.
FISH: If metaphase chromosome spreads were made from all transgenic 
animals in a hemizygous intercross litter, these could then be probed w ith a 
transgene-specific probe. Homozygotes should give a signal on two separate 
chromosomes, hemizygotes on only one. This approach was viewed as a "last 
resort", as it was deemed to be very labour intensive and technically demanding. 
If a single animal in the litter failed to give chromosome spreads, then the 
experiment became partially invalid, since one could not then be absolutely sure 
of full linkage or penetrance. Alternatives were therefore explored initially.
It is also possible to perform FISH on interphase nuclei,usually on the 
white blood cells from a simple blood smear (Paris et ah, 1996). This was attractive 
because it is much less labour intensive than splenocyte culture and making 
metaphase spreads. Furthermore, only a drop of blood from each animal is 
required, so multiple attempts at genotyping can be undertaken.
Unfortunately, pilot experiments were not encouraging, due to high 
background and absence of convincing signals from the interphase nuclei (data 
not shown) and this approach was abandoned.
In the presence of high background, FISH on metaphase chromosome 
spreads has the advantage of being unambiguous - a "true" hybridisation signal 
can be distinguished from non-specific fluorescent spots by the presence of pairs 
of twin spots on replicated sister chromatids.
An intermediate approach which offers the advantages of both of the 
methods discussed above is to make metaphase spreads from lymphocytes 
cultured from blood. A published protocol used only 35-75pl of blood from a tail 
bleed to culture enough peripheral lymphocytes to make good metaphase spreads 
(Shi et ah, 1994). This offers the resolution and discrimination of FISH performed 
on chromosome spreads, combined with the fact that the test animal stays alive 
and the experiment can be repeated. However, during pilot studies (see
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Methods), the lymphocytes failed to proliferate in culture and this method was 
abandoned (data not shown).
A modified protocol was attempted, in which the mouse was sacrificed, 
completely exsanguinated to extract 2-4ml of blood and lymphocytes were 
partially purified by density centrifugation on a Ficoll gradient (McFee et al.,
1997). This method, too, failed to yield any chromosome spreads from mouse, 
although it was found to work very well w ith hum an blood. This reflects the 
experience of others (M. Lee, pers. comm.) in that culture conditions optimised for 
hum an lymphocytes or particular strains of mouse do not necessarily work well 
with all mice.
Another approach to making metaphase chromosome spreads utilised 
embryonic fibroblasts (Evans, 1987; Evans, 1994). These were derived from E12- 
E14 embryos (see Methods) and had the advantage that the cells could be frozen 
down and stored in liquid nitrogen for repeat experiments, but the distinct 
disadvantage that no obvious m utant phenotype could be discerned at this time, 
hence no correlation could be made between homozygosity for the transgene and 
phenotype. This method was found to yield good metaphase spreads, albeit at 
low frequency, but was abandoned in favour of the splenocyte culture method.
Overall, the splenocyte culture method for making metaphase chromosome 
spreads was found to be the most reliable and this was used to generate spreads 
for all FISH experiments shown in this work.
Linkage by statistical analysis
The null hypothesis was taken to be that there was no association between 
the transgene and mutants i.e. that the two traits were independently segregating 
alleles. The transgene is a "dominant" trait (since hemizygotes and homozygotes 
cannot be distinguished and are merely 'transgenic') and the m utant trait was 
assumed to be recessive. A hemizygous intercross therefore has a genotype of 
(Tg/+, M /m ) x (Tg/+, M /m ) where Tg represents the transgene and 'M ' a n d 'm ' 
are wild-type and m utant alleles of some independent locus. 
By Mendelian genetics, and assuming no linkage, this gives expected frequencies 
of:
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9/16 wild-type transgenic (Tg/Tg, M /M ; Tg/Tg, M /m ; Tg/+,
M /M ; T g/+ , M /m )
3/16 m utant transgenic (Tg/ +, m /m )
3/16 wild-type non-transgenic (+/+, M /M )
1/16 m utant non-transgenic. (+ / +,m /m )
Providing sufficient animals from hemizygous intercrosses are genotyped, a 
simple x2 test (see Appendix A) can be applied to see whether the null hypothesis 
can be rejected or not. Expected numbers for each class in a %2 test m ust be 5 or 
greater. Since the smallest class (mutant non-transgenics) represents only l /1 6 th 
of the population, this approach required that at least 80 animals from 
hemizygous intercrosses were bred and genotyped for the transgene.
During the time required to breed and collect this am ount of data, the more 
direct molecular approaches discussed above were also attempted.
Results
Gross phenotype
Following Caesarean re-derivation in Bath, hemizygous intercrosses were 
set up and throughout four subsequent generations to date, m utant animals have 
emerged from these at frequencies consistent w ith a recessive trait. Although 
appearing normal at the time of birth, the m utants showed significant retardation 
in both growth and the onset of fur growth, hence the m utant shown in Figure 5 
was completely nude at a time when its sibling possessed a full coat of fur. They 
frequently had a thin, malnourished appearance and distended abdomens.
The m utants also displayed limited skin pigmentation w ith occasional well- 
demarcated patches at the head and rear quarters of the animal, and w hen the fur 
did eventually grow, this pattern of pigmentation was reflected therein. Figure 6 
shows a full intercross litter with an unusually large num ber of mutants, 
displaying variegated patterns of coat spotting. Animal #5 has a clear patch of 
pigmentation in the mid dorsal region and this was found to occur at lower 
frequency than spotting at the head and rump. Ventral pigmentation was always 
entirely absent. Coat pigmentation in all m utants to date has been black i.e.
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Figure 5. 10-day old Harry littermates
O ne m utant and one wild-type animal at 10 days post-partum, derived 
from an early hemizygous intercross. The smaller animal entirely lacked 
pigmentation, had very little fur and was clearly debilitated in appearance 
and movement.
Figure 6. Full Harry intercross litter
A full litter from a hemizygous intercross, culled at 8 days of age, w ith an 
unusually large number of mutants. Non-transgenics are indicated by a 




C57BL/6 in nature, rather than the dominant brown (agouti) colour of the 
CBA background present in these crosses..
Most mutants either died or were killed before day 14, but all those 
allowed to live have so far died within four weeks with grossly distended 
abdomens. On dissection, the entire intestinal tract, apart from a small variable 
region of the colon, was usually found to be distended and full of liquid faecal 
material. This was suggestive of a blockage in the distal colon.
During subsequent intercrosses, it was observed that the degree of coat 
spotting was loosely correlated to growth retardation and time of death: Smaller 
animals tended to have less fur growth and skin pigmentation, more distended 
abdomens, and tended to die sooner, some by as early as day 6 post-partum. 
Larger animals lasted longer and tended to have more coat colouring. Figure 7 
shows two age-matched mutants from separate crosses (i.e. different parents) each 
with a respective wild-type sibling for size comparison (the wild-type animals 
were all roughly the same size within each litter). The lateral and dorsal views 
show the different degrees of coat spotting. It will be noted that the larger m utant 
has more coat spotting. Wild-type animals could be black or brown in coat colour, 
with brown the dominant colour, as predicted. Mutant animals were invariably 
black in colour when pigmented patches were present.
A single intercross litter produced 6 pups, two of which were fully wild- 
type, two mutants with very limited skin pigmentation and two apparently wild- 
type animals, which upon closer inspection both had small white belly spots. 
They were otherwise fully normal, and both were transgenic (presumed 
hemizygote). These were the only such animals observed in more than 200 "wild- 
type" transgenic animals from hemizygous intercrosses.
Association between transgene and phenotype
As mentioned in the introduction, a number of possible approaches to this 
problem were attempted, with statistical breeding analysis, densitometric analysis 
of Southern blots and FISH analysis of metapase chromosome spreads from 
splenocyte cultures being the avenues pursued in most detail.
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Figure 7. Variation in coat spotting in Harry mutants
a) 10-day old Harry m utant with wild-type sibling for comparison
b) 11-day old Harry m utant with wild-type sibling for comparison
c) Dorsal view of both mutants. The older m utant is considerably smaller 
and shows much less coat spotting.
d) Lateral view of both mutants.
Figure 8. Transgene genotyping by Southern blotting and densitometry
a) Scanned autoradiogram showing digested genomic DNA from a full 
Harry hemizygous intercross litter which has been Southern blotted and 
simultaneously hybridised with two probes, generating an endogenous 
band (DMR probe) and a transgene-specific band (Luc probe). 
Transgenic status (by luciferase assay) is shown above each sample. #1 
was a m utant animal, and the remaining 6 were wild-type.
b) Profile plots of the intensities of the endogenous and transgene-specific 
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Association by statistical analysis
Taking the null hypothesis to be that the transgene and the fully recessive 
m utant trait are at independently segregating loci, in a doubly heterozygous 
intercross, this gives a predicted Mendelian distribution of 9/16 transgenic wild- 
type, 3/16 transgenic mutant, 3/16 non-transgenic wild-type and 1/16 non- 
transgenic mutant. Data for 223 Harry pups from hemizygous intercrosses can be 
summarised into a 2x2 contingency table:
Table 6 Collated breeding data from multiple Harry intercrosses
wild-type m utant I
transgenic 124 52 176
(125.4) (41.8)
non-transgenic 47 0 47
(41.8) (13.9)
Z 171 52
Overall S = 223
Expected values are given in brackets below each observed value. 
Using the formula given in Appendix A, this gives
X2 = 16.5
and for 1 degree of freedom this gives P < 0.0001
This means that the null hypothesis can be rejected with a 99.9% confidence 
limit, or to pu t it another way: that the data obtained would be expected to occur 
at a frequency of less than 0.01% if the transgene and m utant locus were not 
linked.
Association by Southern blotting analysis
Figure 8 shows a scanned autoradiogram of a Southern blot probed with a 
transgene-specific and an endogenous probe (the probes corresponded to the 
regions marked DMR and Luc indicated on Figure 1) and the densitometric 
values obtained from the scanned image by integrating the area under each peak. 
Table 7 below shows the numerical values obtained from the scanned film, 
together w ith subsequent numerical analysis and correlation w ith genotype.
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Table 7. Densitometric analysis of Southern blotted DNA from  a single 















1 Mut + 36622 28077 1.30 + /+  ?
2 Wt - 14216 20046 0.71 - / -
3 Wt + 25468 25295 1.00 + /-
4 Wt + 16049 20852 0.77 + /-
5 Wt + 20751 23139 0.90 + /-
6 Wt . . 1438 14037 0.10
7 Wt + 16922 9739 1.74 +/+?
To casual inspection, the transgene signal in lane 1 appears to be strongest, 
and since this was the only m utant in the litter, this might support the conclusion 
that it was also the only homozygote. Indeed, taking the Luc/DM R value (the 
ratio of the respective integrated density measurements) as a measure of the copy 
number of the transgene, lane 1 (the mutant) has a higher Luc/DM R than lanes 
3,4, and 5, suggesting that it is a homozygote. However, lane 7 has the highest 
value of all, and this animal was wild-type. Furthermore, lane 2 has a value of 
0.71, which is close to the value for lane 4 (0.77), a wild-type transgenic. Since lane 
2 is clearly non-transgenic, this quantitative analysis has to be treated with a 
degree of suspicion. Lane 6 is also non-transgenic and has a Luc/DM R ratio of 
0.10, some seven times lower than that seen in lane 2. The variation in 
background levels makes it impossible to subtract background and normalise the 
ratios. Analyses of other Southern blots have proved equally ambiguous.
Association by FISH analysis
A full litter consisting of 7 pups from a hemizygous intercross was tested 
for the transgene by luciferase assay (data not shown). There were no non- 
transgenics in this litter. 3 of the pups showed a clear m utant phenotype at 6 days 
of age, and all were culled and chromosome spreads prepared from each 
individual. These therefore comprised 3 mutants and 4 wild-types. The spreads
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were then hybridised with the "H" construct - a probe specific for the transgene. 
FISH analysis clearly showed that all 3 mutants were homozygous, and all 4 wild- 
type transgenics were hemizygous (Figure 9).
Discussion
Harry transgenic mice carry a transgene-associated mutant trait
The Harry transgenic line showed a clear, reproducible m utant phenotype 
manifest in the progeny of hemizygous intercrosses at a frequency consistent with 
a recessive trait. The statistical analysis clearly showed tight genetic linkage 
between this m utant locus and the transgene.
The FISH analysis confirmed this linkage, and suggested full penetrance of 
the recessive phenotype in that all 3 homozygotes displayed a m utant phenotype.
While FISH analysis alone provided good evidence for linkage in this case, 
it should be borne in mind that the protocol proved to be technically demanding 
and that FISH genotyping was not working reliably during the early phases of 
this project. (With reference to the methods detailed in chapter 2, it will be noted 
that for efficient proliferation of splenocytes in culture, spleens from multiple 
animals needed to be pooled. This was clearly impossible in the genotyping of 
single animals, and the number and quality of spreads from some of the animals 
in the genotyped litter were very low.) Pending a working direct molecular 
approach, statistical analysis of breeding data was opted for because it offered a 
time-consuming but reliable method of establishing linkage.
Densitometric analysis of Southern blots proved an unreliable measure of 
transgene copy number. Two factors might have had a bearing upon this:
Firstly, the loading of genomic DNA in the tracks was uneven. Although 
spectrophotometric assay of the DNA samples was impossible due to the presence 
of varying amounts of contaminating protein, if a fluorimeter had been available, 
it m ight have been possible to accurately measure DNA concentration in these 
samples and hence achieve equal loadings on the Southerns.
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Figure 9. Harry genotyping by FISH analysis
Metaphase chromosome spreads from all 7 transgenic animals from a
Harry hemizygous intercross. Spreads were hybridised with a transgene-
specific probe (red) and counterstained with DAPI (cyan).
a), b) and c) Mutant animals. Two transgene signals can be discerned for
each (arrows), and these are all therefore homozygous (+/+)
d), e), f) and g). Wild-type animals. One transgene signal can be discerned
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Secondly, the autoradiograms were quantitated using a simple 256-level 
grayscale flatbed scanner. With the use of a laser-scanning densitometer, it might 
have been possible to obtain more accurate values for the bands seen on the films, 
or for the background, which would have allowed normalisation of the signal 
ratios. This might have facilitated unambiguous genotyping.
Candidate loci for disruption by the transgene insertion
The m utant phenotype observed closely resembled that associated with the 
sl (Piebald lethal) allele of the s locus with pigmentation restricted to the head and 
rear quarters, growth retardation and death at around 3 weeks of age (Lane, 1966; 
Lyon et al, 1996). As well as the s locus, mutations at two other loci are known to 
produce precisely this phenotype, and it is associated in all three cases with 
defects in the migration and colonisation of specific groups of neural crest cells.
Neural crest cells arise from the interaction between surface ectoderm and 
the neural tube shortly after the neural tube closes (around E8.5 in mouse). They 
then migrate away along the entire length of the neural tube following two major 
pathways initially (see Figure 10 below). The majority of crest cells follow the 
ventro-medial route, which lies along the anterior portion of the somites through 
clefts between the dermamyotome and the sclerotome. These then migrate to and 
colonise a wide variety of areas around the developing embryo, contributing to a 
very diverse range of structures (Le Douarin & Teillet, 1973). Neural crest 
derivatives form the bulk of the peripheral nervous system, with crest cells 
aggregating in clusters near the neural tube and forming the dorsal root ganglia of 
the spinal cord. Others form peripheral glia and myelinating Schwann cells, and a 
group of neuroblasts derived from neural crest migrate along the entire length of 
the gut wall, colonising it and giving rise to the enteric nervous system (Gershon 
et al.r 1993). This comprises both enteric ganglia controlling gut motility and a 
complex set of neuroendocrine cells of the gut. Neural crest give rise to a large 
and complex panoply of connective tissue structures, perhaps the most critical of 
these being the neural crest-derived cardiac septa discussed in the context of 
truncus arteriosus in chapter 3 (Conway et al, 1997a). Neural crest cells also form
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the cartilaginous elements of the lower jaw and related bones of the inner ear. In 
addition to this, neural crest cells of restricted fate arising from the anterior region 
of the neural tube (cephalic crest cells) contribute substantially to the bones of the 
skull and face.
Following ventro-medial migration of neural crest, after a short delay, a 
smaller number of neural crest cells migrate away from the neural tube along the 
dorso-lateral route, moving away from the posterior region of the somites in 
between the dermatome and the ectoderm (Erickson et al., 1992). These 
preferentially colonise the developing skin and differentiate into melanocytes. A 
few melanoblast-related neural crest cells migrate to the inner ear and make a 
highly specialised contribution to the cochlea. The only non-crest derived 
melanocytes are those found in the retinal pigmented epithelium, discussed 
below.
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Figure 10. Neural crest cell migration pathways and derivatives
(Reprinted from "Principles of Development, by Lewis Wolpert et. al. Copyright 
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In the piebald lethal phenotype mentioned above, there are primarily three 
classes of neural crest cell derivatives which are known to be affected
Firstly, the neural crest-derived melanocytes which give rise to skin 
pigmentation are reduced or absent and these were clearly defective in Harry, 
giving rise to the patchy skin colouring. The exact mechanism by which 
melanocytes colonise the skin and hair follicles in the mouse is uncertain, and the 
mechanism by which these large patches of unpigmented skin and hair are 
generated is controversial. However, it is thought that defects in neural crest cells 
which act early upon melanoblasts, as opposed to defects in differentiating 
melanocytes, tend to give rise to large patches of unpigmented skin, since removal
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of a single melanoblast can cause complete absence of melanocytes over a wide 
area.
Secondly, there are two classes of melanocyte forming the pigmented layer 
behind the retina. The thin layer of pigmented retinal epithelium immediately 
adjacent to the rods and cones is neuroectodermally-derived and is normal in 
piebald mice, but the layer of choroidal melanocytes embedded in the sclera 
outside and apposed to the pigmented retinal epithelium is neural crest-derived 
and absent. This led to an early description of piebald mice as "black-eyed 
whites", since they have white (or nearly so) coats, but unlike albino mice, possess 
dark eyes.
Thirdly, enteric neurons are depleted or absent in the colon due to 
defective migration and colonisation of the neural crest cells which populate the 
gut wall, and this aganglionosis leads to the condition of toxic megacolon 
(Webster, 1974; Bolande, 1975). Harry showed the gross signs of this, with the 
characteristic distended abdomen, and gut dissections revealed a severely 
constricted colon with faecal impaction and consequent distension.
The s locus gene product is now known to be the endothelin-B receptor 
(Ednrb), and a num ber of alleles exist. These have variable phenotypes dependent 
on the severity of their effects on the migration and differentiation of neural crest 
cells upon reaching their targets in the gut wall and the epidermis, leading to 
pigmentation defects and, in the case of piebald-lethal (which is a null allele of the 
Ednrb gene), failure to properly innervate the colon (Hosoda et al, 1994). In the 
absence of enteric ganglia, the resultant toxic megacolon (grossly enlarged colonic 
membranes and structures and lack of colonic peristalsis, w ith attendant blockage 
of the lumen) can cause systemic sepsis leading to growth retardation and death.
Death in  piebald mice is actually normally caused by systemic sepsis, 
rather than enteric infection, and this is thought to be an effect of the severely 
depressed immune system relating to the general debilitation caused by the 
colonic obstruction (Caniano et al, 1989), rather than any more subtle aspect of 
the m utant phenotype, since the same result can be observed in surgically- 
induced megacolon (Brann et al, 1977).
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It is interesting to note that no Harry mutants survived beyond 4 weeks, 
whereas in a study of classical piebald lethal (sl ) mice it was found that two 
distinct patterns of mortality were evident: some 64% of mice died at 3 to 4 weeks 
of age with severe enterocolitis, while the remainder died at 9 to 11 weeks with 
abdominal distension and megacolon (Fujimoto, 1988). This represents a less 
severe phenotype than that observed for Harry but this could be accounted for by 
allele or strain background differences. It may also be accounted for by an 
insertional event at the other recessive locus known to cause piebaldism -  the 
lethal spotted (Is) locus which encodes the cognate ligand for the endothelin 
receptor B, endothelin-3 (Edn3) (Baynash et ah, 1994). The Is null phenotype is 
almost identical to piebald-lethal (Lane, 1966), but shows subtle differences in the 
coat spotting, the aganglionosis and the timing of death, with Edn3 - /-  mice 
showing an appreciably milder phenotype than that seen in Ednrb - /-  mice.
A third locus, Dom (dominant megacolon), is known to cause the piebald 
lethal phenotype but this acts as an autosomal semidominant (Lane & Liu, 1984; 
Kapur et ah, 1996). Dom arose in 1984 as a spontaneous mutation in hybrid stocks 
(C3HeB/FeJLe-fl/fld' x C57Bl/6JLe$) maintained at the Jackson Labs. Following 
characterisation and fine-scale mapping studies over the last 13 years, the gene 
product of the Dom locus was recently identified by two independent groups as 
the SRY-related transcription factor SoxlO (Herbarth et ah, 1998; Southard-Smith 
et ah, 1998).
Homologous loci for Ednrb, Edn3 and SoxlO have all been identified in 
humans, and mutations at these loci are known to cause megacolon in new-born 
babies (Hofstra et ah, 1996; Kusafuka & Puri, 1997; Kuhlbrodt et ah, 1998c). This is 
known clinically as Hirschprung disease (HD), and has an incidence of 1 in 5000 
live births. It can also manifest in later life, but is usually found as a congenital 
defect and diagnosed within 3 months of birth (Robertson et ah, 1997).
Hirschprung disease presents as an heterogenous condition and a higher 
incidence is associated with other genetic disorders such as Down's syndrome and 
Waardenburg-Shah syndrome (discussed below). It is generally divided into three 
classes: The most common form, representing some 74% of patients is short- 
segment HD, in which aganglionosis extends as far as the rectosigmoidal junction.
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The second class is long-segment HD, where aganglionosis extends beyond the 
rectosigmoidal junction, but does not involve the small intestine. The last class, 
representing some 12-14% of patients, are the most severely affected group, in 
which aganglionosis extends beyond the ileo-cecal junction into the ileum, 
sometimes as far as the stomach (Martucciello, 1996; Robertson et al., 1997). Since 
HD is caused by incorrect enteric innervation, and since the enteric nervous 
system is derived from the neural crest, HD can be referred to clinically as a 
neurocristopathy, one of several (Martucciello, 1996).
HD provides a classic example of a multigenic congenital syndrome: as 
well as the three loci already cited, mutations affecting the c-ret proto-oncogene 
and its cognate ligands, glial-derived neurotrophic factor (GDNF) and neurturin 
have also been implicated in human cases of Hirschprung disease (Lyonnet et al., 
1994; Angrist et a l, 1996).
Applying "reverse genetics" to extrapolate from hum an genetic syndromes 
to mice, c-ret and its ligands should also be considered as candidate loci for the 
Harry mutation, c-ret is a tyrosine kinase cell surface receptor, and GDNF and 
neurturin have recently been identified as two of its ligands.
The c-ret protooncogene has been knocked out in mice, but can probably be 
excluded as a candidate locus for the Harry phenotype on the grounds that ret - / -  
mice die shortly after birth due to bilateral renal agenesis (Schuchardt et al., 1994), 
and also display total intestinal aganglionosis. GDNF-null mice exhibit a similar 
phenotype to ret - /-  mice, with renal agenesis and a complete lack of enteric 
neurons (Sanchez et a l, 1996). Mutations in the GDNF/r e t  system can therefore 
have a more severe effect on enteric neurogenesis than mutations in the 
endothelin system. Mutations at the RET locus are known to be a major cause of 
Hirschprung disease in humans (Martucciello, 1996). Interestingly, GDNF 
appears to be only a minor susceptibility locus for Hirschprung disease in 
humans, perhaps suggesting a degree of compensation by other neurotrophic 
factors which do not exist in the mouse (Angrist et al., 1996). This highlights the 
dangers of extrapolating from rodent models to the hum an disease condition. 
Neurturin has also been implicated in familial Hirschprung disease (Doray et a l,
1998).
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Hirschprung disease in humans is frequently found in combination with 
W aardenburg syndrome (WS). A Dutch eye doctor, P. J. W aardenburg, was the 
first to notice that some people with two different colored eyes frequently had 
hearing problems. Dr. Waardenburg went on to study other characteristics of the 
syndrome which is now named after him (Online Mendelian Inheritance in Man, 
h ttp :/ /w w w .ncbi.nlm .nih.gov/om im /, 1999).
These auditory-pigmentary syndromes are caused by physical absence of 
melanocytes from the skin, hair, eyes, or the stria vascularis of the cochlea, where 
neural crest-derived melanocytes of an unusual nature are found interspersed 
with neurectodermally-derived tissue and play a critical role in the formation and 
maintenance of the acoustic ganglion (Deol, 1967). There are 4 main classes of 
WS, with all featuring skin and eye pigmentary disturbances, along with cochlear 
deafness in some cases. WS1 and 2 are distinguished by the presence in WS1 of 
dystopia canthus (a subtle facial defect with a widened bridge of the nose due to 
aberrant development of the neural crest-derived facial cartilage, widely used as a 
pathognomonic indicator of this syndrome). WS3, also known as Klein- 
W aardenburg syndrome, features upper limb abnormalities including hypoplasia 
of the musculoskeletal system, flexion contractures, fusion of the carpal bones, 
and syndactyly, as well as the more usual facial and pigmentary disturbances. 
WS4, commonly referred to as Waardenburg-Shah syndrome, consists of WS 
combined w ith Hirschprung disease, and is the only member of this group of 
congenital disorders to consistently display an enteric phenotype (short-segment 
Hirschprung is occasionally seen in classic WS) .
All these syndromes affect neural crest derivatives in various ways, and 
WS1 and 3 have now been associated with a range of mutations in the Pax3 gene, 
with WS3 representing more severe mutations, (sometimes to homozygosity) in 
this gene (Read & Newton, 1997). Pax3 is a 'paired box' domain transcription 
factor w ith important functions in the specification and migration of neural crest 
cells. The upper limb abnormalities observed in WS3 are a result of defects in the 
migration of muscle pioneer cells, which, like neural crest, arise close to the neural 
tube and migrate to their sites of action. Whilst it is clear that Pax3 is expressed in 
neural crest cells, its mode of action in inhibiting their migration is not always
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cell-autonomous. Recent work has shown that Pax3 expression in tissues lying in 
the pathways of crest migration may serve to down-regulate expression of extra­
cellular matrix molecules which block such migration, and thus Pax3 could be 
considered to also be "clearing a path"for neural crest cells (Henderson et al., 
1997). There are a large number of m utant alleles of Pax3 in the mouse, the most 
widely known being the "Splotch" mouse, a useful model for neural tube defects 
(Copp, 1994). As the name suggests, Splotch, and several other alleles of Pax3, 
feature coat spotting in the mouse, but to date there has been no report of any 
mutation in Pax3 affecting crest-derived enteric neurons. It could perhaps be 
considered a weak candidate gene for the mutation seen in Harry.
In an interesting study using interspecific hybrids between Spretus and 
Splotch (Spd) mice, two modifer loci were m apped which strongly influenced the 
craniofacial phenotype seen in Splotch mice, reminiscent both of the heterogeneity 
seen across the spectrum of WS1 and WS3 patients and of the variation in coat 
spotting seen in Harry mutants (Asher et al., 1996).
In contrast to WS1 and 3, WS2 is a more heterogenous condition, with 
several distinct loci implicated. Some 15% of cases have been found to involve 
mutations at the M itf (micropthalmia-associated transcription factor) locus. This 
encodes a basic helix-loop-helix leucine zipper transcription factor, and again, 
there are a plethora of alleles at this locus in the mouse. Mutations at the M itf 
locus affect one or more of three different traits: eye size, pigmentation, and 
capacity for secondary bone resorption. However, although M itf is known to play 
a crucial role in the specification and differentiation of neural crest cells, in this 
regard it is thought to be specific for melanoblasts and terminally differentiating 
melanocytes (Opdecamp et al, 1997). None of the 20 alleles of this gene in mouse 
or hum an mutations in M itf have been shown to have an effect upon enteric 
neurons. This gene can probably therefore be discounted as a candidate locus for 
the m utation seen in Harry.
WS4 presents a more interesting case: Again, this is an heterogenous
syndrome with multiple causative and susceptibility loci. Given its similarity to 
mutants such as piebald lethal and lethal spotting in the mouse, it is hardly 
surprising that mutations in the hum an homologues of Ednrb, Edn3 and SoxlO
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have all been implicated in this condition. Interestingly, heterozygous mutations 
in the human EDNRB and EDN3 genes can cause Hirschprung disease alone, 
whilst homozygosity gives the full clinical picture of WS4. On the other hand, 
heterozygosity for mutations at the SOXIO locus can give the more severe 
Waardenburg-Shah condition. This parallels the situation in mouse, where 
mutations at Ednrb and Edn3 are recessive, whilst the only known mutaion in 
SoxlO is semi-dominant, with homozygosity being embryonic lethal. The 
situation is complicated in humans by the presence of susceptibility loci such as 
mutations in the GDNF gene, which by themselves may not show a phenotype, 
but which can modulate the severity of the phenotype seen with a heterozygous 
mutation at other loci such as RET (Angrist et a l, 1996).
WS4 does not feature dystopia canthus, hence the neural crest cells which 
give rise to cranio-facial structures appear unaffected despite a report that, in 
contrast to the situation in rodents, SOXIO is expressed in crest-derived facial 
mesenchyme during human embryonic development (Bondurand et a l, 1998).
Clearly, combined W aardenburg-Hirschprung phenotypes bear many 
similiarities to piebald lethal phenotypes in the mouse, as seen in Harry mutants 
(Martucciello, 1996). To date, the mouse homologues of the only known loci 
implicated in WS4 are the ones already discussed and considered above: Ednrb, 
Edn3, SoxlO and Ret and its ligands. This still leaves some 15% of hum an cases of 
WS4 unaccounted for however.
Modifer genes
It is curious that the extreme phenotype observed early during Harry 
breeding in Oxford (and shown in Figure 3) has never reappeared. However, 
strain background effects must be considered. In a recent analysis using piebald 
(s) mice inbred onto two different genetic backgrounds, six genetic modifiers were 
m apped which act as quantitative trait loci (QTLs) to modify coat spotting in these 
mice (Pavan et al., 1995). By implication, these loci interact with pathways 
involving the Ednrb gene, and could perhaps also modify the degree and extent of 
aganglionosis in piebald-lethal (sl) mice. In this context, it is interesting to note 
that the allele of the Ednrb gene used in these mapping experiments (the classical
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piebald mouse, s) is known to express the mRNA at levels of around 28% of wild- 
type but that this is sufficient to completely abrogate the aganglionic phenotype, 
although the mice still show coat colour spotting (Hosoda et al, 1994).
Extending the argument, similar (or indeed the same) QTLs might act to 
modify the phenotype observed in Harry piebald mice. This argument, whilst 
speculative, gains weight from the observation that the level of coat colour 
spotting and the growth retardation (and by implication, the severity of the toxic 
megacolon) was seen to vary widely between different crosses, with a loose 
inverse correlation between coat spotting and growth retardation. This strongly 
suggests that modifer genes are segregating independently of the transgene, 
probably differentially derived from the mixed C57B1 and CBA backgrounds used 
to propagate the strains.
Although the phenotype was considered to be fully recessive, two animals 
from the same litter (out of several hundred wild-type transgenics bred to date) 
showed a white belly-spot, but no other phenotype. Again, this can probably be 
explained with reference to modifier genes, with this cross containing a 
particularly "severe" combination which led to a very mild coat colour 
phenotype, even in presumptive hemizygotes with one m utant and one wild-type 
allele of the gene affected by transgene integration. Although these animals were 
killed, they could have been tested for homozygosity by FISH analysis. Given the 
severe nature of the mutation in homozygotes, however, it was considered 
unlikely that the very mild phenotype seen in these animals could have resulted 
from modulation of the phenotype in a homozygous animal.
Summary
Overall, at this stage of the investigation there could be said to be three 
strong candidate loci for the recessive m utant piebald lethal phenotype observed 
in Harry transgenic homozygotes. These are Ednrb, Edn3 and SoxlO. ret and its 
ligands were considered weak candidates, firstly due to the lack of any renal 
phenotype and secondly, due to the restricted nature of the gut phenotype.
The only evidence which might favour the Edn3 locus over the others is the 
observation that the coat colour of Harry m utants was always black. The black
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colour derives from the recessive a (non-agouti) allele derived from the C57 
background, and lies close to Edn3 on distal Chr 2. If the mutation seen in Harry 
mice was caused by transgene insertion into the C57 chromosome of the original 
injected C57/CBA Fi zygote, and if it were close to the Edn3 locus, it would be 
predicted to be linked to the recessive black coat colouration phenotype seen in 
these mice.
Clearly, the mutation seen in Harry does not necessarily have to be at a 
known locus. As for novel loci, it has been suggested that there is a second 
endothelin B receptor gene, since activation of the receptor with the specific 
agonist sarafotoxin S6c can mediate opposite effects, specifically vasodilation and 
vasoconstriction. However, two separate studies seem to indicate that this is not 
the case, at least in mice, since in s1/  sl (piebald-lethal) animals, which entirely lack 
the Ednrb gene, no ligand-binding activity (endothelin 1) was present, and 
sarafotoxin failed to elicit either vasodilation or vasoconstriction in the relevant 
tissues from these mice (Giller et al., 1997; Mizuguchi et al., 1997). Another group 
have done the same in rats - this study suggests that the endothelial ETB receptor 
mediating dilation and the smooth muscle cell ETB receptor mediating 
constriction may not represent two different subtypes (Clozel & Gray, 1995).
An alternative might simply be a mutation in a gene directly upstream  of 
either Ednrb or Edn3 such as the endothelin converting enzymes (ECE) which 
convert preproendothelins into the active form of the ligand by cleavage. A defect 
in ECE-1 has been shown to cause Hirschprung disease and cardiac defects in a 
hum an patient (Hofstra et a l, 1998). A similar defect in the ECE responsible for 
activation of endothelin 3 in the mouse might be predicted to replicate the lethal 
spotting phenotype seen in Edn3-null mice. (Xu et al., 1994)
I l l
CHAPTER FIVE:
HARRY - DETAILED CHARACTERISATION OF THE PHENOTYPE 
Introduction
With a clear m utant phenotype associated with the transgene and given the 
three strong candidate loci mentioned in the previous chapter, a bipartite 
approach was adopted and performed in parallel. The m apping of the transgene 
integration site, to eliminate or reinforce a candidate gene is discussed in the next 
chapter. Alongside this, a detailed characterisation of the phenotype was 
undertaken, with special attention paid to the presence or absence of features 
from known m utant phenotypes associated with the candidate loci.
The investigations included the status of melanocytes via studies of coat 
colouration, covered in the previous chapter, and further to this, retinal histology 
was performed to determine the status of the neural crest-derived choroidal 
melanocytes. Gut dissection and histology was performed in order to determine 
whether the megacolon observed was truly associated with a reduction in enteric 
neurons, and to assess the extent of such hypo- or aganglionosis. Finally, the 
transgene was introgressed onto a different genetic background by breeding to 
congenicity to assess strain-dependent variation in the phenotype.
Results
Coat spotting
Coat colouration was discussed in the previous chapter, but it is w orth re­
iterating that to date, a single litter has shown evidence of a mild coat colour 
phenotype in 2 presumptive hemizygous animals. These were the only such 
animals observed out of some 200 transgenic offspring from hemizygous 
intercrosses.
Retinal histology
The choroid layer forms a dark brown vascular sheet which separates the 
outer, fibrous sclera from the retina (Figure 11a). It gains its colour from
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Figure 11. Retinal histology in Harry mutants
a) Diagrammatic representation of layered structure of the wall of 
posterior eye, showing retina, choroid and sclera. (Taken from 
"Principles of Anatomy & Physiology, 6th Edition, by Gerald J. Tortora 
and Nicholas P. Anagnostakos; Copyright (®) 1990 by 
HARPERCOLLINS. Reprinted by permission of Addison-Wesley, 
Educational Publishers.)
b) Whole eyes from wild-type (left) and m utant (right) Harry mice, 
dissected at day 10 post-partum. The m utant eye can be seen to have a 
lighter, brownish colour.
c) wild-type retina x 200 (H&E staining)
d) mutant retina x 200
e) wild-type retina x 400
f) mutant retina x 400 (ret = retina; rpe = retinal pigmented epithelium; 













numerous melanin deposits laid down by choroidal melanocytes, which derive 
from the neural crest. The choroid is immediately apposed to the outermost layer 
of the retina, which consists of the neuroectodermally-derived retinal pigmented 
epithelium, however the innermost section of the choroid comprises the largely 
unpigmented choriocapillary layer, the major blood supply to the retina. The 
choriocapillary layer is separated from the retina proper by the lamina vitrea, a 
thin, complex structure mostly composed of basal lamina-type extracellular 
matrix (Ross et al, 1989). During histological preparation, the retinal pigmented 
epithelium very often separates from the inner layers of the retina.
Harry mutants lacked, or had a severe reduction, in the neural crest- 
derived choroidal melanocytes, while the neuroectodermally-derived retinal 
pigmented epithelium remained unaffected. This could actually be seen without 
the aid of microscopic sections simply by examining whole eyeballs from wild- 
type and m utant mice under a dissecting microscope. The m utant eyeball could 
clearly be seen to have a reduced level of pigment, manifest as a lighter, slightly 
speckled, dark brown appearance, compared to the solid purplish-black colour of 
the wild-type (Figure lib ) . At the histological level, the choroidal melanocytes 
were absent or severely reduced while the retinal pigmented epithelium was 
unaffected (Figure llc-f).
Megacolon
Intestinal tracts were examined from around 30 wild-type and m utant 
animals. The particular m utant shown in Figure 12 was atypical in that the 
obvious constriction point lay above the ileo-cecal junction. This was observed 
only twice out of around 30 such dissections, with the constriction point more 
commonly lying somewhere in the colon, most often in the region distal to the 
ileo-cecal junction i.e.closer to the anus.
The relevant features of gut anatomy are illustrated diagrammatically in 
Figure 12b, with the outer muscularis consisting of an outer layer of longitudinal 
and an inner layer of circular smooth muscle. Contractions of these orthogonally 
opposed layers generate peristaltis and propel food through the gut. Sandwiched 
in between these layers of muscle are found the neural crest-derived myenteric
Figure 12. Gut histology in Harry mutants
a) Dissected whole intestinal tracts from wild-type (left) and mutant (right) Harry 
littermates culled at 19 days of age. The constriction point (arrowed) appears 
to lie above the ileo-cecal junction in this particular mutant.
b) Composite diagram of the layers and structures found in the gut wall at various 
levels throughout the intestinal tract. (Taken from "Principles of Anatomy & 
Physiology, 6th Edition, by Gerald J. Tortora and Nicholas P. Anagnostakos; 
Copyright (©) 1990 by HARPERCOLLINS. Reprinted by permission of 
Addison-Wesley, Educational Publishers.)
Longitudinal sections through the wall of the colon, stained with
H & E, x 400 magnification. The various layers aredemarcated on the right. From
top to bottom: MU = mucosae; SM = sub-mucosae; CM = circular smooth muscle;
MG = putative myenteric ganglia; LM = longitudinal smooth muscle.
c) Wild-type Harry colon.
d) Mutant Harry colon.
e) The wild-type Harry colon shown immunostained in Figure 13.
f) The mutant Harry colon shown immunostained in Figure 13.
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ganglia (neurons and glia) which collectively comprise the plexus of Auerbach. 
This plexus mostly controls peristalsis (Tortora & Anagnostakos, 1990). The inner 
submucosa consists of dense connective tissue which binds the inner mucosa to 
the outer muscle layer. It is highly vascular and contains the other component of 
the neural crest-derived enteric nervous system - the less abundant ganglia which 
make up the plexus of Meissner. This forms part of the autonomic nerve supply 
to the muscularis mucosae (which maintains the inner epithelium  in folds to 
increase surface area for absorption) and is also im portant in controlling 
secretions to the gastrointestinal tract. This plexus contains a large number of 
different neuroendocrine and neuronal cell types and is less well-characterised 
than the plexus of Auerbach. A subset of these cells stain w ith chromium or silver 
salts, as do the neuroendocrine chromaffin cells of the adrenal medulla, and are 
therefore sometimes referred to as enterochromaffin cells (Pearse, 1973).
Histological sections through wild-type and constricted regions of mutant 
colons were stained with haematoxylin and eosin and examined for obvious 
morphological differences. The eosin staining shown in Figure 12c and d is quite 
weak, but these sections show the difference in morphology between wild-type 
and affected m utant colon, with a dramatic reduction in the thickness of the 
muscle layers and severely disorganised mucosae. Sections 12e and f are sections 
from the same tissue blocks used in the immunofluorescence experiments shown 
in Figure 13. These mice were killed at an earlier stage than those in 12c and d, 
hence the pathology is not as advanced, but clear differences in the muscle layer 
thicknesses can still be observed.
Numerous clustered cells w ith large oval nuclei - putative myenteric 
ganglion cells - are apparent in 12c and e (wild-type) between the muscle layers, 
and these are almost entirely absent in 12d and f (mutant).
Sections through wild-type and m utant colons were immunostained for 
a-neurofilament, a general neuronal marker. In these sections, these only 
distinguished myenteric neurons of the external Auerbach's plexus, as cells of the 
inner plexus of Meissner are not as numerous, and this plexus does not contain as 
many neurofilamentous fibres (Burns & LeDouarin, 1998). Furthermore, non-
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Figure 13. Myenteric ganglia in Harry mice revealed by a-neurofilament 
staining
Longitudinal sections through the wall of wild-type (a) and m utant (b and
c) Harry colons. The lumenal aspect is at the top of each picture, 
a-neurofilament is stained red and nuclei are counterstained w ith DAPI 
(cyan).
a) Wild-type. Significant continuous staining can be seen between the 
longitudinal (LM) and circular (CM) smooth muscle layers, presumably 
corresponding to the myenteric plexus. The sub-mucosae (SM) also 
show staining, but it is difficult to unambiguously discern the plexus of 
Meissner, due to the high level of background.
b) Mutant. The muscle layers are much thinner, and a-neurofilament 
staining is restricted to bright patches (arrowed) with lower levels of 
continuous staining present.
c) Control (no a-neurofilament Ab). Note the high level of non-specific 
background, particularly at the lumenal border and in the sub-mucosae.
Figure 13
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specific fluorescent signal in the inner submucosal layers m ade it impossible to 
identify submucosal ganglia by this method. In the wild-type colon, 
immunofluorescence showed an almost continuous layer of bright neurofilament 
staining between the two layers of smooth muscle, corresponding to the 
myenteric ganglia (Figure 13). Fibres could be seen penetrating into the circular 
smooth muscle layer. Harry mutants showed limited bright staining clustered in 
small patches, with fainter background staining visible suggesting a significant 
reduction in myenteric neurons, hence hypoganglionosis and megacolon.
Introgression onto other genetic backgrounds
This was not performed rigorously, but rather, data became available as a 
spin-off from work being carried out in another laboratory: Many of the
transgenic lines used in this work, including Harry and Holly, are still 
maintained at their point of origin in Oxford. Parallel studies carried out there 
involved the introgression of the various transgene constructs onto different 
genetic backgrounds in order to assess the effects of strain background on 
regulatory regions of the lgfl/H19 loci (via monitoring comparative levels of 
expression of the luciferase reporter). During the course of this work, the Harry 
line was backcrossed onto the 129J/Sv strain for at least 12 generations to produce 
a congenic strain (Flaherty, 1981).
Given the existence of a congenic strain, it was a trivial, but informative, 
experiment to set up hemizygous intercrosses and do a cursory analysis of the 
m utant phenotype on this different genetic background.
Intercrosses were performed between Harry hemizygotes congenic on 
129J/Sv at the 12,13 and 14th generation of backcrossing. Very few viable pups 
resulted, with many being consumed before analysis. The only full intercross 
litter to yield clear results consisted of 6 pups with 1 found dead on the day of 
birth. Two of the remaining 5 went on to show clear evidence of the m utant 
phenotype, with growth retardation and abnormal skin pigmentation. One 
m utant presumably died and was consumed before day 6, and the other was 
found dead on day 6. After culling all the pups, the rem ainder of the litter was 
analyzed.
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The m utant which survived until day 6 had the customary bulging 
abdomen, and dissection revealed the expected megacolon. This was relatively 
severe, since it died only 6 days after birth with significant growth retardation 
compared to wild-type siblings, but this animal showed significantly greater skin 
pigmentation than any m utant bred on the C57/CBA background described 
previously. Essentially, the animal had only a small unpigmented patch covering 
some 50% of the right lateral head and shoulder, and lacked pigmentation on the 
skin of the limbs and tail. The bulk of the dorsal surface was fully pigmented. Fur 
growth had not yet commenced in these pups at the time of death, so it was 
impossible to determine whether the m utant animals would have developed fur 
of the parental strain colour (agouti), or whether it would have been black as with 
all m utants on the original C57/CBA background.
Discussion
The coat colouration and retinal histology show that neural crest-derived 
melanocytes were severely reduced or absent in Harry mutants. The gut 
histology shows that neural crest-derived myenteric neurons were also severely 
reduced in these animals, leading to toxic megacolon and death within 4 weeks of 
birth. This experiment may seem to have been redundant, but it should be noted 
that hyperganglionosis can also lead to megacolon, as seen in mice which 
overexpress HoxA-4 (Tennyson et al.f 1998) or in mice which lack Ncx/HoxllL.l 
(Hatano et ah, 1997) (although these can probably be ruled out as candidate loci in 
Harry m utants on the grounds that they appear to have no effect upon 
melanocyte development). It was therefore deemed im portant to assess whether 
the megacolon observed in Harry mutants was truly caused by a lack of enteric 
neurons.
The variation in the degree of hypoganglionosis (as measured by the point 
of constriction seen in the gut and variation in time of death), as w ith the variation 
in coat spotting, could be accounted for by postulating the presence of modifier 
genes segregating independently in these crosses. In this context, it should be 
noted that during comparative studies of the Ednrb - / -  knockout mouse (made by
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targeted deletion) and the classical sl/s l piebald lethal mouse (which has a 
spontaneously derived deletion of the entire ednrb gene), it was found that coat 
colouration in the sl/s l mice was almost entirely absent, compared with the 
significant dark patches seen in almost all Ednrb knockout mice. Since both mice 
have essentially the same genetic defect, this anomaly was ascribed to strain 
background differences (Hosoda et aL, 1994).
This explanation could account for the phenotype observed when the 
transgene was transferred onto the 129 background. In effect - although it should 
be noted that the following conclusions are draw n from very limited data and 
must be viewed as highly tentative - the m utant phenotype was similar to that 
seen on a C57/CBA background, except that the severity of the gut phenotype (as 
evidenced by early lethality) increased whilst the hypopigmentation decreased 
dramatically.
Overall, the phenotype seen in Harry mutants closely resembled that seen 
in Ednrb and Edn3 null mice, with the only possible difference being the occasional 
observation of presumptive hypoganglionosis extending beyond the colon into 
the small intestine. Although hypoganglionosis was seen never to extend beyond 
the ileo-cecal junction in studies of Ednrb and Edn3 m utants (Baynash et al., 1994; 
Hosoda et al., 1994), this could perhaps be ascribed to strain background effects, 
with both knockouts generated and maintained on a 129/Sv x C57BL/6J hybrid 
background, as distinct from the mixed C57BL/6J x CBACa background of the 
Harry transgenic line.
As a further cautionary argument against ruling out either Ednrb or Edn3 as 
candidate loci purely on the grounds that these mutations restrict their effect to 
the colon, it should be noted that in the rat, mutations at the Edn3 locus can cause 
an essentially identical piebald lethal phenotype (the spotting lethal rat), but that 
the hypoganglionosis often does extend beyond the ileo-cecal junction into the 
distal small intestine (Nagahama et al, 1985). Furthermore, in the equine 
equivalent of piebald-lethal, a mis-sense m utation in the endothelin-B receptor 
gene leads to Lethal White Foal Syndrome, in which homozygosity for the m utant 
allele results in aganglionosis from the jejunum to the rectum - a more severe 
effect than that seen in other species (Metallinos et al., 1998). Taking the above
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into account, it could therefore be argued that a novel allele of either Ednrb or 
Edn3 in the mouse might generate the same phenotype.
The final strong candidate locus, SoxlO, presented a more complex case. 
The locus was originally identified as Dom (dominant megacolon), a 
spontaneously-occurring mutant in stocks maintained at the Jackson Labs (Lane
6  Liu, 1984). With the identification of the gene, the locus has now been renamed 
SoxlO and the mutation formally reclassified as SoxlODom 
(http://www.informatics.jax.org, 1999). As the original name suggests, this 
mutation is an autosomal semidominant, with a milder phenotype seen in 
heterozygotes than in homozygotes. SoxlODom/  SoxlODom homozygotes are usually 
embryonic lethal by E13. Heterozygous SoxlODom/+  mice show white belly- 
spotting and white feet, coupled with megacolon. This was shown to vary on 
different genetic backgrounds, but coat spotting was never found to be as extreme 
as that seen in Harry mutants. The time of death due to toxic megacolon was 
found to vary more widely with genetic background, with a more severe enteric 
phenotype on a C57BL/6J background. The enteric hypoganglionosis in 
SoxlODom/+  heterozygotes was found to extend beyond the ileo-cecal junction in 
some cases (Kapur et a l, 1996). Although the cause of death in SoxlODom/  SoxlODom 
homozygotes prior to E13 is not known, they have been reported to completely 
lack enteric neurons below the rostral foregut (Herbarth et a l, 1998).
Many transgene insertional mutations exert an effect via loss-of-function, 
and since the Harry mutation was essentially fully recessive, it seems reasonable 
to speculate that the transgene insertion in Harry might have caused a loss-of- 
function mutation at the affected locus, particularly given the similarity of the 
phenotype to the two known recessive null mutations at Ednrb and Edn3.
SoxlO encodes an HMG-box transcription factor which has been shown to 
play an essential role in neural crest development, discussed more fully in chapter
7 (Herbarth et al., 1998; Southard-Smith et a l, 1998). The SoxlODom mutation is a 
frameshift truncation which leaves the DNA-binding HMG-box domain intact but 
removes almost all the amino acids carboxy-terminal to it. This carboxy-terminal 
region has been shown to contain transactivation domains which interact with 
other transcription factors of the POU domain class. The intact amino-terminal
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region upstream  of the HMG-box may also contain transactivation domains. It 
has been suggested that the SoxlODom m utation might exert its effect due to 
haploinsufficiency of wild-type SoxlO protein, but it is just as reasonable to 
speculate that the SoxlODom m utant might act as a dominant negative to suppress 
the wild-type molecule. Were this the case, then a true null m utant of SoxlO might 
reasonably be supposed to have a similar phenotype to Dom heterozygotes, except 
it would be recessive. Although highly speculative, the above chain of argument 
allows for the possibility of Harry being a loss-of-function recessive mutation at 
the SoxlO locus. However, this model does not account for the fact that 
SoxlODom/Soxl0Dom homozygotes are embryonic lethal by E13. It is possible that 
the truncated SoxlODom gene product might act as a dominant negative on other 
closely related Sox genes. Although the native targets of SoxlO are unknown, 
most Sox proteins recognise the core binding motif 5'-A ACA AAG-3'. Some 
degree of SoxlO protein specificity is probably generated through interactions 
with POU domain transcription factors binding to nearby sites on the DNA 
(Kuhlbrodt et ah, 1998a; Kuhlbrodt et ah, 1998b). Since SoxlODom lacks some of the 
domains necessary to interact with these factors, but not the DNA-binding 
domain, it might non-specifically block binding sites required by other Sox 
proteins.
Even if the SoxlODom mutation does exert its effect through 
haploinsufficiency, this still does not rule out the m utation seen in Harry as being 
at this locus, since the transgene insertion may not necessarily have caused simple 
loss of function but something more complex. This is discussed in more detail in 
chapter 7.
Summary
Detailed characterisation of the phenotype seen in Harry m utants revealed 
all of the features consonant with it being a m utation in any of the Ednrb, Edn3 or 
SoxlO genes with little to discriminate between them at the phenotypic level.
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CHAPTER SIX:
HARRY - LOCATION OF THE TRANSGENE INTEGRATION SITE 
Introduction
As discussed in Chapters 4 and 5, w ith three strong candidate genes for the 
m utant phenotype observed in Harry homozygotes and no obvious way of 
distinguishing between them at a phenotypic level, it was deemed essential to 
map the transgene insertion site. This was initially pursued via fluorescent in situ 
hybridisation (FISH) on metaphase chromosome spreads, followed by linkage 
m apping using PCR-based microsatellite polymorphisms to corroborate and 
refine the map position.
FISH - background and considerations
Following the establishment of protocols for the gentle denaturation and 
hybridisation of chromosomal DNA, early in situ experiments using isotopic 
labelling and autoradiographic detection perm itted the detection and localisation 
(in skilled hands) of single copy mammalian genes (Harper et al., 1981). 
Improvements in banding protocols following ISH made the identification of 
successfully hybridised chromosomes easier, but the limitations of radioactive 
detection meant that localisation of the probe signal was still technically difficult, 
requiring the examination and statistical analysis of silver grains from 50-100 
metaphase spreads. With the introduction of fluorescently-labelled probes, and 
the addition to the hybridisation cocktail of an excess of moderately-repetitive 
(Cot-1) unlabelled genomic DNA to suppress non-specific background, FISH has 
become a routine method used widely to detect and localise single-copy 
sequences with high precision (Heng et a l , 1997).
The recent advent of affordable microscope cameras incorporating cooled 
charge-coupled devices (CCDs) has greatly enhanced the detection of faint FISH 
signals. CCD cameras are a spin-off from astronomical research, and have the 
advantage that digitised images can be generated using very long exposures, by 
virtue of integrating the light intensities captured at individual pixels on the CCD 
chip over long time periods (seconds to minutes) (Tanke et a l, 1995). Following
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image-processing using sophisticated algorithms (again, a spin-off from 
astronomy), good results can be obtained from relatively poor FISH slides with 
very low signal-to-noise ratios.
One final recent innovation in FISH technology, or rather ISH technology 
(since the detected label need not be fluorescent), has been the introduction of 
peroxidase/tyram ide detection protocols (Raap et al., 1995; van Gijlswijk et al, 
1996). Essentially, these revolve around the use of horseradish peroxidase to 
catalyse the deposition of a tyramide-conjugated label (fluorescent or otherwise) 
covalently linked to the substrate around the site of enzyme activity. In the 
context of chromosomal in situ, the enzyme can be localised to the hybridised 
probe either by direct conjugation to the probe itself prior to hybridisation, or, 
post-hybridisation, by conjugation of the enzyme to a hapten-binding moiety such 
as streptavidin. Regardless of the method used, this technique offers at least 5- 
fold greater sensitivity (signal-to-noise ratio) than conventional FISH, due to the 
enzyme's ability to catalytically deposit far more label at the target site than can 
be achieved via the passive binding methodologies used to date. The use of non- 
fluorescent label bypasses the need for fluorescent microscopes and expensive 
digital imaging technology - simple brightfield photography suffices. Although 
relatively new, the rapid adoption and patenting of this technology by 
commercial concerns (in other words, the speed of its transfer from the laboratory 
to the marketplace) attests to its power and attractiveness (TSA™, NEN Life 
Sciences, 1999).
Use of FISH to detect transgene integration
Compared to many single-copy genes, for which cDNA is often the only 
sequence available for use as a probe, transgenic mice offer themselves 
particularly well to FISH protocols due to the multi-copy nature of most 
integrated transgene arrays. There can be said to be three key elements to 
successful FISH m apping of transgene integration sites: Firstly, generation of 
high-quality metaphase chromosome spreads; secondly, a good probe and a 
hybridisation protocol which generates strong signals from the transgene; and 
thirdly, unambiguous chromosomal identification.
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With regard to the first point, various methods exist for making metaphase 
spreads, and these were discussed in more detail in the introduction to chapter 4. 
In the FISH experiments discussed therein, spreads were prepared from 
individual animals strictly for the purposes of genotyping and did not need to be 
of high quality. In contrast, during the m apping studies discussed in this chapter 
and chapter 11, spleens from multiple animals were pooled. Using this 
modification, the splenocyte culture method was found in our hands to routinely 
generate good spreads with the long, extended chromosomes that are essential for 
G-banding and mapping.
The second point, quality of probe, protocol and strength of signal, proved 
more taxing, but after several attempts, a working protocol was obtained and with 
slight modifications this was found to routinely generate a strong transgene signal 
which could easily be distinguished from background and from fainter signals 
caused by cross-hybrisation of the transgene probe to the endogenous Igft/H19 
locus on distal Chr7 (since the transgene constructs carry elements of this region). 
Early experiments used conventional photography with high-speed colour film, 
but, unsurprisingly, a cooled CCD camera, coupled with image-processing 
algorithms, was found to greatly augment the detection and documentation of 
fainter FISH signals.
Given high-quality chromosome spreads and routine detection of the 
transgene signal, this left identification of chromosomes. In humans, karyotyping 
is routinely done by Giemsa-trypsin banding which generates a characteristic 
pattern of horizontal dark (G) and light (R) bands along the length of each 
chromosome, and the variation in size and centromere position throughout the 
hum an karyotype assists in chromosomal identification (Franke & Oliver, 1978). 
Unfortunately, for unknown reasons, mouse chromosomes are all acrocentric 
(with the centromere at one end) and they do not band as clearly as human 
chromosomes with the Giemsa-trypsin protocols.
This difference in the quality of G-banding may reflect the different nature 
of the short highly repetitive sequences (SINE elements) present in the hum an and 
mouse genomes. In humans and mice, the dark-staining G-bands correspond to 
AT-rich gene-poor regions containing long interspersed LI (LINE) elements which
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are retroposon-derived and homologous between species (Silver, 1995). 
However, the lighter R-bands correspond to GC-rich gene-rich regions containing 
short interspersed sequences (SINE elements). SINE elements appear to have 
evolved out of small cellular RNA species. Unlike LINE elements, they appear to 
have originated independently in different species. In humans, the SINE elements 
belong primarily to one family - the Alu sequence elements which derive from 
7SL RNA, a small cytoplasmic species involved in protein synthesis. In the 
mouse, the majority of SINE elements belong to the B1 and B2 families which are 
quite divergent from the Alu sequences, although the B1 element also appears to 
have been derived from 7SL RNA independently of the Alu family. Early FISH 
experiments revealed the close correlation between G-banding patterns and these 
repetitive sequence families in the two genomes, and this is thought to reflect 
differences in chromosomal structure between G and R-bands, which may 
prejudice the differential integration of LINEs and SINEs into genomic regions. 
There is a report from a laboratory using atomic force microscopy to examine the 
physical structure of chromatin, which states that constricted regions exist on 
(untreated) metaphase chromosomes which correspond exactly to the G-banding 
pattern that would be obtained after giemsa-trypsin treatment (Musio et al., 1994). 
Thus, the differently banded regions almost certainly relate to underlying 
structural differences at the chromatin level.
Regardless of the underlying mechanisms involved, G-banding mouse 
chromosomes and subsequent identification proved to be a significant challenge. 
G-banded chromosome spreads with transgene integration sites marked with 
arrows were sent to an independent cytogenetics laboratory (M. Lee, MRC HGU, 
Edinburgh) for an expert opinion as to the chromosomal identity. The 
preliminary assignments from this were used to design linkage mapping 
experiments by informing the choice of sets of primers for microsatellite PCR 
(discussed below).
In addition to this, as an alternative method for unambiguous 
chromosomal assignment, double FISH was attempted: Using the mouse genome 
database (http://www.informatics.jax.org, 1999) to identify suitable probes, 
various phage lambda clones containing some 12-20kb of genomic sequence were
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obtained. The genomic clones were chosen on the basis of their origin within the 
"best guess" chromosomes from the G-banded FISH experiments, and were 
selected to lie in a region of the target chromosomes distinct from the transgene 
integration site. In the double FISH experiments, the genomic clones and the 
transgene probe were differentially labelled to yield a red and a green signal after 
FISH. Co-localisation of the signals on the same chromosome would provide an 
unambiguous map position for the transgene integration.
It m ust be pointed out that a similar experiment could have been 
performed using "chromosome paints". These are derived either from 
chromosome-specific repetitive sequences which span the full length of the 
chromosome, or from chromosome-specific alpha-satellite sequences localised to 
the centromere. They are therefore used to "paint" a specific chromosome a 
distinctive fluorescent colour following FISH. They can be purchased pre-labelled 
for all 21 mouse chromosomes (Ventana Medical Systems). However, each 
individual paint costs in excess of £200, and with several provisonally assigned 
target chromosomes to choose from, this was deemed to be a prohibitively 
expensive approach.
Linkage mapping - background and strategic considerations
Linkage mapping of loci - in this case a m utant allele associated with the 
transgene - is based upon the ability to detect other loci of known position on the 
genetic map, and showing some degree of association during breeding crosses 
between the allele of interest and m apped loci. This hinges upon two key factors:
Firstly, successful detection of a polymorphism at the locus of interest. In 
the case of the Harry line, this was trivial - the transgene itself acts as a dominant 
allele, and its presence can be easily detected by luciferase assay. Furthermore, 
from the genotyping experiments, it was known that any m utant animal, by 
definition, was homozygous for the transgene. Therefore, the exact transgenic 
genotype could readily be determined for all animals.
Secondly, detection of a variety of polymorphisms throughout the mouse 
genome at known map positions. There are a variety of approaches to this, and 
the main ones can broadly be classified as using: phenotypic loci (classical); 
restriction fragment length polymorphisms (RFLP); interspecific backerosses;
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recombinant inbred (RI) strains; PCR of microsatellite and other short sequence- 
tagged sites.
Classically (i.e. prior to the development of recombinant DNA techniques 
in the late 1970s), new m utant loci were m apped with respect to visible, 
phenotype loci. This required enormous breeding programmes, and had the 
distinct drawback that, even in an inbred laboratory animal like the mouse, where 
a novel allele can be bred onto a specialised genetic background carrying multiple 
visible genetic markers, there simply aren 't enough visible traits which can be 
used as markers to provide detailed coverage of the genome. This is illustrated by 
the observation that when the first genetic m ap of the mouse was published in 
1941, it listed a mere 24 loci, of which 9 had not been assigned to any linkage 
group (Silver, 1995). This should be viewed in light of the fact that mouse 
genetics was a 26-year old science at this point.
The application of recombinant DNA methodologies to the problem of 
detecting genetic polymorphisms resulted in the development of restriction 
fragment length polymorphism (RFLP) mapping. This hinges around neutral 
nucleotide substitutions creating or removing restriction enzyme recognition sites 
at various positions throughout the genome. Digesting genomic DNA with 
suitable restriction enzymes and probing with an appropriate DNA fragment 
gives a diagnostic pattern of bands on a Southern blot. In humans, given the 
highly out-bred nature of the population, a large num ber of RFLPs can invariably 
be found between two individuals, even closely related ones (excepting identical 
twins). Given a DNA probe for a test locus, a polymorphism can almost always 
be found.
In the mouse, RFLPs initially offered the possibility of an abundance of 
neutral (i.e. non-phenotypic) polymorphisms scattered throughout the genome 
which could be m apped and used as a reference framework for m apping novel 
alleles. Unfortunately, early studies of the mouse genome using RFLPs quickly 
revealed that all the classical inbred strains of laboratory mouse were more closely 
related than had been previously thought. For example, all the mitochondrial 
genomes were found to be identical, implying maternal lineage leading back to a 
single common female ancestor, who may have lived as recently as 1920 (Ferris et
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al, 1982). It is highly probable that during the derivation of the classical inbred 
strains during the early 20th century, interstrain contamination and interbreeding 
was much more prevalent than the records of the time suggest. The end result is 
that it is relatively difficult to find sufficient RFLPs between two classical inbred 
strains to be useful for the purposes of genome-wide linkage scanning.
This frustrating situation was resolved with the discovery that a separate 
species of mouse - M. spretus - could be bred with laboratory mice (which are all 
strains of the species M. musculus) (Silver, 1995). Spretus males crossed with 
laboratory females generate viable offspring, of which the males are sterile but the 
females viable. These interspecific Fi hybrid females can be backcrossed to inbred 
laboratory males in m apping crosses. The signal advantage of this interspecific 
breeding protocol is that some 3 million years of evolution separate the two 
species. As a consequence, the genomes are highly divergent and RFLPs can be 
found for practically every DNA probe tested.
The spretus backcross revolutionised mouse genetics in the 1980s and many 
hundreds of loci were quickly placed on the genetic map. Large "panels" of DNA 
samples from interspecific backcrosses were prepared and made available to the 
community. The power of these panels derives from the hundreds of loci that 
have already been typed on them. If a new locus is found to show a 
polymorphism, it can be tested against an existing panel. This effectively acts as a 
backcross without actually having to perform the breeding experiment, and the 
locus can be rapidly mapped. This approach has been most effective in the 
mapping of new genes following the cloning of their cDNA, and large-scale 
collaborative backcross panels exist for this purpose.
The fourth approach, the use of recombinant inbred strains (RI) bears some 
similarities to an interspecific backcross panel in that it gains its power from the 
accumulation of data from typing hundreds of loci on a pre-existing panel. Unlike 
interspecific backcross panels, however, where the DNA in a given panel is a 
finite resource, the DNA used is derived from sets of inbred RI strains and 
therefore represents an inexhaustible resource.
Briefly, since this approach is inappropriate for m apping a transgene (until 
a flanking polymorphism has been obtained), a set of RI strains is derived by
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crossing two inbred lines to generate a population of genetically homogenous Fi 
animals and then further in-crossing these Fi progeny to generate a population of 
F2 animals. The chromosomes of these F2 animals will each contain a random  
assortment of segments derived from each parental genotype. At this stage, F2 
males and females are selected randomly and inbred for at least 20 generations to 
create a true, inbred strain, with >99.8% homozygosity fixed into the genome. 
Multiple strains can be created from the same initial inter-strain cross, and these 
are collectively known as a set of RI strains.
Each RI strain can effectively be viewed as a "frozen" set of meiotic cross­
overs between the parental strains, with each chromosome containing alternating 
segments from each genome. With the accumulation of large datasets for sets of 
RI strains, new loci which are found to be polymorphic between the two parental 
strains of a given set can be very quickly m apped by testing the new probe against 
the relevant RI panel. Various panels now exist, and some have been typed for 
very large numbers of known markers to give strain distribution patterns (SDPs) 
for each locus. By way of illustration of the power of this approach to mapping, 
provided that a polymorphism can be demonstrated for a locus of interest 
between the two parental strains of the BXD RI set (C57L6 and DBA), all that is 
required is that each strain in the set is typed once for this polymorphism. In the 
case of the BXD set, this amounts to typing 26 strains by Southern blotting or PCR. 
With over 1500 loci already typed for the set, by comparing the SDP of the new 
locus to existing datasets this can immediately give a m ap position to within 
<10cM, and possibly much less (http://www.inform atics.jax.org, 1999).
In the context of mapping a transgene integration site, the existing 
interspecific backcross and RI panels are unfortunately useless, since the 
polymorphism at the test locus (i.e. the transgene) simply will not exist in the test 
DNA (unless some genomic sequence flanking the transgene integration has been 
obtained and a polymorphism established). The easiest solution in this case 
would therefore be to generate a new panel by performing an interspecific 
backcross between spretus and the transgenic line of interest. Clearly, the 
resulting panel would have to be typed de novo for a large num ber of markers - a
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formidable undertaking. Generating a set of RI strains from the transgenic line 
and some other strain would be an even larger task.
Fortunately, in the 90s, an alternative solution has become available 
utilising polymorphic PCR-based DNA markers, often microsatellites. The most 
common class of microsatellite-based markers consist of a variable-length region 
of di-nucleotide repeats flanked by unique sequences to which PCR primers can 
be designed. Their usefulness derives from the fact that the long dinucleotide 
repeat structures (microsatellites containing runs of (CA)n and (GA)n are most 
commonly utilised) will very frequently mispair during recombination or 
replication. This "slippage" leads to contraction or expansion of the length of the 
repeat. The actual size of the microsatellite is therefore highly polymorphic, even 
between inbred mouse strains. Estimates of the mutation frequency are 
complicated by position and sequence-dependent effects, but one detailed study 
concluded that the rate of mutation per microsatellite locus per generation was 5- 
50 fold higher than that observed at classical loci (Dietrich et al., 1992). In 
practical terms, this means that the microsatellites mutate fast enough to generate 
polymorphism between inbred strains, but not so fast that they cannot be 
followed through several generations within a given strain background.
A given pair of PCR primers will generate a short product (generally 
primers generating products of 50-400bp are used), and the exact size of this 
product may well be polymorphic between mouse strains. Detecting 
polymorphism is simply a matter of running the PCR reactions out on a high- 
resolution gel. The power of this approach was quickly recognised, and a great 
deal of effort was therefore put into establishing a very large number of typed 
markers and placing them on the genetic map, with PCR product information (i.e. 
band size) available for a number of inbred strains. The report published by the 
team at the Whitehead Institute in 1996 contained 7,377 genetic markers, 
consisting of 6,580 highly informative simple sequence length polymorphisms 
(mainly microsatellite PCRs), integrated with 797 restriction fragment length 
polymorphisms (the difference between these two numbers speaks to the much 
lower rate of polymorphism found between mouse strains using restriction 
enzymes) and placed on the mouse genetic map (Dietrich et al., 1996). This gave
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an average of one marker per 0.2cM - roughly one every 400kb in the mouse. 
Many more have continued to be added since that time. The Whitehead Institute 
maintains a database which details map positions, microsatellite sequence, PCR 
primers, reaction conditions and predicted product sizes for a large number of 
typed strains (Whitehead Institute, MIT, 1999). Their last set of collated data lists 
some 12,000 markers for the mouse genome. Research Genetics have made most 
of the primer pairs detailed on the W hitehead Institute database available to the 
genetics community at low cost (Research Genetics Inc., h ttp ://www.resgen.com, 
1999).
Transgene integration site mapping by genome-wide linkage scan
With reference to the Methods chapter, it will be seen that all transgenic 
lines in this study were originally derived by micro-injection of construct DNA 
into a C57/CBA F1 zygote. With only one integration site in the case of Harry, it 
logically follows that the transgene integrated into either a paternally-derived C57 
chromosome or a maternally-derived CBA chromosome. During subsequent 
breeding, a mixture of incrossing between hemizygous animals and outcrossing to 
non-transgenic C57/CBA Fi animals was used. There was no particularly strict 
rationale to this - incrossing was used preferentially to m aintain strains and 
generate mutants, w ith outcrossing as required when stocks were low to reinject 
"hybrid vigour" back into the line and quickly build up numbers. The end result 
of this has been the generation of transgenic lines containing an heterogenous mix 
of C57 and CBA genomes in variable proportions.
Although microsatellite PCRs are not well documented for the CBA strain, 
it is quite closely related to the C3H strain and data for this strain, and for C57, do 
exist. The degree of similarity between CBA and C3H lies in the fact that both 
lines derive from the same original cross, with CBA selected for a low mammary 
tumour incidence and C3H for a high incidence (Strains Listing 
http://www.inform aticsjax.org, 1999). Hence, primers polymorphic between 
C57 and C3H are likely to also be polymorphic between C57 and CBA.
The chromosomal segment containing the transgene will have retained its 
original genetic character (i.e. C57 or CBA) out as far as the closest 
recombinational breakpoints. Thus, if the transgene integrated into the C57
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chromosome, closely-linked markers for the transgene are highly likely also to be 
C57 alleles. Given the heterogeneity of the genetic background in Harry mice, it 
would have been difficult to perform a backcross to either C57 or CBA purebred 
mice, since many of the loci in Harry are likely to be homozygous for a given 
background.
One strategy would have been to backcross Harry hemizygotes to a third 
background containing a third allele at all test loci which could be distinguished 
from both C57 and CBA alleles.
An alternative would have been to transfer the transgene (and its 
associated chromosomal segment) onto a pure inbred background (introgression) 
and to perform a more standard 2-background backcross from there. Formally, 
this would have necessitated breeding each test line onto the chosen background 
for at least 10 generations followed by an intercross to create a congenic line 
(Flaherty, 1981). This can take upwards of 2.5 years. With the aid of test PCRs to 
determine which of the offspring at each generation carried the maximum 
amount of the target background this can be reduced to 5 generations (marker 
assisted selection protocols or "speed congenics") (Markel et al., 1997; Wakeland 
et al., 1997). However, even combined with super-ovulation of pre-sexual females 
and in vitro fertilization of the oocytes to reduce generation time ("super-sonic 
congenics"), this would still have required the best part of a year to achieve.
Regardless of the method used, given a suitable backcross protocol for the 
Harry line, a genome-wide linkage scan would require a bare minimum of a 
backcross panel of 72 animals typed for 46 well-spaced markers (Silver, 1995). 
This approach requires the investigator to perform and analyze >3000 PCR 
reactions and to purchase some £1000 w orth of PCR primers, simply to gain an 
initial map position to within <20cM of the transgene integration site. Further 
primers would need to be purchased for finer m apping of the integration site and 
a larger backcross panel would be required. In the particular case of Harry, some 
of the primer pairs might prove not to be polymorphic between C57 and CBA 
(this was indeed found to be the case for -10% of primers purchased and used in 
our laboratory), in which case more primers might need to be purchased to 
complete the scan.
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Overall, genome-wide linkage scanning can be considered to be an effective 
and powerful method for rapidly mapping a transgene integration site provided 
the laboratory is already set up for performing and analyzing large numbers of 
PCR reactions, and provided that the expensive resources (hundreds of PCR 
primers) have already been purchased. For a small laboratory not already 
performing such analyses, such as ours, the cost and time involved was deemed 
prohibitive unless a large number of lines were to be analysed. The heterogenous 
genetic background of our transgenic lines added extra difficulties to such an 
approach.
Use of microsatellite PCR to rapidly screen candidate loci
Although, for the reasons discussed above, a genome-wide linkage 
scanning approach was ruled out, with some candidate loci emergent from the 
phenotype studies and with data from the G-banded FISH experiments, an 
attractive alternative presented itself: Microsatellite PCRs could be performed 
using only a few primers specific for markers known to be close to the putative 
integration site, or close to attractive candidate loci such as Ednrb.
The nature of the transgene integration assisted greatly in this, since, as 
discussed above, the transgene in Harry logically had to reside in a chromosomal 
segment containing either C57 or CBA alleles. Homozygous Harry mutants 
therefore would almost certainly be homozygous for closely-linked genetic 
markers unless a meiotic recombination breakpoint happened to lie close to the 
transgene. Rather than performing a backcross and analyzing all offspring, 
simple analysis of only the mutants from hemizygous intercrosses could be 
performed. Provided that at least one of the parents was shown to be 
heterozygous at a given test locus, homozygosity in a sufficient num ber of mutant 
animals would provide proof of linkage. In effect, this can be viewed as a rather 
complicated backcross:
It will be seen that if one parent is heterozygous and one homozygous at a 
test locus, this is identical to a conventional backcross protocol and each m utant 
animal resulting from the cross is the equivalent of one backcross offspring i.e. 
one informative meiosis (Figure 14a).
Fig. 14 Inform ative meioses from  two differen t backcross schem es
a)
=  C 57 allele  
= C B A  allele
1 inform ative 
m eiosis
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M U T A N T NOT TESTED
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M U T A N T
IS
X
N O T  T E ST E D
a) If only one parent is polymorphic (heterozygous) at a given test locus, the cross is equivalent 
standard backcross, yielding one informative meiosis per mutant offspring.
b) If both parents are heterozygous, each mutant (homozygous for the transgene by definition) 
yields two informative meioses at the locus under test.
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Similarly, if both parents are heterozygous, each m utant animal is 
equivalent to two backcross samples i.e. two informative meioses (Figure 14b). In 
both cases, homozygosity at a given locus for any m utant animal indicates no 
recombination with respect to the transgene. No linkage between the transgene 
and the locus under test gives a Mendelian distribution of genotypes in the 
mutants, depending upon the exact genotypes of the parents.
Results
Mapping by FISH
A number of chromosome spreads derived from Harry hemizygotes were 
G-banded, destained and subsequently hybridised with the transgene probe. It 
was clear from these experiments that the transgene had integrated into a 
medium-length chromosome around two-thirds of the way dow n from the 
centromere. The G-banding pattern suggested Chr 15, but was not considered 
sufficiently unambiguous for confidence in this result (Figure 15).
Double FISH was attempted with the Lifr probe (which m aps to proximal 
Chr 15) and the transgene construct, but this was unsuccessful - multiple signals 
were obtained w ith the Lifr probe and it was impossible to distinguish the Chr 15- 
specific signal (data not shown).
Linkage mapping
Following FISH analysis, the candidate locus microsatellite PCR linkage 
approach was adopted and primers were chosen, using the W hitehead Institute 
database, such that at least 2 primer pairs close to the Dom, Ednrb and Edn3 loci 
on chromosomes 15, 14, and 2 respectively were tested (Whitehead Institute, 
h ttp://w w w .genom e.w i.m it.edu/, 1999; Copeland et al., 1993;Dietrich et al, 
1994;Dietrich et ah, 1996) The primers chosen were selected on the bases that they 
were close to the candidate gene (within lcM  in all cases), and polymorphic 
between C57 and C3H strains, in the hope that this would extend to CBA mice, as 
explained earlier.
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Figure 15. Transgene mapping by combined FISH and G-banding
Metaphase chromosome spreads from a hemizygous Harry animal, G- 
banded and then hybridised with a transgene probe using FISH.
a) FISH signal from the previously G-banded metaphase chromosome 
spread shown in b). One transgene signal is visible (arrow).
b) G-banding from the corresponding metaphase chromosome spread. 






















4.2c? n/a C57 C57 C57 CBA CBA
4.9f? n/a FI FI FI C57 C57
4.1c? n/a C57 C57 C57 CBA FI
4.11 9 n/a FI FI FI C57 CBA
4.3 c? n/a C57 C57 C57 FI FI
4.5? n/a C57 C57 C57 C57 FI
4.4c? n/a FI FI FI FI FI
4.69 n/a FI FI FI C57 CBA
+ /+  mutants
A1 4.4c? x 4 .6 9 C57 C57 C57 C57 FI
B1 4.3c? x 4 .5 9 n/t n/t n/t C57 FI
B2 4.3c? x 4.5 9 n/t n/t n/t C57 FI
B3 4.3c? x 4.5 9 n/t n/t n/t FI FI
Cl 4.4c? x 4.69 C57 C57 C57 FI FI
C2 4.4c? x 4.6 9 C57 C57 C57 FI FI
D1 4.3c? x 4.5 9 n/t n/t n/t FI FI
D2 4.3c? x 4.5 9 n/t n/t n/t FI C57
El 4.4c? x 4.69 C57 C57 C57 C57 CBA
E2 4.4c? x 4.6 9 C57 C57 C57 FI FI
E3 4.4c? x 4.6 9 C57 C57 C57 FI FI
FI 4.3c? x 4.5 9 n/t n/t n/t FI FI
F2 4.3c? x 4.5 9 n/t n/t n/t C57 n/t
J1 4.4c? x 4 .6  9 C57 C57 C57 C57 n/t
J2 4.4c? x 4.6 9 C57 C57 C57 C57 n/t
K1 4.3c? x 4.5 9 n/t n/t n/t FI n/t
K2 4.3c? x 4 .5  9 n/t n/t n/t FI n/t
LI 4.1c? x 4 . l l  9 C57 C57 C57 FI n/t
M l 4.2c? x 4.9 9 C57 C57 C57 FI n/t
M2 4.2c? x 4 .9? C57 C57 C57 C57 n/t
m 4.4c? x 4.6 9 C57 C57 C57 n/t n/t
PI 4 .2 d* x 4 .9  9 C57 C57 C57 n/t n/t
P2 4.2c? x 4.9 9 C57 C57 C57 n/t n/t
Ql 4.1c? x 4 .1 1 9 C57 C57 C57 n/t n/t
R1 4.2c? x 4 .9  9 C57 C57 C57 n/t n/t
SI 4.2c? x 4 .9  9 C57 C57 C57 n/t n/t
S2 4.2c? x 4.9 9 C57 C57 C57 n/t n/t
S3 4.2c? x 4 .9 9 C57 C57 C57 n/t n/t
S4 4.2c? x 4.9 9 C57 C57 C57 n/t n/t
S5 4.2c? x 4.9 9 C57 C57 C57 n/t n/t
T1 4.1c? x 4.11 9 C57 C57 C57 n/t n/t
T2 4.1c? x 4.11 9 C57 C57 C57 n/t n/t
U1 4.4c? x 4.69 C57 C57 C57 n/t n/t
VI 4.2c? x  4.99 C57 C57 C57 n/t n/t
V2 4.2c? x  4.9 9 C57 C57 C57 n/t n/t
V3 4.2c? x 4 .9 9 C57 C57 C57 n/t n/t
W1 4.1c? x 4 . l l ? C57 C57 C57 n/t n/t
W2 4.1c? x 4 .1 1 9 C57 C57 C57 n/t n/t
W3 4.1c? x 4 . l l ? C57 C57 C57 n/t n/t
W4 4.1c? x 4.11 9 C57 C57 C57 n/t n/t
XI 4 .4 ?  x 4 .6 9 C57 C57 C57 n/t n/t
Informative
meioses
43 43 43 17 18
n/a = not applicable n/t = not tested
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During test PCRs, some primers were found not to be polymorphic 
between these strains and these were discarded.
Four Harry hemizygous intercrosses were set up, and DNA samples 
prepared from the parents and from a number of resultant mutants. Initially, the 
parents were typed for all the markers used in this study, and only the mutants 
from informative crosses were tested for particular markers.
Following test PCRs to establish polymorphism (data not shown) genomic 
DNA from homozygous mutants was initially tested with 2 markers close to SoxlO 
on Chr 15, one marker close to Ednrb on Chr 14 and one marker close to Edn3 on 
Chr 2. From cursory inspection, it was clear that both the Chr 2 and 14 markers 
showed what appears to a Mendelian distribution of genotypes, particularly since 
hemizygous parents showed homozygosity for both CBA and C57 genotypes 
(Figure 16). While the numbers tested were not statististically significant, they 
strongly suggested non-linkage to either Ednrb or Ednr.
On the other hand, all the mutants tested were homozygous for the C57 
allele of both the Chr 15 markers, suggesting linkage. Further mutants were 
tested with 3 separate Chr 15 markers to confirm linkage. The data from all 
microsatellite PCRs performed are summarised in Table 8
In all, 43 informative meioses were found to show no recombination 
between the transgene and D15Mitl, D15Mit2 and D15Mit71, with the C57 allele 
present in all cases (indicating that the transgene had integrated into the 
paternally derived C57 chromosome). Using Genelink software and the mapping 
data table from Silver (see Appendix B), given zero recombination between each 
of these three markers and the transgene, they are linked within 8cM of each 
other with a 95% confidence limit.
Discussion
The FISH mapping proved slightly ambiguous due to the technical 
difficulty of obtaining high-quality G-banding and making subsequent 
chromosomal assignments. However, the transgene had clearly integrated in the 
central region of a medium-length chromosome. This almost certainly ruled out 
Edn3 as a candidate locus, since this lies at the distal end of Chr2 - a long
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Figure 16. Microsatellite PCR gels
Scanned silver-stained sequencing gels, showing representative results 
obtained with 4 of the microsatellite PCR primer pairs used in the linkage 
mapping studies. Note that fainter satellite bands frequently appear above and 
below the specific major product, particularly when the PCR reaction is analyzed 
under denaturing conditions, as here.
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chromosome. However, both Ednrb and SoxlO lie in the central region of Chrs 14 
and 15, respectively. The preliminary assignment from the G-banded FISH 
experiments pointed towards Chr 15, suggesting that the transgene might have 
integrated close to the SoxlO gene.
Linkage mapping using microsatellite PCR primers confirmed this, first 
with non-linkage being strongly suggested between the transgene and markers 
close to Ednrb and Edn3, and then with no recombination observed between the 
transgene and three Chr 15 markers in 43 informative meioses. All three markers 
lie very close to SoxlO on Chr 15. (D15Mitl, D15Mit2 and D15Mit71 have 
previously shown 0,2 and 1 recombinants with SoxlO in a 252-animal interspecific 
backcross (Puliti et al., 1995).
Given a distance of 8cM between the transgene and these markers with a 
95% confidence limit, Figure 17 shows a graphical representation of all loci within 
15cM of SoxlO which are known to cause a coat colouration phenotype.
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Figure 17. Coat colouration loci within 15cM of SoxlO
(Mouse Genome Database, 1999)
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(Distances from the centromere are shown in cM down the left-hand side.)
SoxlO remains the obvious candidate, however there exist three other loci 
known to affect coat colour in the mouse which lie nearby which could also be 
considered as candidates, since all lie within the 95% confidence limit.
dp (Dilution-Peru)
The dp locus (Dilution-Peru) lies well within the 95% confidence limit, some 
5cM away from the markers tested, dp arose from a cross between CBA and a 
Peru-Harland female. dp homozygotes show a relatively mild phenotype 
featuring only diluted coat colour, slightly darker than that of misty, which is 
itself merely a slight lightening of normal coat colour (m/m) (Lyon et al, 1996).
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The dp gene product is unknown and mutants are viable and fertile (Wallace, 
1971). This can probably be eliminated as a candidate locus for transgene 
integration, largely on the grounds that whilst very little is known about the 
affected locus, the phenotype does not resemble that seen in Harry homozygotes 
whilst there are much stronger candidates nearby. Mutations which give rise to 
the coat spotting seen in Harry mutants tend to affect melanoblast migration 
a n d /o r survival during development, giving rise to large patches of unpigmented 
skin which entirely lack melanocytes. On the other hand, mutations which dilute 
coat colour tend to exert an effect during melanocyte terminal differentiation, 
such as Myo5a (dilute) which affects melanocyte morphology, or mutations which 
affect melanogenesis, such as Tyrc (albino) (Yokoyama et al., 1990; Mercer et al., 
1991).
bt (belted)
A similar argument pertains to bt, the belted locus, which lies within the 
mean distance estimated between the transgene and the markers tested, bt arose 
as a spontaneous mutation in the DBA strain, and as the name suggests, shows a 
mild coat colour phenotype, with homozygotes having a white belt across the 
back in the m idtrunk region and a white belly patch. These sometimes coalesce to 
form a continuous white belt, bt was first described in 1945 and has a long history 
of use as a visible marker in mapping crosses. As a consequence, there is a great 
deal more mapping data for this locus than for dp. (bt has however, been shown 
to show recombination with respect to the dp locus (Wallace & Green, 1974).) The 
gene product of bt is also currently unknown, and even although it shows no 
enteric phenotype it is not inconceivable that it is a hypomorphic allele of SoxlO. 
However, in the original paper describing the Dom mutation at the SoxlO locus, 
Dom was shown to recombine with bt in 26/252 animals in a D om /+  x bt/+  cross, 
giving a recombination fraction of 10.3%, according to the author's calculations 
(Lane & Liu, 1984). This suggests close linkage between bt and SoxlO, but not 
allelism. In support of this, recent fine mapping studies, as yet unpublished, have 
shown that bt lies at least 5cM away from SoxlO (D. Foernzler, pers. comm.).
Even given that bt is a separate locus from SoxlO, this does not preclude its 
being disrupted by the transgene. However, the gene function of bt would have
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to closely parallel that of SoxlO, since the phenotype observed in Harry 
homozygotes matches that seen in SoxlODom heterozygotes almost exactly.
gt (grey tremor)
The third locus shown in figure 17, gt (grey tremor), lies within 2cM of 
SoxlO. This locus is another recessive m utation in an unidentified gene which 
arose spontaneously in mouse stocks at the Jackson Labs, and homozygotes have 
reduced yellow coat pigment (hence grey), white feet, tail and belly and a white 
blaze on the head (Sweet, 1981). Besides this coat colour phenotype, they also 
display a neurological defect, with tremor and convulsions from around day 8 
post-partum. Most homozygotes die by 3 months of age, but when gt was 
introgressed onto a heterogenous genetic background many mutants were found 
to survive and were viable. Histopathology revealed that gt/gt homozygotes 
suffer from extensive de-myelination in the peripheral and central nervous 
system, coupled with severe progressive spongiform encephalopathy in the CNS 
and early death. Heterozygotes appeared normal but suffer from mild 
spongiform encepalopathy in the CNS from around 2 months of age onward 
(Sidman et al., 1985).
Detailed histopathological examination of gt/gt mutants revealed that in 
homozygotes, the encephalopathy manifested as extensive vacuolation of grey 
and white matter. Vacuoles in white matter were found to be caused by 
interlamellar splitting of myelin sheaths. Astrocytes lacked vacuoles and seemed 
substantially unaffected. Dendrites were focally swollen and contain irregular 
vacuoles. By the end of the first month post-partum, virtually the entire neuraxis 
was involved with vacuolation more severe in grey than in white matter. 
Astrocytic proliferation was mild and neuronal loss inconspicuous.
No virus particles or "scrapie-associated fibrils" were found. However, the 
progressive spongiform encephalopathy was highly reminiscent of the disease 
patterns seen in BSE, Creutzfeld-Jakob syndrome, kuru, scrapie and other such 
syndromes attributed to unconventional transmissible agents. In two separate 
studies, wild-type mice from strains susceptible or resistant to scrapie or certain 
murine viruses were inoculated intracerebrally with homogenised extract from 
the brains of severely affected gt/gt homozygotes (Sidman et al., 1985; Hoffman et
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al, 1987). In both cases, the mice were found to develop mild CNS phenotypes 
(slight tremor or hunching, some evidence of vacuolation) and gt mice were 
concluded to harbour a transmissible agent with an unusually long incubation 
time. It was unknown whether the gt locus itself represented a susceptibility locus 
to this agent, or whether it represented the site of integration of the agent into the 
host genome, permitting vertical transmission through the germline.
At the time the original studies were carried out, BSE had not become the 
cause celebre it is today and no further reference to gt mice appears in the literature 
for ten years. However, a recent study flatly contradicted the transmissible agent 
hypothesis, finding no evidence of any phenotype transmitted by intracerebral 
inoculation of gt/gt brain homogenate (Carlson et al, 1997). They suggest that the 
animals used in previous studies may have been harbouring an infectious agent 
which was completely independent of the gt locus.
The most suggestive piece of data from the 1985 histopathological study 
carried out by Sidman, Kinney and Sweet is the passing observation that m utant 
weanlings often develop a gastrointestinal illness with abdominal distension and 
watery fecal material with gas bubbles. This is highly suggestive of enteric 
hypoganglionosis, but no detailed examination of the status of enteric neurons 
was undertaken. The only known mutant at the SoxlO locus, SoxlODom, features 
the coat spotting and enteric hypoganglionosis seen in Harry mutants. No other 
peripheral nervous system phenotype has been reported, nor has any effect upon 
the CNS. SoxlODom/  SoxlODom homozygotes die before E13 of unknown causes, 
however. It is known that SoxlO is highly expressed in the myelinating Schwann 
cells of the PNS, which are neural crest derived, and in non crest-derived glia and 
oligodendrocytes of the CNS (Kuhlbrodt et al, 1998b). Given all this, it is 
reasonable to speculate that gt may well be a novel allele of SoxlO, with a very 
mild melanoblast and enteric neuroblast phenotype, but a much more severe glial 
phenotype.
Strong support for this hypothesis comes from the recent description of a 
unique patient with a novel heterozygous mutation in SOXIO (Inoue et al, 1999). 
The m utation consists of a 12bp deletion at the stop codon, leading to a frameshift 
and an extra 82 amino acid residues added onto the end of the full-length wild-
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type SOXIO protein. The patient not only presented with Waardenburg-Shah 
syndrome, including long-segment Hirschprung disease, she also had profound 
peripheral neuropathy and leukodystrophy (degeneration of the white matter in 
the CNS), consistent with severe myelination defects in both peripheral and 
central nervous systems. The white matter defects are reminiscent of those seen in 
gt mice. Further evidence that SOXIO mutations can affect glial function comes 
from a pair of siblings heterozygous for a point mutation which truncates the 
SOXIO protein in the middle of the carboxy-terminal transactivation domain 
(Southard-Smith et al, 1999). Both patients were classified as having WS4, but also 
suffered from ataxic cerebral palsy and nystagmus (rapid, jerky eye movements), 
both suggestive of peripheral neuropathy.
wn (white-nose)
A final locus not shown on the map in Fig. 17 is wn  (white nose), a recently 
described coat colour mutant which has been mapped to this region of Chr 15 
(Marks et a l, 1999). wn is an autosomal recessive trait giving rise to an 
unpigmented region near the head, most often a white streak down the face, but 
with considerable variation in the size and position of this white patch. The only 
paper describing this mutation stated that it was not allelic with SoxlO, but the 
mapping data gave a 6.3cM 95% confidence interval which comfortably overlaps 
the SoxlO locus. It is therefore quite possible that wn  represents a hypomorphic 
allele of SoxlO, or if another coat colour locus really does exists close to SoxlO, that 
wn  and the Harry mutation are allelic.
Summary
In terms of the genetic mapping data from these experiments, bt, SoxlO and 
gt can all be considered to be roughly equidistant from the transgene and all 
deserve consideration as candidate loci for the observed phenotype. Dp can 
probably be discounted, both on the grounds of distance and weakness of 
phenotype. Given the close similarity between the Harry m utant and the 
phenotype of the only known mutation at the SoxlO locus, apart from the 
dominant nature of the latter, it seemed logical to assume that the transgene had 
disrupted SoxlO function in some way. Given also that neither bt or gt have been
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cloned, the only straightforward experiment that presents itself with respect to 
these loci is to breed these m utant stocks against Harry to look for 
complementation, bt is still widely available, and mice carrying gt are still 
maintained in the McLaughlin Research Institute in Montana (G. Carlson, 
personal communication).
With detailed knowledge of the SoxlO gene available, it was decided to 
investigate the status of this gene in Harry transgenic mice at the molecular level.
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CHAPTER SEVEN: 
HARRY - NATURE OF THE TRANSGENE INTEGRATION EVENT
Introduction
With the transgene integration site closely linked to the SoxlO locus, it was 
decided to investigate the status of this gene in Harry mutants. At this point, it is 
worth reviewing the current state of knowledge about this gene and its function, 
paying particular attention to its properties in oligodendroglial cells in vitro and in 
the enteric nervous system in vivo, the two areas where most research to date has 
been focussed.
Origins of the enteric nervous system
The enteric nervous system (ENS) is the largest and most complex sub­
division of the peripheral nervous system (PNS) (Gershon et al., 1993). The adult 
ENS contains about the same number of intrinsic neurons as the spinal cord, and 
also contains a wide variety of types of neuron. Enteric neurons are grouped into 
complex microcircuits which resemble those seen in the brain and these 
collectively form complex neuronal networks which are capable of semi- 
autonomous function, even in the absence of any input from the CNS (Gershon et 
al., 1981). Again, paralleling the situation in the brain, enteric neurons are not 
supported by the Schwann cells found in the remainder of the PNS, but by enteric 
glia, which resemble astrocytes, the support cells found in the CNS (Gershon & 
Rothman, 1991). (Outwith the ENS, glial cells of the PNS can be generally 
grouped into either myelinating or non-myelinating Schwann cells. Similarly, 
glial cells of the CNS can be broadly defined as myelinating oligodendrocytes and 
non-myelinating astrocytes, although there are several sub-types of astrocyte and 
other non-neuronal support cells exist in the CNS which may not strictly fall into 
either class) (Barres, 1997)).
Referring to Figure 12b in chapter 5, it will be seen that, at a gross level, the 
enteric nervous system is composed of two plexuses of interconnecting ganglion 
cells (neurons and glia), forming a pair of concentric meshes embedded in the gut 
wall. The outermost plexus of Auerbach lies in between the circular and
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longitudinal muscularis and is commonly referred to as the myenteric plexus. The 
inner plexus of Meissner lies in the submucosae and these cells are far fewer in 
number than the Auerbach neurons. The myenteric plexus has been more closely 
studied and defined, and enteric ganglia in this region consist of dense clusters of 
neurons intermixed with glial cells, which partially ensheath axon bundles. These 
enteric glial cells express the same molecular markers as Schwann cells, but are 
ultrastructurally distinct (Gershon & Rothman, 1991).
Using in situ hybridisation and vital dye labelling, it has been shown that a 
common pool of neural crest cells gives rise to most of the ENS and the superior 
cervical ganglion in the mouse (Durbec et al.r 1996). In the chick, (where many of 
the original detailed anatomical studies of crest migration were performed using 
chick-quail chimerae), these cells originate from both cranial (somite 1-5 level) and 
anterior trunk (somite 6-7 level) regions of the neural tube and are referred to as 
vagal neural crest cells (Le Douarin & Teillet, 1973). Trunk neural crest cells 
arising posterior to somite 7 give rise to the more posterior sympathetic ganglia 
and contribute substantially to the foregut ENS. Posterior again to this, the sacral 
neural crest arises from the region caudal to somite 28 and contributes to the post- 
umbilical ENS (see discussion below). A similar arrangem ent pertains in the 
mouse and other organisms studied, although somite numbers differ.
Vagal neural crest cells migrate away from the neural tube around E9 in 
the mouse and colonise the wall of the developing gut. At some point, these 
neural crest cells become specified as "neuroblasts", and are fated to become 
enteric neurons or glia. The question of exactly when and how this fate is 
established and whether these cells are irreparably committed to a neuronal fate is 
an interesting and controversial one which exceeds the scope of this work. 
However, it is worth touching briefly upon some aspects of this debate.
The predominant model of neural crest patterning has postulated that 
multipotent neural crest cells are developmentally naive and migrate haphazardly 
away from the neural tube. They then encounter environmental cues which both 
guide their migration and inform their differentiation. Some crest cell populations 
have been shown to be multipotent in vitro and crest derivatives such as the 
precursors of enteric or sensory ganglia backgrafted to new locations often
154
differentiate according to their new environment, although this plasticity can be 
limited to specific fates (Le Douarin, 1981). Subpopulations of neural crest cells 
may be partially specified at an earlier, pre-migratory stage, and neural crest cells 
have been shown to transiently accumulate in a cell-free region adjoining the 
neural tube which has been termed the migration staging area (MSA), where such 
specification may occur (Wehrle-Haller & Weston, 1997). Such a specified cell 
may be shown to be differentiated in the sense that it expresses unique lineage 
markers, but may not yet be irreparably committed to a particular fate. If this 
specification merely dictates which migratory route a neural crest cell will follow, 
then the environmental cues encountered en-route could determine the final 
distribution of crest derivatives. This "phenotype-directed model" of neural crest 
cell patterning has recently been shown to apply to melanocytes, where, in the 
chick, ventral migration of neural crest precedes dorsolateral migration by nearly 
24 hours and ceases as dorsolateral migration begins. Melanoblast specification 
precedes migration and only melanoblasts migrate dorsolaterally (Reedy et al, 
1998).
Such a phenotype-directed model can be hypothesised to exist with respect 
to the vagal, trunk and sacral neuroblast precursors, which originate from distinct 
regions of the neural tube, migrate along distinct pathways and differentiate to 
form different final structures, but which all show at least partial plasticity of final 
cell fate when transplanted to an inappropriate migratory region (Le Douarin, 
1981).
It is important to draw a distinction between instructive and selective 
signals. The former act to direct cells towards a particular fate, while the latter act 
to promote or block the survival of particular fated lineages. In crest 
development, it has proved easier to demonstrate the existence of selective 
signals, with instructive signals so far only being identified during in vitro studies. 
For example, the tyrosine kinase receptor kit and its ligand have been shown to be 
a crucial selective factor for the survival of melanoblasts (Wehrle-Haller & 
Weston, 1997), while bone morphogenetic protein (BMP2) acts as an instructive 
factor to fate crest cells towards the autonomic neuronal lineage in an in vitro 
system (Shah et al, 1996). The difficulty in distinguishing instructive signals
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which may be im portant in vivo lies in the fact that such signals are often 
im portant regulators of a number of different developmental processes, and 
mutations in such genes have pleiotropic effects which make it difficult to 
distinguish their role in the neural crest. This may not necessarily apply to 
selective signals to the same degree, however. With reference to the two example 
molecules given above, a null m utation in kit results in the dominant white 
spotting (W) phenotype. Mice homozygous for kitw entirely lack melanocytes 
and erythropoetic stem cells and are sterile due to a lack of primordial germ cells, 
the three lineages where this molecule acts as a survival factor (Geissler et ah, 
1988). On the other hand, a targeted null mutation in Bmp2 has dramatic effects 
upon cardiac and am nion/ chorion function, resulting in embryonic lethality long 
before any effect upon the neural crest can be discerned (Zhang & Bradley, 1996).
It has become increasingly clear from studies where neural crest cell 
explants have been cultured in vitro that one important mechanism of neural crest 
cell specification could act via the generation of a m ultipotent precursor 
population, w ith subsequent apoptosis and removal of unwanted cells during 
m igration along specific paths. Neuronal precursors on the dorso-lateral pathway 
have been shown to exist, but to be subsequently removed during an episode of 
apoptosis (Wakamatsu et al, 1998). A "proof-reading" mechanism, perhaps 
involving the differential expression of receptor tyrosine kinases has been 
postulated to act to cause removal of inappropriately specified neural crest cells 
by apoptosis (Wehrle-Haller & Weston, 1997).
Overall, neural crest cell specification is probably achieved via a mixture of 
the above mechanisms. Instructive signalling could initially direct cells towards 
multipotent lineages. Selective signals before or during migration could then act 
to promote survival of particular lineages and cause removal of inappropriately 
fated cells. Upon arrival at target tissues, further signalling would then occur in 
conjunction w ith the micro-environment in which the neural crest cells find 
themselves to regulate proliferation and differentiation.
Regardless of the exact nature and timing of neuroblast specification, vagal 
crest-derived neuroblasts are seen in the murine foregut at around E9.5 by virtue 
of their earliest known marker, dopamine p-hydroxylase (DBH). These cells are
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referred to as transiently catecholaminergic (TC), as between E9.5 and E14 they 
express all the characteristics associated with sympathetic neurons (expression of 
tyrosine hydroxylase, aromatic L-amino acid decarboxylase and DBH, storage of a 
catecholamine and transmembrane transport of norepinephrine) (Gershon et ah, 
1993). TC cells proliferate and migrate along the entire length of the developing 
gut, colonising the gut wall with cells which differentiate and proliferate in situ 
into enteric ganglia. Unlike sympathetic neurons, these TC cells are proliferative 
and do not express neuronal markers such as neurofilament proteins until after 
they have started to differentiate at their target sites. They are therefore 
considered to be genuine neuronal precursors.
During this time, the gut wall changes from a tube of uniform mesenchyme 
to a differentiated annular organisation, as observed by changes in extracellular 
matrix molecules such as tenascin, laminins and chondroitin sulfate proteoglycan 
(Newgreen & Hartley, 1995). Changes in these ECM molecules proceed in a 
rostro-caudal wave, and markers for differentiating enteric neurons also appear in 
such a wave, which lags slightly behind intestinal maturation. These changes in 
the micro-environment through which the neuroblasts migrate may inform their 
colonisation and differentiation at target sites.
It is thought highly likely that TC cells do not represent the totality of the 
vagal crest cells migrating through the gut, and that these cells only give rise to a 
subset of the enteric nervous system. It is also believed that TC cells cease to be 
catecholaminergic when they terminally differentiate into enteric neurons and 
glia, although a subset of enteric neurons are catecholaminergic in the mature 
ENS.
Simultaneous with the migration of enteric neuroblasts, trunk-derived 
neuroblasts migrate to and colonise their target tissues to give rise to the 
sympathetic ganglia (except for the most anterior ones), the dorsal root ganglia 
adjacent to the spinal cord and most of the foregut ENS (Durbec et ah, 1996) as 
well as the chromaffin cells of the adrenal medulla. Cells of this sympathoadrenal 
lineage can be distinguished from other trunk neural crest cells by their 
expression of catecholaminergic enzymes. They can be further distinguished from 
the enteric neuroblast lineage by the latter's absolute dependence upon the ret
157
tyrosine kinase receptor for correct development, ret-/- null mice entirely lack 
structures derived from the vagal neural crest (their intestines are completely 
aganglionic below the stomach), while the sympathoadrenal lineage remains 
unaffected.
The contribution of the sacral neural crest, originating caudal to somite 28, 
to the ENS has been controversial. The original studies of Le Douarin and Teillet 
using chick-quail chimerae suggested that sacral crest made a substantial 
contribution to the post-umbilical ENS (Le Douarin & Teillet, 1973). However, in 
studies where the vagal crest contribution was removed, either by severing the 
bowel during development, or by culturing aneural hindgut segments in vitro 
with sacral neural tube explants, no sacral crest contribution was seen (Gershon et 
al., 1993). Despite these findings, vital dye and retroviral labelling clearly 
indicated an ascending contribution to the distal gut from the sacral neural crest. 
It recently became possible to definitively resolve this controversy, at least in 
chick, w ith the development of a completely quail-specific monoclonal antibody. 
In a set of experiments using chick-quail chimerae, the authors made the 
interesting discovery that the sacral neural crest does indeed make a significant 
contribution to the ENS, but that the vast bulk of the sacrally-derived cells are 
found in the colon, and display a proximo-distal gradient of distribution with the 
greatest number at the terminal end of the gut (Bums & LeDouarin, 1998). 
Furthermore, these sacrally derived enteric neurons are not seen in the gut until 
after the vagally-derived enteric neuroblasts have begun to colonise the terminal 
colon. This raises the possibility that sacral crest cells require interaction with 
vagally-derived cells in order to colonise an d /o r proliferate in the colon. This 
would explain why severing the bowel above the ileo-cecal junction during 
development leads to a complete absence of enteric neurons in the colon (Allan & 
Newgreen, 1980).
The SoxlODom mutation
As mentioned previously, SoxlO had been described only as the mutant 
locus Dom for a number of years, but the gene product was identified recently by 
two independent groups (Herbarth et al, 1998; Southard-Smith et al, 1998). The 
original description of the locus in 1984 was as a spontaneous m utation arising in
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stocks kept at the Jackson Laboratories (Lane & Liu, 1984). The white spotting 
phenotype of Dom/+ mice is relatively mild compared to Harry mutants, even on 
similar genetic backgrounds (C57BL/6J and C3HeB/FeJLe-^/a, which is similar to 
CBA, as discussed in the previous chapter), w ith usually only white feet and a 
white belly spot of variable size being observed. However, the megacolon 
observed in Dom/+ m utants presented in a very similar manner to that seen in 
Harry mutants, with affected animals having a thin, malnourished appearance 
and the characteristic bulging abdomen due to fecal impaction in the gut. Time of 
death varied from 2 days to 12 months, and was found to be somewhat dependent 
on genetic background. No Dom/Dom homozygotes were observed in the original 
breeding studies and homozygosity has been found to be lethal before E13 for 
unknown reasons. The only exception to this is seen on a C57BL/6J x 
C3H/HheOuJ hybrid background, where a very few homozygous embryos 
develop to term  and Dom/Dom pups die within a few hours of birth (Herbarth et 
a l, 1998). Histopathological studies of the enteric nervous system in Dom/+ 
animals revealed a consistent lack or reduction of enteric ganglion cells in the 
terminal gut. This showed wide variation in the level at which innervation ceased, 
but in all cases, the terminal 2mm of the gut was either fully aganglionic or 
severely hypoganglionic (Puliti et al, 1996). Occasionally, the aganglionic 
segment was seen to extend throughout the colon up to the cecum.
Migration of enteric neuroblasts
A useful system for the study of enteric neuroblast migration 
through the gut has been the development of a line of transgenic mice carrying 
the lacZ reporter gene driven by the upstream  reporter region of the hum an DBH 
gene (Kapur et al, 1992). Enteric neuroblasts (and other TC cells) in these D/3H- 
nlacZ mice can be easily detected using stains for the reporter enzyme, and under 
normal circumstances, these cells were found to migrate rostrally-to-caudally 
along the gut from E9.5 until E13.5, at which point the entire length of the gut was 
colonised. (It is important to stress that although expression of DBH is considered 
to be the definitive marker for enteric neuroblasts, it has not been proven that all 
enteric neuroblasts express this gene i.e. it is possible that the developing gut also 
contains vagal crest derivatives which are not transiently catecholaminergic. The
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cells which stain blue for lacZ in the gut of transgenic embryos may therefore not 
represent the totality of enteric neuroblasts.)
When this transgene was introgressed into the Is (lethal spotting) m utant 
strain, which carries a null allele of the endothelin-3 gene, enteric neuroblasts in 
Is/Is mice were found to progress normally through the gut and then to halt 
abruptly at the ileo-cecal junction around E12.5. Colonisation of the proximal and 
mid-colon proceeded thereafter, but at a retarded rate and in an irregular pattern. 
The terminal colon was never colonized in these m utant mice. Similar results 
were obtained in sl mutants, which are null for the endothelin-B receptor (Kapur 
etah, 1995).
In contrast, when the transgene was introgressed into the Dom m utant 
strain and used to track enteric neuroblasts, it was found that in Dom/+ embryos, 
colonisation of the entire gut was impaired from the earliest stages examined 
(E ll) (Kapur et ah, 1996). Again, migration was found to be delayed at the ileo­
cecal junction around E12.5. However, vagal neural crest cells normally reach the 
distal colon on E13.5 in wild-type embryos, and a num ber of presumptive enteric 
neuroblasts (which stained blue for the transgene) were observed in the distal 
colons of a subset of Dom/+ embryos on a C3HeB/FeJ background. This 
observation suggested a degree of "catch-up" in Dom/+ enteric neuroblast 
migration, via some mechanism which does not exist in Is or sl mutants, or in 
Dom/+ mutants on a C57BL/6J background, where this phenomenon was never 
observed.
SoxlO expression during development
Following fine-scale m apping studies, the product of the Dom locus was 
identified by two independent groups of researchers as the transcription factor 
SoxlO (Puliti et ah, 1995; Pingault et ah, 1997; Herbarth et al., 1998; Southard-Smith 
et ah, 1998). This gene had previously been partially sequenced and classified 
based on its highly conserved HMG-domain. This DNA-binding motif is the 
hallmark of the Sox (Sn/-type HMG box) genes, and a degenerate PCR strategy 
had previously amplified seven different HMG box sequences from a mouse 
embryo cDNA library and classified them as various Sox genes (Wright et ah, 
1993).
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The structure of the SoxlO gene and the known salient features of the 466 
amino acid protein itself are summarised in Figure 18. In the Dom mutation, 
renamed SoxlODom, a single nucleotide insertion causes a frameshift just 
downstream of the HMG-box, resulting in a wild-type amino-terminus and HMG- 
domain attached to 99 novel amino acids and prem ature termination. In situ and 
Northern hybridisation studies showed that SoxlO is expressed in newly forming 
neural crest cells at E9.5 and that expression is maintained in a subset of crest cells 
as they migrate to their target tissues. Subsequent to this, SoxlO expression is also 
seen in the developing CNS and correlates with oligodendrocyte precursors. 
SoxlO expression in the CNS of adult rodents, consistent with its expression in 
cultured oligodendrocytes, corresponds to glial cells, with expression greatest in 
regions with high myelinated fibre content (Kuhlbrodt et al., 1998b). Outwith the 
CNS, expression in adults is confined to glial cells of the peripheral nervous 
system, including Schwann cells (Kuhlbrodt et al., 1998b; Southard-Smith et al, 
1998).
In SoxlODom /+ and SoxlODom/SoxlODom embryos, neural crest cells 
expressing SoxlO are seen to be developmentally delayed in their migratory 
pathways at E10.5, and by E11.5 no SoxlO expression is detectable in homozygous 
m utant embryos. This appears to be due to apoptosis and loss of neural crest cells 
near this time (Kuhlbrodt et al., 1998b; Southard-Smith et al., 1998). This ablation 
of a subset of neural crest cells almost certainly accounts for the fact that 
SoxlODom/SoxlODom embryos entirely lack enteric neurons below the rostral 
foregut, and show substantial reductions in peripheral ganglia which normally 
have a substantial contribution from the vagal neural crest (Herbarth et al., 1998). 
In addition, no early melanoblasts were detectable in E10.5 and E ll .5 
SoxlODom/SoxlODom embryos, as assayed by dopachrome tautomerase (Dct), a 
marker for this lineage (Southard-Smith et al., 1998).
It should be stressed at this point that although SoxlO expression is seen in 
neural crest cells emerging along the full length of the neural tube, the SoxlODotn 
mutation only affects melanoblasts and derivatives of the vagal neural crest. 
Clearly, however, the SoxlO signal in emergent melanoblasts fated to migrate 
down the dorso-lateral pathway could overlay and mask any signal from cells
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migrating along the earlier ventral route. However, a more detailed study of the 
expression pattern of SoxlO in emergent neural crest cells suggests that ventrally 
migrating trunk neural crest cells do express SoxlO, and that such expression 
precedes the formation of dorsal root ganglia (Pusch etal., 1998).
It should also be stressed that although SoxlO is expressed widely in glial 
cells of both central and peripheral nervous systems, including those which 
originate from trunk neural crest, the SoxlODom m utation only appears to cause a 
phenotype in vagal neural crest cell derivatives and melanoblasts, at least in 
heterozygotes. The cause of death in homozygotes remains unknown.
It is tempting to speculate, in light of the apoptosis observed in 
SoxlODom/SoxlODom embryos, that one initial im portant role of SoxlO in the 
developing embryo is as a survival factor specific to vagal neural crest and 
melanoblasts and that subsequent to this, it fulfils a less critical role throughout 
the lifespan of all or most glial cells. Similar apoptosis has recently been shown to 
occur in undifferentiated enteric neuroblasts lacking the ret gene product, and it 
has been suggested that one function of ret is to promote the survival of these 
cells (Taraviras et al., 1999). Since ret appears to serve no function in 
melanoblasts, this might imply that ret lies downstream of SoxlO in vagal neural 
crest but not the melanocyte lineage (where c-kit may subsume the role of ret).
The molecular nature of the SoxlODom mutation
Work in oligodendroglial cell cultures has shown that the mouse and rat 
SoxlO protein, as with many other Sox genes, possesses no intrinsic transcriptional 
activation (transactivation) properties, but rather that it functions synergistically 
with other transcription factors to modulate transcription (Kuhlbrodt et al., 
1998b). The HMG box is known to act as a DNA-binding dom ain and many Sox 
proteins recognise the motif 5'-AAACAAAG-3'. This motif was used in an in vitro 
reporter assay in glioblastoma cells to show that SoxlO itself would not activate 
transcription, but that it would interact with the POU domain transcription factor 
Tst-l/O ct6/SCIP to significantly increase the latter's ability to activate 
transcription. SoxlO was also shown to interact with Pax3 and the zinc finger 
transcription factor Krox20 in the same system, upregulating and downregulating 
the respective transcriptional activation ability of these two factors. (All three
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transcription factors are known to be involved in the development of Schwann 
cells.) Thus SoxlO was hypothesized to be a transcriptional m odulator, rather 
than a transcription factor, at least in glial cells.
From deletion construct experiments using the system described above, it 
was hypothesized that SoxlO contained a synergy domain amino-terminal to the 
HMG-box which could interact with nearby transcription factors to modulate 
their activity. Hum an SOXIO was cloned and 4 separate m utations in the gene 
were implicated in familial cases of Waardenburg-Shah syndrome (Pingault et al., 
1998; Pusch et al., 1998). These 4 mutations were replicated in the cloned human 
and rat SoxlO cDNAs and all were tested in a follow-up study using the same 
oligodendroglial cell culture system for their ability to intrinsically transactivate a 
reporter gene with a Sox binding site upstream  and for their ability to synergise 
with Tst-l/O ct6/SCIP (Kuhlbrodt et al., 1998c). Interestingly, hum an SOXIO was 
found to have a weak intrinsic transcriptional activation ability, unlike the 
situation in rodents. This was found to reside in the carboxy-terminal 113 amino 
acids of the hum an protein. The ability to bind DNA was also required, as two 
mutations which removed or affected the HMG-box also abolished DNA binding 
and synergy. The synergy domain which interacts w ith the N-terminal region of 
Tst-l/O ct6/SCIP was found to reside in the amino-terminal 60 amino acids of 
SOXIO, although this synergistic enhancement was found to be reduced in the 
absence of the carboxy-terminal transactivation domain. The authors postulate 
that the hum an carboxy-terminal transactivation domain interacts with the 
synergy domain in some way.
Since the synergy domain resides in the amino-terminus of the protein, and 
since the SoxlODom mutation does not affect either this region or the HMG box, it 
is therefore puzzling that the synergistic effect is completely abolished in the 
SoxlODom protein. Based on the presumptive interaction between the carboxy- 
terminal domain and the synergy domain, Kuhlbrodt et. al. speculate that the 
novel 99 amino acid carboxy terminus of the SoxlODom protein might act as a 
repressor of synergy, rather than simply being a passive deletion of the carboxy- 
terminus (Kuhlbrodt et al., 1998c). Hence the SoxlODom m utation might act as a 
true dominant, rather than via haploinsufficiency of wild-type SoxlO protein.
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The differences between hum an and rodent SoxlO are also evident in the 
observation that during hum an development, SOXIO is expressed in the cranial 
neural crest-derived cephalic mesectoderm, which gives rise to facial cartilages 
(Bondurand et al.f 1998). This is not seen in mouse or rat and the authors suggest 
that human SOXIO may have additional roles in development. Dystopia 
canthorum (widening of the medial canthus of each eye) is due to defects in the 
cephalic crest contribution to the facial cartilages, and is a classic indicator of WS 
type 1 and 3. It is not normally associated with WS4, however, the unique patient 
with the novel mutation in SOXIO giving rise to extremely severe PNS and CNS 
defects also presented with WS4, including profound deafness, long-segment 
Hirschprung and heterochromia iridis (Inoue et al, 1999). Unusually, she also 
had dystopia canthorum, indicating that SOXIO does seem to play some role in 
cephalic neural crest, consistent with its expression pattern in hum an embryos.
Sox genes and POU domain transcription factors in Schwann cells
The role of POU domain transcription factors in the differentiation of 
Schwann cells is now beginning to be unravelled. Tst-l/Oct6/SCIP is essential for 
terminal differentiation of myelinating Schwann cells and is also expressed in 
CNS oligodendrocytes. A targeted deletion of this gene resulted in a severe defect 
in peripheral nerve myelination but failed to give any CNS phenotype 
(Bermingham et al, 1996; Jaegle et al, 1996). The closely related transcription 
factors Bm-1 and Bm-2 also show a similar expression pattern to Tst-l/Oct6/SCIP 
in oligodendrocytes and some degree of functional redundancy may well apply. 
Thus, it is possible that a double or triple knockout of these genes might be 
required to give a phenotype in the CNS.
Following on from the detailed investigation of SoxlO's ability to synergise 
with Tst-l/Oct6/SCIP, oligodendroglial cells were found to express Soxll, and this 
protein was found not to interact with Tst-l/Oct6/SCIP, but to synergise with Bm- 
1 and Bm-2, which do not interact with SoxlO (Kuhlbrodt et al, 1998a). The 
comparison between the two Sox genes is informative, as rat Soxll possesses a 
strong carboxy-terminal transactivation domain. The synergy domain is 
unidentified as yet, but does not lie w ithin the amino-terminal 43 amino acids.
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It is hypothesized by the authors that Sox proteins interact with class III 
POU domain transcription factors in a combinatorial manner to help specify or 
maintain cell identity in the PNS (Kuhlbrodt et al, 1998a). It is furthermore 
suggested that there is considerable overlap in the functions of these class III POU 
domain transcription factors in glial cells. By implication, this may extend to their 
transcriptional partners, the Sox genes. In support of this argument, it has been 
observed that SoxlO is actively transcribed in both the precursor and the mature 
oligodendrocyte, however Soxll expression is down-regulated during the early 
stages of differentiation of both oligodendrocytes and Schwann cells. The Soxll 
expression pattern closely resembles that of Brn-1. Sox4 is also expressed in a 
similar pattern to Soxll in the oligodendrocyte lineage, and functional 
compensation by other, closely-related Sox genes may explain why there is no 
glial phenotype in the Sox4-/- knockout mouse (Schilham et al., 1996).
This suggested mechanism of specific gene activation by combinatorial 
interactions accords well with a proposed similar model involving POU domain 
and LIM homeodomain proteins. It has been estimated that there may be 
hundreds of different POU-domain proteins, each expressed in different 
subclasses of neurons (He & Rosenfeld, 1991). Similar num bers of LIM-domain 
genes exist, and it has been suggested that combinatorial interactions between 
POU and LIM domain proteins could confer neuronal identity (Tsuchida et al, 
1994; Anderson & Jan, 1997).
Sox gene function in chicken and Drosophila
In parallel with the studies of SoxlO and Soxll discussed above, detailed 
domain-swap experiments have been performed using a similar in vitro reporter 
assay system to dissect and compare the functions of Soxl, Sox2, Sox3 and Sox9 
(cloned from chicken) (Kamachi et al, 1999). The closely related S o x l/2 /3  
proteins are all expressed in the lens and will all activate a 5-crystallin minimal 
enhancer element. The distantly related Sox9 protein plays a crucial role in 
chondrogenesis, and will activate a minimal enhancer element derived from the 
collagen gene Collal. Using these enhancer elements in a reporter assay system, 
constructs containing various domains of these Sox genes were tested. It was 
found that the HMG-box domain conferred only limited specificity on each Sox
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gene, and that specificity was conferred mainly through interaction with partner 
factors which bound to nearby enhancer elements, and that interactions between 
Sox genes and partner factors were mediated by the region of the protein 
immediately carboxy-terminal to the HMG-box. The actual transactivation 
domains were found to be distal to this, lying closer to the carboxy-terminus of 
each molecule. Interestingly, the amino-terminal domain of Sox9 was found to act 
as a repressor of transactivation activity.
A similar arrangement has been found to pertain w ithin the TCF/LEF 
family of HMG-box transcription factors, which were initially identified as being 
important in lymphocyte differentiation, but have now been grouped with the Sox 
gene family (Schilham & Clevers, 1998). Four hum an Tcf (T-cell factor) genes 
have been identified, with one ancestral homologue in Drosophila, named dTCF or 
Pangolin (Castrop et al, 1992; Brunner et al, 1997). It has now been shown that 
dTCF binds to the enhancer region of engrailed via its HMG-domain, and that it 
synergistically interacts with Groucho to repress engrailed expression (Cavallo et 
al, 1998). However, following activation of the p-catenin signalling pathway, a 
separate domain of the dTCF protein can interact with Armadillo (the p-catenin 
homologue) and synergistically upregulate expression of engrailed (van de 
Wetering et al, 1997).
Sox9 is co-expressed with Sox5 and Sox6 in regions of chondrogenesis and 
further work on the Col2al enhancer element has shown that all three proteins 
bind to nearby sites in this region and upregulate expression of the gene 
(Lefebvre et al, 1998). In addition, it was found that the long isoforms of Sox5 and 
Sox6 (L-Sox5 and L-Sox6) heterodimerise via a coiled-coil (leucine zipper) domain 
lying amino-terminal to the HMG box, and that this interaction greatly enhanced 
their binding to adjacent HMG target sites. Studies of this coiled-coil domain in L- 
Sox6 (also known as Sox-LZ) have shown that it can mediate homodimerisation, 
resulting in repression of transactivation ability (Takamatsu et al, 1995; Lefebvre 
et al, 1998). Thus, it is entirely possible that some of the im portant partner factors 
for Sox proteins are actually other Sox proteins, w ith homo- and 
heterodimerisation occurring.
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Given the importance of dimerisation for the mode of action of Sox5 and 
Sox6, it would be useful to know whether SoxlO contains a coiled-coil domain 
which might mediate homo- or heterodimerisation. Coiled-coil domains consist 
of a bundle of a-helices - generally two, but occasionally three or four - wound 
together into a superhelix (Lupas, 1996). The packing in the centre of the 
superhelix involves a distinctive "knobs-into-holes" packing, in which a residue 
from one a-helix packs into a space surrounded by four sidechains of the facing 
a-helix. Negative supercoiling reduces the number of residues per turn of each 
a-helix to 3.5, allowing sidechains to repeat every seven residues, the hallmark 
"heptad repeat" of a coiled-coil domain. Prediction of coiled-coil domains 
therefore hinges around scanning the amino acid sequence w ith a "window" of 
multiples of seven residues, looking for heptad repeat motifs. The prediction 
algorithm COILS is available on the Web, and is the heart of a program that 
compares a sequence to a database of known parallel two-stranded coiled-coils 
and derives a similarity score (http://w w w .isrec.isb-
sib.ch/software/COILS_form.html) (Lupas et al., 1991). By comparing this score 
to the distribution of scores in globular and coiled-coil proteins, COILS then 
calculates the probability that the sequence will adopt a coiled-coil conformation. 
Given a query sequence, COILS scans the amino acid sequence with a "window" 
of 14, 21, or 28 residues (based on the diagnostic heptad repeat) and assigns a 
probability value from 0 to 1.0 for each residue forming part of a coiled-coil 
domain. A coiled-coil domain can be confidently assigned if more than one 
w indow results in a high probability score and the 21-residue window appears to 
be the most accurate predictor of coiled-coils.
Both L-Sox5 and Sox-LZ (i.e. L-Sox6) gave very strong predictions for 
coiled-coil domains amino-terminal to the HMG box when their sequences were 
run  through the COILS program, and this accords perfectly w ith published data 
on the functional leucine-zipper coiled-coil domain in these proteins (Lefebvre et 
al., 1998). However, not only do SoxlO, SoxlODom and Sox9 lack (so far as is 
known) the alternatively-spliced amino-terminal domain of L-Sox5 and L-Sox6 
where this coiled-coil domain lies, but none of these three proteins showed any 
significant predictions for a coiled-coil domain (data not shown). While it is
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dangerous to draw firm conclusions from a cursory analysis of SoxlO using only 
one algorithm, it is probably safe to assume that SoxlO does not have a leucine- 
zipper dimerisation domain analogous to that found in Sox5 and Sox6. The 
SoxlODom mutation may therefore be viewed as being less likely to exert its effect 
by acting as a dominant negative inhibitor of SoxlO homodimerisation via a 
coiled-coil domain.
A proposed general mechanism of Sox gene function
Although many Sox genes are still poorly characterised, the published data 
allows the postulation of a general mechanism for Sox gene function. The HMG- 
box domain is responsible for binding DNA, and introduces a bend in the DNA 
when it does so (Werner et al., 1995). However, the specificity of Sox gene 
function is probably not solely conferred by the region, since Sox genes appear to 
be fairly promiscuous in binding to their target sequences. It is likely that Sox 
genes achieve target specificity through interactions with partner factors such as 
POU domain proteins or other Sox proteins, which bind to nearby sequences in 
the promoter region. An individual Sox protein may interact w ith more than one 
partner factor, and these combinatorial interactions could mediate repression or 
activation of genes in specific tissues.
SoxlO001* and enteric pathogenesis
Many of the studies on the expression pattern and the molecular nature of 
the SoxlO gene have been carried out with regard to glial cells of the PNS and 
CNS. However, the critical defect observed in SoxlODom m utant mice and human 
WS4 patients is the intestinal aganglionosis (indeed there is no observed 
phenotype in either the PNS or CNS in SoxlODom/+ heterozygotes). There are 
several possibilities as to the pathogenic mechanism of this condition.
Firstly, since enteric neuroblasts are entirely absent in homozygotes due to 
apoptosis of the neural crest cells which give rise to them, it is possible that in 
hemizygotes the pool of neural crest cells available to generate enteric neuroblasts 
is somewhat reduced. Since the terminal colon is the last region to be colonised, 
such a reduction in starting numbers of precursor cells might reasonably be 
expected to affect this region. The numbers of enteric neuroblasts observed
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migrating down through the gut in the DpH-nlacZ transgenic experiments argues 
against this, however (Kapur et al.r 1996). It is also known that enteric neuroblasts 
have enormous proliferative capacity during their migratory phase (Young et ah, 
1998).
A simple explanation for the aganglionic phenotype observed in SoxlODom, 
Is and sl m utant embryos has been proposed by Newgreen et al. who made a 
detailed study of the growth kinetics of the gut itself relative to the migration of 
enteric neuroblasts during chick and quail embryogenesis (Newgreen et al, 1996). 
They found that the rate of growth of regions of the gut was relatively slow until 
the time at which neural crest derived cells (as determined by those cells which 
expressed the HNK-1 epitope) arrived, at which point the growth rate 
dramatically increased. Although it is not possible to use the same antibody in 
mouse in order to repeat this study in m utant embryos (the HNK-1 epitope is a 
conserved carbohydrate moiety associated with glycoproteins found mainly on 
the cell surface of migrating neural crest, but current monoclonal antibodies to 
HNK-1 do not cross-react with mouse), they hypothesize that any delay in the 
arrival of vagal neural crest derivatives might jeopardise their ability to fully 
colonise the rest of the gut due to a growth wave outstripping their migration. 
While this is an attractive hypothesis, it does not account for Kapur's observation 
of a few cells labelled with DpH-nlacZ arriving in the terminal gut at the correct 
time during Dom/+ embryogenesis, despite an earlier delay in migration (Kapur 
et al, 1996). These might, of course, correspond to some few sacrally-derived 
enteric neuroblasts, if such were shown to be transiently catecholaminergic at this 
time. Although sacral neural crest derivatives are almost certainly not TC during 
migration to the gut, and probably do not express the HNK-1 epitope during 
migration, if a few cells successfully colonised the terminal gut, they might 
become TC at this time or shortly after differentiation to enteric neurons.
The exact nature of sacral neural crest during m urine development is 
somewhat under-characterised, due to a lack of specific markers. However, a 
recent study using antibodies to the transcription factor Phox2b, which appears to 
be a good marker for both migratory enteric neuroblasts and differentiated enteric 
neurons in rodents, has shown that no Phox2b-labelled cells appear in the hindgut
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until after the vagal wave of enteric neuroblasts arrives (Young et al., 1998). Vital 
dye labelling studies have shown that sacral crest has migrated into this region 
prior to the arrival of the vagal wave, hence these early sacral crest cells either do 
not contribute to the ENS or absolutely require some interaction with the vagally- 
derived cells before they can acquire enteric neuroblast characteristics (see below) 
(Serbedzija et ah, 1991).
Cell autonomous and non-autonomous effects during enteric neurogenesis
It was found, using aggregation chimerae between wild-type and mutant 
embryos, that the defect in colonisation of the colon seen in both Is and sl mutants 
was not strictly cell-autonomous (i.e. did not solely reflect a defect in the mutant 
neuroblasts). There are sharp differences in morphology, ECM expression 
patterns and enteroendocrine secretory products between the colon and the small 
intestine immediately below and above the ileo-cecal valve. It is possible that the 
defect observed in Is and s1 mutants partly reflects changes in the micro­
environment of the gut wall which impairs the migration an d /o r colonisation of 
neuroblasts in this region and this has been suggested to be the case with respect 
to an observed abnormal accumulation of basal lamina components in the colonic 
wall of Is adult mutant mice (Payette et a l, 1988).
Further studies using an in vitro culture system have shown that the 
hindgut of Is/Is mice is a non-permissive environment for both m utant and wild- 
type neural crest cells, and it seems clear that in this mutation, at least, failure to 
express endothelin-3 in the hindgut mesenchyme creates a non-permissive 
microenvironment and causes aganglionosis independently of any defects in 
neural crest cells (Jacobs-Cohen et a l, 1987). Excess axonal innervation is seen in 
the aganglionic region of Is/Is mice and it has been suggested that the gut micro­
environment may be permissive for axonal growth in the absence of intrinsic 
innervation (Payette et a l, 1987).
Using aggregation chimerae between wild-type and SoxlODom/+ embryos, it 
was found that the SoxlODom mutation was also not strictly cell-autonomous 
(Kapur et a l, 1996). In other words, the ability of a neuroblast to colonise the 
distal gut is not solely an intrinsic property dictated by the presence or absence of 
the SoxlODom mutation, but can be affected by the cellular environment in which
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the neuroblast finds itself. Chimeric mice with aganglionic distal colons were 
found to lack both wild-type and SoxlODom /  + neurons in the affected regions, 
implying that the presence of m utant cells in some way affected the migration 
an d /o r proliferation of wild-type enteric neuroblasts.
This finding is curious, since, given that SoxlO is a transcription factor, the 
gene might reasonably be expected act in a cell-autonomous manner, and indeed, 
aggregation chimera experiments with its closest relative, Sox9, have shown that 
this gene does act in a cell-autonomous manner to direct cell fate along a cartilage 
formation pathway at an early stage (Bi et al., 1999; Healy et al., 1999).
If the SoxlODom defect truly is non cell-autonomous, it is possible that 
SoxlODom fails to fulfil some role in conditioning the micro-environment of the 
colonic wall so as to be suitable for colonisation by enteric neuroblasts. Given the 
lack of observed expression of SoxlO in this region, this seems unlikely, although 
it is conceivable that Soxl0-expressing enteric neuroblasts might activate SoxlO 
expression in the gut wall via interaction with mesenchymal cells upon arrival, 
constituting part of a paracrine/autocrine feedback loop necessary for the 
proliferation of neural crest cells in their target micro-environment. This has been 
directly refuted by recent work from the same lab that performed the original 
aggregation chimera studies with SoxlODom mutants: wild-type neural crest can 
colonise SoxlODom /SoxlODom intestinal grafts placed under the renal capsule of 
wild-type host mice (Kapur, 1999). This suggests that the enteric 
microenvironment is probably normal in SoxlO mutants.
An attractive alternative hypothesis for the mechanism of 
hypoganglionosis suggests itself from the recent findings of Burns and Le 
Douarin, w ith regard to the putative interaction required between vagal and 
sacral neural crest derivatives in order for the latter to successfully colonise the 
terminal gut (Burns & LeDouarin, 1998). This interaction was also mooted by 
Young et al. who point out that sacral neural crest cells are highly unusual in that 
they express none of the markers associated with enteric neuroblasts until after 
the arrival of the vagally-derived cells (Young et al., 1998). Young and co-workers 
could not categorically state whether the sacral neural crest did in fact make a
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contribution to the ENS, but Burns and Le Douarin have definitively 
proved that this is the case, at least in the avian embryo.
Given that sacrally-derived wild-type crest cells would not have been 
detected in Kapur and co-workers earlier study (since they would likely not have 
expressed the DBH-nlacZ transgene), it is possible that in those chimeric animals 
most affected, there was a very substantial m utant contribution to the sacral 
neural crest. This could have led to a severely hypoganglionic distal colon, even 
in the presence of substantial numbers of vagally-derived wild-type enteric 
neuroblasts migrating down the gut rostral-to-caudally. However, if this model 
were to prove correct, the aganglionosis would reflect a cell-autonomous defect in 
SoxlODom/+ neural crest cells.
If this hypothetical interaction between the two groups of neural crest cells 
were further postulated to have a narrow window of opportunity, it might also 
explain why the delay in the migration (rather than a complete absence) of 
vagally-derived enteric neuroblasts in SoxlODom/+ (non-chimeric) embryos could 
lead to a severe reduction in the number of neurons in the terminal gut, since the 
sacral crest cells might "miss their chance" to interact with them and hence fail to 
become potentiated for a neuronal or glial fate.
Glial cells and the pathogenesis of megacolon
It is known that the ganglia of the myenteric plexus are composed of 
multiple neurons and glia clustered together in small groups with inter-linking 
fibres which stain positive for neurofilament, and that individual enteric 
neuroblasts are capable of giving rise to both cell types (Gershon & Rothman,
1991; Natarajan et a l, 1999). This is in accord with the multi-potent nature of 
neural crest cells of the sympathoadrenal lineage, which are known to form 
neurons, glia and the chromaffin cells of the adrenal medulla (Durbec et a l, 1996; 
Burns & LeDouarin, 1998). It has further been established during the course of the 
DBH-nlacZ <-> wild-type aggregation chimera studies that the enteric ganglia are 
not necessarily of clonal origin i.e. that more than one enteric neuroblast may 
contribute to each ganglion (Kapur et a l, 1993). Since SoxlO expression is 
maintained in the developed PNS and CNS only in glial cells, it is possible that its 
expression in the ENS becomes restricted to the glial cells after the neuroblasts*
* Strictly speaking, the term neuroblast refers to a purely neuronal precursor, but is used, in this context, 
to refer to neuronal-glial precursors.
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have fully differentiated. If this were the case, SoxlODom mutation might 
reasonably be expected to exert an effect upon enteric glia directly, rather than 
upon the migratory precursors.
In support of this "glial effect" hypothesis, a recent experiment specifically 
ablated glia in adult mice, and found that reducing the num ber of enteric glia in 
the mature ENS had a particularly dramatic phenotypic effect (Bush et al., 1998). 
The m utant mice in these experiments carried a GFAP-HSVTk transgene 
consisting of a viral thymidine kinase gene driven by the mouse glial fibrillary 
acid protein (GFAP) promoter. When gancyclovir was administered to these 
mice, a dramatic loss of the glial cells of the jejunum and ileum (but not the 
stomach or colon) was found, due to the production of cytotoxic nucleotide 
metabolites by the action of thymidine kinase upon gancyclovir. These mice 
developed a fulminating jejuno-ileitis and died less than 20 days after 
commencement of gancyclovir treatment. The pathology of this rapid onset 
intestinal disease was quite reminiscent of that seen in megacolon, with 
inflammation of the bowel and degradation of the mucosal lining. It had been 
previously thought that such inflammation might be a consequence of the sepsis 
seen in mice with megacolon (Caniano et al., 1989), but the condition seen in the 
GFAP-HSVTk mice was claimed to be independent of bacterial overgrowth. This 
has led to a resurgence of interest in entero-glial cells, w ith some researchers 
claiming that they may act as a bi-directional interface between the nervous and 
immune systems, by virtue of being both responsive to and producers of both 
cytokines and neurotransmitters (Ruhl & Collins, 1995).
There certainly exists strong evidence from other studies of inflammatory 
bowel diseases such as Crohn's disease and ulcerative colitis that reduced or 
abnormal enteric innervation can lead directly to an inflammatory response 
(Dvorak et al., 1993). The plexus of Meissner almost certainly interacts intimately 
with the immune system. It has been shown by careful morphometry that in the 
hum an lower bowel, enteric nerve fibres of the plexus of Meissner are very closely 
apposed to most lymphoid cells in the gut wall, and that significant loss of these 
fibres is implicated in inflammatory bowel disease (Kubota et al., 1992). The 
plexus of Meissner is much more severely affected in the Is m utant than the
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myenteric plexus, and abnormal distributions of enteric lymphoid cells have been 
demonstrated in the affected intestines of sl mutants (Payette et al, 1987; 
Fujimoto, 1988; Caniano et al., 1989).
Further to this, Fihn and co-workers claim to show that the myenteric 
plexus regulates fluid secretion and epithelial permeability in the rat small 
intestine, although since this work is in the form of a meeting abstract, it cannot be 
fully assessed as yet (Fihn et al, 1997).
Overall, the pathogenesis of the inflammatory reaction seen in the gut wall 
lying above the constricted region in megacolon probably does not simply reflect 
defects in the myenteric plexus and is unlikely to be merely a secondary effect of 
sepsis.
Enterochromaffin and APUD cells
One final consideration is the possible role of the enterochromaffin cells in 
the ENS and in the pathogenesis of megacolon in SoxlO m utant mice.
The endocrine system can be divided into two main components, with the 
first being the classical endocrine organs such as pituitary and thyroid glands, and 
the second being the so-called "diffuse endocrine system" (MacSween & Whaley, 
1992). This consists of cells dispersed singly or in small groups throughout 
various non-endocrine organs including the gastrointestinal tract. Indeed, it has 
been estimated that the total mass of the diffuse enteric endocrine system may 
well exceed that of many of the classical endocrine organs (Pearse, 1973).
All of the cells of the diffuse endocrine system stain with silver salts when 
an exogenous reducing agent is added during incubation. In addition, a subset of 
these cells will reduce silver salts directly, and this is known to be associated with 
expression of 5-hydroxytryptamine (5-HT) These are known as argentaffin or 
enterochromaffin cells and can be delineated using Fontana-Masson staining 
(Culling, 1974).
Enterochromaffin cells fall within the gamut of APUD cells (amine 
precursor uptake and decarboxylation), which also include the neural crest- 
derived endocrine chromaffin cells of the adrenal medulla. APUD cells are 
known to comprise a large part of the enteric endocrine system, and consist of at 
least 20 different cell types, responsive to different stimuli and secreting different
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products (Pearse, 1973). Their exact origin has been controversial, but it seems 
clear that at least some enterochromaffin cells are neural crest-derived, whilst 
others are not, and instead derive from differentiation of local multi-potent stem 
cells (Le Douarin & Teillet, 1973; Pearse, 1973; Andrew, 1974; MacSween & 
Whaley, 1992). The use of their biochemical properties as a marker for a purely 
neural crest origin is therefore inappropriate.
The original studies on the aganglionic gut of SoxlODom/+  heterozygotes 
included Fontana-Masson staining, and the authors showed that enterochromaffin 
cells were also severely reduced in parallel w ith the reduction in enteric ganglia in 
these m utant mice (Lane & Liu, 1984). Since the origin of these cells was 
controversial, the authors refused to speculate on the significance of this. 
Regardless of the mechanism of their ablation in these mutants, since the 
enterochromaffin cells are clearly part of the enteric endocrine system, it might be 
predicted that their absence would have a dramatic effect on the ability of the 
animals to absorb nutrients, or even upon gut motility, since endocrine secretions 
are thought to feed back into the intestinal neuromuscular complex and promote 
an increased motile response (Tortora & Anagnostakos, 1990).
Overall, the actual mechanism by which the SoxlODom m utation produces 
the dramatic megacolon phenotype is somewhat unclear. It is emphatically clear 
that a reduction or loss of enteric glia cells can have drastic physiological 
consequences, even if enteric neurons remain intact. Thus, it is possible that the 
SoxlODom mutation might exert an effect at two levels: Firstly, in the neuronal 
precursor cells, by a delay in their migration with consequential reduction in the 
number of enteric ganglia in the terminal gut (by whatever mechanism). 
Secondly, the mutation might act to reduce survival within a subset of enteric glial 
cells after neuroblast colonisation and differentiation.
SoxlODom in melanogenesis
Surprisingly little work has been done on the role of SoxlO in  melanoblasts, 
although a great deal is known about the differentiation of melanoblasts into 
melanocytes.
Melanoblasts migrate away from the MSA along the dorso-lateral pathway 
and colonise the developing epidermis around E12.5. Subsequent to this, they
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colonise and proliferate in the developing hair follicles around E14.5 (Aubin- 
Houzelstein et al, 1998). At around the same time, other melanoblasts migrate to 
and colonise the inner ear, the eye and, curiously, the leptomeninges covering the 
ventrolateral surfaces of the medulla oblongata and the upper cervical cord
(Morse & Cova, 1984; Boissy & Nordlund, 1997). The melanocytic cells of this
latter region are believed to give rise to extremely rare primary malignant 
melanomas of the CNS (Fish et al, 1990).
In the adult skin of the mouse, therefore, there reside two distinct
populations of melanocyte. The first consists of a group of melanocytes in the 
basal epithelial layer of the epidermis, and the second consists of those 
melanocytes populating the germinative bulb of the hair follicle. The former 
differentiate and start to produce melanin around E16. Their numbers 
dramatically increase shortly after birth, with skin pigmentation readily visible by 
day 3 post-partum in the mouse. Epidermal pigmentation in the trunk of wild- 
type C57BL6 mice remains for several weeks after birth (Mayer, 1967b). Hair 
follicle germination also begins around E16, although fur growth lags somewhat 
behind skin pigmentation in the post-natal mouse. Throughout the growing 
phase of the hair cycle (anagen), melanogenesis occurs, w ith the melanocytes in 
the hair follicle actively transferring melanin granules to the surrounding 
keratinocytes which form the hair shaft (Aubin-Houzelstein et al., 1998). These 
two processes are considered to occur separately and to be regulated 
independently, although they share important regulatory molecules such as the c- 
kit/SCF receptor-ligand system.
While it is relatively straightforward to envision a mode of action for a 
mutation which completely abolishes skin pigmentation, the mechanism by which 
only certain large areas lacking pigmentation are generated in coat spotting 
mutants such as piebald (s) has long been a bone of contention. Three major 
hypotheses have been put forward (reviewed in (Mayer, 1967b)). Schaible 
proposed that only 14 stem melanoblasts survive and migrate to specific pigment 
centres in the epidermis, and that subsequent proliferation of melanocytes from 
these centres results in a fully pigmented coat. In this model, mutations which 
generate coat spotting do so by eliminating certain stem melanoblasts or
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restricting their proliferation, resulting in large unpigmented regions (Schaible, 
1969).
Alternatively, following early experiments in various patterning mutations, 
Mintz suggested that two types of melanoblast were created: one viable, and one 
"pre-programmed" to die. According to this model, after the initial stages of 
migration are complete, the death of certain melanoblast clones leaves gaps in the 
coat that may never be filled in by the viable melanoblasts (Mintz, 1967).
A third hypothesis, favoured by Mayer and others, suggested that 
melanoblasts migrate in large numbers to all regions of the integument, but that in 
spotting mutants they fail to differentiate in certain areas of the skin (Mayer, 
1965; Mayer, 1967a). This model permits a m utation to affect either the 
melanoblast (cell autonomous) or the surrounding environment (cell non- 
autonomous), but the end result is a failure of differentiation of melanoblasts 
rather than a defect in proliferation or migration.
Although far more is now known about the molecules involved in these 
processes, little progress has really been made beyond Mayer's studies towards 
determining the exact mechanism of coat spotting in the mouse and in hum an 
pigmentary disorders reviewed in (Boissy & Nordlund, 1997)). It has become 
apparent though that, as with enteric neuroblasts, mutations in the endothelin- 
3/endothelin-B receptor act both cell autonomously in the melanoblast and cell 
non-autonomously in the tissue environment in which the melanoblast 
differentiates and that this may be a consequence of different actions of these 
molecules during different times in melanoblast development (Mayer, 1967b; 
Mayer, 1977). Endothelin-3 in particular has been found to regulate survival and 
proliferation of early melanoblasts and to directly stimulate their differentiation 
into melanocytes at a later point in development. (Reid et ah, 1996). The 
Ednrb/Edn3 receptor-ligand system therefore acts in a similar fashion to c-k.it/SCF 
in the melanoblast lineage.
One suggestive finding has been the discovery of a "community effect" 
postulated to act during the proliferation of melanocytes in hair follicles during 
development (Aubin-Houzelstein et al., 1998). The recessive patchwork (pwk)
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mouse mutation appears to be in a gene which encodes a non cell-autonomous 
signal for melanoblast survival in hair follicles. Patchwork mice show a 
variegated coat colour pattern with individual hairs either fully coloured or 
entirely white. In homozygous pwk/pwk embryos, most melanocytes were seen to 
apoptose around E18.5 and the majority of hairs were white. However, a number 
of different melanoblasts colonise each single hair follicle (Mintz, 1967), and 
aggregation chimerae between pwk/pwk and wild-type embryos showed that the 
patchwork effect disappeared or was severely ameliorated if sufficient wild-type 
cells were present. It was also clear from these experiments that pwk/pwk 
melanoblasts could survive and proliferate if an above-threshold number of 
melanoblasts (wild-type or mutant) were present, hence the "community effect".
If borne out, this result might have relevance to the findings of Kapur and 
co-workers when they examined aggregation chimerae between wild-type and sl, 
Is and Dom m utant embryos and observed that a relatively small wild-type 
contribution could completely rescue the aganglionic phenotype. This could be 
explained by the existence of a similar community effect w ith respect to enteric 
neuroblast proliferation upon reaching their target sites. Intriguingly, it has been 
found that when trunk neural crest cells are cultured in vitro, they progressively 
lose the ability to form neurons, and become restricted to a glial-melanocyte fate. 
It was established that cell-cell contact leads to loss of the neurogenic 
subpopulation by apoptosis (Maynard & Weston, 1998). This phenomenon is 
almost a mirror image of the "community effect".
It is known that melanoblast migration is somewhat delayed compared to 
other neural crest lineages. One attractive hypothesis is that early neural crest 
cells are biased towards a neuronal-glial fate, while later ones become biased 
towards a glial-melanocyte fate. In addition, there may be a restricted window of 
opportunity for melanoblasts to migrate and successfully proliferate in the 
epidermis, since melanoblasts express the c-kit tyrosine kinase receptor and have 
an absolute requirement for its cognate ligand, SCF (stem cell factor or Steel 
factor), to be presented to these cells before they can migrate and proliferate. SCF 
is transiently produced by the dermamyotome and is localised on the lateral 
migration pathway shortly before melanoblasts begin to migrate away from the
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MSA (Wehrle-Haller & Weston, 1995). If SoxlO m utations caused a delay in 
melanoblast migration, this might lead to the melanoblasts missing their chance to 
encounter SCF and begin migration. Alternatively, the SoxlO mutations might 
down-regulate c-kit or SCF expression in migrating melanoblasts and cause 
apoptosis and loss of significant numbers of melanoblasts. Similar arguments can 
clearly be applied with respect to SoxlO and other receptor/ligand complexes 
such as Ednrb/Edn3, and this might be considered more likely than c-kit/SCF, given 
that this latter does not appear to play any significant role in enteric neurogenesis.
This is somewhat in accord with the model put forward by Wehrle-Haller 
and Weston, who suggested that different combinations of tyrosine kinase 
receptors expressed by neural crest cells in combination with their cognate ligands 
(which can be found on migratory pathways in soluble or cell-bound form) act to 
direct the migration and differentiation of neural crest cell populations (Wehrle- 
Haller & Weston, 1997). kit and ret clearly fit this model, and although Ednrb is 
not itself a tyrosine kinase receptor, ligand binding does cause the receptor to 
activate the nonreceptor tyrosine kinase pl25FAK (focal adhesion kinase), as well as 
interacting with intracellular signalling pathways likely to be shared by the "true" 
receptor tyrosine kinases, such as G-proteins (Zachary & Rozengurt, 1992).
While it is unknown whether SoxlO acts cell autonomously or not in the 
melanoblast, it might be predicted from the close similarity between the 
phenotype of SoxlODom and the Ednrb and Edn3 null mutants that it acts both at the 
level of the early melanoblast and during their final differentiation in the skin. 
The most parsimonious explanation, of course, would be to postulate that SoxlO 
lies immediately upstream of one or either of these genes.
No downstream targets of SoxlO have yet been identified, however, hence 
the above is purely speculative.
Function of SoxlO in neural crest cells
Returning to the specification of neural crest fates, although SoxlO clearly 
plays some role in setting up both autonomic nervous system and melanocyte 
lineages, the central question is whether SoxlO plays an instructive or permissive 
role. At the time of writing, this remains unanswered, but experiments (as yet 
unpublished except in abstract form), using retrovirus to shuttle tagged wild-type
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SOXIO protein into mouse embryo explant cultures should go some way towards 
addressing this issue (Dunn et al., 1999).
Investigation o f the nature o f the transgene integration event 
The nature of the Harry mutation
With the transgene closely linked to SoxlO in Harry mice and given a 
phenotype which was very similar to a known SoxlO mutant, it was decided to 
investigate the status of this gene at a molecular level, to try and assess the nature, 
if any, of a transgene-induced mutation at this locus.
Strategy
To investigate the status of SoxlO in Harry mutants, initial experiments 
were designed simply to assess whether the SoxlO gene was being expressed at 
all, and this was achieved using RT-PCR. Following
this, Northern blotting was used to determine the status of the mRNA in m utant 
animals.
The nature of the transgene integration was investigated by determining 
the num ber of copies of the construct present in the Harry genome using a 
m ethod of titrating out a transgene-specific signal until it matched the intensity of 
a 2-copy endogenous signal. Following this, the transgene integration site was 
m apped in some detail.
This done, the status of the SoxlO gene itself was assessed by restriction 
m apping the region containing the gene in transgenic and wild-type samples and 
looking for polymorphisms which might be associated with the transgene.
Results
SoxlO RT-PCR
W ith no SoxlO probe available initially, primers were designed to amplify a 
specific product from SoxlO mRNA. These are detailed in the methods chapter, 
but were chosen to lie outside and to flank the highly conserved HMG box and to 
prime from regions which were also not homologous to the closely related Sox8
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and Sox9 genes (Figure 18). It should also be noted that the HMG box contains a 
large intron, hence no PCR product should have amplified from contaminating 
genomic DNA, and this was shown to be the case in control amplifications (data 
not shown). RT-PCR was performed using the Promega Access kit, which has the 
advantage that the inital reverse transcription reaction occurs at 48°C, rather than 
the more usual 45°C. This helps to alleviate the problem of secondary structure in 
the mRNA, which can often cause RT reactions to terminate prematurely. A 
conventional RT-PCR method, with reverse transcription at 45°C was found to 
give no product with these primers (data not shown).
SoxlO RT-PCR reactions were performed on total brain RNA from all 6 
pups in a Harry intercross litter containing one m utant animal. Although very 
faint, the predicted 700bp product was amplified from and detected in 4 of the 6 
animals in the litter, including the homozygous m utant (Figure 19). This showed 
that the Harry mutation was not a simple deletion of the SoxlO locus, since at least 
the central portion of the message is expressed in the CNS.
Rather than try and repeat this RT-PCR for the remaining two animals in 
the litter, since the m utant was clearly expressing SoxlO at some level, it was 
decided to use Northern blotting to investigate the transcript.
SoxlO Northern blotting
The RT-PCR product was unsuitable as a probe for Southerns and 
Northerns, since the HMG box comprised a large proportion of the sequence. 
This region is so highly conserved that it could confidently be predicted to cross- 
hybridise to other Sox sequences, except under highly stringent conditions (Sox8 
and Sox9 are respectively 86% and 83% identical at the nucleotide level over a 
160bp region of the HMG box).
Total brain RNA from the same intercross litter tested by RT-PCR was 
transferred to a filter by Northern blotting and hybridised w ith a SoxlO probe 
derived from the 3' end of the cDNA (probe SoxlOB on Figure 18) which does not 
contain the HMG box. A separate filter prepared in parallel with the same 
samples was hybridised with a probe to a housekeeping gene, glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) for use as an RNA loading control. Wild- 
type levels of full-length SoxlO message were seen in all lanes (Figure 20). This
Figure 18. Structure of the SoxlO gene and protein
Composite diagram showing SoxlO in tron/ exon structure, the frameshift in 
the Dom mutation and restriction sites based on a combination of published 
work (Kuhlbrodt et al., 1998b;Pusch et al., 1998; Southard-Smith et al., 1998), 
unpublished data (G. Scherer, personal communication) and restriction 
mapping in this laboratory using the two probes shown at the bottom  of 
the figure.
The putative domains in the protein are based upon published work 
(Kuhlbrodt et al., 1998a; Kuhlbrodt et al., 1998b; Kuhlbrodt et al., 1998c; 
Pusch et a l, 1998).
The RT-PCR primers used to amplify SoxlO are shown as arrows marked 
96, 97, 98 and 99 (see Materials and Methods, chapter 2).
SoxlOA and SoxlOB are cDNA fragments used as probes in Southern and 
Northern blotting experiments.
Figure 19. SoxlO RT-PCR from  brain total RNA.
A SoxlO-specific 700bp product amplified via nested RT-PCR using 
primers 98/99 followed by primers 96/97 (see Materials and Methods, 
chapter 2). Product can be seen in 4 out of the 6 animals in the litter, 
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experiment was repeated using RNA samples from a different intercross litter 
and similar results were obtained (data not shown).
Transgene copy number determination
Since densitometric measurement of bands was previously found to be 
unreliable as a quantititative method in our hands (see chapter 4), this experiment 
was based on logarithmic dilution of a transgene-specific band and comparison to 
an undiluted endogenous band, with both bands being obtained simultaneously 
in the sample using the same probe and the same restriction digest. A Kpnl digest 
using a probe to the 3' portion of the CCD was chosen as being ideally suited for 
this purpose. In non-transgenic DNA this gives a single band around 12kb, 
whereas in digested Harry DNA, it gives a single, strong, transgene-specific band 
of around 5kb, along with some fainter, subsidiary bands that probably 
correspond to junction fragments or truncated transgene constructs. In undiluted 
transgene DNA, the upper endogenous band provides a "gold standard" of 2 
copies (since there are 2 endogenous copies of the genomic region containing the 
CCD). During progressive dilution of the transgenic DNA, the stronger transgene 
band would be predicted to fade out. Dilutions based on a logarithmic 
progression were chosen to correspond to integral values of the transgene relative 
to the original sample. The dilution which gave a transgene band of the same 
intensity as the endogenous band in the undiluted lane could therefore be used as 
a yardstick to estimate transgene copy number. (For example, if the transgene 
band were to display equal intensity to the original 2-copy endogenous reference 
band after the sample had been diluted 4-fold, then there would be roughly 8 
copies of the transgene represented in this band.)
Table 9 below shows the dilutions performed with each sample made up to 
20fil final volume and digested overnight with Kpnl in a final volume of 25pl. 
Each lane on the blot corresponds to an entire digested sample.
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Table 9. Dilutions of Harry genomic DNA used for copy num ber 
titration




T G T G T
G
T G T G T G TG
Volume of 
DNA (pi)
20 20 13.33 10.0 8.0 6.67 5.7 5.0 4 .44 4 3.63 3.33 3.07 2.86
Transgene 
copy #
0 2 3 4 5 6 7 8 9 10 11 12 13 14
The results of this are shown in Figure 21. The X-ray film was pre-flashed 
to give a linear response (Sambrook et al., 1989), however it is obvious that the 
transgene band does not begin to diminish towards the intensity of the 2-copy 
reference band until the very lowest dilution tested in this experiment, which 
corresponded to 14 copies of the transgene. Judging from the relative intensity at 
the 14-copy dilution, there are unlikely to be significantly more than 14 copies. 
Taking into account the extra bands on the blot, which probably correspond to 
junction fragments or partial copies of the transgene, the copy number was 
therefore deemed likely to lie somewhere between 15 and 30 copies, pending 
further investigation.
Restriction map of the transgene array
Samples of non-transgenic, hemizygous and homozygous genomic DNA 
were digested with various restriction enzymes, Southern blotted and the filters 
hybridised with 3 different probes corresponding to various regions of the 
transgene construct, specifically the 5' end (probe P3), the 3' end (probe CCD) and 
the m iddle (probe LUX). These are shown diagramatically in Figure 22a. There 
are four potentially methylation-sensitive restriction sites in the construct, three 
EcoRI and one SacI (restriction sites which overlap a CpG dinucleotide). No 
information was available concerning the methylation-sensitivity of BstEII.
A preliminary map of the transgene array with the relevant restriction sites 
m arked is shown in Figure 22b. This map cannot be viewed as definitive, as some 
of the bands in various lanes remain unexplained or open to multiple
Figure 20
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interpretations. It is almost certain that at least some of the unexplained bands 
were due to methylation-sensitive enzymes failing to cut at methylated sites in a 
fraction of the DNA sample. It is also likely that strain-specific RFLPs existed 
between the parental strains, since such was shown to be the case during 
restriction mapping of the SoxlO locus (discussed below).
A representative autoradiogram from DNA hybridised with the CCD 
probe is shown in Figure 22c. As an example, both Kpnl and Apal are predicted 
to cut the transgene construct only once, near the centre. In a head-to-tail array, 
digestion with either of these enzymes should give a full-length construct band of 
5.2kb. In the corresponding lanes on the blot, multiple fainter bands can clearly 
be seen flanking the more intense predicted 5.2kb band.
SoxlO polymorphism mapping
In an effort to detect transgene-associated polymorphisms in or near the 
SoxlO gene, wild-type, hemizygous and homozygous genomic DNA was digested 
with various restriction enzymes, Southern blotted and the filters hybridised with 
probes SoxlOA and SoxlOB which corresponded to the 5' and 3' end of the gene 
(see Figure 18).
No polymorphisms were detected on blots probed w ith SoxlOA and 
SoxlOB (Figure 23) apart from naturally occurring ones found to be present 
between C57 and CBA following test Southerns using parental strain DNA (data 
not shown). Although the SoxlO gene had a dearth of restriction sites appropriate 
for use with these probes to scan the flanking regions, it was possible to determine 
that there was no polymorphism either within the gene itself or w ithin ~3kb of the 
5' end of the gene and ~1.5kb of the 3' end of the gene.
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Figure 22a. Map of the ”H" transgene construct
Detailed map of the "H" construct used to generate the Harry transgenic 
line, including restriction sites used in mapping. Potentially methylation- 
sensitive sites are marked with an asterisk. Regions of the construct are 
indicated (P3 = Igf2 promoter P3; Luc = luciferase coding region; SV40 = 
SV40 large t intron and polyadenylation signal; CCD = centrally conserved 
domain from IgfZ/H19 intergenic region). Probes used in restriction 
mapping are shown arrowed below.
Figure 22b. Map of the Harry integration site
Preliminary map of the structure of the integration event in the Harry 
transgenic line. Suspected deletions are circled at a and b. Flanking and 
interspersed genomic DNA is indicated by dotted lines.
Figure 22c. Representative autoradiograph from restriction mapping 
experiments
-Southern blot of wild-type and hemizygous transgenic DNA digested with 
various enzymes and hybridized with probe CCD shown in Figure 22a.
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Fig. 22a
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Figure 23a. Polymorphism mapping with 5’ SoxlO  probe
Homozygous, hemizygous and non-transgenic genomic DNA digested 
with various restriction enzymes, rim out on 0.3% agarose, Southern 
blotted and hybridised with a probe derived from the 5' end of the SoxlO 
cDNA (probe SoxlOA on Figure 18).
Figure 23b. Polymorphism mapping with 3f SoxlO probe
Homozygous and non-transgenic genomic DNA digested with various 
restriction enzymes, run  out on 1% agarose, Southern blotted and 
hybridised with a probe derived from the 3' end of the SoxlO cDNA (probe 
SoxlOB on Figure 18).
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From the RT-PCR results and Northern blotting, it is clear that Harry 
mutants express essentially wild-type levels of full-length SoxlO mRNA in the 
CNS, at least post-natally. Furthermore, it is also clear, that despite a large and 
complex integration site containing at least 15 copies of the transgene, there is 
nodisruption within or in the immediate vicinity of the SoxlO gene itself. There 
are a number of possibilities arising from these data.
Firstly, it is possible that the gene affected is simply not SoxlO. Although it 
seems highly improbable that a second gene performing a very similar function 
would exist within 1.6cM of SoxlO, tandem  gene duplications are not unheard of 
and a gene derived by such an event would be predicted to be closely linked to 
SoxlO. Furthermore, given the existence of two nearby loci which also affect coat 
colour in some respect (gt and bt), it is not inconceivable that one or both of these 
loci represent genes distinct from SoxlO which also play a role in neural crest cell 
development. The transgene could therefore be disrupting gene function at a 
locus distinct from SoxlO. Applying Occam's Razor, however, given the close 
similarity between the phenotype observed in Harry m utants and SoxlODom 
heterozygotes, this explanation must be classed as being of low probability.
Assuming that SoxlO is the affected locus, it is possible that the transgene 
insertion induced some rather subtle mutation in the SoxlO gene which w ould not 
affect the length of the transcript, such as the nucleotide insertion leading to the 
frameshift seen in the SoxlODom mutation. Given the often chaotic events usually 
associated w ith transgene insertion, this can also be considered as low probability, 
but it is not inconceivable that a small region of the gene could have been affected 
during the upheaval accompanying transgene insertion, perhaps by a small 
insertion, translocation or deletion event.
It is possible that alternative splicing of SoxlO mRNA occurs and 
that the transgene insertion has reduced the level of or entirely ablated a minor 
transcript which plays a crucial role in neural crest. There have been reports in 
the literature of a 2.7kb SoxlO major transcript in hum an testis, quite distinct from 
the normal 3.1kb transcript in other tissues (Bondurand et al., 1998). No alternate 
transcripts have been reported for the mouse, however, despite published results
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from several Northern blotting experiments (Herbarth et al, 1998; Kuhlbrodt et 
al, 1998b; Pusch et al, 1998).
The gene structure of SoxlO is uncharacterised upstream  of the canonical 
start site indicated by the very 5' end of the cDNA shown in Figure 18, and there 
could certainly be other exons and alternative start sites in this region. If such an 
alternative transcript was roughly the same size as the known 3kb message, or if it 
was simply expressed at low levels relative to the major transcript in the CNS, 
then its reduction or absence in m utant brain total RNA might not be detected on 
Northern blots. It should be noted that a neural crest-specific transcript would be 
predicted to be present at very low levels compared to the CNS transcript 
detected on the blot shown in Figure 20, by virtue of the fact that there are almost 
no neural-crest derived tissues present in the brain. All glial cells in the CNS are 
of neurectodermal origin.
There is good evidence for the existence of alternatively-spliced transcripts 
in other Sox genes, with Sox5 and Sox6 in particular possessing well-characterised 
long isoforms, L-Sox5 and L-Sox6 (SoxLZ) (Takamatsu et al., 1995; Hiraoka et ah, 
1998; Lefebvre et al., 1998). L-Sox5 and L-Sox6 both possess a large amino- 
terminal region not present in the short isoforms which contains the leucine- 
zipper coiled-coil domain critical for dimerisation between Sox proteins. It has 
also been shown that the long form of Sox5 is expressed in the early mouse 
embryo (E8.5), as well as in the adult testis at a low level compared to the short 
isoform (Hiraoka et al, 1998).
SoxlO is known to be expressed from around E9.5 onwards by in situ 
hybridisation studies, but the earliest published N orthern blot data is from E12.5 
embryos (Southard-Smith et al, 1998). Other studies, including this one, have 
only looked at RNA derived from neonatal or adult tissues (Herbarth et al, 1998; 
Kuhlbrodt et al, 1998b).
It is therefore at least a formal possibility that SoxlO has an alternate long 
isoform which is chiefly expressed in the early embryo.
Another possible explanation is that, rather than disrupting an alternative 
transcript, the transgene could have disrupted an enhancer region which controls 
expression of SoxlO in developing neural crest cells, but plays no role in
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governing expression in the CNS. This "distant enhancer" hypothesis is 
attractive, because such an element could lie quite distant from the gene (which 
would explain the lack of polymorphisms detected by restriction mapping), and 
because disruption of such an enhancer could specifically influence expression 
during neural crest development whilst leaving CNS expression unaffected 
(which would explain the N orthern blotting results).
There is some support for this hypothesis from studies of the closely- 
related Sox9 gene, in which it was shown that there existed im portant regulatory 
elements scattered across a large upstream region (Wunderle et al, 1998). In 
these experiments, a number of transgenic mouse lines were derived bearing 
YACs containing a lacZ reporter construct driven by varying amounts of the 
genomic region surrounding Sox9. A YAC containing some 350kb of upstream 
DNA gave patterns of expression of the reporter which corresponded to the 
normal patterns observed for Sox9, although no expression was seen in the 
gonads. The absence of elements lying at least 50kb upstream  of the coding 
region caused significant down-regulation of Sox9 expression in chondrogenic 
tissues during murine embryonic development. It was found that the regulatory 
elements required for correct tissue-specific expression of Sox9 lay in various 
regions between 50 and 350kb upstream of the gene. Deletion of these elements in 
hum an patients by virtue of translocation breakpoints located at least 200kb 
upstream  of Sox9 was found to recapitulate the campomelic dysplasia (a genetic 
syndrome involving severe dysfunction of chondrogenesis and autosomal sex 
reversal) found in patients containing mutations within the coding region of the 
gene.
Staying within the confines of this "distant enhancer" hypothesis, it is 
possible that the transgene integration has caused a slight global decrease in the 
level of transcript, rather than a tissue-specific effect. This might well not be 
detectable by Northern blotting, but such a slight decrease m ight be enough to 
"tip the balance" and cause a dramatic phenotype. This model would imply that 
the wild-type levels of SoxlO expression lie very close to a threshold level, below 
which a phenotype manifests. Threshold dosage effects have been observed for 
other transcription factors such as Pax6 and GU3, particularly in the context of
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hum an clinical genetic defects with variable expressivity or partially penetrant 
phenotypes, and haploinsufficiency has been mooted as a possible mechanism by 
which SoxlODom/+ mutants display their phenotype. In support of this mechanism, 
the molecular defect present in a single patient classified as suffering from a rare 
congenital disease -  the Yemenite deaf-blind hypopigmentation syndrome - has 
recently been elucidated as a single base-pair transversion w ithin the HMG box of 
SOXIO (Bondurand et al., 1999). Functional analysis of the m utation showed that 
binding of the protein to a DNA target was completely abolished, at least in vitro. 
The phenotype seen in the patient consisted of skin hypopigmentation and 
hearing impairment, although no Hirschprungs was described (Hennekam & 
Gorlin, 1996). Since the proband was heterozygous for w hat was apparently a 
null m utation of SOXIO, this would suggest that haploinsufficiency could account 
for at least the melanoblast component of the SoxlODom/+  phenotype.
However, such a model seems inconsistent w ith the robust, fully penetrant 
recessive phenotype observed in Harry mutants.
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CHAPTER EIGHT:
HARRY - FINAL DISCUSSION
Nomenclature of the Harry mutant
In the absence of any firm molecular evidence of transgene-associated 
disruption at the SoxlO locus, the evidence that the Harry m utation is truly a novel 
allele of SoxlO remains circumstantial, pending further investigation. However, 
given the very close similarity between the SoxlODom/+ m utant phenotype and that 
seen in Harry homozygotes, the tight linkage to the SoxlO locus and the absence of 
any other strong candidate loci in the immediate vicinity, it is suggested that 
Harry does in fact represent a transgenic insertional m utation at the SoxlO locus. 
According to the rules laid down by the Committee on Standardized Genetic 
Nomenclature for Mice (Lyon et al., 1996), it is therefore proposed that this allele 
be given the designation SoxlOTzNRPLucH1Ward [with the superscripted suffix 
composed of Tg (transgene);N (non-homologous insertion);Rp (reporter); LucH 
(luciferase H construct); l(allele number);Ward (designated laboratory code)].
Future work
Complementation between SoxlOTgNRpLucHIWard and SoxlODom
A  number of possible experiments suggest themselves in order to resolve 
the question of the exact nature of the Soxl 0T8NRPLucH1Ward mutation. The most 
apparently straight-forward of these would be to cross transgenic hemizygotes 
with SoxlODom /+ animals of breeding age and see if the mutations complement. 
This is rather a complex experiment, however, since SoxlODom heterozygotes 
display the full phenotype observed in Soxl 0TiNRPLucH1Ward homozygotes. If the 
two mutations are allelic at the SoxlO locus, this might be predicted to result in a 
more severe phenotype. On the other hand, even if they are allelic, given the 
recessive nature of SoxlOT8NRPLucH1Ward and the dominant nature of SoxlODom, it is 
possible that a compound SoxlODom/  SoxlOTzNRPLucH1Ward animal might display 
exactly the same phenotype as a SoxlODom/+  heterozygote. Furthermore, due to 
the severity of the phenotype in heterozygotes, it is difficult to maintain a
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breeding colony of SoxlODom animals. They are currently maintained on a B6C3Fe- 
a/a background by the Jackson laboratory, however, where the phenotype is 
relatively mild and are therefore commercially available (h ttp://w w w .jax.org,
1998).
Complementation between SoxlOTeNRpLucH1Ward and bt
Similarly, it might also prove worthwhile to test both SoxlOT8NRPLucH1Ward 
against bt (belted) for complementation. Although SoxlODom and bt were shown to 
recombine with respect to each other, current mapping data available shows that 
they are closely linked (Mouse Genome Database, 1999). Recent mapping studies 
have shown that these two loci actually lie some 5cM apart, but this remains 
unconfirmed, pending publication (D. Foernzler, pers. comm.). Even if SoxlO and 
bt do prove to correspond to different genes, given that both loci are involved in 
melanocyte differentiation and /o r proliferation, the two genes might interact in a 
doubly heterozygous animal to give a compound phenotype.
Irrespective of the allelic or non-allelic nature of these two loci, in the 
absence of firm molecular evidence of transgene-associated disruption at the 
SoxlO locus in Harry mice, the presence of a second nearby locus with an effect on 
melanoblast proliferation makes it imperative to test whether the mutation seen in 
these mice might be at the bt locus rather than SoxlO. bt mice are widely 
available, with the mutant allele having been bred onto multiple genetic 
backgrounds due to its utility as a visible, viable phenotypic marker 
(http://www.informatics.jax.org, 1998).
Complementation between Soxl0TgNRpLucmWard and wn
Exactly the same arguments pertain to a complementation test between the 
Harry line and the mutant wn (white nose), perhaps with even more force, given 
that the mapping data for wn places it much closer to SoxlO than bt (Marks et al.,
1999).
Transgenic rescue of the SoxlOTgNLucH1Ward phenotype
If a transgenic line could be constructed that over-expressed SoxlO under 
the influence of a neural crest-specific promoter such as the hum an DJ3H promoter
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region used to successfully tag enteric neuroblasts and catecholaminergic neurons, 
this could be crossed with the SoxlOTsNLucH1Ward line to see if it could rescue the 
m utant phenotype. This could provide definitive proof that the locus affected by 
transgene insertion was indeed SoxlO, but m ust be considered as a rather chancy 
experiment with a number of possible pitfalls.
In order to rescue the phenotype seen in SoxlOT8NLucH1Ward mutants, the 
exogenous wild-type SoxlO would have to be expressed in the same subset of 
neural crest cells which are most affected by the m utant allele. If the DJ3H 
promoter fulfilled this requirement and the transgene did indeed rescue the 
phenotype, then the matter would settled. However, if the transgene failed to 
rescue the phenotype, it would be unclear whether this was because the mutation 
affects a critical role of SoxlO in some other subset of neural crest cells, or whether 
the mutation seen in Harry homozygotes was caused by disruption of a different 
gene. Different promoters, such as a constitutive one from a housekeeping gene, 
would have to be harnessed to drive expression of SoxlO in this event. However 
SoxlO is clearly a potent transcriptional modulator, if not a transcriptional 
activator in its own right, and over-expression in a transgenic line might well lead 
to some undesirable phenotypic side-effects. Constitutive over-expression of 
SoxlO might be predicted to have dramatic effects upon Schwann cells in the PNS, 
for example, which might well compromise viability of the transgenic line. The 
use of a large genomic region containing the SoxlO gene (such as a cosmid or a 
BAC) as the injected transgene construct might obviate this problem.
While the transgenic rescue approach is attractive, therefore, it has to be 
approached with a degree of caution.
Further genetic and physical mapping
It is clearly possible to continue to refine the map position by genotyping 
more animals, and since the D15Mit260 marker has been placed on the physical 
map less than 40kb away from the SoxlO gene, this might prove to be the most 
useful marker in order to unambiguously link the transgene m utation to the SoxlO 
locus. However, this marker was found not to be polymorphic between C57 and 
CBA, so the transgene would first have to be introgressed onto another 
background.
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A more direct approach would be to extend the physical mapping by 
obtaining probes for regions flanking the SoxlO gene and scanning for transgene- 
associated polymorphisms at progressively greater distances from the gene. This 
has the danger that should the transgene prove to have disrupted a very distant 
regulatory element, or should it prove to have disrupted an entirely separate 
locus, a great deal of time and effort could be expended establishing such 
polymorphisms. One useful approach to physical m apping could take advantage 
of the fact that a BAC containing the gene has been identified and m apped and is 
commercially available (Research Genetics Inc., http://w w w .resgen.com , 1998). 
The SoxlO gene lies within 25kb of one end of this BAC (Southard-Smith et al., 
1998). W ith the use of Cre-loxP mediated end-labelling to efficiently and quickly 
restriction map the BAC (Mullins et al., 1997), probes flanking the gene could be 
rapidly isolated and used to scan flanking genomic DNA in wild-type and 
SoxlOTzNRPLucH1Ward mice for transgene-associated polymorphisms.
A useful starting point for such an exercise would be to take advantage of 
the sequence already in the database for a 40kb hum an cosmid covering the entire 
SOXIO gene, and a database detailing the 431 sub-clones obtained after shotgun 
cloning BAC 43P19, containing the mouse SoxlO gene (Pusch et al, 1998; Southard- 
Smith et al., 1999c). The hum an cosmid ends some 3kb upstream  of exon 1 of 
SOXIO, however comparative BLAST analysis of the subclones obtained from the 
murine BAC reveals a short region of 160bp with >95% conservation at the 
nucleotide level between mouse and human. This conserved region lies some 
2.7kb upstream  of exon 1 of SOXIO, and shows no BLAST hits to any protein or 
EST databases. It is possible that this region represents an alternative exon of 
SoxlO, something which has been suggested to exist by several authors, but not 
yet defined (Pingault et al, 1998; Southard-Smith et al, 1999). It is also possible 
that it is an upstream enhancer element. Regardless of its nature, it could be used 
as a probe to scan for transgene-associated polymorphisms upstream  of SoxlO. 
Unfortunately both the mouse BAC and the hum an cosmid terminate shortly 
upstream  of this element, so no further comparative sequence analysis is possible 
at the present time. However, when the hum an and mouse genome sequences are
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published, it will be possible to compare large segments of the genomes in this 
way to identify regulatory elements upstream  of genes.
One important consideration w ith respect to this long-range mapping 
approach is that there exists good evidence that important regulatory elements 
exist >350kb upstream of the closely-related Sox9 gene, and that such a mapping 
exercise might have to cover a very large region (Wunderle et al., 1998).
Is there an alternate SoxlO transcript in the early embryo?
One key experiment which might help to shed light on the nature of the 
SoxlOTzNRPLucH1Ward mutation would be to perform Northern hybridisation using 
RNA derived from E9.5-E12.5 embryos, to determine whether there might exist 
any alternatively-spliced transcripts. SoxlOT8NRPLucH1Ward/SoxlOT8NRPLucH1Ward 
homozygotes can be detected at any stage of development by use of the closely- 
linked polymorphic microsatellite markers D15Mit2, D15Mitl and D15Mit71. 
RNA could therefore be isolated from genotyped embryos at various stages and 
hybridised with SoxlO probes.
No published data exists prior to E12.5, and since SoxlO is known to be 
expressed from E9.5 onwards in the developing peripheral nervous system and 
presumptive pre-migratory neural crest, the existence of such an alternate 
transcript would provide an attractive mechanism for the mode of action of the 
Soxl 0T8NRPLucH1Ward allele.
Neural crest cell apoptosis
Even without detailed knowledge of the precise molecular nature of the 
mutation, the SoxlOTzNRPLucH1Ward m utant embryos represent a unique resource for 
the dissection of neural crest cell migration and ontogeny during development.
It might prove informative to ascertain the degree of apoptosis in 
SoxlOT8NRPLucH1Ward/  SoxlOTsNRPLucH1Ward embryos during neural crest cell migration. 
Using the TUNEL (Tdt-mediated dUTP-X nick end labelling) assay for apoptotic 
cells, extensive apoptosis of presumptive neural crest derivatives has been 
observed in SoxlODom homozygotes , with essentially no melanoblast or enteric 
neuroblast precursors present by E11.5 (Southard-Smith et al., 1998). 
Interestingly, in SoxlODom homozygotes, which are embryonic lethal by E13,
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apoptosis was also seen in structures not known to be affected in heterozygotes, 
such as dorsal root ganglia. The obvious experiment would therefore be to obtain 
staged SoxlOTiNRPLucH1Ward/  Soxl0 T8NRPLucH1Ward embryos and perform TUNEL 
assays to see whether and where any apoptosis of neural crest cells occurs. The 
microsatellite markers known to be closely linked to the transgene can be used to 
genotype DNA prepared from yolk sacs to identify homozygous embryos.
Aggregation chimera studies
Even if significant apoptotic loss of enteric neuroblast precursors was 
observed in Soxl 0 Tz NRPLucH1Ward mutants, this would not directly answer the 
question of how the aganglionosis arises in the terminal gut. One crucial (and 
long-standing) question has been the exact nature of the contribution of the sacral 
neural crest to the hindgut and its relevance to enteric neurogenesis. Since it is 
now known that a large component of the enteric nervous system in the colon is 
derived from sacral neural crest, at least in avian embryos, but that sacral crest 
cells express none of the markers traditionally associated with enteric neuroblasts, 
it is im portant to determine the exact timing and nature of murine sacral crest 
migration and proliferation in the gut (Bums & LeDouarin, 1998). A number of 
experiments with Soxl 0 Tz NRPLucH1Ward m utant embryos might prove fruitful in this 
regard.
Since the mouse lacks specific markers for enteric neuroblasts, it would be 
difficult to track the progress and proliferation of these cells in the gut without 
introgressing the m utant allele onto the DflH-nlacZ strain of mice (Kapur et al, 
1992). One attractive alternative would be to make aggregation chimerae between 
SoxlOTzNRPLucH1Ward homozygotes and ROSA-26 embryos, which are available and 
maintained in Bath (Prof. J. Slack). This line of transgenic mice contains a lacZ- 
based enhancer trap event which has been bred onto an albino background to 
make homozygotes fully viable and fertile (Zambrowicz et al, 1997). This results 
in essentially wild-type embryos which constitutively express p-galactosidase in 
all cells. In aggregation chimerae stained with X-gal, therefore, all wild-type cells 
would stain blue and m utant cells would be unstained. This would allow a direct 
visual assay for the level of wild-type contribution to the chimera. It would be 
predicted, from the results obtained in aggregation chimera experiments in
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So;dODom, Ednrb and Edn3 mutants, that a relatively small wild-type contribution 
could rescue the aganglionic phenotype in Soxl0T8NRPLucH1Ward mutants. lacZ 
staining can be combined with immunohistochemical staining (Bernex et al, 
1996), and immuno-staining for glial or neuronal markers in fully developed 
colons would allow assessment of wild-type versus m utant contribution to the 
ENS. In combination, these data might help elucidate how a relatively small 
number of wild-type cells can rescue the aganglionic phenotype, if such were 
found to be the case.
SoxlOTsNRPLucH1Ward m utant embryo cells clearly contain an exogenous 
transgene which might be used to track m utant cells in aggregation chimerae with 
fully wild-type or other (different) m utant embryos such as SoxlODom . However, 
it has proven technically difficult to reliably detect the transgene in tissue sections 
or wholemount preparations, either by luciferase immunohistochemistry or by in 
situ hybridisation (M. Charalambous, unpublished results). Tissue-specific 
luciferase activity has been imaged directly by simply placing enzyme substrate 
onto explanted organs and thick tissue slices, however this required the use of a 
highly-sensitive photomultiplier linked to a cooled CCD camera, and the cellular 
resolution was rather poor (A. W ard & M. White, unpublished results). Thus, at 
the present time, the transgene unfortunately cannot be considered useful as a 
high-resolution marker for m utant cells when planning experiments. However, 
Northerns, RNAse protection assays or Westerns for luciferase could provide a 
useful measure of the relative contribution of transgenic to wild-type tissue in 
chimeric mice, albeit not with the high spatial resolution achievable through 
microscopy-based methods.
Determination of the cell autonomous or non-autonomous nature of the 
SoxlOTgNLucH1Ward mutation by organ culture
An organ culture system has recently been developed in which mouse fetal 
gut can be cultured in vitro in such a way that its three-dimensional organisation is 
maintained, and that supports morphogenesis and development of the ENS 
(Natarajan et al, 1999). It was used to show that a null m utation in c-ret functions
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cell autonomously with respect to enteric neuroblasts by demonstrating that 
isolated wild-type neuroblasts could successfully colonise and proliferate in 
c-ret-/- segments of gut lacking intrinsic neuroblasts. On the other hand, older 
experiments in a similar, but less sophisticated organ culture system, proved that 
the Is mutation was non cell-autonomous in nature (Jacobs-Cohen et al., 1987).
The new organ culture system offers a decisive means of determining the 
cell autonomous or non-autonomous nature of mutations which affect enteric 
neurogenesis. Although isolation of enteric neuroblasts is technically demanding 
and requires a fluorescence-activated cell sorter (FACS) and whilst it is currently 
unclear whether the organ culture method is robust and replicable, it offers an 
attractive system for studying the nature of the SoxlOTzNLucH1Ward mutation.
SoxlO expression patterns
Another aspect of the m utant phenotype which has not been studied in any 
detail is the expression pattern of SoxlO in the ENS of post-natal m utant animals. 
It is clear that the gene is expressed in early neural crest and in enteric 
neuroblasts, but it is unclear in which subsets of neural crest derivatives SoxlO 
expression is maintained during adult life. From the data available in the PNS, it 
would be predicted that SoxlO might be restricted to the enteric glia, and 
antibodies to glial fibrillary acidic protein (GFAP) combined with in situ 
hybridisation with the SoxlO message could be used to investigate this hypothesis.
Studies of enteric neural crest derivatives outwith the myenteric plexus
While the experiments described in the preceding paragraph do not require 
SoxlOTzNRPLucH1Ward mutants, it might also be informative to use similar methods to 
investigate the status of the plexus of Meissner and the enterochromaffin cells in 
wild-type and m utant animals. While there are no specific markers for the plexus 
of Meissner, and these cells are small and difficult to observe, GFAP antibody 
staining can be used to reveal glia in this plexus and Fontana-Masson staining can 
be used as a straightforward method of assessing the status of enterochromaffin 
cells in SoxlOTsNRPLucH1Ward mutants (Culling, 1974).
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Studies of melanoblasts in SoxlO TgNRpLucHIWard mutants
This area has received very little attention, both in the current and in other 
studies. It remains an open question as to whether SoxlO is im portant for early 
melanoblast specification or migration or whether the known mutations act later 
on during migration along the dorso-lateral pathway to reduce the number of 
melanoblasts reaching the epidermis. It might well prove interesting to use early 
melanoblast markers such as dopachrome tautomerase or c-kit to study 
melanoblast migration in SoxlOTzNRPLucH1Ward m utant embryos.
The wide variation in coat spotting patterns seen between different genetic 
backgrounds in both SoxlODom and SoxlOTzNRPLucH1Ward points to a number of 
modifier genes interacting epistatically with SoxlO to regulate melanoblast 
survival an d /o r proliferation. One possible approach to this problem would be to 
follow on from the work of Pavan and Tilghman, who m apped six QTLs which 
modify the severity of coat spotting in the s (piebald) mouse, which expresses low 
levels of the Ednrb gene product (Pavan et ah, 1995). In order to replicate this type 
of experiment with the SoxlOTzNRPLucH1Ward mutation, the transgene would need to 
be introgressed onto to two separate genetic backgrounds and bred to 
congenicity. One background would need to show a relatively mild coat spotting 
phenotype and the other a severe one (either C57 or CBA would fulfil this latter 
requirement). M utant Fi offspring from a cross between these two inbred strains 
could then be scored for severity of phenotype, and a genome-wide scan 
instigated, preferably using an established RI panel for rapid m apping of modifier 
loci. Given that the QTLs mapped in the Pavan and Tilghman study pertain to 
Ednrb, it would be interesting to see which loci might exert an effect upon SoxlO.
In fact, this experiment has now been performed and published with 
respect to the Soxl 0Dom allele (Southard-Smith et al, 1999). The m utant allele was 
introgressed onto both C57BL/6 and C3H backgrounds, and a C3H allele on Chr 
10 was found to act as a recessive modifier of white forelock in hypopigmented 
mutants (Southard-Smith et al, 1999). The kit ligand on Chr 10 presents itself as 
an obvious candidate for the modifier locus.
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Coat colour
Following on from the observation that all m utant animals which lived 
long enough to develop fur had black coats, and hence lacked phaeomelanin in 
their hair follicles, it would be interesting to see whether this still held true 
following transfer of the transgene onto a fully agouti background such as 
CBA/Ca. Agouti strains carry the wild-type A  allele at the agouti locus, which 
gives rise to a sub-apical yellow band in an otherwise black hair. In genotypes 
having both black and yellow pigment in the hair, the melanocytes can switch 
back and forth between black and yellow, but the mechanism controlling the 
switch is not known. If the SoxlOTzNLucH1Ward mutation were found to specifically 
abrogate the production of yellow pigment in some manner, this m utation could 
provide an interesting avenue of approach to the long-standing problem of how 
variegated colour is established in hairs (Galbraith & Arceci, 1974).
One simple experiment which could be profitably done is simply to 
microscopically examine pigmented and non-pigmented regions of 
SoxlOTzNLucH1Ward/ SoxlOT8NLucH1Ward m utant skin. It has been reported that in the 
lateral flanks (outwith the pigmented regions at head and rum p, which are 
considered to be special cases) the classical s allele results in entirely unpigmented 
epidermis, even in those regions where the fur is coloured (Mayer, 1967b). Given 
the early appearance of occasional pigmented patches on the flanks of 
SoxlOTzNLucH1Ward mutants, it would prove interesting to know what effect the 
mutation has on the different populations of epidermal and follicular melanocytes 
in those regions where pigmentation does occur.
Amelioration of SoxlODom /SoxlODom lethality on a particular genetic
background
One outstanding puzzle about the exact nature of the SoxlODom m utation is 
the question of why a few homozygotes survive to term  on a C57BL/6J x 
C3H/HheOuJ hybrid background. On the surface, this would seem to be very 
similar to the original background on which the m utant allele is consistently lethal 
during embryogenesis, however, it presumably contains one or more modifier 
genes which act to ameliorate the lethal nature of the allele. Since the cause of 
lethality is currently unknown, and seems unlikely to be related to enteric
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neurogenesis, it might prove interesting to introgress the Soxl 0T8NRPLucH1Ward allele 
onto this background and examine the level of severity of the post-natal m utant 
phenotype.
Neural crest contribution to inner ear development
A further possible aspect of the SoxlODom and Soxl0T8NRPLucH1Ward m utant 
phenotypes which has not been investigated is the status of the neural crest 
contribution to the inner ear. It is known that the integrity of the stria vascularis 
in the inner ear is crucially dependent upon the presence of intermediate cells of 
neural crest origin (which are actually of melanoblast derivation), and that these 
are frequently reduced or absent in mice mutated at the Ednrb locus (Deol, 1967). 
It is further known that deafness to varying degrees is a common pathological 
feature of WS4, and that some hum an patients with mutations in the SOXIO gene 
had this symptom (Pingault et aL, 1998). It is therefore a strong possibility that at 
least a subset of SoxlOTsNRPLucH1Ward homozygotes might have had inner ear 
defects. This was not studied during the course of these investigations, since the 
preparation of histological specimens from the inner ear requires specialised 
skills, and the interpretation of histopathology in this structure might well have 
proven difficult in inexperienced hands. However, the scope of future 
investigations could encompass the inner ear (if sufficient justification could be 
found). Again, the use of aggregation chimerae between ROSA-26 and 
SoxlOTzNRPLucH1Ward homozygous mutants might prove fruitful in illuminating 
poorly-understood aspects of the role of neural crest in inner ear development.
At a less technically demanding level, it is also possible to use non-invasive 
hearing tests on mice, such as the "click box" developed at the Institute of Hearing 
Research in Nottingham. This generates a brief 20KHz tone at 90dB SPL when 
held 30cm above the mouse, and is used as part of the more comprehensive 
SHIRPA protocol, which tests for behavioural and functional abnormalities 
(h ttp ://www.mgc.har.m rc.ac.uk/ m utabase/shirpa_summary.html, 1998).
However, given that SoxlOTzNLucH1Ward mutants generally present in a rather 
debilitated manner, due to the toxic megacolon component of the phenotype, the 
use of such a behavioural hearing test might well be inappropriate.
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The role of SoxlO  in the CNS and the g t (grey tremor) mutation
Perhaps the most baffling aspect of both the SoxlODom and the 
Soxl 0TsNRPLucH1Ward mutations is the lack of any apparent phenotype in either the 
CNS or PNS. Given that SoxlO is known to be abundantly expressed in glial cells 
of multiple lineages throughout adult life, it seems odd that neither of the two 
SoxlO mutants display any apparent peripheral or central nervous system 
pathologies. In the case of SoxlOTzNRPLucH1Ward , this can perhaps be explained by 
recourse to an enhancer-specific reduction in the SoxlO message which does not 
affect SoxlO expression in adult life, and the Northern result from brain RNA from 
6-day old animals supports this hypothesis. In the case of SoxlODom, however, this 
explanation will not suffice. The simplest explanation would be to postulate a 
threshold effect, whereby haploinsufficiency of SoxlO has a dramatic effect during 
neural crest development, but has little impact upon mature glial cells. Another 
explanation might be that SoxlODom acts as a true dominant allele to repress or 
activate inappropriate genes during neural crest development to detrimental 
effect, but again, that such transcriptional modulatory activity has little effect in 
mature glial cells, since these clearly utilise quite a different set of genes during 
their lifetime. A third explanation, which applies equally well to both SoxlO 
mutants, is that in some lineages, there is functional compensation for reduced 
levels of SoxlO by other, closely-related Sox genes such as Sox4 and Soxll. Recent 
work has shown that not all oligodendrocytes of the CNS can be considered equal, 
since, although all oligodendrocytes express platelet-derived growth factor alpha- 
receptor (PDGFRa), ablation of the ligand, platelet-derived growth factor A 
(PDGF-A), by targeted mutagenesis has revealed that only a subset of myelinating 
cells are affected in this knockout (Fruttiger et al., 1999).
Another explanation which pertains to both mutants is that there actually is 
an effect in the CNS and PNS, but that m utant animals simply do not live long 
enough for this to become readily apparent. The only m utants to survive to 
breeding age are SoxlODom/+  heterozygotes on a B6C3Fe-^a background, and 
these rarely survive much beyond 18 months. It is possible that a neurological 
phenotype developing in these animals might be masked by and attributed to the 
more obvious and dramatic enteric phenotype. It is certainly true that SoxlODom
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homozygotes were generally very wobbly and uncertain in their movements, 
however this was attributed to their severely debilitated condition, with systemic 
sepsis and presumptive malnourishment, rather than a myelination defect caused 
by any m utant phenotype in Schwann cells.
One intriguing possibility is that g t (grey tremor) mice might represent a 
third m utant allele at the SoxlO locus (see discussion in chapter 6). The phenotype 
seen in g t mutants is almost the complement of that seen in S o x lO TsNRPLucH1Ward 
homozygotes with only a very mild effect upon some neural crest derivatives (a 
mild coat colour defect and possible slight enteric defects) but very severe 
progressive defects in glia of both PNS and CNS, the two regions known to 
express SoxlO throughout adult life, but seemingly unaffected in 
S o x l0 TzNRPLucH1Ward and SoxlODom mutants. Although g t/+  heterozygotes show an 
abnormal phenotype, this is comparatively mild and of late onset. If, by breeding 
g t and SoxlOT8NRPLucH1Ward heterozygotes together, these two mutations were 
shown to be non-complementary (i.e. to be allelic), this might help resolve two 
separate questions: the nature of the SoxlOTzNRPLucH1Ward locus and that of the gt 
locus. This latter may prove to be of particular interest to the virology 
community, since gt was originally found to act as as a transmissible agent 
causing a spongiform encephalopathy (Sidman et a\.r 1985). This was confirmed 
by other workers (Hoffman et al., 1987), but subsequently refuted by a third 
group (Carlson et ah, 1997). Linkage of the gt phenotype to a mutation at a 
molecularly-defined locus might resolve this controversy.
In this context, it is worth mentioning that the phenotype of the unique 
patient described by Inoue et al appears to be, in effect, a combination of gt and 
SoxlODom (Inoue et al., 1999).
The g t strain was actually discontinued by the Jackson labs, due to its 
potential nature as a biohazard. However, it is currently maintained at the 
Institute of Virology in Montana, where studies by Carlson and co-workers 
refuted the transmissible nature of the gt phenotype (Carlson et al., 1997). The line 
was subsequently downgraded from biohazardous status and is now maintained 
under standard conditions. It might therefore be possible to cross g t with 
SoxlOT8NRPLucH1Ward and test for complementation.
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Conclusion
In summary, the m utant phenotype seen in the Harry transgenic line 
appears to be caused by transgene-associated disruption of unknown nature at the 
SoxlO locus. This gives rise to a fully recessive m utant phenotype which closely 
resembles that seen in animals heterozygous for the other known mutation of this 
gene, the SoxlODom allele. The m utant phenotype is characterised by white coat 
spotting and enteric aganglionosis, caused by a reduction in the numbers of 
melanoblasts and vagal neural crest derivatives.
Although the precise nature of the transgene insertion event is currently 
unknown, this does not preclude the use of this m utation as a potentially useful 




HOLLY - INITIAL CHARACTERISATION OF THE PHENOTYPE
Introduction
As discussed in chapter 3, during primary screening an initial hemizygous 
intercross using Holly mice generated 3 abnormal animals with corneal opacity in 
a single litter of 7 animals - a frequency consistent with a recessive m utant 
phenotype. Following Caesarean re-derivation and establishment of the Holly 
line in Bath, further hemizygous intercrosses were therefore set up w ith three 
initial aims as given for Harry mutants in Chapter 4. Firstly, to see if the 
phenotype was reproducible, recessive and fully penetrant. Secondly, to 
characterise the phenotype itself at a gross level with a view towards assigning 
candidate loci, should such exist. Thirdly, and vitally, to ensure that the 
phenotype truly was associated with the transgene i.e. that the transgene insertion 
site was genetically linked to the phenotype.
Results
Gross phenotype
Following establishment of the Holly line in Bath, hemizygous intercrosses 
throughout four subsequent generations of animals have generated m utant 
animals at frequencies consistent with a recessive trait.
All animals appeared normal at birth, but from around day 15 onwards 
progressive opacity of the corneas was visible. This was difficult to detect in the 
early stages, usually requiring that animals be inspected closely for a slight but 
distinctive greying and dullness of the corneal surface. However, by about 4-6 
weeks of age, regions of the cornea were very obviously opaque and grey-white in 
colour. The affected region varied in size from 30-100% of the cornea, but was 
most commonly an elliptical patch covering some 50% of the visible corneal 
surface. Older m utant animals (>2 months) frequently had a "half-shut" 
appearance to their eyes, with the eyeball sunken in its socket behind half-closed 
eyelids.
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Several Holly mutants showed reduced size (20-40%) compared to their 
littermates at an advanced age, although no such difference was observed prior to 
weaning, and this effect was not seen consistently.
The Holly line has been found to be a rather poor breeder, particularly in 
hemizygous intercrosses, and the root cause of this appears to be the consumption 
of litters shortly after birth by the parents, rather than any defect in the pups 
themselves.
Association between the transgene and phenotype
Unlike Harry, the m utant phenotype seen in Holly mice did not seem to 
compromise life-span and all mutants which were allowed to live reached 
breeding age. It was therefore decided to use crosses between mutants and non- 
transgenic animals to assess whether the m utant animals were homozygous for 
the transgene.
In all, 5 adult Holly animals showing the corneal phenotype were mated 
with non-transgenic animals, but only one male successfully sired offspring and 
these were limited to one litter with each of two non-transgenic females. These 
two litters totalled 15 pups, all of which were transgenic. Given a null hypothesis 
that the father is hemizygous for the transgene, it would be predicted that 50% of 
the offspring would be non-transgenic. Using a simple y} test, this gives
X2 “ 15
and for 1 degree of freedom this gives P < 0.0001
This gives statistically significant rejection of the null hypothesis, which is to say 
that the m utant Holly father was probably homozygous for the transgene.
Although mutants appeared to be at least partially viable, attempts to 
determine homozygosity for the transgene by this method were unsuccessful, 
since no further offspring were derived from any of the Holly mutants, although 
only 5 such animals were tested.
Using the more laborious breeding protocol detailed in chapter 4, data for 
111 pups from Holly hemizygous intercrosses were collated and are summarised 
below into a 2x2 contingency table. As before, with the null hypothesis that there
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is no association between the "dominant" transgene and a recessive m utant trait, 
expected ratios would be 9/16 transgenic wild-type, 3/16 wild-type non- 
transgenic, 3/16 mutant transgenic, 1/16 m utant non-transgenic.
Table 10. Collated breeding data from m ultiple Holly intercrosses
wild-type m utant X
transgenic 60 19 79
(62.4) (20.8)
non-transgenic 32 0 32
(20.8) (6.9)
X 92 19
Overall X = 111
Expected values are given in brackets below each observed value. 
Using the formula given in Appendix A, this gives
X2 = 7.67
and for 1 degree of freedom this gives P < 0.01
This means that the null hypothesis can be rejected with a 99% confidence 
limit, or, to put it another way, that the data obtained would be expected to occur 
at a frequency of less than 1% if the transgene and m utant locus were not linked.
FISH genotyping was performed by hybridising the transgene probe to 
metaphase chromosome spreads prepared from a single transgenic m utant and a 
single transgenic wild-type littermate (Figure 24). The m utant was homozygous 
for the transgene while the wild-type animal was hemizygous.
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Figure 24. FISH genotyping of mutant and wild-type Holly mice
a) Metaphase chromosome spread from wild-type transgenic H olly  male. 
One transgene signal can be seen (arrow).
b) Metaphase chromosome spread from mutant H olly  male. Two 



















While FISH analysis was not performed as rigorously as was done for the 
Harry line, in combination with the statistical analysis, the data obtained was 
taken as reasonable proof that the Holly transgenic line carried a recessive m utant 
trait which was associated with the transgene and primarily affected eyes from 




HOLLY - DETAILED CHARACTERISATION OF THE PHENOTYPE 
Introduction
With a distinct opthalmopathy developing in homozygous Holly 
transgenics from around post-natal day 15 onwards, examination of the eye at a 
gross and histological level was undertaken (see Results). This rapidly led to the 
conclusion that the observed phenotype was strongly suggestive of pathology 
relating to glaucoma, a condition caused by prolonged elevation of intra-ocular 
pressure.
At this point, with a potentially glaucomic phenotype, a discussion of the 
details of eye physiology seems pertinent. Although there are some differences 
in the fine details, particularly in the iris and the irido-corneal angle, the murine 
and hum an eye are very similar in construction and the details described below 
for the hum an eye apply equally to the mouse in their essential aspects (Chew, 
1996; Tomarev et al, 1998).
Anatomy and physiology of the anterior mammalian eye
For a variety of reasons, not least the maintenance of its spherical shape, 
the eye maintains a considerable intra-ocular pressure (IOP). In humans, an IOP 
of around 12-20mm Hg is considered normal, but this value can drop as low as 
6mm or range as high as 25mm Hg without being considered pathological (Gorin, 
1977). Data for IOP in the mouse has been somewhat scarce in the past, but John 
and coworkers have recently rectified this situation by developing an invasive 
assay using a glass microneedle attached to a pressure transducer, which is 
inserted into the anterior chamber directly through the cornea (John et al.r 1997). 
Measurements in four common inbred strains maintained under identical 
conditions revealed considerable inter-strain variation in average IOP, ranging 
from 7.7±0.5mm Hg in BALB/cJ mice up to 13.7±0.8mm Hg in the C3H/HeJ 
strain, with C57BL/6J and A /J strains falling somewhere in the mid-range. 
Further to this, recent work in the DBA/2J strain, a model for primary open-angle 
glaucoma, suggests that the normal range for these mice (prior to the onset of
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glaucoma) is around 4-15mm Hg, although there is a marked difference between 
the sexes in this strain (John et al.f 1998).
As mentioned above, IOP is critical in maintaining the shape of the eye, 
with correct curvature of the cornea being particularly important for clarity of 
vision. The curvature of the cornea is maintained by the pressure of the aqueous 
humour in the anterior chamber. The cornea is the chief refractive element of the 
eye, being even more important than the lens in the establishment of the path that 
light rays will take on their way to the retina (Ross et al., 1989). The advantage of 
the lens, of course, is that its shape can be adjusted to focus on objects at different 
distances.
Aqueous hum our is produced in the posterior chamber of the eye, which 
lies between the lens and the iris. It has an ionic composition similar to that of 
plasma, although it contains a much lower protein content (<0.1%, compared to 
around 7% in plasma), and is considered to be largely produced by active 
secretion from the ciliary body, rather than passive diffusion of fluid under 
pressure from the capillaries, (although this may contribute some small fraction) 
(Gorin, 1977). Following production in the posterior chamber, the aqueous 
hum our (often referred to as simply aqueous) then flows through the iris into the 
anterior chamber, and exits via outflow channels at the corneal periphery. In 
addition to the constant production of aqueous by the ciliary body, which has 
been estimated to be around 1% of the volume of the anterior chamber per 
minute, there is a constant and substantial exchange of fluid and ions by simple 
diffusion between the anterior chamber and the iris capillaries. Overall, this 
results in a rapid turnover of aqueous in the anterior chamber, coupled with a 
sustained level of pressure in the chamber, which maintains corneal curvature.
The outflow system for the drainage of aqueous lies in the anterior 
chamber angle, where the iris meets the cornea at the limbus. This has been best 
characterised in humans, where the fluid first passes through a loose trabecular 
meshwork of tissue which, under normal conditions, probably presents no 
significant obstacle to the passage of fluid or macromolecules. At some point 
thereafter, the aqueous enters the outflow tract proper, the canal of Schlemm, 
which encircles the limbus and communicates with scleral veins and hence out to
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the systemic circulation (Ross et al., 1989). Despite several ultra-structural 
studies, the exact nature of the junction between the trabecular mesh work and the 
canal of Schlemm remains contentious, however the outflow of fluid is considered 
likely to be via active transport rather than passive diffusion or dialysis, and to be 
mediated by the single, continuous layer of endothelial cells lining the canal 
(Tripathi, 1972; Gorin, 1977; Ltitjen-Drecoll & Rohen, 1996).
Within the angle itself, only higher primates and hum ans actually possess a 
true trabecular meshwork, consisting of laminated sheets and beams of 
extracellular matrix material surrounding an organised outflow vessel wall (canal 
of Schlemm). Most other mammals possess a reticular meshwork, spread over a 
wider area of the sclera. Many smaller vessels bend into this meshwork, rather 
than a single, large outflow channel (Ltitjen-Drecoll & Rohen, 1996). The chamber 
angle itself is filled with radial, interlacing strands of pectinate ligament. 
However, the essential nature of the outflow mechanism appears to be conserved 
in animals, with cells secreting and laying down copious extracellular matrix to 
create a filtering mesh surrounding the outflow vessel walls, across which an 
endothelial layer of cells mediate active transport to remove fluid.
The outflow pathway in mice has traditionally been thought to conform 
with that seen in the other lower mammals, but interestingly, a recent detailed 
ultrastructural study of the murine angle has contradicted this model (Tamm et 
al., 1999). The authors found that mice actually possess a single, large 
circumferential outflow vessel directly equivalent to the canal of Schlemm, and 
that the fine structure of the trabecular meshwork is closer to that of primates than 
other mammals. They therefore suggest that the mouse may be the superior 
model animal for conditions affecting aqueous outflow in humans.
Under normal circumstances, aqueous is produced in the posterior 
chamber by the ciliary body, circulates through the pupil into the anterior 
chamber and exits via the outflow system in the chamber angle (Fig. 25a). The 
rate of inflow and outflow are finely controlled and delicately balanced to 
maintain IOP. As previously mentioned, the composition of aqueous is 
substantially similar to that of de-proteinated plasma, and, apart from the
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Figure 25a Production and outflow pathway of aqueous
Section through a wild-type adult mouse eye, with the anterior to the right 
(cornea) and the posterior to the left (retina and sclera). x40
The aqueous is produced by the ciliary body (cb) in the posterior chamber 
(pc), which lies between the iris and the lens. It should be noted that the region 
immediately posterior to the ciliary body is entirely filled by the vitreous hum our 
(vh - invisible in this histological preparation) and the lens and offers little room  
for aqueous to circulate. The boundaries of this region are indicated by dotted 
lines. The secreted aqueous therefore largely flows (thick arrows) through the 
posterior chamber, out into the anterior chamber (ac) through the valve-like pupil 
of the iris and exits via the outflow system in the anterior chamber angle where 
the cornea meets the iris.
The disruption of the lens fibres is an artifact of sectioning, and is very 
common in histological preparations from mature crystalline lens tissue.
Figure 25b. Pupillary block
This diagramatically illustrates the pathological mechanism of angle 
closure by pupillary block, the most common cause of angle-closure glaucoma.
As the lens comes into contact with the iris, fluid is retained in the posterior 
chamber. This causes the iris root to balloon out and make contact with the 
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maintenance of IOP, the primary role of the aqueous is to exchange nutrients and 
metabolites with the avascular cornea and lens tissues.
The cornea itself is composed of three major structural layers (seen clearly 
in Fig. 27e). The outer corneal epithelium consists of five or six layers of stratified 
non-keratinised squamous epithelium and shows a high regenerative capacity, 
concomitant with its rapid turnover under normal conditions (Ross et al., 1989). 
Slow-cycling stem cells in the limbus provide the corneal epithelium with a steady 
supply of transiently amplifying (transit) cells, which proliferate briefly before 
terminal differentiation (Matic et al, 1997). The epithelial cells show a typical 
proliferative cycle, with a basal layer of columnar cells underlying several layers 
of cells which become progressively flatter as they approach the surface. As cells 
migrate towards the surface, their metabolic activity decreases and the 
cytoplasmic organelles disappear. The entire corneal epithelium turns over 
roughly every seven days (Ross et a l, 1989; Chung et al., 1992). The corneal 
epithelium is continuous with the conjunctival epithelium and under normal 
circumstances, the undersurface of the former presents a flat appearance and the 
undersurface of the latter is more rugose.
The corneal epithelium sits upon Bowman's membrane -  a thin, 
homogenous basement membrane layer. Underlying this is the thick corneal 
stroma, which consists of many thin lamellae of parallel bundles of collagen 
fibrils, with successive layers laid down at various angles across each other. The 
collagen fibrils form a transparent crystalline lattice, surrounded by a poorly- 
defined "ground substance" containing corneal proteoglycans. The highly 
specialised nature of the corneal ECM, which contains several unusual collagens, 
contributes to the transparency of this structure (Wessel et al., 1997). There are a 
few flattened fibroblasts and a number of lymphocytes scattered between the 
lamellae, although during an inflammatory response (e.g. due to corneal 
infection), enormous numbers of lymphocytes and leukocytes migrate into and 
infiltrate the stroma.
Underlying the stroma is a further basement membrane layer, Descemet's 
membrane, which, as with Bowman's layer, is believed to act as a barrier to the 
spread of infection (Ross et al., 1989). The corneal endothelium forms the
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innermost layer, and consists of a single layer of flattened polygonal cells. This is 
continuous with the endothelium covering the anterior surface of the iris. The 
corneal endothelium is involved in the diffusion of nutrients from the aqueous 
into the corneal stroma, and is also known to actively transport water out of the 
stroma. This is important for the maintenance of corneal transparency, and injury 
to the endothelium or interruption of this transport process can rapidly result in 
corneal clouding (clearly evident in mouse eyes examined within less than a 
minute of death). The most significant differences between the stromal layers of 
the sclera and the cornea are the avascularity and the active dehydration of the 
latter, and the opacity of the sclera is primarily due to its high water content.
The lens is a transparent, avascular structure, which in adult life is 
composed of >80% dry weight of crystallins (Wistow, 1993; Robinson & 
Overbeek, 1996). These are contained in the lens fibres, which are hugely 
elongated flattened cells which have lost their nuclei and organelles during 
terminal differentiation. The lens fibres are derived from the subcapsular 
epithelium, which is present only on the anterior half of the lens as a single layer 
of cuboidal cells. New lens fibres derive from the equatorial subcapsular 
epithelial cells, which increase greatly in height and then undergo terminal 
differentiation into lens fibres (Ross et al., 1989). The entire lens is surrounded by 
the capsule, which is a greatly thickened basal lamina (some 10 to 20pm under 
normal circumstances) produced by the subcapsular epithelium. The lens capsule 
is elastic and composed primarily of type IV collagen. This is laid down in 
lamellar fashion, similar to that seen in the corneal stroma (Ross et al., 1989). The 
lens capsule is thickest at the equator, where the zonules or suspensory ligaments 
are attached. These run between the lens and the ciliary body, and hold it tautly 
in position. Contractions of the ciliary muscles result in changes in the shape and 
hence the focal length of the lens.
The cornea does not appear to contain any of the crystallins found in 
abundance in the lens. Crystallins are generally thought to have been recruited in 
a taxon-specific manner from metabolic enzymes and stress-protective proteins, 
with the same molecules being expressed and playing quite different roles in non­
ocular tissues -  a process known as "gene-sharing" (Piatigorsky & Wistow, 1989).
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It is believed that the lens exploits the heat shock protein function of some 
crystallins to protect against protein aggregation during aging
In contrast to the lens, the cornea contains mostly water-insoluble 
structural proteins such as collagen, but the water-soluble component warrants 
further examination. The corneal epithelium appears to have independently 
recruited metabolic enzymes such as aldehyde dehydrogenase class 3 (ALDH3), a 
tumour-inducible detoxification enzyme (Piatigorsky, 1998). ALDH3 is present at 
very high levels in the bovine cornea (10-40% of all water-soluble protein) 
(Cuthbertson et al, 1992). Similarly, the enzyme transketolase (TKT) makes up 
some 10% of the total water-soluble corneal protein in the mouse (Sax et al, 1996). 
Both enzymes probably play a role in protecting the corneal epithelium against 
oxidative stress, vital given its frequent exposure to UV light, but the very high 
levels of expression suggest a possible structural role as well, analogous to that of 
the lens crystallins.
Pathology of glaucoma
The clinical condition known as glaucoma encompasses a group of complex 
diseases involving the death of retinal ganglion cells and the degeneration of the 
optic nerve head, with consequent visual impairment. Glaucoma is the second 
leading cause of blindness in the United States, and causes around 10-15% of 
blindness in most countries (John et al, 1997; John et al, 1998). It is generally 
caused by a disturbance in the delicate balance between the inflow and outflow of 
aqueous, most often by obstruction of the outflow system, although there are a 
variety of other conditions which can lead to glaucoma besides simple obstruction 
of this kind. Many forms of glaucoma are therefore associated with an increased 
IOP.
While a detailed discussion of clinical glaucoma is beyond the scope of 
this thesis, it is broadly accepted that "normal" IOP in hum ans is around 16mm 
Hg ± 3mm, although this may vary much more widely and still be considered to 
be non-pathological (Gorin, 1977). Observed IOP above ~20mm Hg usually 
warrants further examination, and sustained levels of pressure above ~26mm Hg 
generally lead to opthalmological problems. The clinical symptoms resulting 
from a rise in IOP vary depending on the degree and duration of such elevation,
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but the most common and serious defect is visual loss due to ischaemic atrophy of 
the axons in the nerve fibres of the optic disc and secondary atrophy in the inner 
nerve fibre layer of the retina (MacSween & Whaley, 1992).
Types of glaucoma
Glaucoma is classified as either primary or secondary, the latter being a 
complication of some other condition, such as diabetes. The primary form of the 
disease is further divided into open and closed angle glaucoma, and population- 
specific genetic modifiers pertain to each, with open angle more common amongst 
Caucasians, whilst closed angle glaucoma is more common amongst Chinese and 
shows highest incidence amongst Inuits (Gorin, 1977; Lim & Constable, 1987; 
Johnson et ah, 1996). A third primary form of the disease is congenital glaucoma.
Open angle glaucoma
The most common form of glaucoma, and the leading cause of preventable 
blindness in the United States, is chronic primary open angle glaucoma (POAG). 
This is an insiduous disease which can lead to severe visual impairment w ith few 
or no symptoms during progression. It is viewed as a condition in which the 
anterior chamber angle stays open, but the trabecular meshwork becomes 
defective. The resultant increased resistance to the outflow of aqueous leads to a 
gradual rise in IOP, which may be chronic or periodic in nature. The retina 
becomes damaged quite slowly in open angle glaucoma, although the exact 
mechanism by which elevated IOP causes this damage remains somewhat 
contentious. One important aspect of the retinopathy associated with glaucoma is 
that the ganglion cells of the inner nerve fibre layer degenerate long before the 
deeper photoreceptor layers of the retina.
Several theories have been proposed for the extreme sensitivity of the glial 
and ganglion cells of the optic disc and retina to elevated pressure, ranging from 
purely mechanical (where the vitreous hum our physically damages the retina by 
pressing against it), through ischaemia (in which the pressure causes a loss of 
efficient blood supply to the cells) to blockage of axoplasmic transport of nutrients 
and enzymes from the neuronal perikaryon along the axons (Anderson, 1972; 
Gorin, 1977). The primary site of damage is actually the optic nerve-head and
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advanced glaucoma often results in extensive excavation or "cupping" of this area. 
Recent work has lent weight to the hypothesis that the damage is actually caused 
by the blockage of mitochondria in this region (Levy, 1996). It is clear that 
elevated IOP leads to physical compression of the axons in the optic nerve-head 
by the extracellular basement membrane surrounding them - the lamina cribrosa. 
This much is uncontentious, however proponents of the mitochondrial exclusion 
hypothesis contend that this compression blocks axoplasmic transport of the 
mitochondria to more distal regions of the nerve fibres, with the consequent lack 
of ATP leading to cellular degeneration. Regardless of the exact mechanisms 
involved, elevated IOP in chronic open angle glaucoma frequently results in 
visual field loss, particularly in arc-shaped well-defined regions (arcuate 
scotomas), but this is gradual in progression.
Angle-closure glaucoma
Due to the subtle nature of open angle glaucoma, it is not often diagnosed 
at an early stage. In stark contrast, angle-closure glaucoma has a very rapid onset 
and most frequently presents in middle-age as a unilateral red eye associated with 
blurred vision, pain or headache (Lim & Constable, 1987). It is caused, as the 
name suggests, when the periphery of the iris suddenly apposes itself to the 
corneal periphery and blocks the anterior chamber angle. During an acute attack 
of angle-closure glaucoma, the vessels of the iris frequently become congested, 
and there is oedema of the corneal stroma, leading to loss of transparency. The 
pupil dilates and becomes irregular in shape and insensitive to light. In severe or 
prolonged attacks, adhesions (synechiae) can form between the peripheral iris and 
the anterior wall of the angle, or between the pupillary region and the lens.
The IOP increases very rapidly in angle-closure glaucoma, and as a result 
of this, specific opacities (Glaukomflecken of Vogt) can develop on the anterior 
surface of the lens. These regions appear to be areas of anterior epithelial necrosis 
and as they become covered up by newly formed lens fibres, cataract develops 
(Anderson, 1972).
Attacks of angle-closure glaucoma can resolve as rapidly as they occurred, 
but recurrent acute attacks lead to atrophy of the iris, with consequent irregularity
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of the pupillary opening and localised depigmentation (Gorin, 1977; Lim & 
Constable, 1987).
Chronic congestive angle-closure glaucoma is not as dramatic as the acute 
form, and is rarer, but the mechanism of angle closure remains the same. In the 
chronic form of the disease, patients generally have minimal symptoms: recurrent 
mild ache over the eyes, halos around lights and slightly blurred vision. Closure 
of the angle appears to be more gradual, and the eye has a chance to adjust to the 
slowly rising IOP. This gradual rise in IOP probably blocks further formation of 
aqueous, and the eye stabilises at a lower IOP than that seen in acute cases -  
generally around 40mm Hg, as opposed to 60mm Hg or higher in the acute 
condition (Gorin, 1977). Of particular relevance to the pathology seen in Holly 
mutants is the observation that in chronic congestive angle-closure glaucoma, the 
full thickness of the iris usually comes into contact with the anterior wall 
throughout a large portion of its circumference. This usually results in broad 
peripheral anterior synechiae and permanent partial blockage of the outflow 
system.
The possible association between the lens and angle-closure glaucoma is 
self-evident. Conditions in which the anterior surface of the lens comes into 
contact with the iris will frequently result in pupillary block and this is the most 
common clinical cause of angle-closure glaucoma (Fig. 25b). Predisposing 
conditions include formation of tumours within the eye, frequently melanomas, 
which physically push the lens forward; the formation of cataracts, which can 
sometimes induce absorption of water and consequent swelling of the lens; and 
loosening or ruptures of the zonules which hold the lens in position, leaving it free 
to move forward. This last condition -  anterior dislocation of the lens - causes a 
rapid rise in IOP as the pupil becomes blocked. The lens may protrude into the 
anterior chamber and come into contact with the cornea. If this happens, both 
cornea and lens become opacified, since the corneal endothelium and the lens 
epithelium can no longer carry out metabolic exchange w ith the aqueous 
(Anderson, 1972; Gorin, 1977; Lim & Constable, 1987). The lenticular opacity 
associated with such anterior synechiae has been shown in some cases to be 
associated with sub-capsular fibrous metaplasia (Kissane, 1990).
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Congenital glaucoma
This has traditionally been considered separately by clinicians with respect 
to the adult onset forms of glaucoma, but numerous developmental conditions 
which feature abnormalities of the anterior chamber give rise to glaucoma which 
can be either open or closed-angle in nature (Shields et al., 1996). True congenital 
glaucoma is already manifest at birth, but infantile and juvenile glaucoma become 
apparent during the first two or sixteen years of life, respectively (Kanski, 1994). 
The subsequent development of such congenital glaucomas essentially mirrors 
that seen in adults, although diagnosis and treatment presents obvious difficulties 
(Dickens & Hoskins, 1996).
Results
General appearance
Older Holly mutants (>6 months) frequently had a "sunken", half-shut 
appearance to one or both eyes. It was found that eyes w ith this appearance 
frequently tore during enucleation. This was not observed with eyes from 
younger animals (3-6 weeks) and may reflect some structural defect in the sclera 
which developed in parallel with the cataract and corneal opacity. Eyeballs were 
occasionally (2 out of 20) found to be smaller on one side than the other i.e. there 
was occasional unilateral micropthalmia.
Corneal opacity and iris dysplasia
When enucleated eyes were examined under the dissecting microscope, 
eyeballs from an 8-week old m utant animal displayed very obvious abnomalities 
of the cornea, manifesting as opacity and greyness, and a distorted appearance at 
the limbus (Fig. 26). Superficially, this resembled hyperplasia of the corneal 
epithelium, with thickening and overgrowth at the edges (Fig. 26a).
Obvious dysplasia of the iris was visible in around 30% of cases, 
particularly in older animals, with occasional patches of reduced pigmentation 
visible around the iris (Fig. 26b).
In addition to this, bulges in the sclera were frequently seen around the 
circumference of the limbus (Fig. 26c and d). These had a translucent appearance
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Figure 26. Morphological abnormalities in Holly mutant eyes
a) Whole eyeballs removed from wild-type (left) and m utant (right) Holly 
littermates, culled at 16 weeks of age. The limbus (corneo-scleral 
junction) is indicated by arrows
b) Iris dysplasia in a m utant Holly eye, culled at 6 weeks of age. 
Breakdown of iris pigmentation is also apparent (arrows)
c) and d) Dark bulges (arrows), apparently herniated protrusions visible a t 
intervals around the limbus in m utant Holly eyes.
e) and f) Wild-type and m utant lenses from littermates culled at 8 months 
of age. The cataract has fully progressed to fill almost the entire lens.
g) and h) Lenses from two sibling mutants culled at 18 days post-natally, 
looking down upon the anterior pole. Remnants of the ciliary body can 
be seen attached around the lens equator (cb). Only very slight corneal 
opacity was visible in these mutants at this time, and cataracts canfce 
seen starting to form at the anterior pole of each lens.
Figure 26
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with reduced scleral pigment, and superficially resembled "blebbing" caused by a 
weakening or thinning of the wall of the eye in these regions, with the vitreous 
humour bulging out, perhaps under intra-ocular pressure. Eyes removed from 
older mutants (>6 months) were frequently found to be misshapen, having an 
ovoid or "squashed" appearance, and this may have reflected presumptive 
structural defects in the sclera or around the limbus.
Lens cataracts
When lenses from older (>6 months) mutants were examined, these were 
found to be severely cataractous, with the bulk of the lens having a milky white 
appearance when compared to wild-type (Fig. 26e and f). Examination of lenses 
from 18-day old mutants, which were just beginning to show slight corneal 
opacity revealed slight opacities at the anterior pole of the lens (Fig. 26g and h). 
Examination of -20 m utant lenses subsequently confirmed that in all cases, 
mutant animals developed bilateral cataracts, which originated at the anterior 
pole around or shortly after the corneal opacity at day 15, and that in most cases, 
these cataracts progressed to fill most of the lens by around 6 months of age.
Histology
Whole eyes from 13-month old wild-type and m utant Holly females were 
sectioned and stained with H&E as detailed in Methods. While the wild-type eyes 
had a round, firm appearance following enucleation, the m utant eyes displayed 
the typical ovoid, squashed appearance seen in older m utant animal (Fig. 27a and
b). It was also clear that the anterior chamber in the m utant eye had virtually 
disappeared, with the angle fully closed (Fig. 27c and d). The corneal epithelium 
itself was substantially unaffected in the m utant eye, but the corneal stroma and 
endothelium were both severely affected (Fig. 27e and f). The m utant lens had a 
grossly thickened capsule, and showed severe disorganisation of the nuclei of the 
lens fibres and epithelium (Fig. 27g and h). Finally, the retina was almost 
completely degenerated (Fig. 27i and j).
Sectioning of two more eyes from 13-month old m utant animals revealed 
histopathology consistent with the initial tentative diagnosis of glaucoma induced 
by angle closure. The anterior chamber angle was fully closed in all cases, with
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Figure 27. Ocular histopathology of Holly mutants.
5jj,m sections from 13-month old wild-type and m utant Holly females. All
sections stained with H&E.
KEY: angle = anterior chamber angle; cb = ciliary body; cen = corneal
endothelium; cep = corneal epithelium; cor = cornea; ir = iris; lc = lens
capsule; le = lens epithelium; ret = retina; str = corneal stroma.
a) Wild-type eye, with a rounded appearance, and an open anterior angle. 
x40
b) Mutant eye, showing a distorted, flattened appearance and a closed 
angle. x40
c) Wild-type anterior chamber, showing corneal layers, iris and lens. xlOQ.
d) Mutant anterior chamber, showing complete angle closure, grossly 
thickened and distorted lens capsule and a dysplastic cornea. xlOO
e) Wild-type cornea, showing corneal layers. x400
f) Mutant cornea. The corneal epithelium appears relatively normal, but 
the stroma is disorganised and thickened and the corneal endothelium 
cannot be clearly distinguished. The cornea is apposed to the lens, but 
the two structures are distinct. x400
g) Equatorial region of wild-type lens, showing well-organised lens fibres 
containing nuclei close to the sub-capsular lens epithelium. x200
h) Equatorial region of m utant lens, showing thickened lens capsule and 
disorganised lens epithelium. x200
i) Wild-type retina. x200



















the iris closely apposed to the cornea. The corneal stroma was thickened and 
disorganised, with the undersurface of the corneal epithelium displaying a rugose 
appearance in some cases, reminiscent of its appearance in the conjunctiva (Fig. 
28a and b). The lenses showed severe degeneration of lens fibres, disorganisation 
and proliferation of the sub-capsular epithelium and thickening of the lens 
capsule. In one case, the lens was attached and fused (anterior synechia) to the 
cornea. Serial sectioning revealed that the point of attachment was highly 
localised, but both the corneal stroma and the lens capsule showed over- 
proliferation in and around this region. In addition, massive sub-capsular fibrous 
metaplasia could be seen underlying this region of attachment (Fig. 28a and b). 
PAS staining revealed that the subcapsular fibrosis observed had a strong 
glycoprotein component, consistent with the notion that it was caused by 
abnormally proliferating lens epithelium cells laying down capsular material (Fig. 
28c and d).
As previously mentioned, the retinal degeneration associated with 
glaucoma in hum an patients tends to occur in localised regions and typically, the 
innermost ganglion cells and nerve fibre layer degenerate much earlier than the 
remaining layers of the retina (Anderson, 1972; Kissane, 1990). This was 
observed in the retinas of Holly mutants, with serial sections revealing that some 
regions of the retina had a substantially normal appearance, while other areas 
were almost entirely degenerated. Intermediately affected regions showed the 
characteristic thinning of the nerve fibre layer and reduced numbers of ganglion 
cells, with the remaining retinal layers unaffected (Fig. 28e and f). It was not clear 
whether there was any cupping of the optic disc.
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Figure 28. Anterior synechia and retinal degeneration
a) and b) Synechia between lens and cornea in 13-month old Holly m utant 
eye. Apart from the usual thickening of the lens capsule itself, there 
appears to be large-scale sub-capsular fibrous metaplasia immediately 
below the point of attachment. The sub-capsular epithelial cells also 
show abnormal foci of proliferation, accompanied by significant cortical 
degeneration of lens fibres. H& E x200.
c) Prominent synechial attachment (syn) between lens and anterior 
choroid. The lens capsule (lc) and the fibres underlying it stain strongly 
with PAS. Abnormally proliferating lens epithelium (le) can be seen 
underlying the point of synechic attachment. It should be noted that 
the structure outside the choroid is sclera, not cornea, due to the plane 
of section. PAS-Haematoxylin, x200.
d) Wild-type cornea and lens, PAS-haematoxylin stain, making Descemet's 
membrane (DM) and the lens capsule (lc) prominent. The twin purple 
lines running vertically through the cornea are artifacts due to folding 
during sectioning. The lens epithelium (le) can be seen underlying the 
lens capsule. x200
e) Wild-type retina, with an almost continuous layer of ganglion cell 
nuclei (GCN) surmounting a thick nerve fibre layer (NF). H&E x200
f) Mutant retina from a 13-month old animal, showing relatively intact 
inner and outer plexiform layers and cell nuclei, but significantly 
thinned nerve fibre layer and reduced numbers of ganglion cells. H&E 
x200.
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Examination of a single eye sectioned at an earlier stage from an 18-day old 
m utant revealed that even at this time, the anterior angle was fully closed, with 
the iris adhered to the cornea (Fig. 29a). In addition, the cornea was apposed to 
the lens, leading to the characteristic sub-capsular metaplasia of the lens 
epithelium cells. Immunostaining for proliferating cell nuclear antigen (PCNA) is 
a marker for DNA synthesis, and hence a useful marker for actively proliferating 
cells (McCormick & Hall, 1992). Immunostaining of the 18-day old m utant eye 
sections and age-matched controls revealed that cell proliferation in the m utant 
cornea was unaffected, but that proliferation in the lens was severely 
downregulated, despite the appearance of numerous extra cells in the anterior 
polar region of the lens, where it had been apposed to the cornea (Fig. 29c-f).
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Figure 29. Anterior developing cataract in an 18-day mutant eye
. a) Whole eye from an 18-day Holly mutant. The eye cup itself can be seen 
to be substantially normal, with correct curvature and the retina norrinal 
in appearance. The cornea is however collapsed and draped over the 
lens, with the anterior angle fully closed. The anterior pole of the l©ns 
has a disorganised appearance where it lies apposed to the cornea.
H&E x 40
b) The anterior pole of the lens, showing that the cornea and lens lie 
apposed to each other, but have not fused. The cornea appears 
superficially normal, although there may be some breakdown of the 
endothelium in the region apposed to the lens. There is a large region 
of abnormal fibrous metaplasia (fm) in the subcapsular epithelum 
underlying the region of contact. H&E xlOO
c) a-PCNA staining of a wild-type age-matched control eye, showing a 
continuous single layer of stained nuclei in the corneal basal epithelium 
(ce) and in the lens epithelium (le). The corneal endothelium show j 
little signs of proliferation, consistent with its non-renewing nature 
xlOO
d) Detail of figure c) showing the subcapsular lens epithelium. Practically 
every cell at the anterior pole of the lens is proliferating. x400
e) a-PCNA staining of the m utant eye shown in a) and b). The corneal 
epithelium (ce) still shows a continuous layer of proliferating cells, bu> 
the lens epithelium shows very few proliferating cells until one moves 
well away from the region apposed to the cornea. In particular, the 
region of fibrous metaplasia (fm) whilst containing numerous cells, as 
evinced by H&E staining in b), contains almost no proliferating cells.
f) Detail of figure e) showing proliferation in the lens epithelium starting 
some distance away from the abnormal polar region.




Histology revealed that the structures affected in Holly m utants eyes were 
not restricted to the cornea and lens. The anterior chamber of the eyes of Holly 
mutants had practically disappeared, with concomitant closure of the anterior 
chamber angle. In hum an patients, this invariably leads to the clinical condition 
known as acute angle-closure glaucoma, which has a variety of side-effects.
The ocular phenotype seen in Holly mutants becomes obvious only at 
some point after the eyes open, since no opacity of the cornea was observed until 
at least day 16 or 17.
During mouse development, as with other mammalian species, the eyelids 
close and then reopen at a later stage. In the mouse, the eyelids close at some 
point between E15.5 and E17, but the exact timing of closure varies widely, even 
within a single litter (Kaufman, 1992). Although the reason why the eyelids fuse 
closed in the first place is somewhat unclear, it is considered likely that the 
conjunctival sac formed by eyelid closure provides protection for the developing 
cornea and shields it from potentially toxic metabolites in the amniotic fluid 
during differentiation.
At some point during development, the eyes re-open, but the exact timing 
of this re-opening varies widely across the animal kingdom, w ith calves and 
guinea pigs born with open eyes, and dogs, cats and mice with closed eyelids. 
This is thought to reflect the developmental stage at which the animal is born, 
since eyelid closure is one of the last morphogenetic events of embryogenesis. 
The eyes re-open in the mouse around days 12-14 post-partum.
Around the time that the eyes open in mouse, the cornea undergoes a 
massive program of differentiation and change, with the corneal epithelium 
becoming multilayered and stratified (Piatigorsky, 1998). It m ight be predicted 
that mutations which affect the differentiation or stratification of the corneal 
epithelium would become manifest around this time. However, histological 
examination clearly showed that the corneal epithelium was substantially
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unaffected, even in advanced stages of the phenotype, in which the eye was 
distorted and shrunken (phthisical), the lens was fully or mostly cataractous and 
the retina was almost entirely degenerate.
It is also the case that the aqueous outflow pathway only becomes active at 
around day twelve post-natal, just as the eyes open. A detailed study of the 
formation of the trabecular meshwork and other outflow structures in the murine 
angle has been performed using fluorescently-tagged lectins to label both cells 
and extracellular matrix (Vanden Hoek et al., 1987). It was found that at the time 
of birth, the aqueous outflow structures exist only as anlagen, comprising loosely 
arranged cells and extracellular matrix. There is little change during the first six 
days post-partum, but they differentiate into functional structures during days 6- 
14. The outflow pathway becomes active around day 12, after which point some 
further m aturation occurs. It might therefore be predicted that a m utation which 
compromises aqueous outflow would only exert a phenotype from day 12 
onwards, as seen in Holly.
The Holly ocular phenotype -  primary causal candidate loci
As stated previously, there are a very large num ber of loci which can cause 
lens cataracts (at least 48 independent loci are listed in the Mouse Genome 
Database as of early 1999), but very few which cause associated corneal defects. 
There are a large number of crystallin genes, for example, and mutations in many 
of these are known to cause cataracts. However, as mentioned previously, the 
cornea does not contain any of the crystallins found in abundance in the lens. This 
in no way precludes transgene-associated disruption at a locus which encodes a 
gene common to both lens and cornea. Three pertinent examples of genes of this 
type are worth mentioning at this point: the gap junction genes Gja3 and Gja8 and 
transforming growth factor p i (TGFpi).
The gap junction genes (formerly known as connexins, but reclassified 
partly due to conflicting nomenclature of the Cx genes in different species) are 
expressed in a highly tissue-specific manner and are known to play important 
roles in mediating cell-cell communication, often critical for the maintenance of 
tissue integrity (Bruzzone et al., 1996). The connexin gene Gja3 (formerly Cx46 in 
mouse) is expressed in the lens and a targeted null mutation in this gene has been
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shown to cause cataracts in mice (Gong et al., 1997). Gja3 is not expressed in the 
cornea, however, where the epithelial cells express mainly Gja8 (formerly Cx50) 
and Gjal (formerly Cx43) (Matic et al., 1997). This latter is also expressed in the 
lens and although Gjal-/- null mutants die at birth due to cardiac defects (hence no 
information is available on possible corneal defects), the knockout phenotype 
includes developing cataracts in the lens (Reaume et al, 1995; Gao & Spray, 1998). 
Similarly, Gja8 is expressed in both lens and cornea, and although the gene has 
not yet been knocked out in mouse, it is considered to be an excellent candidate 
for the No2 bilateral congenital cataract m utation (Steele et al, 1998). 
Furthermore, mutations in GJA8 are now known to cause autosomal dominant 
pulverulent (Coppock) cataract, which also happened to be the first autosomal 
disease condition mapped in humans (Renwick & Lawler, 1963; White et ah, 1992; 
Geyer et al., 1997; Shiels et al., 1998).
Mutations in connexin genes have therefore been convincingly shown to 
cause congenital cataracts, and given their overlapping expression (in some cases) 
in the cornea, might be predicted to cause corneal defects as well, although this 
does not appear to be the case for the mutations studied so far.
Lens epithelial cells can be induced to differentiate into fibroblast-like cells 
by wounding or under prolonged metabolic stress such as that induced by 
synechial attachment of the lens to the cornea, and these can lead to anterior 
subcapsular cataracts (Srinivasan et al., 1998). TGFpi is thought to be involved in 
this process, since intact rat lenses or epithelial explants cultured in the presence 
of this growth factor develop similar changes (Liu et al., 1994; Hales et al., 1995). 
The exact nature of these alterations bears some resemblance to the cataracts seen 
in Holly mutants, with subcapsular fibrous metaplasia, an accumulation of ECM 
and thickening of the lens capsule. Transgenic mice which overexpress TGFpi 
under the control of a lens-specific aA-crystallin promoter also develop anterior 
subcapsular cataracts, as well as corneal opacification and structural changes in 
the iris and ciliary body (Srinivasan et al., 1998). This phenotype bears some 
resemblance to that seen in Holly mutants at a superficial level, however at the 
histological level the corneal epithelium presents with a disorganised and
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exfoliating appearance, quite distinct from the well-organised epithelial structure 
seen in Holly.
The point has been made, however, that lens and cornea do share common 
genes of critical importance to the maintenance of structural integrity and 
transparency, and that mutations in such genes can lead to phenotypes 
resembling that seen in Holly homozygotes.
The ocular phenotype as a secondary effect of glaucoma
On the other hand, angle-closure glaucoma in hum an patients is known to 
be capable of inducing all or most of the histopathological abnormalities seen in 
the eyes of Holly mutants, at least in the advanced stages of the phenotype, and 
could reasonably be invoked as an explanation for the dramatic changes seen in 
the eyes of older m utant animals. To deal with these in sequence: the corneal 
opacity is the first obvious manifestation of the phenotype, and corneal oedema 
and opacity is one of the first consequences of elevated IOP. The localised regions 
of opacity observed on the cornea may be explained either by regions of contact 
(i.e. incipient synechiae) between the iris and the cornea, or between lens and iris, 
or even, in extreme cases, between lens and cornea. Alternatively, the cornea may 
not be truly opaque, but the developing cataracts in the lens give this impression. 
This is speculative, however, and really requires slit-lamp microscopy to confirm 
or refute this hypothesis. Detailed dissection might prove sufficient, but it is 
technically difficult to avoid any displacement of internal structures such as the 
lens during micro-dissection of unfixed eyes. The 18-day m utant sections shown 
in Fig. 29 came from a mouse where corneal opacity could only just be detected by 
careful examination of the eye. The cornea appears relatively normal in the 
section, but corneal opacity would be difficult to discern in H&E sections. 
Certainly the anterior pole of the lens shows a large region of fibrous metaplasia, 
adjacent to the region where the lens and cornea are in contact in the sections. The 
fact that the lens epithelial cells have largely ceased to proliferate in this region 
suggests the following scenario: the lens and cornea come into contact with each 
other, creating a region in which the aqueous cannot circulate freely. Under these 
hypoxic conditions, the lens epithelium appears to proliferate abnormally, then 
ceases, giving rise to an anterior polar cataract. The corneal endothelium in the
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hypoxic region may also be affected, leading to partial breakdown of the 
endothelium and Descemet's membrane. This could lead to localised corneal 
oedema, giving rise to opacity. In this scenario, the pronounced cataracts seen in 
older mice are a consequence of sustained hypoxia in the anterior pole of the lens.
The development of this kind of cataract is poorly understood, since in 
hum an patients, anterior synechiae of this type almost invariably cause early pain 
and discomfort, with consequent rapid medical intervention to alleviate the 
contact between the affected tissues. However, in one rare case, a patient 
presented with an anterior lens dislocation which had been present for well over 
four months, and the result was an entirely cataractous lens affixed to the iris by 
fibrous tissue (Hein & Maltzman, 1975). In addition, the sub-capsular fibrous 
metaplasia observed in m utant Holly lenses bears some resemblance to 
photographs reproduced in articles on the pathology of glaucoma, showing 
similar regions underlying synechiae (Anderson, 1972; Kissane, 1990).
As mentioned previously, in addition to the metabolic stress caused by 
synechiae of this kind, wounding or the presence of exogenous TGFpi can both 
induce lens epithelial cells to differentiate to a proliferative fibroblast-like 
morphology, leading to anterior subcapsular cataract (Font & Brownstein, 1974; 
Hales et al., 1995; Srinivasan et al., 1998). The morphology observed in isolated 
lenses cultured in the presence of TGFp is not dissimilar to that seen in Holly 
mutants, with characteristic spindle-shaped cells being seen below the lens 
capsule in both cases (Hales et al, 1995).
Overall, it seems plausible to suggest that the cataracts observed in Holly 
mutants were secondary to such anterior synechiae, although an expert second 
opinion from an experienced pathologist would be required to establish this 
beyond question.
It is possible that the "angle closure" seen in sectioned eyes is secondary or 
even artifactual - since the m utant eyes appeared ovoid and squashed upon 
removal, an alternative explanation might be a rather low IOP, leading to the 
collapse of the cornea onto the iris and lens during handling and processing for 
histology. Two factors argue against this, however: firstly, the synechiae seen 
between lens and cornea strongly suggest prolonged apposition of these two
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structures during the lifetime of the affected animal; secondly, the pattern of 
degeneration of the retina in intermediately affected regions is pathognomonic for 
prolonged elevation of IOP.
IOP was not measured directly in this study, hence the above is conjectural, 
albeit based on strong circumstantial evidence. Measurement of IOP in mice is 
highly technically demanding, with only one group in the world currently capable 
of performing it (John et al., 1997).
In fact, the distorted shape of the eyes in older m utants is consistent with 
phthisis bulbi - the final stage of ocular degeneration following a prolonged 
glaucomic period. In a phthisical eye, the production of aqueous is reduced, 
leading to lowered IOP (hypotony), deformation and atrophy of the globe, and 
widespread atrophy of internal structures (Kissane, 1990). This may well explain 
the "half-shut" appearance of one or both eyes in older mutants, and the fragility 
of these tissues during extirpation. It can also be invoked as an explanation for 
the total degeneration of the retina seen in some areas.
The blebbing seen around the limbus remains unexplained, however, and 
no such bulges were successfully identified and analyzed at the histological level. 
There are reports of bulges or weaknesses in the sclera following prolonged 
glaucoma, termed staphylomas, but these are not restricted to the limbus 
(MacSween & Whaley, 1992).
W hat is unclear from these results is how the angle actually closes. The 
two most likely scenarios, based on studies of hum an glaucoma, are that either the 
lens becomes dislocated, perhaps due to defects in the ciliary ligaments, and 
moves forwards to cause so-called pupillary block angle-closure glaucoma (c.f. 
Fig. 25b). Alternatively, the anterior angle itself may close first, with the iris 
adhering to the cornea, perhaps through some abnormality of the corneal or 
irideal endothelium (which share the same embryological origin). This would 
cause a rapid rise in IOP, but production of the aqueous would be downregulated, 
perhaps leading to pressure drop in the anterior chamber and collapse of the 
corneal onto the lens.
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Summary
In summary, the ocular component of the phenotype seen in Holly 
homozygotes is consistent with acute angle-closure glaucoma, with the prolonged 
condition leading to bilateral cataracts, retinal degeneration and severe corneal 
dystrophy, terminating in phthisis bulbi. There are currently no genes known to 
lead directly to angle-closure glaucoma.
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CHAPTER ELEVEN:
HOLLY - LOCATION OF THE TRANSGENE INTEGRATION SITE
Introduction
There are a very large number of genes which can cause cataracts and other 
defects in ocular development. Indeed, it has been estimated that some 2500 
genes participate in the development of the Drosophila compound eye, and that 
some important molecular mechanisms are highly conserved in mammals 
(Haider et al, 1995). Although there are relatively few loci which cause glaucoma, 
given the large number of cataractogenic mutations in the database, the observed 
phenotype did not allow specific candidate genes to be confidently assigned 
without a map position (http://www.inform atics.jax.org, 1999).
Although seven genes have now been identified which are susceptibility 
loci for open-angle glaucoma, some of which have been cloned in mice, no loci 
are currently associated with angle-closure glaucoma in mice or humans 
(Sarfarazi, 1997; Wirtz et al, 1998). The DBA/2J strain of mouse has been found to 
develop progressive open-angle glaucoma of a highly specialised type (pigment 
dispersion with iris atrophy) from around 4 months onwards, due to the 
interaction of two loci on Chr 4 and Chr 6 (John et al, 1998; Chang et al, 1999). 
This inbred strain of mice has therefore been mooted as a useful model for this 
disease and for the study of retinal degeneration in other forms of glaucoma.
The genetics of angle-closure glaucoma in hum ans are much less well 
described than the pathology and diagnosis of the disease. In hum an patients, the 
most common aetiological factor predisposing towards an acute attack of angle- 
closure glaucoma is the combination of a shallow anterior chamber and a narrow 
angle (Gorin, 1977). The genetics of this have been investigated for a number of 
years, and point to at least one major autosomal dom inant gene which 
significantly affects the depth of the anterior chamber and acts as a susceptibility 
locus for angle-closure glaucoma (Miller, 1970).
Peters' anomaly is a clinical condition which features corneal clouding and 
adhesions between lens, iris and cornea, often leading to glaucoma and cataracts.
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Since it has been found in association with several different genetic and 
nongenetic clinical syndromes, it is considered to be a morphological entity rather 
than a distinct clinical entity. In particular, it has been shown that mutations in 
Pax6 can cause a variety of different types of aniridia, some of which feature 
Peters' anomaly, but that, conversely, this gene is normal in most cases of Peters' 
anomaly (Churchill et al.f 1998). This leaves a large num ber of cases of this 
condition with a definite genetic component where the loci affected are unknown.
Since the genetics of angle-closure glaucoma are so poorly defined, the 
identification of a major locus in mice could provide useful data as a starting point 
for a genetic screen. Mapping this locus would perm it investigators to target the 
syntenic region when screening hum an DNA obtained from familial pedigrees 
involving this disease.
Consequently, as with the Harry mutant, m apping by FISH and linkage 
m apping using microsatellite PCRs was performed to determine the transgene 
integration site. Partly due to the poor breeding performance of the Holly line, no 
productive hemizygous intercrosses were available at the time the linkage 
mapping studies were carried out. A modified backcross protocol was therefore 
adopted, crossing hemizygous Holly males against non-transgenic C57/CBA Fi 
females. With no prior knowledge of which genetic background the transgene 
had integrated into, each transgenic pup tested from these crosses was effectively 
worth "half" a backcross offspring. It follows from this that twice as many 
offspring needed to be tested to reach statistical significance, compared to a 
standard backcross. In addition, only offspring of transgenic parents shown to be 




Initial FISH results clearly indicated that the transgene had integrated very 
close to the centromeric end of a long chromosome, although the G-banding was 
rather poor (data not shown). This led to preliminary assignment to either Chr 1 
or Chr 4. Subsequent G-banding experiments gave higher quality results and
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following successful FISH of these spreads, the transgene was deemed to have 
integrated into proximal Chr 1 (Figure 30).
The transgene was also shown not to have integrated into Chr 4 by double 
FISH. A genomic probe to distal Chr 4, consisting of some 15kb of genomic 
sequence from the Dvl (dishevelled) locus was differentially labelled and 
hybridised to metaphase chromosome spreads derived from a homozygote at the 
same time as the transgene probe. Although the background levels were very 
high in these experiments, examination of multiple spreads confirmed that the 
green transgene-specific signal lay on a discrete chromosome from the red Dvl 
signal on Chr 4 (Figure 31).
A Chr 1 specific probe was obtained, containing some 17kb of genomic 
DNA from distal Chrl cloned into phage lambda vector. Unfortunately, 
however, the phage stock failed to infect host bacteria, and no DNA could be 
obtained for use in FISH experiments.
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Figure 30. Transgene mapping by combined FISH and G-banding
a) G-banded metaphase chromosome spread from a homozygous H oll^ 
male with hybridisation sites arrowed following FISH with a transgene 
probe.
b) Corresponding FISH signals from the same spread shown in a). Two 
transgene signals are visible (arrowed).




Figure 31. Double FISH with a Chr 4-specific probe and the transgene
Two representative metaphase chromosome spreads from a homozygous 
Holly male with hybridisation signals (arrowed) corresponding to the 
transgene (green) and a Dvl probe specific to distal Chr 4 (red).
Figure 31
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Table 11. Microsatellite PCR genotyping results for Holly
Data gathered from hemizygous (+/-) transgenic male parents crossed with 
non-transgenic Fi females and from transgenic offspring of these crosses.
A n im al 
+ / - parents
Father D lM it6 6
gen otyp e
D 4 M itl0 1
gen otyp e
3.1Ac? n/a FI FI
3.2Ac? n/a FI FI
3.2Bc? n/a CBA FI
3.2Cc? n/a FI n/t
2.2 c? n/a FI n/t
+ / -  offspring
A l 3.1Ac? FI FI
A3 3.1Ac? CBA FI
A4 3.1Ac? FI CBA
A5 3.1A<? FI C57
A6 3.1A<? FI FI
A7 3.1Ac? CBA C57
A8 3.1Ac? FI FI
B1 3.2Ac? FI C57
B2 3.2 A<? CBA FI
B3 3.2Ac? FI C57
B4 3.2Ac? FI FI
Cl 3.2Bc? n/t C57
C2 3.2Bc? n/t FI
C3 3.2Bc? n/t FI
C4 3.2B<? n/t C 57
C5 3.2Bc? n/t CBA
E l 3.2Cc? FI n/t
E2 3.2Cc? CBA n/t
E3 3.2Cc? FI n/t
E4 3.2C<? CBA n/t
FI 2.2 c? CBA n/t
F2 2.2c? FI n/t
F3 2.2 c? FI n/t
F4 2.2c? FI n/t
F5 2.2c? CBA n/t
G1 3.2C<? FI n/t
G2 3.2Cc? FI n/t
G3 3.2Cc? CBA n/t
H I 2.2c? CBA n/t
H 2 2.2c? FI n/t
H3 2.2c? FI n/t
H 4 2.2c? FI n/t
H5 2.2c? CBA n/t
H 6 2.2c? CBA n/t
In form ative
m eio se s
29 16
n/a = not app icable n/t = not tested
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Linkage mapping
Based on the preliminary assignments of Chr 1 and Chr 4, two pairs of 
primers were chosen for the proximal region of each of these chromosomes. 
DlMit64 failed to amplify a specific product, even under a range of annealing 
temperatures, buffers and magnesium concentrations and this primer pair was 
abandoned. On Chr 4, all H olly parents tested with D4Mit263 were found to be 
CBA homozygous at this locus, and therefore this primer pair could not be used 
without first crossing Holly animals onto a C57 background to generate 
heterozygous parents. DlMit66 and D4Mitl01 were found to be both 
polymorphic between C57 and CBA, and to be heterozygous in some of the 
parents used in the backcross.
Since all useful parents are heterozygous at the locus tested, if there is no 
linkage between transgene and marker, then transgenic offspring should show a 
Mendelian distribution of 25% C57, 50% FI and 25% CBA. For statistical 
significance in a y} test, expected numbers in each class must be 5 or more, 
therefore at least 20 offspring must be tested.
Although the numbers for D4Mit263 were not sufficient for significance, it 
was clear from early results that both C57 and CBA homozygotes were present at 
this locus in numbers approximating to a Mendelian distribution, suggesting non­
linkage, whilst no C57 homozygotes were observed for DlMit66 amongst 
transgenic offspring. Further offspring were tested for DlMit66 alone. In total, 29 
transgenic offspring of doubly heterozygous parents were tested for this marker, 
resulting in 29 informative meioses. The data obtained for both loci are 
summarised in Table 11.
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Taking the null hypothesis to be that there is no linkage between the 
transgene and DlMit66, the data from 29 transgenic offspring can be summarised 
into a 1x3 contingency table thus:
Table 12. Contingency table for linkage betw een the transgene and 
DlM it66
C57 homozygotes FI CBA homozygotes '
Observed 0 18 11 £ = 29
Expected 7.25 14.5 7.25
Applying a simple y} formula, this gives: 
y} = 10.03
And for 2 degrees of freedom, this gives P < 0.01
The null hypothesis can therefore be rejected, and the transgene is probably linked 
to this marker and hence to proximal Chr 1.
Discussion
Candidate genes based on map position and phenotype
The results from the initial G-banding experiments were somewhat 
ambiguous, but the preliminary chromosomal assignment of the transgene 
integration site to the proximal end of either Chr 1 or Chr 4 allowed judicious 
choice of microsatellite primers. Chr 4 was eliminated by double FISH, and 
further G-banding experiments yielded high-quality results which strongly 
favoured proximal Chr 1. Linkage mapping using microsatellite PCR confirmed 
this map position, with statistically significant linkage shown between the 
transgene and DlMit66, which lies around 9cM from the centromeric end of Chr 
1. Since the num ber of offspring tested in the backcross was quite low (due to 
poor breeding performance), linkage to this marker is not particularly tight, 
however the FISH data places the transgene integration site very close to this
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region, somewhere in cytogenetic band A3. A linkage map of known genes in this 
region is shown below (Fig. 32).
Figure 32. Linkage map of proximal Chromosome 1.







































(Known human homologues are shown to the right, with their 
chromosomal positions.)
There are no genes known to cause any ocular phenotype in mouse in this 
region. Mouse chromosome 1 is syntenic to human chromosome 8q and 
chromosome 6q, with the syntenic breakpoint lying somewhere between Terfl and 
Col9al (Human-Mouse Homology Maps;
http://www.ncbi.nlm .nih.gov/Hom ology/, 1999). There are no loci known to 
cause either cataracts or glaucoma which map to either of these syntenic regions 
in humans, although the gene causing autosomal dominant Stargardt disease is
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known to lie in the syntenic region Chr 6ql3-15. This condition is restricted to 
retinal degeneration, however, and the causative gene has recently been identified 
as the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene (Felbor et al, 1998; 
Gehrig et al., 1998).
Of the genes shown in Figure 32, both Eyal and Col9al can be considered 
as reasonable candidates on the grounds that they might cause an ocular 
phenotype if disrupted, and these possibilities are discussed below. A third gene, 
Gripl, might be viewed as a candidate on the ground that it may be associated 
with non-insulin dependent diabetes. Since diabetes can cause glaucoma, Gripl 
must be considered as a candidate gene, and this is also discussed below in more 
detail. The other known genes in this region which have been discounted as being 
much less likely candidates are as follows: Egml represents the egg modifier 
locus 1, mapped using RI strain distribution patterns, which is involved in 
imprinting effects. Kcnb2 is a potassium voltage gated channel with neurological 
and smooth muscle functions, fz  (fuzzy) is a recessive m utation in an unknown 
gene giving rise to wrinked skin and frizzy hair. Oprkl encodes the opioid 
receptor kappa 1, which is thought, from its expression patterns in the brain, to be 
involved in the control of autonomic and neuroendocrine functions (Yasuda et al, 
1993). Ddx3 encodes a member of the DEAD-box (aspartate-glutamate-alanina- 
aspartate box) group of proteins, which are believed to act as RNA helicases. 
Ddx3 is believed to be the murine homologue of Xenopus An3, which is 
differentially expressed in the oocyte and is believed to play an im portant role in 
translational activation in the early embryo (Sowden et al, 1995). The exact 
function of Ddx3 is unclear at present, but it is known to be expressed abundantly 
during embryonic development and to show only low levels of expression during 
adult life, with expression being largely restricted to specific regions of the brain. 
The lack of known expression in the post-natal eye argues somewhat against 
disruption at this locus being responsible for the Holly m utant phentotype. tb 
(tumbler) is a mutation in an unknown gene giving rise to a neurological 
phenotype with locomotor dysfunction (Mouse Genome Database, 1999). Terfl 
encodes a telomeric repeat binding factor. bw5 and Obql are QTLs for body 
weight and obesity, respectively, which have been m apped but whose genes
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remain uncloned. Ptpnl8 encodes protein tyrosine phosphatase non-receptor type 
18, which is believed to play a critical role in the maintenance of the 
undifferentiated state of haematopoetic stem cells, but shows very limited 
expression outside the bone marrow in the adult mouse (Cheng et a l, 1996). 
Apart from Eyal and CoWal, all remaining loci shown in Figure 32 are either 
pseudogenes (suffixed with -rsN where N is some integer) or represent known 
retrovirus integration sites in various strains of mice(Mpmv42 and Pmv45).
Gripl as a candidate gene
Gripl encodes a glucocorticoid receptor interacting protein which interacts 
with the hormone-binding domain of the glucocorticoid receptor and may 
mediate its interaction with the nuclear transcription machinery (Hong et al, 
1996). It appears to be the murine orthologue of hum an TIF2 (transcriptional 
intermediary factor 2) (Voegel et al, 1996). Although no mutations at this locus 
have been identified, a closely related molecule, steroid receptor coactivator 1 
(SRC-1) has been knocked out by targeted deletion (Xu et al, 1998). This resulted 
in a mild phenotype in which target organs such as uterus, prostate, testis and 
mammary gland exhibited a mild decrease in organ growth in response to steroid 
hormones, hence the mice are considered to be partly steroid hormone resistant. 
It was also found that expression of Gripl/TIF2 was upregulated in the SRC-1 null 
mice, suggesting a degree of functional compensation by the former molecule in 
the absence of the latter. This might imply that disruption of the Gripl locus by 
transgene insertion would only result in a mild phenotype, due to functional 
compensation by SRC-1, but this cannot be asserted with confidence, as Gripl may 
perform roles which SRC-1 cannot compensate for.
It has been found that both Gripl and SRC-1 functionally interact with 
hepatocyte nuclear factor 4 (HNF-4), and mutations in this latter gene are known 
to cause type I mature onset diabetes of young (MODY), a form of non-insulin- 
dependent diabetes mellitus (Wang et al, 1998). Since the hypertension 
associated with some forms of diabetes can cause glaucoma, Gripl cannot be ruled 
out as a candidate gene. However, the secondary glaucoma associated with 
diabetes tends to be of the open-angle variety, and acute angle-closure is rarely, if 
ever seen in diabetics (Gorin, 1977).
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Although little is known about the expression pattern of Gripl, it is known 
that one of its cognate partners, Hnf4, is not expressed in the eye (Freeman et al, 
1998). Furthermore, given the functional redundancy between this gene and 
SRC-1, it seems likely that even if transgene insertion had entirely abolished Gripl 
function in Holly homozygotes, this would result in only a mild phenotype, 
rather than the dramatic acute onset glaucoma seen in these mice
Eyal as a candidate gene
A much stronger candidate gene is Eyal, one of four known mouse 
homologues of the Drosophila eyes absent (Eya) gene (Xu et al, 1997b; Zimmerman 
et al, 1997; Borsani et al, 1998).
The ancestral Drosophila gene, as the name suggests, is known to be an 
important regulator of eye development and encodes a transcription factor which 
acts immediately downstream of the "master regulator" eye gene, Eyeless or Pax6, 
and in tandem  with another gene vital for eye development, sine oculis (Cheyette 
et al, 1994; Xu et al, 1997b; Bonini et al, 1998). Murine Pax6 has been shown to 
functionally compensate for a lack of Eyeless in Drosophila, and the same has been 
shown to be true for Eya in experiments where the murine Eya2 cDNA was 
expressed in Drosophila eyes absent mutants (Bonini et al, 1997). As with Pax 
genes, Eya genes are highly conserved throughout evolution, and both ancestral 
gene families are thought to have been initally involved in functions not related to 
vision, with subsequent recruitment to the developing visual system (Duncan et 
al, 1997).
Continuing this theme of extreme conservation of developmental pathways 
in vastly disparate organisms, two murine homologues of sine oculis have been 
cloned, Sixl and Six2 and these homeobox genes have been shown to lie 
immediately downstream of Pax6, and to interact synergistically with Eya genes 
(Oliver et al, 1995; Bonini et al, 1998). The Pax-Six-Eya hierarchy is considered to 
be highly conserved throughout evolution, and is thought to play an important 
role in the development of the eye, from the early placode stage onwards (Xu et 
al, 1997a; Xu et al, 1997b).
Although at the time these experiments were performed there were no 
known mouse mutants of Eyal (but see Chapter 12 Discussion), it is highly
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conserved between mouse and fly and is known to be expressed in developing 
anterior chamber structures during murine eye development (Xu et al., 1997b). 
These include expression in the developing lens, ciliary body and prospective 
corneal ectoderm, precisely the structures most affected in H olly  mutants. In 
contrast, Eyal is expressed in more posterior structures during eye development, 
including the retina and the sclera. Eya3 is also expressed in the eye, although less 
is known about this gene, and still less about Eya4 (Zimmerman et al, 1997; 
Borsani et al, 1998).
All four genes lie on different chromosomes, and the first three genes also 
show expression in regions of the embryo other than the developing eye, with 
Eyal and Eyal thought to play important roles in the patterning of the tendons in 
the distal limb of the mouse and similarly, in the patterning of connective tissues 
in the developing avian limb (Xu et al., 1997a; Mishima & Tomarev, 1998). Eyal 
also shows significant expression in the developing kidney and inner ear.
Although no mouse mutants of Eya2 exist, as mentioned previously the 
gene can functionally compensate for a lack of the ancestral gene in the eyes absent 
m utant fly (Bonini et al., 1997). In addition, murine Eyal m aps very close to a 
known cataract locus, lop4 on Chr 2 (Duncan et al., 1997). Eyal is therefore likely 
to have an important role in eye development.
Given the expression pattern and the high degree of homology between 
Eyal and Eyal, it seems reasonable to suppose that Eyal might play an important 
role in murine eye development, and that disruption of expression of this gene by 
transgene insertion might give rise to the phenotype seen in H olly  homozygotes.
Arguing somewhat against this supposition is the accumulation of a weight 
of evidence concerning mutations in the hum an EYA1 gene. It has recently 
become clear that multiple independent mutations in this gene are responsible for 
familial and some sporadic cases of branchio-oto-renal dysplasia (BOR syndrome) 
(Abdelhak et al, 1997a; Abdelhak et al, 1997b; Vincent et al, 1997; Kumar et al, 
1998). An association between branchial arch defects and hearing loss has been 
recognised since the nineteenth century, but Melnick and colleagues identified 
associated renal defects in 1976, and BOR syndrome was formally classified as a 
clinical entity, featuring a pathognomonic triad of branchial arch, otic and renal
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abnormalities (Melnick et ah, 1976). The syndrome features incomplete 
penetrance and variable expressivity, concomitant with the large number of 
independent mutations (at least fourteen at last count) in the EYA1 gene 
(Abdelhak et al, 1997a; Abdelhak et ah, 1997b; Vincent et ah, 1997; Kumar et ah, 
1998). Hearing loss is common, as is renal agenesis or severe abnormalities of the 
collecting system, and these are consistent w ith the observed expression of EYA1 
in the developing ear and kidney (Kalatzis et ah, 1998).
However, despite the observed expression in anterior structures of the 
developing eye, this syndrome has no ocular component, which might suggest 
that EYA1 does not play a critical role in eye development. Balanced against this, 
however, is the fact that the investigators were specifically looking for mutations 
which cause BOR syndrome. It is possible that there are other mutations in the 
EYA1 gene which give rise to a quite different clinical set of symptoms, and that 
hitherto these have not been grouped along with BOR syndrome, hence the DNA 
from these patients has simply not been screened for mutations in the EYA1 gene.
In light of this, it is suggestive that a second clinical entitity, branchio- 
oculo-facial (BOF) syndrome, has been proposed to be genetically related to BOR 
syndrome, largely on the grounds of observed similarities in defects in the 
branchial arches in these patients, and sporadic renal abnormalities in patients 
classified as having BOF syndrome (Legius et ah, 1990; Fielding & Fryer, 1992; 
McCool & Weaver, 1994; Lin et ah, 1995b; Su et ah, 1998). The putative genetic 
overlap between BOR and BOF syndrome is hotly contested, however, and there 
are currently no genetics available for BOF syndrome which might support this 
hypothesis (Legius & Fryns, 1992; Lin et ah, 1992). The vast bulk of data on BOF 
syndrome resides in the realm of detailed clinical observation (Lin et ah, 1995a).
BOF syndrome, as the name suggests, does feature a variety of ocular 
abnormalities, including micropthalmia, coloboma, anopthalmia, myopia and 
cataract, and the broad range of these is consistent with multiple mutations in a 
transcription factor likely to regulate a number of processes during eye 
development such as EYA1 .
Both mouse and human Eyal are expressed in connective tissue precursor 
cells and in developing tendons along with Pax6 and Six genes, and the conserved
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Pax-Six-Eya hierarchy is thought to play an important role in connective tissue 
development, in addition to its critical role in eye and ear development (Oliver et 
al., 1995; Xu et al., 1997a; Mishima & Tomarev, 1998). Despite this, no peripheral 
connective tissue disorders have been observed in BOR syndrome. This could 
reflect functional compensation by other members of the Eya family, or might 
again point towards the restricted nature of the EYA1 mutations so far discovered 
in these patients.
A Japanese research group has recently presented a poster detailing a 
mutation in the EYA1 gene in three separate patients w ith congenital eye 
abnormalities, with one patient being classifed as having Peter's anomaly - a 
condition showing considerable overlap with the Holly m utant phenotype 
(Azuma et al., 1999). Although this work is as yet unpublished, if verified, it 
clearly allows for the possibility that mutations in murine Eyal might generate the 
phenotype seen in Holly mice.
Overall, despite the lack of any proven association between EYA1 and 
congenital eye defects, the mouse Eyal gene m ust be considered a good candidate 
for disruption by transgene insertion in the Holly transgenic line.
Col9al as a candidate gene
CoWal encodes the a l  chain of type IX collagen. The fibrils of type IX 
collagen, as with most collagens, are composed of triple helical heterotrimers of 
three genetically distinct subunits, the al(IX), a2(IX) and a3(IX) chains. 
Unusually, however, these triple helices are interrupted by non-collagenous 
domains, hence type IX collagen is classified as a member of the FACIT (fibril- 
associated collagen with interrupted triple helices) class of extracellular matrix 
proteins (Shaw & Olsen, 1991).
Individual type IX molecules contain three triple-helical sections, COL1, 
COL2 and COL3 interrupted by globular non-collagenous domains, designated 
NCI, NC2 and NC3 (van der Rest et al, 1985; Irwin & Mayne, 1986). In hyaline 
cartilage, assembled collagen type IX molecules are found attached at periodic 
intervals to the surface of type II collagen fibrils (consisting of bundles of cross- 
linked staggered type II collagen chains) with the long arm, comprising COL1, 
COL2, NCI and NC2 thought to lie along the surface of these fibrils, covalently
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crosslinked to the underlying type II collagen. The NC3 domain acts as a flexible 
hinge, so that the short arm, COL3 projects out from the surface into the 
perifibrillar matrix (Muragaki et al., 1990). The al(IX) chain has two alternatively 
spliced transcripts, encoding a long and a short form of the message, and the short 
form lacks the large amino-terminal globular domain NC4 (Muragaki et al., 1990). 
This is shown diagrammatically in Fig. 33
Figure 33. Structure of type IX collagen in association with a type II fibril




The alternatively spliced NC4 domain at the end of the projecting short 
arm is believed to interact with other, as yet unidentified, molecules, hence, type 
IX collagen, as with other members of the FACIT group, is believed to mediate 
interactions between collagen fibrils and other components of the extracellular 
matrix. This may provide the basis for anchoring and precisely positioning 
collagen fibrils within a three-dimensional matrix. In vitro studies with 
chondrocyte cell cultures have led to the suggestion that type IX collagen might 
act as a "spacer" to keep adjacent collagen fibrils from fusing together (Shaw & 
Olsen, 1991; Mallein-Gerin et a l, 1995). Apart from joints, type II and IX collagens 
are abundant in cartilage and in the vitreous of the eye (Swiderski & Solursh, 
1992; Liu et a l, 1993b).
Detailed studies of the expression patterns of these two transcripts revealed 
that, in the mouse, the long form was preferentially expressed in cartilage and
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lung, while the short form was preferentially expressed in the eye and heart 
(Muragaki et al, 1990; Liu et al., 1993a). Both transcripts are down-regulated 
around the time of birth, although low levels of message persist throughout adult 
life (Abe et al, 1994). This probably reflects a low turnover of type IX collagen 
fibrils during adult life.
The expression pattern of Col9al in the developing eye is particularly 
suggestive (Liu et al, 1993a). In situ hybridisation studies revealed that this gene 
(predominantly the short form) is first expressed at E10.5 in the neural ectoderm 
but not the surface ectoderm. This becomes restricted to the anterior neural retina 
by E13.5, but around the time of birth expression is dramatically up-regulated for 
a brief period of time. In the neonatal mouse, expression is exclusive to the inner 
non-pigmented layer of the presumptive ciliary epithelium. During the first three 
weeks post-partum, the ciliary epithelium becomes fully differentiated and 
becomes, of course, largely responsible for the production of aqueous (Gorin, 
1977). After this time, Col9al expression was found to be greatly reduced and 
entirely restricted (in the adult eye) to the junction between the folds of the 
mature ciliary body and the neural retina. By 6 weeks of age, expression was 
undetectable by in situ hybridisation.
Collagen IX fibrils are known to be present in the vitreous, which contains 
large amounts of extracellular matrix proteins, and it is tempting to speculate that 
the expression pattern of Col9al during embryonic development correlates with 
the production of vitreous to fill the globe (Yada et al, 1990).
Given the specialised and highly restricted expression pattern of Col9al in 
the ciliary body, it is reasonable to speculate that disruption of this gene by 
transgene insertion might have some effect upon either a structural element of the 
developing eye, such as the vitreous, or upon the m aturation of the ciliary body 
itself. In particular, such a defect might not give rise to any phenotype until 
around the time the eyes open and the aqueous flow becomes established, 
precisely the time of onset of glaucoma in H olly  mutants. This gene must 
therefore be considered as a very attractive candidate for transgene disruption.
Set against this hypothesis are detailed studies of the phenotype resulting 
from targeted deletion of the Col9al gene in mice (Fassler et al, 1994; Hagg et al,
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1997). Absence of the al(IX) chain leads to a functional knockout of the entire 
type IX collagen molecule, since the triple-helix cannot assemble without all three 
subunits being present. Homozygous null mutants are viable and appear normal 
at birth, but as they age, they develop a severe noninflammatory degenerative 
joint disease, which is considered to be a model for osteoarthritis in humans 
(mutations in the hum an COL9A2 gene, encoding one of the other subunits of the 
collagen IX heterotrimer, are known to cause multiple epiphyseal dysplasia 2, which 
progresses to include osteoarthritis (Briggs et al., 1995)). This accords well with 
the postulated role of collagen IX in maintaining the long-term structural integrity 
of cartilage, but since no opthalmopathy is present in Col9al-/~ mice, it argues 
against this gene being disrupted in Holly mutants.
Fortuitously, however, a second directed mutation of a slightly unusual 
nature was also generated in Col9al at around the same time that the conventional 
knockout experiment was being performed, and this m utant provides strong 
circumstantial evidence to support Col9al as a candidate gene for disruption in 
Holly mutants (Nakata et al, 1993). These researchers took a different tactic, and 
decided to generate a fnms-dominant form of the al(IX) chain which would 
interfere with the correct assembly of type IX collagen. To this end, they 
generated a transgene construct containing the al(IX) long form cDNA with a 
central deletion encompassing a large portion of the two major triple-helical 
domains and the flexible hinge region between them. This truncated form of the 
molecule, consisting of the regions amino- and carboxy-terminal to the central 
deletion, fused together in-frame, was driven by an upstream  collagen type II 
promoter, and had a collagen type II enhancer region placed immediately 
downstream. This m utant form of the al(IX) chain was predicted to act as a trans- 
dominant allele, interfering with the correct assembly of type IX collagen, and the 
authors showed that the severity of the phenotype observed correlated with the 
transgene dosage, suggesting that such was indeed the case.
Three transgenic founder mice were derived containing this construct, 
although it is perhaps not strictly accurate to call the single female a "founder", 
since she proved to be sterile, even after ovary transfer to wild-type female hosts. 
This female transgenic was also found to have opaque and irregular corneas when
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her eyes opened. The remaining two founder males appeared normal, but a 
number of Fi mice from both of these animals had somewhat small eyeballs.
Following incrosses between hemizygous Fi animals, some 15% of the F2 
generation were found to develop opaque and irregular corneas, which were 
sometimes infiltrated with blood vessels. The published photographs, although 
poor quality, suggest the presence of localised grey patches on the corneal surface, 
highly reminiscent of those seen in Holly mutants. These animals were assumed 
to represent transgenic homozygotes, although this was not proven. These 
putative homozygotes also showed mild proportionate dwarfism and had a mild 
ossification defect leading to ovoid vertebral bodies. Transgenic hemizygotes 
showed no overt skeletal or ocular abnormalities, but, as with the knockout 
mutant mice, tended to develop progressive osteoarthritis, most noticeably in the 
knee joint, with changes in the articular surfaces visible by light microscopy at 
around 6 weeks of age.. The final conclusion was that the transgene did act in a 
dominant fashion to disrupt assembly of type IX collagen, leading, in the 
hemizygous state, to a mild chondrodysplasia predisposing for early onset 
osteoarthritis, a condition closely resembling the phenotype observed in the 
knockout animals.
The ocular phenotype was not investigated in any great detail, hence it is 
impossible to say whether the corneal opacity was caused by glaucoma, as in 
Holly mice, or by some structural defect in the cornea. In this regard, the authors 
suggest that, in light of the fact that type IX collagen is not thought to be 
expressed in the cornea normally, it is possible that the use of the type II collagen 
promoter may have driven expression of the transgene in the cornea, leading to 
ectopic phenotypic effects in this region. Clearly, if this were to be the case, it 
would weaken the argum ent for Col9al being affected by transgene integration. 
However, no evidence was presented in support of this hypothesis.
Given the apparent similarity between the Holly phenotype and aspects of 
the phenotype seen in mice homozygous for the centrally deleted al(IX) 
transgene, the CoWal gene presents itself as an excellent candidate for transgene- 
associated disruption.
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Coll9al and Coll2al as candidate genes
Two loci not shown on the map in Figure 32 are Coll2aland Coll9al, both 
close relatives of Col9al, which encode the a l  chain of type XII and type XIX 
collagens respectively. Coll9al was initially isolated from a human 
rhabdomyosarcoma cDNA library, and has been m apped by FISH analysis in 
mouse and shown to lie very close to Col9al, w ith both genes localised to 
cytogenetic band A3 on proximal Chr 1 (Inoguchi et al., 1995; Khaleduzzaman et 
al, 1997).
While very little is known about this gene, type XIX collagen is also a 
member of the FACIT group, and in humans, shows significant expression in 
many basement membranes (Myers et al, 1997). In the mouse, initial ubiquitous 
expression during embryogenesis becomes restricted to strong expression in 
brain, eyes and testis of the adult (Sumiyoshi et al, 1997). Given its expression in 
the eye, this gene also cannot be ruled out as a candidate gene.
Similarly, although even less information is available, COL12A1 encodes 
yet another closely related FACIT collagen subunit, and maps very close to 
COL9A1 and COL19A1 on Chr 6ql2-13 in humans (Gerecke et al, 1997). 
Collagen type XII also has long and short alternatively spliced isoforms and is 
found in abundance in stroma of the cornea, where it is considered to play a role 
in the spacing of the fibrils and hence the maintenance of corneal transparency 
(Gerecke et al, 1997; Wessel et al, 1997; El Shabrawi et al., 1998). Intriguingly, 
COL12A1 is rapidly and reversibly upregulated at the mRNA level in response to 
mechanical stress (Trachslin et al, 1999).
Given that COL12A1, COL9A1 and COL19A1 are closely related and lie 
together, it has been suggested that all three genes arose by gene duplication 
(Gerecke et al, 1997). The murine homologue Colllal is known to be expressed in 
the cornea, and would present an excellent candidate gene were it not for the fact 
that it lies just beyond a syntenic breakpoint with respect to hum an Chr 6 and 
actually maps to mouse Chr 9 (Oh et al, 1992). It can therefore be discounted as a 
candidate for transgene disruption in Holly mutants.
As mentioned in chapter one, transgene integration can often lead to wide­
spread disruption around the integration site, and it is possible that multiple
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genes have been affected in Holly mutants. A compound phenotype involving 
both Col9al and another gene such as Coll9al might explain the observed 
differences between Holly mutants and the phenotype resulting from targeted 
mutations in the Col9al gene (Nakata et al., 1993; Fassler et al., 1994; Hagg et al., 
1997).
MyoC/TIGR as a candidate gene
It should be noted that the myocilin (Myoc) gene, also known as Trabecular 
meshwork-Inducible Glucocorticoid Receptor (TIGR) is one of the few well- 
characterised glaucoma susceptibility loci, and that this gene maps to distal Chr 1 
in the mouse (Tomarev et al., 1998). Although it lies some 83cM from the 
centromere, and therefore lies at least 70cM away from the site of transgene 
integration in Holly mice, long-range effects cannot be entirely discounted in 
cases of transgene-associated insertional mutation, although they must be classed 
as being of low probability, given the map distances involved.
Prolonged exposure to gluocorticoids such as dexamethasone has long 
been known to cause a rise in IOP associated w ith increased resistance to outflow 
of the aqueous. The TIGR gene encodes an extracellular glycoprotein which is 
expressed at very high levels by the endothelial cells lining the trabecular 
meshwork in response to prolonged exposure to dexamethasone. It has been 
proposed that the TIGR protein may become deposited in the extracellular spaces 
of the trabecular meshwork and impede aqueous outflow, although this remains 
contentious (Nguyen et al., 1998). Notwithstanding the fact that the exact 
function of the Myoc/TIGR gene is still somewhat obscure, mutations in the human 
gene are known to cause primary open-angle glaucoma, and may be responsible 
for at least 3% of cases of this condition (Adam et al, 1997; Stoilova et al, 1997; 
Stone et al., 1997; Stoilova et al, 1998). Although no known mutations in the 
mouse gene exist, the molecule is 82% conserved at the amino acid level between 
mouse and human, and in particular all fourteen residues where mutations in 
hum an TIGR can lead to glaucoma are conserved (Tomarev et al, 1998). 
Furthermore, the mouse gene is expressed in the correct regions (retina, iris and 
ciliary body) to play a role in glaucoma. It therefore seems highly likely that 
mutations in this gene could lead to glaucoma in the mouse. Circumstantial
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evidence to support this hypothesis comes from comparative sequencing of this 
gene in three inbred mouse strains with varying levels of "normal" IOP. The 
average IOP in C3H/HeJ, C57BL/6J and BALB/cJ strains is 13.7 , 12.3 and 7.7 
mm Hg respectively (John et ah, 1997). The latter strain has a significantly lower 
IOP than the first two, and also possesses an alanine residue at position 164, 
whereas C3H and C57 both have threonine. This residue is not affected in any of 
the known mutations in the hum an TIGR gene, however, and it is not known 
whether the observed polymorphism has any physiological significance 
(Tomarev et ah, 1998).
All the known mutations in humans are single amino acid substitutions 
predisposing to the relatively mild, or at least slow-onset, primary open-angle 
form of glaucoma. It is tempting to speculate that a more disruptive mutation in 
mouse MyoC such as truncation or complete ablation might have a dramatic effect 
upon the ultrastructure of the trabecular meshwork, and could lead to acute 
angle-closure glaucoma, but this remains conjectural pending a knockout 
experiment. Given the distance between the transgene and this locus, Myoc/TIGR 
must be viewed as a valid but low probability candidate gene.
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CHAPTER TWELVE:
HOLLY - NATURE OF THE TRANSGENE INTEGRATION EVENT
Introduction
With a firm map position for the transgene and two strong candidate genes 
in this region, it was decided to investigate the status of both Eyal and CoWal in 
Holly mutants at the molecular level by performing Northern blotting on total 
RNA from wild-type and m utant animals using appropriate probes.
Preparation of the probes and RNA proved quite time-consuming, so in the 
interim some preliminary analysis of kidneys in Holly m utants was undertaken 
on the grounds that mutations in Eyal (in BOR syndrome) and in collagen genes 
(such as mutations in type IV collagen in Alport's Syndrome) can cause renal 
defects. In addition, there exists clinical evidence for genetic links between 
nephropathy and closed angle glaucoma (Fiore et al, 1985).
In BOR syndrome, the renal abnormalities cover a broad spectrum, even 
within individual pedigrees, ranging from fairly subtle glomerular lesions, 
through megaureter (gross enlargement of the collecting system) up to bilateral 
agenesis in extreme cases (Melnick et al., 1976; Dumas et al, 1982).
Clearly Holly mutants do not feature renal agenesis, but a significant 
number of these mice showed reduced bodyweight, and breeding performance, 
even in hemizygotes, had been markedly poor. In the homozygotes, this could of 
course be secondary to distress caused by the ocular phenotype (since acute angle- 
closure glaucoma often causes considerable discomfort or pain in humans), but in 
hemizygotes, which have apparently unaffected eyes it m ight be due to partial 
renal dysfunction and attendant distress.
The Eyal gene
The complete structure of the hum an EYA1 gene has been determined, and 
consists of some nineteen exons spread over around 156kb of genomic DNA. 
(Abdelhak et al., 1997a). The overall size and exon-intron structure of the mouse 
Eyal gene appears to be similar, as revealed during an investigation of an 
interesting Eyal mouse mutant: A spontaneous mutation causing deafness and
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circling behaviour (most often associated with defects in the vestibular system of 
the inner ear) has recently been characterised at the molecular level, and proved to 
be due to the insertion of an intracisternal A particle (IAP) element into intron 7 of 
the Eyal gene (Johnson et al, 1999). This retrotransposed IAP element, of which 
around 2000 exist in the mouse genome, affects splicing and causes reduced 
expression levels and aberrant transcripts of Eyal. The resulting phenotype 
strongly resembles BOR syndrome in humans. The m utation is considered to 
provide a good model of BOR syndrome, and has been designated Eyalbor. It 
should be noted that no ocular anomalies were observed in Eyalbor m utant mice.
Furthermore, although the results were not published at the time these 
experiments were undertaken, a targeted null m utation of Eyal has now been 
generated (Xu et al, 1999). Heterozygous mutants showed hearing loss and renal 
abnormalities consistent with BOR syndrome, although the phenotype was 
somewhat milder than that seen in mice homozygous for the Eyalbor allele. No 
ocular anomalies were observed. Homozygous knockout mice entirely lacked 
ears and kidneys, and were born with open eyelids, although no detailed 
investigation of the eye was undertaken. Homozygotes died around the time of 
birth, however, long before any glaucomic phenotype could be discerned, even if 
such were present.
Alternative splicing generates different length mRNA transcripts in both 
humans and mice, and the probe generated to mouse Eyal by RT-PCR (see 
Methods) hybridised to two bands of approximately 4.3 and 2.9kb. The upper 
band is in accordance with published results from Northern blots of mouse RNA 
hybridised with probes derived from the 3'UTR of Eyal (Abdelhak et al, 1997b) 
and almost certainly corresponds to an Eyal signal. The lower 2.9kb band has not 
been previously reported and cross-hybridisation of the probe to another Eya 
homologue cannot be excluded. However, over the region of the Eyal mRNA 
used to generate the probe, the closest known homologue, Eyal, is 53% 
homologous at the nucleotide level, which would not be expected to generate a 
strong band at the stringency used in these hybridisations. Over the same region, 
Eya3 and Eya4 are 37% and 28% homologous to Eyal at the nucleotide level, 
respectively.
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The C ol9al gene
The gene itself contains 38 exons. The long form contains the large 
globular amino-terminal NC4 domain, which is encoded by exons 1-7 (Savontaus 
et al., 1998). The short form utilises an alternative promoter located in intron 6 to 
drive expression and entirely lacks the NC4 domain. The two isoforms of Col9al 
are very similar in size, hence although the probe pM Col9al-l (derived from 
exons 36-38 at the 3' end of the coding sequence) recognises both isoforms, only a 
single band at around 4kb is visible on hybridisation (Abe et al., 1994). The probe 
pMCol9al-2 (derived from exons 2-6) is specific for the long isoform.
The functions of the two different isoforms are unknown, although both 
forms are expressed in prechondrogenic mesenchyme and then differentially 
regulated thereafter (Abe et al., 1994). A detailed study of the two isoforms 
during mouse development revealed that in the perichondrium and periosteum of 
E14.5-E18.5 embryos (i.e. during cartilage condensation and differentiation) the 
long isoform was preferentially expressed in the cartilaginous anlage, whilst the 
short form was confined to the surrounding mesenchyme (Savontaus et al., 1998). 
In the eye, only the short form was detected, with expression in the vitreous, the 
ganglion layer of the retina, and weak expression in the lens. No signal was 
detected in the cornea or sclera at any stage of embryonic development, and no 
trace of the long isoform could be found. This is in marked contrast to the 
situation in the developing chick eye, where type IX collagen is believed to play a 
critical role. During avian corneal development, the acellular primary stroma 
swells and becomes populated by neural crest-derived mesenchymal cells which 
migrate in from the periphery. Type IX collagen is strongly expressed in the 
chick cornea, and stromal swelling correlates with proteolysis of the al(IX) chain, 
w ith loss of the NC4 domain essentially converting the long isoform to the short 
one, albeit post-translationally (Fitch et al., 1998). It has been suggested, although 
not proven, that this proteolysis changes the nature of the interaction of collagen 
fibrils with the ECM, allowing stromal swelling and the ingress of mesenchymal 
cells. Another study on chick has shown that the type IX collagen found in 
abundance in the vitreous contains only the short form of the al(IX) chain, which 
agrees with the in situ data from mouse (Yada et al., 1990).
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The function of type IX collagen was probed directly in mouse by two 
separate groups of researchers making directed mutations in the gene. The first of 
these consisted of the trans-dominant transgene construct mentioned in the 
previous chapter, consisting of a truncated form of al(IX) which interfered with 
the assembly of type IX collagen (Nakata et ah, 1993). Apart from the major 
component of the phenotype in these transgenic mutants, namely osteoarthritis, 
most intriguingly some 15% of the F2 generation - putatively homozygous for the 
transgene - developed opaque or irregular corneas, which were sometimes 
infiltrated with blood vessels. The authors offered no explanation, but suggest 
that, perhaps the use of the rat type II collagen prom oter/enhancer to drive 
expression of the transgene might have contributed to this aspect of the 
phenotype. They conceded that "the clarification of the eye phenotype....will 
need further study", but the only further reference in the literature to this mutant 
is a subsequent X-ray study on the joint and vertebral degeneration (Kimura et al,
1996), with the eye component of the phenotype seemingly dropped after the 
publication of Fassler et aVs paper the following year, when they generated a 
CoWal null allele (Fassler et ah, 1994). This group generated a targeted mutation 
in the gene and showed that no al(IX) chain was generated in homozygotes. 
They subsequently went on to prove that lack of this chain completely abolishes 
the assembly of type IX collagen i.e. that the other two subunits cannot 
compensate for the lack of the first (Hagg et ah, 1997). They also showed that the 
absence of type IX collagen in no way compromised fibrillogenesis in all tissues 
examined, and suggested that type IX collagen was primarily im portant for the 
long-term maintenance of tissue stability in certain cartilages. The knockout study 
performed by Fassler et al essentially backed up Nakata and co-workers with 
respect to the osteoarthritic phenotype, but they found no ocular anomalies, even 
though they were looked for.
Leaving aside the possibility that the corneal abnormalities seen in the 
earlier study were merely a result of ectopic expression of the transgene under the 
control of the type II collagen promoter, one plausible explanation for the lack of 
an ocular phenotype in the knockout mice lies in the strain backgrounds, and 
perhaps most particularly in the special nature of the C57BL/6 strain. Fassler et al
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made their knockout in ES cells, which are 129 derived, and following initial 
crosses of chimeric crosses to either BALB/C or C57BL/6, they proceeded to 
breed their knockout back onto a pure 129/Sv background. In contrast, Nakata 
and co-workers generated and maintained their transgenic line on a pure 
C57BL/6 background. Not only are these strains very distinct, but it has been 
known for many years that C57BL/6 mice spontaneously develop ocular 
abnormalities at low frequency.
Some 5-15% of C57BL/6 mice develop a range of ocular defects, including 
micropthalmia, anopthalmia, corneal opacity and cataracts (Pierro & Spiggle, 
1967). This was originally attributed to a delay in separation between the lens 
vesicle and the surface ectoderm, but more recently, studies using chimeric mice 
made by aggregation of embryos from C57BL6 and other strains have shown that 
the lens cells of C57BL/6 appear to be developmentally retarded (Robinson et al, 
1993). The lens appears to be able to catch up in growth later on, but on occasion, 
the abnormally small lens vesicle can become completely enveloped by the optic 
cup, leading to arrested development and micro- or anopthalmia.
Given this established defect in the C57BL/6 strain, it is possible that this 
might contribute additively to the Col9al m utation introduced by Nakata et al on 
this strain background, but not on the 129 background used by Fassler et al. In 
other words, that the defect in lens development in C57BL/6 acts as a modifier to 
enhance an ocular phenotype in Col9al mutants.
Results
Northern blotting
No detectable signal could be resolved with either Eyal or Col9al probes 
hybridising to RNA prepared from adult tissues, both m utant and wild-type 
(data not shown). However, RNA prepared from the head (both brain and 
surrounding mesenchyme, excluding eyes) and hindlimbs of E17 and E15 
embryos gave a strong signal with all three probes used (Figure 34). RNA 
prepared from kidney and eye gave only very weak signals, even though there 
was sufficient RNA to give a strong signal w ith GAPDH.
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Figure 34. Northern blotting of embryo RNA from Holly
hemizygous intercrosses
Band sizes: Eyal 4.3kb and 2.9kb
Col9al 3.5kb 
GAPDH 1.3kb
a) H olly 5.3 d  x 4.3 9 E17 em bryos (x 3)
1) R eference R N A  from  an E9 n on -tg  em bryo
2) H ead  R N A  from  n on -tg  E l 7 em bryo #1
3) H in d lim b  R N A  from  n on -tg  E l 7 em bryo #1
4) H ead  R N A  from  tg E17 em bryo #2
5) H in d lim b  R N A  from  tg  E l 7 em bryo #2
6) H ead  R N A  from  tg E l 7 em bryo #3
7) H in d lim b  R N A  from  tg  E l 7 em bryo #2
b) H olly 5.4c?x5.1 9 E l5 em bryos (x4)
1) H ead  R N A  from  tg E15 em bryo #1
2) H ead  R N A  from  tg  E15 em bryo #2
3) H ead  R N A  from  tg E15 em b ryo #3
4) H ea d  R N A  from  tg  E15 em bryo #4
5) H in d lim b  R N A  from  tg  E15 em bryo #1
6) H in d lim b  R N A  from  tg  E15 em bryo #2
7) H in d lim b  R N A  from  tg E15 em bryo #3
8) H in d lim b  R N A  from  tg  E15 em bryo #4
9) K id n ey R N A  from  tg E15 em bryo #1
10) K id n ey R N A  from  tg E15 em bryo #2
11) K id n ey  R N A  from  tg E15 em bryo #3
12) K id n ey R N A  from  tg E15 em bryo #4
13) Eye R N A  from  tg  E15 em bryo #1
14) Eye R N A  from  tg  E15 em bryo #2
15) Eye R N A  from  tg  E15 em bryo #3
16) Eye R N A  from  tg  E15 em bryo #4
c) H o lly  6.1 d  x6.4 $ E17 em bryos (x8)
1) H ead  R N A  from  tg E17 em bryo #1
2) H ead  R N A  from  tg E17 em bryo #2
3) H ead  R N A  from  tg E l 7 em bryo #3
4) H ead  R N A  from  tg E17 em bryo #4
5) H ead  R N A  from  tg E17 em bryo #5
6) H ead  R N A  from  tg E l 7 em bryo #6  
H ead  R N A  from  tg  E17 em bryo #7  
H ead  R N A  from  tg  E l 7 em bryo #8  
H in d lim b  R N A  from  tg  E17 em b ryo #1
10) H in d lim b  R N A  from  tg  E17 em bryo #2
11) H in d lim b  R N A  from  tg  E17 em b ryo #3
12) H in d lim b  R N A  from  tg  E17 em bryo #4
13) H in d lim b  R N A  from  tg  E17 em bryo #5
14) H in d lim b  R N A  from  tg E17 em b ryo #6
15) H in d lim b  R N A  from  tg  E17 em bryo #7
16) H in d lim b  R N A  from  tg E l 7 em bryo #8
Fig. 34
1 2  3  4  5  6  7
a * #  * H ' % . Eyal
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Referring to Fig 34a, the Col9al signal is entirely absent from the E9 
embryo, as predicted, since there is practically no connective tissue present at 
this stage. In addition, the signal seems to be reduced in the head RNA of 
embryo #3 (track 6). The Eyal signal (upper band) is present in all samples.
In Fig 34b, the Col9al signal (both isoforms) is greatly reduced in the head 
RNA of embryo #2 (track 2), while hindlimb expression remains unaffected 
(track 6). Kidney and eye show insignificant levels of expression of the gene at 
this stage, although it should be noted that less RNA was obtained from these 
tissues, as evinced by the GAPDH signal.
In Fig. 34c, although the signal obtained with the Col9al-l probe (both 
isoforms) is somewhat indistinct, embryo #2 shows a clear reduction in expression 
in head (track 2) but not hindlimb (track 10). This is confirmed with the cleaner 
result using Col9al-2 (long isoform), where again, embryo #2 shows a sharp 
reduction in head expression.
Eyal showed no difference in expression across all samples, but in some 
embryos CoWal showed a dramatically reduced level of expression in RNA 
prepared from the head. In total, embryos from three separate intercrosses were 
tested, and one embryo from each cross was found to show definite reduction in 
Col9al expression in head RNA (3/15 embryos). Eyal expression was examined 
in two of these three crosses and was not found to be affected (data not shown for 
one cross).
Renal histopathology
The kidneys of homozygous mutants were found to be visibly enlarged in 
some mice older than two months (3 out of 5 examined). Younger mutants (15-21 
days old) showed no obvious enlargement (4 examined). Sectioning and PAS 
staining of three grossly enlarged kidneys from separate mice and comparison to 
age-matched controls revealed that in the cortex, the glomeruli and Bowman's 
capsule appeared normal, but that the nephrons were grossly dilated, probably in 
the proximal convoluted tubules (Figure 35). The loop of Henle and the collecting 
apparatus appeared less affected, as the innermost region of the medulla 
appeared normal, although some dilation may have been present.
Figure 35. Renal histopathology
a) Sagittal section showing wild-type nephrons from a two m onth old 
wild-type female. PAS-Haematoxylin xlOO.
b) Sagittal section showing nephrons from a Holly homozygous m utant (2 
month old female) with a grossly enlarged kidney. PAS-Haematoxylin 
xlOO
c) Diagram of two types of nephron: juxtamedullary and cortical 
nephrons.
It should be noted that although the m utant kidney was significantly 
larger than the wild-type, the difference in size between the two regions 
shown in a) and b) is partly due to the oblique plane of section in b) which 
has rendered the m utant nephrons somewhat extended compared to the 
wild-type. The regions which can be seen in the photomicrographs from 
outside to inside are: the cortex, containing the glomeruli (glom) and some 
shorter cortical nephrons; the outer medulla, containing the descending 
and ascending limbs of the longer (and more numerous) juxtamedullary 
nephrons, along with collecting tubules; the inner m edulla, containing the 
thinner loops of Henle and where the collecting ducts (CD) come together 
to drain into the calyx and hence into the ureter.
PAS staining accentuates the proximal convoluted tubules (PCT) by 
virtue of staining their lumenal brush borders. The distal convoluted 
tubules (DCT), the descending and ascending limbs of the nephron in the 
outer medulla and the loop of Henle do not stain strongly with PAS. PAS 
also stains the basement membrane of the glomerulus.
In the mutant, grossly dilated structures can be seen in the cortex, 
and all have brightly stained lumenal surfaces, indicating that they are 
proximal convoluted tubules. The undilated tubules which can also be 
seen in this region lack strong PAS staining, suggesting that they are either 
distal convoluted tubules, collecting tubules or blood vessels. Little or no 
dilation can be seen in the inner medulla. Some dilated structures can be 
seen in the outer medulla, and these may correspond to the descending 
limbs (DL?), although without the diagnostic brush border found in the 
proximal convoluted tubules, this is unclear.
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Some dilation was visible in the outer medulla, probably corresponding to the 
descending limbs, but this was not as marked as that seen in the proximal 
convoluted tubules in the cortex.
Transgene copy number determination
This was performed exactly as discussed previously in chapter 7, with the 
same Kpnl digest giving separate transgene and endogenous reference bands. 
Although the structure of the array in the Holly genome was such that the 
transgene gave two major bands, both transgene signals were visibly fainter than 
the reference endogenous signal by the 8-9 copy dilution, indicating that probably 
between 5-10 copies of the transgene have integrated (Figure 36).
Figure 36. Holly transgene copy number titration
Southern blot of various dilutions of KpnI-digested transgenic DNA 
corresponding to discrete transgene copy numbers (shown above each 
lane) hybridised with a probe which gives a separate endogenous (endo) 
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It proved impossible to obtain a clear signal on Northerns using RNA from 
adult tissues, hence no defined mutants could be tested. 25% of the E15 embryos 
from hemizygous intercrosses should have been homozygous, and the number of 
embryos (3/15) showing a definite reduction in the Col9al signal in head 
mesenchyme was consistent with this ratio.
In principle, the known polymorphism at DlMit66 could have been used to 
assign genotypes to the E15 embryos. Crossing two mice which were each 
heterozygous at this locus would be informative, since embryos homozygous for 
the CBA allele would most likely also be homozygous for the transgene. 
Unfortunately, all parents of breeding age were genotyped and no heterozygous 
mothers could be found at the time these experiments were performed (data not 
shown).
Eyal
Given that Eyal expression was unaffected in two litters, each of which 
contained one sample showing a substantial reduction in Col9al expression, and 
given that Eyal lies at some distance from CoWal (some 5cM on the linkage map), 
it seems reasonable to conclude that the transgene integration has disrupted 
Col9al, but has left Eyal unaffected.
It might seem, in light of the Eyal knockout mouse showing no ocular 
abnormalities, that Eyal can safely be discounted from playing a critical role in 
eye development (or at least a role which cannot be functionally compensated for 
by another gene), but if the findings of Azuma and co-workers with respect to 
mutations in EYA1 in hum an patients with developmental eye anomalies are 
verified, then other alleles of Eyal might yet be found to give rise to an ocular 
phenotype in mouse (Azuma et aL, 1999).
Transgene integration
The exact nature of the integration event remains unclear. The presence of 
multiple strong bands on the Southern blot shown in Fig. 36 points towards a
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complex integration, although the array was not restriction m apped during the 
course of this study. CoWal has a large and complex gene structure, with some 38 
exons spread over around 56kb of genomic DNA. (Savontaus et al., 1998). The 
fact that wild-type levels of both isoforms of CoWal are expressed in embryonic 
hindlimbs argues against disruption of the coding sequence. This suggests that 
the transgene might be acting to perturb regulation of the gene, perhaps by 
disruption of tissue-specific enhancers.
Col9al in the eye
The lack expression of CoWal in RNA from the eyes of E15 embryos, or 
indeed of documented expression of CoWal in the developing mouse cornea 
should not necessarily be taken as a sign that transgene-associated disruption to 
this gene could not be responsible for the phenotype. Firstly, although a 
significant amount of RNA (around lOpg) was obtained from the eyes of a single 
embryo, the vast bulk of this RNA could be from cells which simply do not 
express CoWal, such as the neuroectoderm. The actual CoWal expressing moiety 
could be a small fraction of the total, reducing the chances of detecting any signal 
on Northerns from single embryos. The published in situ data suggests that the 
short form only is expressed in the vitreous and in the posterior lens (Savontaus 
et al., 1998). There is no data on expression of CoWal in post-natal mouse eyes, 
and given that this is precisely the time when the aqueous outflow pathway is 
being set up, it might be predicted that type IX collagen is only expressed in the 
cornea post-natally. Although type IX collagen is clearly important for the 
development of the embryonic avian cornea the timing of mouse and chick eye 
development is quite different.
Osteoarthritis
The fact that Holly homozygotes do not develop osteoarthritis can be 
explained by the observation that wild-type levels of CoWal are expressed in the 
hindlimbs. Of course, it is not certain that Holly m utants entirely lack joint 
defects, since these were not looked for, and could be relatively subtle. A few 
animals did show slight dwarfism, an observation made by Nakata et al with 
respect to their transgenic m utant (Nakata et al, 1993).
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Renal defects
Although renal pathology is complex and difficult to interpret, the overall 
picture pointed towards severe dilation of the ascending and descending limbs of 
the nephrons, perhaps caused by fluid retention, but featuring relatively normal 
glomeruli. This is important, because compromise of Bowman's capsule 
(glomerulonephritis) is one of the pathological hallmarks of Alport's syndrome, a 
multifactorial genetic disease featuring hematuria (blood in the urine), 
sensorineural hearing loss, progressive renal failure and frequently ocular defects 
such as lenticonus (anterior bulging and dysmorphology of the lens), cataract and 
retinal abnormalities (Colville & Savige, 1997). The autosomal recessive forms of 
the disease are frequently caused by mutations in either COL4A3 or COL4A4, 
components of type IV collagen and the sex-linked form of the disease is caused 
by mutations in COL4A5 (Kalluri et al.r 1994). Essentially, Alport's Syndrome 
features, to a varying degree, defects in basement membranes found in glomeruli, 
the inner ear, the retina and the lens capsule. The lens capsule abnormalities are 
quite distinct from that seen in Holly, and this appears also to be true for the renal 
defects, but the point stands that mutations in a single collagen subunit can lead to 
characteristic defects in a range of structures dependent upon basement 
membrane integrity (Streeten et ah, 1987).
It is unclear whether Holly heterozygotes have similar renal problems, 
although the poor breeding performance points either towards reduced fertility or 
towards some form of stress. The latter explanation is supported by the 
observation that, in two of the three crosses utilised for the Northern experiments, 
the mothers were found to contain several resorbed embryos upon dissection, 
resulting in only three or four live embryos.
C oll9al
Returning to the differences between Holly mutants and the documented 
lack of an ocular phenotype in CoWal null mice, another possible explanation is 
that the transgene integration has also disrupted a neighbouring gene. There is in 
fact, an attractive candidate gene for such an event - Coll9al encodes the a l  
subunit of type XIX collagen, and this gene is known to sit somewhere fairly close 
to CoWal. Type XIX collagen, although poorly-characterised, is another FACIT
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collagen with initial expression throughout the mouse embryo at E ll, with 
expression subsquently restricted to certain tissues in the adult, specifically brain, 
eye and testis (Sumiyoshi et al.r 1997). In humans, expression of type XIX collagen 
has been shown to be largely confined to basement membranes in a wide variety 
of organs (Myers et al., 1997).
It has been suggested that CoWal and Coll9al arose by tandem  duplication 
of the same gene, as the hum an homologues of these two genes also map to the 
same syntenic region, Chr 6q (Yoshioka et al, 1992). Not only does Coll9al lie 
next to CoWal in both mouse and human, but analysis of the hum an gene 
sequences has led Khaleduzzaman et al to support the hypothesis that the two 
genes arose by tandem duplication of an ancestral FACIT collagen 
(Khaleduzzaman et al, 1997). The hum an gene is large and complex, spanning 
over 250kb of genomic DNA, and has an unusually large (>10kb) mRNA 
transcript, with numerous splice variants (Gerecke et al, 1997; Sumiyoshi et al,
1997). The significance of this is unknown, as the translated region is relatively 
small.
Although detailed expression studies have not been performed, it is 
possible that Coll9al plays a role in murine eye development. The possibility 
therefore cannot be excluded that the ocular phenotype seen in Holly mutants is 
caused by disruption to Coll9al, or to both collagen genes.
Summary
Holly transgenic homozygotes appear to show tissue-specific reduction of 
both isoforms of the CoWal gene. The question of whether the ocular phenotype 
seen in Holly mutants is actually caused by a reduction in CoWal remains 
somewhat of a moot point.
The data from the Northerns argues in favour, however the knockout study 
of Fassler et al argues that a complete lack of CoWal does not compromise eye 
development, at least in the 129/Sv strain (Fassler et al, 1994). Holly transgenic 
mice are maintained on a somewhat mixed background, comprising C57BL/6 and 
CBA to varying degrees, and it is entirely possible, given the known defects in 
C57BL/6 lens development and the fact that Nakata and coworkers did see an 
ocular phenotype in a CoWal m utant on their C57BL/ 6 background, that the strain
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background combined with a tissue-specific reduction in CoWal generates the 
phenotype in Holly mice.
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CHAPTER THIRTEEN:
HOLLY - FINAL DISCUSSION
Future work
Nature of the transgene integration
Restriction mapping of both the transgene array and the CoWal genomic 
region is required to shed some light on the exact nature of the disruption at this 
locus. While more precise genetic mapping of the transgene is possible with the 
use of additional markers and a larger backcross, CoWal has only been mapped 
with respect to three other genes in proximal Chr 1 with a 114-mouse Spretus 
backcross panel, hence no accurate data (<lcM) exists to link CoWal to any genetic 
marker, such as a microsatellite (http://www.inform atics.jax.org, 1999). If no 
polymorphism were found in or around the CoWal gene with respect to Holly 
transgenic mice, then having an accurate position on the linkage map for the 
transgene would not be of any great benefit, as a chromosome walk would still 
have to be performed moving away from CoWal in both directions.
Gene expression
While knowing where the transgene has integrated with respect to CoWal 
is important, probably more pressing is determining the expression pattern of 
both isoforms in the developing mouse. The expression of CoWal is maximal 
between E12 and E15 (depending on the isoform) (Perala et al, 1997). It is 
technically difficult to perform wholemount in situ on mouse embryos after E12.5, 
but it would be most informative to serial section embryos first, then perform in 
situ hybridisation and examine the temporo-spatial expression of each isoform in 
Holly mutants. A detailed study of the expression pattern of this gene in wild- 
type mouse embryos has already been published and would provide a useful 
reference series for such a study (indeed, the pM Col9al-l and pMCol9al-2 probes 
used in this work were a gift from the authors) (Savontaus et al., 1998).
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Status of type XIX collagen (Coll9al)
As discussed in the previous chapter, one reason for the observed 
discrepancy between Holly mutants and CoWal knockouts might be that the 
adjacent Coll9al locus has also been affected by the transgene, and that altered 
expression of type XIX collagen might account for the ocular phenotype. It would 
therefore be important to obtain a probe and establish whether the expression of 
this gene is affected in mutants, by Northerns or in situ.
Type IX collagen deposition
Given that the aqueous outflow pathway forms and differentiates post- 
natally, it would probably be more informative to examine gene expression in 
eyes and possibly kidneys from post-partum  days P0-P12 mice, rather than 
embryos. Unfortunately, expression of the gene declines after birth, reflecting the 
low rate turnover of collagen in connective tissues, but even if in situ failed to 
reveal gene expression patterns, it m ight still be possible to examine type IX 
collagen using immunohistochemistry. Commercial antibodies are available, but 
the only isoform-specific ones are two mouse monoclonals which presumably do 
not recognise mouse type IX collagen. Although it m ight not be possible to 
dissect out the expression of each individual isoform of CoWal, therefore, it should 
be feasible to study the expression and deposition of the protein throughout 
embryonic and post-natal development.
Complementation with other CoWal mutants
Another possible explanation as to why CoWal knockouts show no ocular 
phenotype refers to the strain background on which the knockouts were 
maintained. To re-iterate: the trans-dominant truncated al(IX) transgene on a 
C57BL/6 background gave rise to an ocular phenotype which superficially 
resembles that seen in Holly mutants (Nakata et al., 1993). In contrast, the 
targeted null on a 129/Sv background showed no ocular phenotype, even though 
this was looked for (Fassler et al, 1994). It might prove informative to cross Holly 
hemizygotes with CoWal-/+  heterozgotes to see if the transgene insertion 
complements the targeted null allele.
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Another, equally interesting experiment, would be to simply introgress the 
transgene onto purebred strain backgrounds - C57BL/6 and CBA would be 
logical choices to see if the phenotype is greatly exaggerated on the C57BL/6 
background. This would, however, require at least 5 generations of backcrosses.
Osteoarthritis
The logical corollary to the question of why CoWal knockout mice lack an 
ocular phenotype is to ask whether Holly mutants develop osteoarthritis through 
damage to the articular cartilage or show changes in the vertebral bodies. This 
could be addressed most easily by allowing some mutants to go to advanced age 
(9 months being sufficient time to show considerable alteration in the joints of 
CoWal knockouts) and then sectioning knee joints and spines for histology. In 
light of the apparent wild-type levels of expression of CoWal in RNA from the 
hindlimbs of presumptive m utant embryos, it may well be the case that Holly 
mutants show little or no change in articular cartilage
Histopathology
In tandem with gene expression studies, it will be im portant to track the 
pathological progression of this mutant phenotype from birth onwards by simply 
sectioning eyes and kidneys from a series of m utant mice ranging from P0 up to 
full adulthood. Of particular interest will be whether the lens becomes displaced 
and moves forwards to contact the iris (pupillary block angle-closure) or whether 
the iris or cornea is misplaced and adheres to the lens. In addition, if a temporal 
series of PAS stained sections through the cornea were to be assembled, it should 
prove straightforward to determine whether Descemet's membrane is 
compromised before the onset of the phenotype or whether the corneal 
endothelium degenerates as a secondary consequence of prolonged glaucoma and 
presumptive hypoxia in the regions of contact between cornea and lens. This 
question is of considerable interest, since attenuation or absence of Descemet's 
membrane is pathognomonic for Peters' Anomaly (Kanski, 1994; Schottenstein, 
1996).
The renal histopathology is suggestive of some dysfunction in the nephron, 
but this needs to be tracked through different stages of development as for the
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ocular pathology. In addition, assaying for urea nitrogen in serum is a useful 
marker for renal stress and blood samples could be taken for assay at the same 
time as samples are collected for histology.
Animal modelling of glaucoma
Current animal models of glaucoma can be divided into two classes: 
spontaneous and iatrogenic (i.e. arising from treatment of a wild-type animal). 
True inherited glaucomas are relatively rare in animals, but are particularly 
common in certain breeds of dog (cocker spaniels, Basset hounds, St Bernards and 
others). These have the disadvantage that the phenotypes generally take several 
months to manifest and such large animals are expensive to keep in any quantity 
(Chew, 1996). The New Zealand White rabbit also carries a semilethal autosomal 
recessive allele involving both ocular abnormalities (buphthalmos i.e. grossly 
enlarged eyes, outflow pathway defects) combined with systemic abnormalities, 
which give rise to high mortality in this strain (Hanna et al., 1962; Chew, 1996). 
More recently, a genetically isolated colony of rhesus monkeys was found to have 
a high incidence of chronic open-angle glaucoma (Dawson et al., 1993). Apart 
from the expense and difficulties in keeping and handling such large primates, 
these provide an excellent model for glaucoma in humans, since the outflow 
pathway is considered to be much more similar to hum ans than that seen in lower 
animals.
Albino (Al) mutant quails (Cotumix cotumx japonica) carry a sex-linked 
recessive trait leading to bupthalmos and acute angle-closure glaucoma by around 
6 months of age (Takatsuji et al, 1986). The phenotype bears some similarity to 
that seen in Holly mutants, with thickening of the lens, cataract formation, angle 
closure and anterior synechiae. After about one year, corneal oedema, optic disc 
cupping and retinal ganglion cell degeneration are all apparent (Takatsuji et al, 
1988). Thus, at least superficially, the progression of the phenotype in these birds 
seems to mirror that seen in Holly mice, apart from the timing. This strain of 
quail appears to have been somewhat under-utilised in glaucoma research, 
although there exists a body of work concerning the relationship between retinal 
dopamine metabolism, the day-night cycle and the progression of this mutant 
phenotype (Dkhissi et al, 1996; Dkhissi et al, 1998; Dkhissi et al, 1999).
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Glaucoma can be induced in most species of animal artificially by a variety 
of techniques, mostly relying on mechanical blockage of the outflow channels. 
This can be achieved by the injection of various substances into the anterior 
chamber, or, in a more sophisticated manner, by high energy argon laser 
photocoagulation of the trabecular meshwork in monkeys. Other methods 
include the administration of steroids to American cocker spaniels bred for 
susceptibility to glaucoma, and, bizarrely, exposing Japanese quail chicks (and 
certain other species of chickens and turkeys) to continuous daylight during 
rearing results in so-called light-induced avian glaucoma (LIAG) (Lauber & 
Cheng, 1989; Chew, 1996). LIAG is quite distinct from the angle-closure glaucoma 
seen in the aforementioned albino m utant quails.
Traditionally, argon laser trabeculoplasty of rhesus monkeys has been 
widely used to study the effects of chronic IOP elevation. However, the expense 
and also the dwindling supply of these animals preclude their use in large-scale 
studies. Also, the need for frequent IOP measurements, preferably in an 
unanaesthetised state (since general anaesthesia can significantly alter IOP) 
further weighs against the use of primates. One recently developed animal model 
of glaucoma involves the scarring of the outflow pathway in rats by the injection 
of hypertonic saline into the episcleral veins (Morrison et al., 1998). This model 
has significant advantages of both cost and ease of handling, since rats are 
sufficiently docile that their IOP can be measured by the non-invasive use of a 
TonoPen ultrasound tonometer using topical anaesthesia. The saline regime 
administered was shown to regulate the duration and degree of elevation of IOP, 
and furthermore, the administration of glaucoma drops (p-blockers) was shown to 
control IOP and prevent optic nerve damage. This system represents an excellent 
model for chronic open-angle glaucoma, therefore, although it does require some 
skill and specialised equipment for the injection of saline.
Mice have been a somewhat under-exploited resource in glaucoma 
research until recently, since despite the vast wealth of genetics available, only 
one defined inherited condition leading (on occasion) to glaucoma had been 
described: the corneal opacity observed in some older C57BL/6 mice and
discussed in more detail in the introduction to the previous chapter (Pierro &
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Spiggle, 1967). However, with the superb recent characterisation of heritable 
open-angle glaucoma in the DBA/2J strain of mice at both the pathological and 
molecular level, this deficit has been amended (John et al., 1998; Chang et al., 
1999). The advent of the DBA/2J model, coupled with the recent finding that the 
ultrastructure of the murine outflow pathway is more similar to that found in 
humans than had previously been thought, linked to the more obvious benefits of 
the mouse as a model animal, may lead to a rise in status of the mouse in 
glaucoma research (Tamm et al., 1999).
In light of current progress in the use of mice as a model organism for the 
study of glaucoma, the Holly transgenic line might also prove useful in this 
regard.
Anti-glaucoma drug therapy
Another interesting possibility is whether the progression of the 
phenotype, particularly the retinal degeneration, could be delayed using anti- 
glaucomic drugs. This depends upon the phenotype showing a reproducible, 
consistent timecourse, which could be determined by referring to the temporal 
series of eye sections mentioned above. It will be particularly im portant to study 
the retinal degeneration during the first two to three months, since most retinas 
examined after this point showed very severe degeneration, whereas the earlier 
samples (18 day) showed little or no change.
Most anti-glaucoma drug therapy centres around lowering IOP, either by 
lowering the induction of aqueous (p-blockers and carbonic anhydrase inhibitors) 
or by increasing the outflow capacity (miotics) or both (sympathomimetics such as 
adrenaline) (Kanski, 1994). These drugs are generally effective in treating open- 
angle glaucoma.
Closed-angle glaucoma is a medical emergency requiring surgery, and 
given the severe nature of the angle-closure glaucoma in Holly mice, it seems 
unlikely that simply lowering IOP by administration of drug therapy would 
significantly retard the progression of the phenotype. However, recent work has 
shown that a-adrenergic agonists such as clonidine, which are routinely used to 
lower IOP might have a protective effect against the secondary neurodegeneration 
seen in glaucomic retinas (Yoles et al., 1999). This secondary degeneration
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continues, with consequent further loss of vision, in glaucomic patients whose IOP 
has been returned to safe levels. It is believed to be caused by the release of 
cytotoxic substances following the primary insult to ganglion cells under 
conditions of raised IOP, and this parallels the situation seen in traumatic injuries 
to the CNS, where neurons adjacent to the site of traum a are seen to degenerate 
for some time afterwards. The a2-adrenoreceptor agonists clonidine and 
dexmedetomidine are known to ameliorate such secondary neurodegeneration 
following cerebral ischaemia (i.e. strokes), and when tested in a rat model of optic 
nerve degeneration (by unilateral crush injury to the optic nerve) were found to 
exhibit the same neuroprotective effect.
In all likelihood, the crush injury inflicted in the study by Yoles et al does 
not accurately reflect the neurodegenerative syndrome found in glaucoma, and it 
remains an open question as to whether such drugs might retard the progression 
of retinal degeneration in a glaucomic eye. If Holly m utant retinas degenerate in 
a reproducible fashion, this could provide a useful model system for testing such 
drugs.
In the Al m utant quail model of glaucoma, it is interesting to note that the 
presence of high glutamate levels in the vitreous correlates with the presence of 
TUNEL-positive apoptotic retinal ganglion cells (Dkhissi et al, 1999). Glutamate 
is considered to be an excitotoxic amino acid with respect to nerve cells, and this 
may underly the observation that even ganglion cells dying by apoptosis in 
glaucomic eyes cause secondary death of nearby cells. It m ight therefore prove 
interesting to examine the apoptotic status of the retinal layers in Holly mutants, 
and to test the vitreous for the presence of glutamate.
Conclusion
In summary, Holly homozygous transgenics develop closed-angle 
glaucoma as a probable consequence of the transgene integrating close to the 
CoWal locus and disrupting expression of this gene in a tissue-specific manner. 
Although a number of questions remain to be answered, particularly with respect 
to the early ontogeny and the reproducibility of progression of the mutant 
phenotype, the Holly line is potentially an important and useful model of angle- 
closure glaucoma.
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Once the precise nature of the pathology arising in Holly m utants has been 
established, it may well prove worthwhile to try and correlate this with hum an 
congenital glaucomas, such as Peters' Anomaly, and hence to test appropriate 
patients for mutations in COL9A1. Thus Holly may also shed light on the 




Overall, the screen of some 55 transgenic lines represents one of the largest
screens of this nature performed so far, and has to date revealed five bona fide 
transgenic insertional mutations representing a hit rate of -10%, in accord with 
previously published figures (Meisler, 1992). The mapping strategy employed, 
comprising FISH, followed by confirmation and fine m apping using linkage to a 
few PCR-based microsatellite markers is proposed as a good strategy for small 
laboratories unequipped for a full-genome linkage scan. This is made possible by 
virtue of the transgene's nature as a unique, multicopy sequence-tagged site at a 
locus closely linked to the m utant phenotype.
However, of the two mutations selected for characterisation in this study, 
both turned out, in all likelihood, to be mutations in previously characterised 
genes with existing mutant alleles.
In the case of SoxlO, the Harry m utant phenotype adds little that was not 
already known about the role of this transcription factor in a subset of neural crest 
cells during development. On the other hand, the transgene provides a useful tag 
for studying the effects of the m utant allele in wild-type tissue, and vice-versa.
The recessive nature of this mutation makes it easier to maintain stocks as 
compared to SoxlODom, particularly on backgrounds where SoxlODom causes 
lethality before breeding age. In addition, the nature of this m utation is such that 
further investigation could reveal upstream  regulatory elements of SoxlO. Finally, 
the more severe and varied nature of the coat colour aspect of the phenotype 
compared to existing alleles may allow some outstanding questions about the 
nature of melanocyte development to be tackled.
In the case of CoWal, the investigation of the Holly phenotype has raised as 
many questions as it has answered. However, it is clear that, regardless of the 
exact nature of the mutation, this line represents the only known model of acute 
closed-angle glaucoma in a genetically-well defined system, and as such, may be a 
useful resource for future research. In addition, given the lack of disruption to the
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coding region of CoWal, this mutation may also help define regulatory elements of 
this gene.
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APPENDIX A: CHI-SQUARED ANALYSIS
The formula used to perform y} analysis to determine the likelihood of 
linkage between the transgene and a recessive m utant trait was taken from Silver 
(1995). All four classes must have expected values greater than 5, permitting the 
use of the formula:
{a + b)(c + d)(b + d)(a + c)
Where a,b,c and d are the four observed values in the table, n is the total 
number of animals and \ad-bc\ means the absolute, i.e. positive, value of the 
difference between ad and be. This formula has the advantage that it contains a 
correction for continuity (Yates correction) w ithout which 2 x 2  tables can give 
values of y} which are too large (Bailey, 1981).
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APPPENDIX B: CONFIDENCE LIMITS AND MEDIAN ESTIMATES OF LINKAGE 
DISTANCE
Confidence limits and median estimates of linkage distance in the special 
case of no recombinants were derived from the tables in Appendix D of Silver 
(1995). Additional calculation of other confidence limits and linkage distances 
was performed using Genelink V2.0 software (Xavier Montagutelli, 1998) which 
was downloaded from:
f tp: /  /  ftp. pasteur.fr /  pub /  GenSoft /  MSWindows /  linkage_and_mapping/ GeneLink /
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